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Abstract 
Laminin alpha 1 (LAMA1) is a major component of the earliest basement membranes in the 
mammalian embryo. Disruption of the murine Lama1 gene result in lethal failure of germ layer 
differentiation and extraembryonic membrane formation at gastrulation stages, while conditional 
deletion of Lama1 leads to aberrant organization of retinal neurons and vasculature, and defects in 
cerebellar glia and granule cell precursors later in development. Similarly, inactivation of lama1 in 
zebrafish affects lens, retina and anterior notochord development. This diverse range of phenotypes in 
Lama1-deficient animals reflects the complexity of its expression pattern during embryogenesis, 
which is largely conserved among vertebrates. Major sites of Lama1 transcription in the mouse 
embryo are the neural tube, presomitic mesoderm, somites, nephrogenic mesoderm, head 
mesenchyme and the lens. However, little is known about the signaling mechanisms governing the 
spatio-temporal control of Lama1 transcription. Previous studies in our lab revealed a requirement for 
SHH signaling in the transcription of Lama1 in the somites and neural tube of mouse embryos. 
Therefore, I hypothesized that SHH might directly modulate Lama1 expression via the binding of 
GLI transcription factors to regulatory regions in the Lama1 locus.  
In this study, I identified a cis-regulatory element that may be involved in the SHH-dependent 
control of Lama1 expression in the murine embryo. I began my study with a phylogenetic footprinting 
approach that uncovered 25 conserved non-coding elements upstream of the murine Lama1 locus, 
some of which contained GLI binding motifs. Subsequent luciferase reporter-based analysis in cell 
culture with a subset of the CNEs did not provide convincing evidence for enhancer- and/or silencer-
like properties of the elements, except for CNE7. The CNEs were further characterised using an in 
vivo transgenesis reporter screen in zebrafish, which uncovered a skeletal-muscle specific regulatory 
region. In parallel, a detailed survey of the existing literature revealed the presence of a non-
conserved GLI-occupied region in intron 1 of the murine Lama1 gene. Subsequently, I showed that 
this element behaves as a tissue-specific enhancer driving reporter expression in the neural tube of 
mouse and zebrafish embryos. I provided evidence that active Hh signaling is required and sufficient 
for the activity of this enhancer. Finally, I demonstrated that the GLI binding motifs within the 
element are essential for its function. Altogether, these results suggest that SHH may directly control 
Lama1 transcription in the mouse neural tube via an intronic enhancer, and also provide further 
insight in the relationship between cell signaling and the regulated expression of extracellular matrix 
components in development and disease. 
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1. Introduction 
1.1. Basement membranes and animal development 
Metazoan development depends on intimate interactions between cells and their extracellular 
matrices, which provide chemical, mechanical and electrical cues to guide cell behavior. 
Basement membranes (BM) are a major form of extracellular matrix. They are multi-
component meshwork-like sheets, underlying all epithelia and surrounding muscle cells, 
adipocytes, Schwann cells, nerves and endothelia (Colognato and Yurchenco 2000). Major 
constituents of BMs are the laminins, collagen type IV, nidogens, and perlecan, whereas a 
variety of other glycoproteins and proteoglycans are incorporated to BMs in a tissue- and 
stage-specific manner (Scheele et al. 2007) (Figure 1.1). Basement membranes are highly 
dynamic structures, which assemble and dis-assemble repeatedly during embryonic 
development, conferring stability and compartmentalization, and thus are central to organ 
morphogenesis and maintenance (Yurchenco 2011). Cell-surface receptor-mediated contacts 
of cells with BMs are involved in myriads of developmental processes: early germ layer 
polarization and differentiation (Miner et al. 2004), radial sorting of axons by Schwann cells 
(Wallquist et al. 2004), β-islet cell proliferation (Nikolova et al. 2006), hair growth and 
morphogenesis (Li et al. 2003), digit separation and neural tube closure (Miner et al. 1998), 
to name a few. When the interaction between BMs and cells is disturbed, it often results in 
pathological conditions such as muscular dystrophy observed in patients with deficiency in 
laminin α2, or junctional epidermolysisin patients with mutations in the LAMA3, LAMB2 and 
ITGA6 genes (Mitsuhashi and Hashimoto 2003). 
The first basement membrane in the mouse embryo forms within the inner cell mass 
of the blastocyst at ~ stage E5.5, and separates the prospective epiblast from the primitive 
endoderm (Miner 2008), as described later in more detail. One of its major components is the 
product of the laminin alpha 1 gene, subsequently expressed in other structures of the 
developing embryo, and subject of the current study.  
1.2. Laminin alpha 1 – gene organization, protein structure and assembly 
The mouse laminin alpha 1 protein (laminin α1) was first isolated as part of a trimeric 
glycoprotein (laminin-111) from the Engelbreth-Holm-Swarm (EHS) embryonal carcinoma, 
that was also enriched in the basement membranes of normal tissues (Timpl et al. 1979). 
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Figure 1.1. Schematic representation of the structure of basement membranes. Laminins interact with their LN 
domains to form a network, which is anchored to the cell surface via direct interactions of laminins with 
integrins, a-dystroglycan and sulfatides, and indirectly via agrin. Importantly, nidogen, perlecan and agrin 
connect the laminin network with the independently formed collagen IV network to establish the basement 
membrane (double arrows indicate physical interactions between basement membrane components). Adapted 
from Hohenester and Yurchenco (2013).  
Subsequent molecular cloning studies revealed that the three subunits of laminin-111 are 
encoded by distinct but homologous genes – Lama1, Lamb1 and Lamc1, for laminin α1, β1 
and γ1 chains, respectively (Martin and Timpl 1987).  
The Lama1 gene is a member of a diverse family of genes encoding extracellular 
glycoproteins, with representatives in all Eumetazoans, including cnidarians, ecdysozoans 
(Drosophila and Caenorhabditis), and all vertebrates (Domogatskaya et al. 2013). Within 
vertebrate genomes, Lama1 is located in a genomic region featuring conserved synteny 
where Lama1 is always accompanied by the Lrrc30, Ptprm and Arhgap28 protein-coding 
gene loci in a conserved order and orientation, hinting at the existence of constraints on gene 
regulation in the cluster, as discussed later in this study. Moreover, the exonic organization 
and amino acid sequence encoded by the murine Lama1 are also highly similar to the 
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corresponding human, chicken and zebrafish orthologs, as summarised in Table 1.1. This 
suggests for conserved functions of the laminin α1 subunit across vertebrates. 
 
 
Gene  
length in 
bpa 
Number of 
exonsa 
cDNA 
length in 
bpa 
Number of 
aa in 
proteinb 
Predicted molecular 
mass of protein in 
kDac 
% Amino acid sequence 
identity with the murine 
orthologd 
Mouse 125, 380 63 9, 518 3, 084e ~ 338 - 
Human 176, 070 63 9, 657 3, 075e ~ 337 ~ 76% 
Chicken 98, 854 63 9, 401 3, 097f ~ 340 ~ 64% 
Zebrafish 92, 360 63 8, 040 3, 075f ~ 336 ~ 51% 
 
    Table 1.1. Characteristics of laminin α1 gene and protein sequences. 
a,  data obtained from the Ensembl database, www.ensembl.org 
b, data obtained from the UniProt database, www.uniprot.org 
c, data generated via the “Compute pI/mW” tool in ExPASy, www.web.expasy.org  
d, data generated via the “Align” tool in UniProt, www.uniprot.org 
e, evidence at protein level 
f, evidence at transcript level 
1.2.1. Laminin α1 is part of a heterotrimeric complex 
Laminins constitute a diverse family of glycoproteins with critical roles in basement 
membrane composition and formation. Each laminin molecule is a heterotrimer composed of 
one α-, one β- and one γ-laminin subunits (Figure 1.2). The subunit composition determines 
the name of the laminin trimer where subunits α1, β1 and γ1 form laminin-111, for instance 
(Aumailley et al. 2005). In mammals, five alpha (including laminin α1), four beta and three 
gamma subunits have been described each encoded by an individual gene, which in different 
combinations participate in the formation of at least 16 distinct biochemically-recognised 
laminin trimer isoforms (Miner and Yurchenco 2004). Apart from laminin-111, the laminin 
α1 subunit is thought by some authors to be able to partner with laminin β2 and γ1 to form 
laminin-121 in vivo, although this idea is based only on coexpression studies and is currently 
controversial (Durbeej et al. 1996; Sasaki et al. 2010). 
Laminin-111 is the first laminin described and the most extensively studied in terms 
of biochemical and biophysical properties (Timpl et al. 1979; Ekblom et al. 2003). Laminin-
111 has a cross-shape architecture featuring three short arms and one long arm (Figure 1.2) 
(Beck et al. 1990). The three short arms are represented by the N-terminal parts of the α1, β1 
and γ1 subunits, while the long arm is formed by the collective contribution of all three 
subunits (Colognato and Yurchenco 2000). 
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Figure 1.2. Schematic drawing of the domain structure of 
laminin-111. The laminin-111 heterotrimer is cross shaped and 
all three subunits (α1, β1 and γ1) feature common domain 
organization with globular LN and L4 domains, rod-like LE 
domains, and coiled coil domains. Uniquely, α1 (and all other α 
subunits) carries five globular LG domains at its carboxy 
terminus. Adapted from Hohenester and Yurchenco (2013). 
The short arms consist of several globular 
domains - one LN domain and two L4 domains in the 
α1 subunit, and one LN domain and a single L4 
domain in the β1 and γ1 chains. The globular 
domains in all three subunits are separated by tandem 
repeats of laminin-type epidermal growth factor, or 
LE, rod-like domains (Durbeej 2010). The long arm 
of each subunit consists of an extensive α-helical 
coiled-coil domain, which facilitates trimer formation 
(Beck et al. 1993). In addition, the alpha subunits, including α1, are unique in the possession 
of 5 globular domains (LG1-5) at the C-terminus (Tzu and Marinkovich 2008) (Figure 1.2). 
However, there are some exceptions to the so described laminin structure. For instance, 
laminin α3A and α4 are truncated – they lack the short arm, as is the case for laminin β3 and 
γ2 subunits (Miner et al. 1995). 
The LN domain of all three chains in laminin-111 features a beta-sandwich motif with 
several loops and is required for laminin network polymerisation (Schittny and Yurchenco 
1990) as shown by electron microscopy where Ca
2+
-dependent ternary interactions occur 
between the LN domains of one α, one β, and one γ subunit from adjacent laminin trimers, 
thus establishing the “three-arm interaction” model for laminin assembly (Cheng et al. 1997; 
Paulsson et al. 1988). The roles of the LE domains are poorly known except for LEβ3 in the 
γ1 subunit which binds to nidogen-1 and -2 and this interaction appears to be essential for 
kidney development, as discussed below (Willem et al. 2002). The LG1-5 domains of the 
alpha chains have a lectin-like beta-sandwich motif complexed with Ca
2+
 ions, and are 
especially important in establishing contacts with cell surface receptors (Hohenester et al. 
1999). 
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Assembly of laminin heterotrimers occurs in the Golgi apparatus with the initial 
dimerization between the coiled-coil domains of the β and γ chains followed by incorporation 
of the α subunit, and the whole complex is stabilized by several disulphide bonds (Paulsson 
et al. 1985; Tokida et al. 1990). Addition of the α chain is required for secretion of the whole 
laminin trimer (Yurchenco et al. 1997), although studies in mouse and Drosophila have 
shown that α chains can be released from the secreting cells as single subunits (Kumagai et 
al. 1997; Yurchenco et al. 1997). 
1.2.2. Interactions of laminin-111 with other ECM components and cellular receptors 
Multiple interactions exist between laminins and other components of the extracellular 
matrix, as well as between laminin and cell surface receptors. In general, most interactions 
with the ECM occur on the short arms of all three laminin subunits, while interactions with 
the cell surface is mediated by the globular LN and LG1-5 domains of the alpha chains 
(Miner and Yurchenco 2004). For instance, the coiled-coil domain of γ1 interacts with the 
heparan sulphate proteoglycan (HSPG) agrin, and with nidogens, as mentioned earlier, which 
together with perlecan help to establish the linkage between laminin and the collagen IV 
networks (Bezakova and Ruegg 2003; Fox et al. 1991; Hohenester and Yurchenco 2013). 
The major cell receptor partners for laminin-111 are integrins α1β1, α2β1, α6β1, 
α6β4, α7β1, and α9β1, and also α-dystroglycan and syndecans. Contacts with integrins are 
mainly established via the LG1-3 domains of the α subunit (Ido et al. 2004), while LG4-5 
interact with α-dystroglycan, heparan sulfates and sulfated glycolipids (Talts et al. 1999). 
However, a glutamic residue in the C-terminus of the γ1 chain was shown to be required for 
complex formation between LG1-3 and the integrins (Ido et al. 2007).  
The interaction of laminins with integrins and dystroglycan is thought to promote not 
only BM assembly and maintain stability, but also to serve signalling functions, which 
culminate in the activation of intracellular pathways. For instance, integrins activate the PI-3 
kinase signaling pathway in mammary epithelial cells resulting in suppression of apoptosis 
(Boudreau et al. 1995). In another study, Li et al. (2002) examined the function of laminin-
111, integrin and dystroglycan for cell differentiation in embryoid bodies (EBs) derived from 
mouse ES cells. They found that epiblast differentiation and cavitation are dependent on the 
presence of laminin-111 and that both integrin and dystroglycan are important for epiblast 
survival. Thus, laminin reception plays important roles in the control of cell differentiation, 
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survival, proliferation and migration in both embryonic and postnatal processes (Danen and 
Sonnenberg 2003; Yurchenco et al. 2004). 
1.2.3. Laminin-111 and basement membrane assembly 
Laminins, including laminin-111, are essential for BM assembly as demonstrated in culture 
and in vivo. For instance, laminin β1- and γ1-deficient mouse embryos are unable to 
assemble the earliest embryonic and Reichert’s BMs caused by failure of laminin-111 and 
laminin-511 synthesis culminating in embryonic lethality at E5.5 (Smyth et al. 1999; Miner 
et al. 2004). Likewise, laminin α1 constitutive knockout mouse embryos completely lack 
Reichert’s BM, while the embryonic basement membrane is present due to compensation by 
laminin α5, allowing epiblast polarization, cavitation and normal entry in gastrulation (Miner 
et al 2004). Nevertheless, this compensation is incomplete as Lama1
-/-
 embryos die shortly 
after E6.5 (Miner et al. 2004). Likewise, Lamc1
-/-
 embryoid bodies in culture fail to assemble 
a basement membrane between the endoderm and epiblast, while exogenous supplementation 
of laminin-111 restores BM assembly and epiblast polarization. Importantly, this restoration 
is prevented by blocking either polymerization or interactions between the LG domains of 
laminin α1 and cellular receptors (Li et al. 2002). Similarly, a mutant laminin α1 subunit that 
lacks all LG1-5 domains is unable to assemble a basement membrane on the surface of 
cultured Schwann cells (McKee et al. 2007).  
In contrast to the requirement for laminins in early embryogenesis, genetic ablation of 
other BM components – nidogen-1/2, perlecan and collagen IV, reveal that they are not 
essential for initial assembly of BMs but are required later for maintenance of their integrity 
in the skeletal, vascular and respiratory systems, among others (Arikawa-Hirasawa et al. 
1999: Murshed et al. 2000; Poschl et al. 2004). 
1.3. Expression of Laminin α 1 
Laminins are expressed in various tissues during embryonic and postnatal development. In 
general, the alpha subunits exhibit more restricted tissue-specific expression patterns as 
compared to the β and γ subunits. Thus, laminin α1, α3 and α5 are predominantly present in 
the basement membranes of epithelial tissues, while α2 and α4 are associated with endothelia 
and structures of mesenchymal origin (Tunggal et al. 2000). 
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1.3.1. Lama1 expression in the mouse and human 
In the mouse, Lama1 mRNA is first detected at the 2-4 cell stage (Dziadek and Timpl 1985) 
suggesting the possibility of maternal deposition, while Laminin α1 protein is first observed 
in the intercellular space at morula stage (Cooper and McQueen 1983), most likely in the 
form of laminin-111. At early post-implantation stages (E5.5-7.5), Laminin α1 appears 
prominently in the extra-embryonic Reichert’s basement membrane, as part of laminin-111, 
as well as in the embryonic basement membrane, which separates the epiblast from the 
visceral endoderm (Miner et al. 2004). At later embryonic stages (from E9.0 onwards), the 
major site of Lama1 expression is the ventricular/subventricular zone of the central nervous 
system (in both the future spinal cord and in all major divisions of the brain), but also the 
presomitic mesoderm, newly-formed somites, sclerotome, head mesenchyme, lens of the eye, 
and in nephric structures (Chapter 3 of this study; Anderson et al. 2009; Lentz et al. 1997; 
Miner et al. 2004). Laminin α1 expressed in these tissues is observed in the pial basement 
membrane surrounding the CNS; in the somitic, dermomyotomal and myotomal BMs, and in 
the BM of the proximal tubules and ureteric buds of metanephric kidneys (Anderson et al. 
2009; Lentz et al. 1997). With progression of development, Lama1 expression is down-
regulated in anterior somites (Anderson et al. 2009) (Table 1.2).  
Analysis of laminin α1 protein distribution in the adult mouse revealed strong activity 
in only few structures in the nervous and genito-urinary systems, pia matter, brain blood 
vessels, the ECMs that cover the vitreous chamber and lens of the eye, adrenal gland cortex, 
proximal tubules of the kidney, testis; epididymis, prostate, and ovary (Ekblom et al. 2003; 
Falk et al. 1999). No staining was observed in the trachea, lung, adipose tissues, Schwann 
cells, endothelia, myocardium, smooth muscle, thymus, and spleen (Falk et al. 1999). 
In humans, laminin α1 is similarly detected in both fetal and adult proximal tubules of 
the kidneys, in the BMs of the seminiferous tubules of the testes and intestinal mucosa 
glands, and associated with the capillary vasculature in the adult brain (Virtanen et al. 2000). 
1.3.2. Lama1 expression in zebrafish 
The expression pattern of laminin α1 is largely conserved between mammals and zebrafish, 
where in the latter lama1 is first detected as maternally deposited transcripts as early as the  
2-cell stage and later zygotic lama1 is expressed in the neural tube, presomitic mesoderm, 
somites, eyes, otic vesicles, gut and pronephros (Table 1.2; Figures 1.3 and 1.4) (Joseph B. 
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Pickering’s Thesis 2012; Zinkevich et al. 2006). However, by 49 hpf, lama1 expression is 
dramatically down-regulated in the anterior CNS and completely extinguished in the spinal 
cord, somites and presomitic mesoderm (Joseph Pickering’s Thesis 2012), similar to the 
situation in the mouse (Miner et al. 2004). 
1.4. Regulation of Lama1 expression 
The conserved pattern of Lama1 mRNA expression between mouse and zebrafish suggests 
conservation in the mechanisms (signaling and transcriptional) that regulate Lama1 gene 
activity (Anderson et al. 2009; Joseph Pickering’s Thesis 2012; Zinkevich et al. 2006). 
However, the signalling pathways controlling Lama1 expression remain largely unknown.  
1.4.1. Signalling pathways and control of Lama1 expression in vitro 
Some insights have been gained from studies in cell cultures. FGFR2-dominant-negative 
mutant ES cells feature abrogated FGF signaling causing reduced Akt/PKB activation, which 
correlates with decreased expression of laminin-111 and collagen type IV (Li et al. 2001). 
Interestingly, β1-integrin-null embryoid bodies fail to express laminin-111 (Li et al. 2002) 
due to down-regulation in laminin α1 expression, suggesting a feedback role for integrins in 
the control of laminin expression that might be mediated by, among others, the Akt/PKB  
signal transducers (Ekblom et al. 2003). Also, induction of endoderm differentiation in 
retinoic acid-treated F9 embryonal carcinoma cells in culture correlates with the 
simultaneous up-regulation of Lama1, Lamb1 and Lamc1 mRNA expression (Kleinman et al. 
1987). The increase in Lama1 expression during differentiation of F9 cells into parietal 
endoderm was shown to be dependent on SOX7, GATA4 and GATA6 inputs, where SOX7 
is necessary for the activation of Gata4 and Gata6 (Futaki et al. 2004). Altogether, these 
studies reveal that Lama1 expression is responsive to FGF, retinoic acid and β1 integrin 
signaling, although remains unclear whether these effects are direct or indirect. 
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Figure 1.3. Zebrafish lama1 mRNA expression. Expression pattern of zebrafish lama1 mRNA in wild type 
embryos. Maternal transcripts are detected at the 8-cell stage (A). (D-K) During somitogenesis, expression is 
strong in the neural tube, somites and presomitic mesoderm, but by 49 hpf (L, M) lama1 transcripts are 
observed only in some brain structures, in the pouches associated with the branchial arches, and in the otic 
vesicles. (C, D, G, J, K, L, M) lateral views; (E, H) dorsal views; (I) a transverse section as indicated in G; (J’, 
K) transverse sections as indicated in J. Abbreviations: ac, adaxial cells; ant, anterior end; de, diencephalon; flp, 
floor plate; fm, fast muscle progenitors; hb, hindbrain; mhb, midbrain-hindbrain boundary; mt, myotomes; nt, 
neural tube; nc, notochord; llo, lateral line organ; ot, optic tectum; ov, otic vesicle; som, somites; spc, spinal 
cord; pn, pronephros; post, posterior end; psm, presomitic mesoderm; te, telencephalon. (The images are kindly 
provided by Dr. Joseph B. Pickering, University of Sheffield). 
 
Figure 1.4. Conserved domains of Lama1 mRNA expression pattern. A schematic diagram of a generalized 
vertebrate embryo showing the major domains of Lama1 mRNA expression that are shared between mouse and 
zebrafish embryos. Individual domains are highlighted in different colours. A more detailed description is 
provided in Table 1.2 and Section 1.3. 
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 mouse zebrafish chicken* 
Lama1 expression pattern. 
2-4 cell blastula (mat); morula; 
visceral and parietal endoderm; 
neural tube; presomitic 
mesoderm; somites; sclerotome; 
gut endoderm; nephrogenic 
mesoderm; head mesenchyme; 
lens; otic vesicle; optic cup; 
meninges; pharyngeal pouches. 
 
2-cell stage (mat); neural tube; 
otic vesicle; optic cup; lens; 
presomitic mesoderm; somites; 
adaxial cells; fast muscle fibers 
progenitors; notochord; 
nephrogenic mesoderm; gut 
endoderm; hypochord. 
By 49 hpf, lama1 transcripts 
remain detected only in some 
brain structures, in the pectoral 
fins and pharyngeal pouches. 
Ingressing mesoderm during 
gastrulation; neural tube; 
foregut endoderm; head 
mesenchyme; somites; 
sclerotome; nephrogenic 
mesenchyme; optic cup; lens; 
posterior lateral plate 
mesoderm. 
Involvement of HH signalling 
in regulation of Lama1 
expression. 
Lama1 transcription is absent 
from the neural tube and 
somites of Shh-/-, Gli2-/- and 
Shh-/-;Gli3-/- embryos (Anderson 
et al. 2012). 
 
 
smo-/- mutants or cyclopamine 
treatment: early stage embryos 
(up to 15-somites) -> no defects 
in lama1 expression. 25 hpf 
embryos -> reduced lama1 
mRNA levels in presomitic 
mesoderm and anterior neural 
tube; no change in somitic 
expression (Joseph B. 
Pickering’s Thesis 2012) 
ptch1-/-;ptch2-/- or dnPKA 
mRNA treatment: in 15-somite 
stage embryos -> increased 
levels of lama1 mRNA in the 
neural tube, somites and 
presomitic mesoderm; 
expansion of lama1 expression 
along the D/V axis of the neural 
tube. 25 hpf embryos -> lama1 
mRNA levels in somites are 
similar to wt/untreated embryos, 
but levels in the neural tube and 
presomitic mesoderm remain 
increased (Joseph B. Pickering’s 
Thesis 2012). 
 
No data. 
Other signalling molecules and 
TFs implicated in Lama1 
expression. 
FGF, Akt/PKB signalling, 
GATA4, GATA6, retinoic acid, 
β1 integrins, SP1/SP3, YY1, 
SOX7/SOX17, KLF4/KLF5, 
DMRT2. 
No data. No data. 
 
Table 1.2. Summary of the Lama1 mRNA expression pattern together with relevant signaling molecules and 
transcription factors in the embryos of mouse, zebrafish and chicken. Components and antagonists of the HH 
signaling pathway are highlighted in a bold font. The main text includes a more detailed account on the 
signaling pathways and transcription factors implicated in Lama1 expression, together with the relevant 
references (see Section 1.3, 1.4 and 1.6 of this study). *data on Lama1 expression in the chicken embryo is 
based on results from the current study (see Section 3.2.3). Abbreviations: mat, maternal; wt, wild type. 
1.4.2. cis-regulatory elements in Lama1 transcription 
Although the majority of cis-regulatory sequences in the vicinity of Lama1 are unknown, a 
few studies have reported the existence of regulatory sequences involved in the control of 
Lama1 transcription in mouse and human cells in culture (Figure 1.5). For instance, a 435 bp 
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parietal endoderm enhancer (PEE) with binding sites for the ubiquitous transcription factors 
of the SP1/SP3 family, NFY and YY1 was found ~ 3 kb upstream of the murine Lama1 gene, 
and was shown to be required for Lama1 expression in the PYS-2 parietal yolk sac cell line 
(Niimi et al. 2003; Niimi et al. 2004). Subsequent investigation on the same enhancer 
revealed that SOX7 and SOX17 also bind to motifs within that region and suggested a 
synergistic mechanism between SP1/SP3, SOX7/SOX17 and YY1 in conferring parietal 
endoderm-specific expression of Lama1 (Niimi et al. 2004). In addition, analyses of a 2 kb 
region upstream of the transcription start site of Lama1, in the murine Caco2-TC7 intestinal 
cell line, uncovered the existence of binding sites for the Krüppel-like transcription factors 
KLF4 and KLF5, as well as for JUN, CEBPA, FOXA2, NR3C1 and SP1. Mutations in all 
motifs revealed that they are essential for the activity of the 2 kb “promoter” region in Caco2 
cells, while overexpression of exogenous KLF4 leads to repression of its activity (Piccinni et 
al. 2004). Based on this, the authors proposed a model where KLF4 expressed in post-mitotic 
cells of the intestinal epithelium competes for binding with the SP1 and/or KLF5, resulting in 
repression of Lama1 transcription in those cells. In contrast, KLF5 is expressed in a 
complementary pattern in the proliferating zone of the adult gut epithelium - in cells of the 
intestinal crypts, where it might be involved in activation of Lama1 expression (Piccinni et 
al. 2004).   
Another study identified the basal promoter of the human LAMA1 gene - a 237 bp 
region located between -206 and +31 relative to the transcription start site, that is highly 
conserved with the mouse Lama1 promoter and both lack TATA and CCAAT elements 
(Niimi et al. 2006). It appears that the activity of the human promoter depends on the 
cumulative effect of six GC-rich binding sites for the SP1/3 and KLF4/6 transcription factors, 
as revealed in the Laminin-111- producing JAR choriocarcinoma cells (Niimi et al. 2006). 
Taken together, the observations in mouse and human cell lines suggest that conserved inputs 
by SP and KLF factors are involved in regulation of Lama1 transcription. 
 13 
 
Figure 1.5. Schematic representation of the known cis-regulatory elements of the murine Lama1 gene with 
experimentally validated transcription factor binding sites. For more detailed description see section 1. 4. 2 in 
the main text. BP, basal promoter; PEE, parietal endoderm enhancer. Importantly, none of the previously 
identified regulatory elements of Lama1 overlap with any of the conserved non-coding elements (CNEs) 
uncovered in this study (described in detail in Chapter 4). 
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1.4.3. Regulation of Lama1 transcription in embryonic development 
Knowledge on the regulation of Lama1 expression during embryonic development in vivo is 
even scarcer. Intriguingly, E10.5 Dmrt2
-/-
 (doublesex and mab-3 related transcription      
factor 2) mouse embryos display lack of laminin α1 immunoreactivity in the somites, which 
correlates with morphological and molecular (such as reduced expression of Pax3, MyoD and 
Pdgfa) aberrations in the dermomyotome and myotome (Seo et al. 2006). However, it is 
unknown whether the absence of laminin α1 in this case is a result of defect in Lama1 
transcription.  
1.5. Laminin expression in skeletal muscle development 
Most muscles in the trunk of amniote embryos are derived from the myotome in two 
successive waves. First, the myotomes are built by delamination of MYF5
+
 myogenic 
precursor cells from the dorso-medial edge of the dermomyotome followed shortly after by 
migration of cells from the other three lips of the dermomyotome – ventro-lateral, rostral and 
caudal (Figure 1.6) (Gros et al. 2004; Ordahl et al. 2001). During the second wave, the 
already formed myotomes increase in size by the addition of PAX3
+
/PAX7
+
 myogenic cells 
directly from the central dermomyotome, which contributes to the growth of the muscle 
masses in later embryogenesis and also provides progenitor cells for the stem cells of adult 
muscle – the satellite cells (Figure 1.6) (Gros et al. 2005; Relaix et al. 2005; Yusuf and 
Brand-Saberi 2006). 
The distribution of laminins during myotome development is a highly dynamic 
process. Initially, a laminin-111- and laminin-511-containing BM surrounds the murine 
somite. Following de-epithelialisation of the sclerotome, laminin α1 is observed in the 
dermomyotomal and subsequently in the myotomal BMs (Anderson et al. 2009; Bajanca et 
al. 2006; Tosney et al. 1994), but also at the myotendinous junctions of developing 
intercostal muscles (Patton et al., 1997) and, as revealed by studies in our laboratory, at the 
sites of activated satellite cells in adult muscles (unpublished data, Shantisree Rayagiri’s 
Thesis). Later in myotome development, laminin α2, α4 and α5 appear in the basement 
membranes enveloping individual myocytes (Patton et al. 1997). However, in postnatal 
muscle fibers α4- and α5-laminins are absent from the BM surrounding the myofibre, 
although they remain at the neuro-muscular junctions (Patton et al. 1997). Thus, laminin α2 
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is the main laminin α-chain present in the sarcolemmal BM of adult muscle (Gullberg et al., 
1995; Schuler and Sorokin, 1995). 
 
Figure 1.6. Myotome morphogenesis in amniotes and zebrafish. A schematic depiction of the morphological 
events during myotome development in (A) amniote (mouse and chicken) and (B) zebrafish embryos. In both 
groups the myotome is derived from the somites in a series of cell specification and translocation events 
regulated by the SHH, BMP and WNT signals emanating from the notochord, neural tube, surface ectoderm and 
the lateral plate mesoderm (Christ et al. 2007). However, the morphological rearrangements and the muscle 
progenitor compartments in the somites vary between amniotes and zebrafish (Bryson-Richardson and Currie 
2008). (A1, A2) The myotome of amniotes is formed via myoblast delamination (curved black arrows in A1) 
from the four lips of the overlying dermomyotome (shown in red and pink at the edges of the dermomyotome in 
A1). Once in the myotome, the myoblasts become post-mitotic and elongate rostro-caudally (A2) (Bajanca et al. 
2006; Christ et al. 2007). A second population of myotomal cells (orange tubes in A3) is provided via 
ingression of PAX3+/PAX7+ myoblast precursors from the central dermomyotome (an orange plate above the 
primary myotome in A2), which also establish the satellite cell population of adult muscles (dark grey 
arrowheads in A3) (Buckingham 2000). (B) Myotome development in zebrafish features the establishment of 
distinct populations of slow-twitch and fast-twitch muscle fibers (Jackson and Ingham 2013). The first cells 
committed to the trunk skeletal muscle lineage in zebrafish are the slow muscle fibers (SMFs). Their precursors 
are cuboidal cells located in the medial somite (blue circles in B1). Once specified to the myogenic lineage by 
Hh proteins from the notochord, these cells elongate, differentiate into mononucleate slow-twitch fibers and 
start migration – initially dorso-ventrally (black arrows in B1) and then laterally directly through the somite 
(black arrows in B2 and B3) and eventually populate the lateral myotome (B3) (Jackson and Ingham 2013; 
Ochi and Westerfield 2007; Wolff et al. 2003). Meanwhile, cells located in the posterior of somites start to 
elongate forming the medially positioned fast muscle cells (the pink area of somite in B3 and B4) (Stickney et 
al., 2000). Parallel to these events, an earlier cell population in the anterior of each somite relocates to the lateral 
surface of the myotome where it establishes the dermomyomal-like external layer of Pax3+/Pax7+ cells (green 
elipses on the lateral somitic surface in B4), which contribute to further growth of the myotome (green circles 
marked with red arrownheads in B4). Abbreviations: cdmm, central dermomyotome; cl, caudal lip of 
dermomyotome; dml, dorsomedial lip of dermomyotome; dmmll, dermomyotomal-like layer; fmf, fast muscle 
fibers; mp, muscle pioneers; myo, myotome; nc, notochord; nt, neural tube; sc, sclerotome; smf, slow muscle 
fibers. (Adapted from Bryson-Richardson and Currie 2008, and Stickney et al. 2000). 
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1.6. SHH is required for Lama1 expression and myotomal basement membrane 
assembly 
Important insight in the signaling pathways governing Lama1 expression during myotome 
formation in the mouse embryo was provided by studies in our laboratory (Anderson et al. 
2009). 
1.6.1. Shh
-/- 
mutant mouse embryos fail to express Lama1 in the somites and neural tube 
The formation of a laminin-rich myotomal basement membrane (MBM) is important for the 
achievement of correct myotome shape, for its separation from the sclerotome, for proper 
myogenic cell specification, and for neural crest migration (Anderson et al. 2009; Bajanca et 
al. 2006; Tajbakhsh et al. 1996; Tosney et al. 1994). The MBM contains laminin-511 and 
laminin-111 heterotrimers, as revealed by immunostaining (Anderson et al., 2009; Bajanca et 
al., 2006). Importantly, previous work in the lab uncovered an essential role of SHH in the 
formation of the MBM (Anderson et al. 2009). Indeed, in the absence of GLI-mediated SHH 
signalling, Myf5-expressing cells (which enter the myotome from the rostral, caudal and 
ventrolateral dermomyotomal lips) are abnormally located in the ventral somitic 
compartment. Further investigation showed absence of assembled myotomal BM in Shh-null 
and Gli2;Gli3-double null embryos, although fragments of laminin polymers and other BM 
components were detected associated with the myogenic precursor cells (Anderson et al. 
2009). 
Analysis of the expression of Lama1 and Lama5 genes revealed that laminin α1 was 
no longer expressed in the somites and neural tube of Shh-null embryos, whereas the somitic 
expression of laminin α5 was unaffected. Based on the experimental data, Anderson et al. 
(2009) hypothesised that SHH signalling is required for the activation of Lama1expression in 
the somite, and that the lack of Laminin α1 led to the failure of MBM assembly in Shh-
deficient mouse embryos. Supporting this hypothesis, treatment of Shh
-/-
;Gli3
-/-
 mutant 
embryos with 30 µg/ml exogenous laminin-111 restored MBM assembly. Curiously, the 
efficiency of restoration appeared to depend on the dosage of endogenous laminin for the 
same treatment failed to restore the MBM in Shh
-/-
;Gli3
+/-
embryos (Anderson et al., 2009) 
that express GLI3R protein, which presumably represses Lama1 transcription. 
Importantly, restoration of the myotomal basement membrane in Shh
-/-
;Gli3
-/-
mutants 
after laminin-111 addition is a progressive process, in anterior-to-posterior direction, and 
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correlates with the recovery of Lama1 expression, both in the sclerotome and neural tube 
(Anderson et al., 2009). However, the observed delay in the recovery suggests that Lama1 
expression also requires GLI2A function for timely activation in more posterior somites.  
1.6.2. Shh is required for lama1 expression in zebrafish 
Interestingly, 25 hpf smo
-/- 
mutant or cyclopamine-treated wild type fish embryos exhibit 
strong reduction in lama1 expression in the presomitic mesoderm (PSM) and anterior neural 
tube, but not in somites, while lama1 expression is unaffected in early (12-15 somites stage) 
embryos (Joseph B. Pickering’s Thesis 2012), indicating that active Hh signaling is required 
for zebrafish lama1 transcription in the central nervous system, similar to the mouse. 
Moreover, constitutive activation of the Hh pathway in ptch1;ptch2 double mutant fish 
results in strong up-regulation of lama1 expression in the neural tube and PSM, and also in 
the somites (Joseph B. Pickering’s Thesis 2012) (Table 1.2). 
 Altogether, previous studies in our laboratory demonstrate a conserved requirement 
for SHH signaling in Lama1 expression in the neural tube and paraxial mesoderm of 
mammals and teleosts. 
1.7. Functions of laminin α1 in development 
As part of laminin-111, laminin α1 is involved in the formation of the earliest basement 
membranes in the mouse embryo, while later tissue-restricted expression relates to its 
functions in the development of various structures, like the nervous system, eyes, kidneys 
and skeletal musculature. Moreover, several studies have provided insights into the roles of 
zebrafish laminin α1 in embryonic development, as discussed later. 
1.7.1. Laminins and neural development 
Laminins, including laminin-111, are known to participate in multiple aspects of nervous 
system development, from modulating the behavior of neural stem cells to cortical 
morphogenesis and peripheral axon path-finding. 
1.7.1.1. Laminins and neural stem cells 
Culturing human and mouse neural stem/precursor cells (NSPCs) isolated from the 
developing cerebral cortex on laminin-111 matrices enhances their migration, proliferation, 
survival, neurite elongation, arborisation and differentiation into neurons and astrocytes 
compared to cultures on fibronectin, Matrigel or poly-L-ornithine substrates (Flanagan et al. 
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2006). These effects of laminin-111, compared to other matrices, are consistent with the fact 
that human NSPCs express  most of the Integrin receptors for laminin-111, namely integrins 
α1β1, α2β1, α3β1, α6β1, α6β4, and α7β1 (Flanagan et al. 2006). 
Interestingly, when dissociated retinal neuroepithelial cells from 5-day old chicken 
embryos were grown on laminin-111 containing substrates, they proliferated, survived and 
differentiated into neurons in a cell-cell contact dependent manner. However, culturing these 
cells on laminin-211 also supported proliferation but not survival and failed to promote 
neuronal differentiation (Frade et al. 1996). Thus, although laminins containing the α2, α4 
and β2 subunits are expressed in the neural stem cell-niche of the ventricular zone (Lathia et 
al. 2007), these laminins might have functions in modulation of neural stem cell behavior that 
are distinct from that of laminin α1.  
1.7.1.2. Laminins and cortical morphogenesis 
It appears that glial interactions with the pial basement membrane, which is rich in laminin 
α1, α2, α4, α5 and β1 (Anderson et al. 2009; Bajanca et al. 2006), are essential for proper 
CNS development. For instance, combined inactivation of laminin α2 and α4 leads to defects 
in radial glial cells (RGCs) attachment to the pial surface, apoptosis and cortex reduction 
(Radakovits et al. 2009), which are most likely caused by perturbation in β1 integrin 
signaling in RGCs. In fact, mice with conditional inactivation of β1 integrin in the RGCs 
exhibit reduced RGCs proliferation and increased apoptosis due to detachment of the basal 
processes of the RGCs from the pial basement membrane, which culminates in the reduced 
size of the telencephalic cortex (Radakovits et al. 2009).  
Importantly, similar functions of laminin α1 were described in cerebellar 
morphogenesis. Heng et al. (2011) and Ichikawa-Tomikawa et al. (2012) reported that in 
adult Lama1 conditional knockout mice generated by Sox2-Cre mediated deletion of Lama1 
in the epiblast, which circumvents the essential requirement for Lama1 expression in the 
visceral and parietal endoderm during early development (Miner et al. 2004) there is an 
abnormal locomotor phenotype (Ichikawa-Tomikawa et al. 2012). This defect correlates with 
a severe disorganization of the cerebellar layers and with fusion of the folia, as well as with 
excessive proliferation of granule cell precursors in the external granular layer, and with 
defects in their migration, followed by massive cell death, causing a reduced cerebellum in 
Lama1-deficient animals (Heng et al. 2011). Interestingly, these perturbations are associated 
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with a discontinuous meningeal BM, disorganization of the Bergmann glial fibers and end-
feet, and reduction in the number of dendritic processes in Purkinje cells (Heng et al. 2011; 
Ichikawa-Tomikawa et al. 2012). This demonstrates a role of the laminin α1-containing pial 
basement membrane in the control of GPCs proliferation at early stages and in GPCs survival 
later on, which is perhaps mediated by interactions of the radial glial cells with laminin-111 
in the pial membrane.  
A further insight into the function of laminins at the pial surface was provided by 
mutant mice with a deletion in the nidogen-binding site of the laminin γ1 subunit (Halfter et 
al. 2002). Although assembly of the pial BM initiates in the mutant embryos, it is unstable 
and subsequently degenerates, leading to the retraction of radial glial processes from the pial 
surface, and aberrant migration of Cajal-Retzius cells and cortical plate neurons (Halfter et al. 
2002).  
Taken together, these observations demonstrate a critical role of laminins (including 
laminin α1) in radial glial cell morphology, and in neuronal migration and differentiation, 
which is dependent on interactions with the radial glia.  
1.7.1.3. Laminin α1 in axonal growth and migration 
Laminins appear to be important for neurite outgrowth and axonal migration. Culturing avian 
and rodent retinal ganglion cells on laminin-111 or laminin-211 stimulates neurite outgrowth 
in an α6β1-integrin-dependent manner (Cohen and Johnson, 1991). Notably, distinct laminin 
isoforms exhibit different efficiency in promoting neurite outgrowth in cultured murine 
dorsal root ganglion (DRG) neurons, such that laminin-111 and laminin-511 are more potent 
at stimulating neurotrophin-independent neurite elongation compared to laminin-211 or 
laminin-411 (Plantman et al. 2008). Interestingly, antibody-blocking experiments revealed 
that the interactions of laminin-111 with α3β1 and α7β1 Integrins are essential in this 
process, but not the interactions with α6β1 Integrin, which is required for the effects of 
laminin-211 (Plantman et al. 2008). This observation suggests distinct roles for laminin-111 
and laminin-211, mediated by interactions with different integrin receptors in the developing 
CNS. 
Genetic ablation studies provide further insight into laminins and neuronal 
morphogenesis. Conditional inactivation of Lamc1 in the murine neocortex leads to 
lamination abnormalities, failure of neurite ouugrowth and axonal path-finding defects and 
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these requirements are mediated by Integrin-dependent activation of the AKT/GSK-3β 
signaling pathway (Chen et al. 2009). Similarly, the lama1-deficient bashful (bal) mutant 
zebrafish displayed widespread defects in axonal path-finding and outgrowth in the CNS. For 
instance, the forebrain axons, hindbrain reticulospinal axons and retinal ganglion cell axons 
exhibited specific path-finding errors indicating that laminin α1 is required for the 
modulation of axon directionality (Paulus and Halloran 2006). In addition, some axon tracts 
were defasciculated and not fully extended, while other axons showed extensive branching 
(Paulus and Halloran 2006). This role of laminins in axonal migration seems to be conserved 
in evolution for mutational inactivation of either aA or aB laminin subunits in 
Caenorhabditis elegans is also manifested by nerve mis-positioning and defects in axonal 
outgrowth (Huang et al. 2003). 
1.7.2. Laminins and neural crest cells 
The involvement of laminins in neural crest (NC) cell development is well established (Perris 
and Perissinotto 2000). Trunk neural crest cells travelling between the neural tube and 
somites, along the ventro-lateral migration route, abruptly turn laterally upon reaching the 
level of the myotome, enter the anterior half of each sclerotome and preferentially use the 
myotomal basement membrane as a migratory substratum (Tosney et al. 1994).  
Early studies of avian embryo explants in culture have shown that the interaction of 
NC cells with laminin is essential for their emigration and subsequent dispersal from the 
closing neural folds (Bilozur and Hay 1988). Interestingly, laminin and collagen IV proteins 
are down-regulated at the roof plate of the closing neural tube as neural crest cells undergo an 
epithelial-to-mesenchymal transition to leave the neuroepithelium (Duband et al. 1988). 
Notably, the basal surfaces of epithelia along the migratory routes of neural crest cells are 
lined with laminin and collagen IV, whereas the amount of these proteins within the NC 
populations is low (Duband et al. 1988; Krotoski et al. 1988). Curiously, termination of NC 
migration and aggregation into dorsal root and sympathetic ganglia correlates with an 
increase of interstitial laminin and collagen IV within the NC population, suggesting that 
these molecules promote stronger adhesion to the ECM which probably impedes further 
migration (Duband et al. 1988; Krotoski et al. 1988).  
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1.7.3. Laminin α1 in ocular development 
Laminin α1 is present in the two BMs around the retina – in the inner limiting membrane 
(ILM) separating the retina from the vitreous, and in the Bruch’s membrane between the 
retina and choroid (Byström et al. 2006; Libby et al. 2000). Homozygous Lama1
nmf223
 mutant 
mice carrying the non-synonymous mutation Y265C in the short arm of laminin α1 (which 
affects LN domain protein-protein interactions) lack primary retinal vascular plexus and 
exhibit persistent vasculature in the vitreous due to ectopic entry of retinal vessels and 
astrocytes through the inner limiting membrane of the eye (Edwards et al. 2010; Edwards et 
al. 2011). These abnormalities are most likely caused by defects in the organization of the 
ILM which affect its interaction with Müller cells end-feet– the main glial cells in the retina. 
Notably, Lama1
Δ/ Δ
 mutants with Sox2-Cre-mediated conditionally-deleted Lama1 display 
similar but more severe defects in retinal cell number and vasculature correlating with a 
complete absence of the ILM and disorganized Muller cells end-feet. Interestingly, at 1 year 
of age, Lama1
Δ
 homozygotes feature 11% increase in eye diameter compared to wild type 
littermates (Edwards et al. 2010; Edwards and Lefebvre 2013). This is very intriguing, as it 
relates to a study by Zhao et al. (2011) who identified a significant association between high 
myopia in Chinese patients and the rs2089760 SNP located ~ 1.2 kb upstream of the 
transcription start site of LAMA1, presumably in a putative promoter-proximal regulatory 
element of LAMA1 (Zhao et al. 2011). Thus, one can envisage a scenario where reduced 
expression of laminin α1 in the Bruch’s membrane or in the sclera results in abnormal 
eyeball size and shape.  
 Interestingly, the larval-lethal zebrafish bashful a69 (bal
a69
) mutants, which carries a 
C56S point mutation in the N-terminal region of laminin α1, feature a plethora of ocular 
defects such as lens degeneration, corneal dysplasia, dismorphic hyaloid vasculature, ectopic 
photoreceptors in the inner retina, and defects in axonal projections of retinal ganglion cells 
(Zinkevich et al. 2006; Semina et al. 2006). Notably, the defects in the anterior chamber 
appear result from reduced focal adhesion kinase (Fak) activation and are not a consequence 
of the degenerating lens (Semina et al. 2006). 
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1.7.4. Laminin α1 and kidney development 
Lama1 mRNA is expressed in the developing mouse mesonephros (Anderson et al. 2009; 
Miner et al. 2004) and metanephros (Miner et al. 1997; Sorokin et al. 1997), where it is 
transiently expressed by both the nephric duct and the nephrogenic mesenchyme, and is 
exclusively included in the basement membranes of the epithelial ureteric tree and nephric 
tubules but not in the BMs of kidney endothelia (Sorokin et al. 1997). Formation of the 
mammalian definitive kidney, the metanephric kidney, begins at stage E11, by evagination of 
the ureteric bud from the caudal end of the nephric (or Wolffian) duct, which invades the 
nearby metanephric mesenchyme and induces it to condense into the tubular epithelium of 
nephrons (Sorokin and Ekblom 1992). Interestingly, this mesenchyme-to-epithelium 
transition is accompanied by the formation of a new basement membrane around the forming 
tubules that predominantly contains laminin-111 but also laminin-411 (Sorokin et al. 1997). 
Importantly, incubation of mouse metanephric explants with antibodies against the laminin 
α1 subunit blocked the mesenchyme-to-epithelium transition of the nephrogenic 
mesenchyme, either by interfering with laminin network assembly or perturbing the 
interactions of laminin α1 with cellular receptors (Klein et al. 1988). 
Interestingly, mutant mouse embryos harbouring a deletion in the nidogen-binding 
site on laminin γ1 display perturbation in the anterior-to-posterior elongation of nephric 
ducts, resulting in renal agenesis in 80% of the mutants (Willem et al. 2002). Other laminin 
isoforms are also prominently expressed in developing kidneys and have demonstrated roles 
at different stages of nephrogenesis. For instance, laminin-511 appears to be critical for 
glomerulogenesis (Miner and Li 2000), and together with laminin-3A32 are both required for 
ureteric bud branching (Miner and Li 2002; Zent et al. 2001). Thus, various laminin isoforms 
participate at distinct steps of kidney development. 
1.7.5. Laminin α1 in skeletal muscle development 
Laminin α1 is essential for early myotomal development in the mouse (Anderson et al. 2009). 
However, expression data suggest that it may also have some hitherto unknown functions in 
later skeletal muscle morphogenesis (Patton et al. 1997), whereas current research in our 
laboratory is uncovering unexpected roles of laminin α1 in modulating satellite cell behavior 
(Shantisree Rayagiri’s Thesis), thus challenging former studies reporting its absence in adult 
murine muscles (Falk et al. 1999). 
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Although detailed characterization of laminin α1 functions in mammalian skeletal 
muscle development awaits future studies, bashful mutants and lama1-morpholino-treated 
wild type zebrafish embryos already provide some insights in this respect. Zebrafish bal
uwl 
mutants carry a 100 bp insertion in the lama1 locus resulting in a frame-shift and predicted 
truncation of the laminin α1 chain at amino acid residue 1424 (Semina et al. 2006). Similar to 
other bashful mutants, 24 hpf bal
uwl
 homozygous embryos exhibit defects in cell 
differentiation in the anterior notochord, followed by curved tail and shortening of the body 
axis in 5 dpf larvae (Paulus and Halloran 2006). Interestingly, the overall gross morphology 
of skeletal muscles in bal
uwl/uwl
 fish appears normal, further evidenced by the normal 
expression of gli1, gli2, myoD and slow myosin gene expression in the somites, although 
some individual fibers are mis-oriented. However, injection of morpholinos against lama1 in 
wild type fish leads to significant detachment of muscle fibres from the myotendinous 
junctions, and the defects are even stronger on a lama2
-/-
 background, revealing overlapping 
functions between laminin-211 and laminin-111 in zebrafish myofibre attachment to the 
extracellular matrix (Sztal et al. 2012). 
An interesting role for laminin γ1-containing laminins in skeletal muscle development 
was uncovered in the sleepy (sly) zebrafish mutants (Dolez et al. 2011). Sly mutant alleles 
encode severely truncated laminin γ1 chains that lack most of the amino acid sequence after 
the ~ 100
th
 residue (the predicted total length of zebrafish laminin γ1 is 1593 aa), and result 
in notochord cell apoptosis and shortened body axis, that are more severe than in bal mutants 
(Parsons et al. 2002). In addition, sly mutants display failure of engrailed expression in 
muscle pioneers and medial fast fibers due to the ectopic activation of Bmp signalling in the 
central adaxial domain, and this appears to be mediated by promoting the incorporation of 
heparan sulphate proteoglycans (HSPGs) in the BM on the medial surface of the somite 
(Dolez et al. 2011). Thus, laminin γ1, most likely incorporated in laminin-111, -211 and -411 
(Szstal et al. 2011), creates a permissive environment for Shh-dependent induction of 
engrailed expression in the zebrafish somite (Dolez et al. 2011; Maurya et al. 2011) 
1.8. The SHH signaling pathway 
As described earlier, Sonic hedgehog (SHH) was found to be an essential signal for 
activating Lama1 transcription in the somites and neural tube of mouse embryos (Anderson 
et al. 2009). Shh belongs to the hedgehog (hh) family of genes whose origin lies at the dawn 
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of Eumetazoa (Adamska et al. 2007; Ingham et al. 2011). The genome of Drosophila encodes 
only one HH protein that was originally characterized as essential for establishment of 
segment polarity in the fly embryo (Hidalgo and Ingham 1990). The amniote HH family 
includes two more paralogs apart from SHH – indian hedgehog (IHH) and desert hedgehog 
(DHH) (Bitgood et al. 1996; Chang et al. 1994; Echelard et al. 1993; Marigo et al. 1995), 
while the zebrafish genome harbours five hh genes: shha, shhb (or tiggywinkle hedgehog, 
twhh), ihha, ihhb (or echidna hedgehog, ehh), and a dhh ortholog (Avaron et al. 2006; Currie 
et al. 1996; Ekker et al. 1995; Krauss et al. 1993).  
The SHH signalling pathway controls, directly or indirectly, the development of most 
vertebrate organs, and de-regulation leads to congenital defects, as well as to tumour 
formation/progression in humans (Bale 2002; Ingham and McMahon 2001). Notable 
examples of SHH-regulated processes in vertebrate development include cell-fate 
specification in the somite (Borycki et al. 1998; Wolff et al. 2003), craniofacial 
morphogenesis (Hu and Helms 1999), dorso-ventral regionalisation of the spinal cord 
(Dessaud et al. 2008; Ericson et al. 1995), antero-posterior patterning of the limbs (Johnson 
et al. 1994; Lopez-Martinez et al. 1995), gut wall patterning (Ramalho-Santos et al. 2000), 
ventral midline patterning of the prosencephalon (Ekker et al. 1995), tooth formation 
(Dassule et al. 2000), growth of external genitalia (Seifert et al. 2010), and many others 
(Huangfu and Anderson 2005).  
1.8.1. Expression, secretion and diffusion of SHH 
During vertebrate embryogenesis, SHH is expressed at various sites with important 
organizer-like properties, such as the notochord, floor plate, the zone of polarising activity 
(ZPA) in the limb bud, and the frontonasal ectodermal zone (FEZ) (Ericson et al. 1995; Hu 
and Marcucio 2009; Johnson et al. 1994). SHH usually acts as a morphogen at a distance 
from its secretion source, and this role is particularly well documented in dorso-ventral 
patterning of the neural tube, as discussed later (Ingham and McMahon 2001). 
SHH is translated as a ~ 45 KDa pro-protein, that undergoes autocleavage to produce 
two polypeptides - a carboxy-terminal (SHH-C) and an amino-terminal one (SHH-N) (Lee et 
al. 1994). SHH-N carries all signalling activity of SHH and is palmitoylated in the N-
terminus by the HHAT acyl transferase, whereas its C-terminus is covalently-linked to a 
cholesterol moiety (Beachy et al. 1997; Chen et al. 2004). Studies in mutant mouse embryos 
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show that release of SHH-N depends on the transmembrane protein dispatched 1 (DISP1), 
and studies in Drosophila demonstrate that the lipid modifications on HH are essential for its 
secretion and formation of diffusible multimeric HH complexes, and for its signaling potency 
and range of action (Caspary et al. 2002; Chen et al. 2004; Kawakami et al. 2002; Lewis et 
al. 2001). Once released from its source, SHH distribution is modulated by binding to its 
receptor – the twelve-transmembrane-pass protein Patched (PTCH), and to the vertebrate 
Hedgehog-interaction protein HHIP (which is absent in Drosophila), both restricting 
hedgehog’s diffusion range (Bishop et al. 2009). 
Mechanistically, hedgehog ligands exert their effects by blocking the generation of 
repressor forms of the transcription factor cubitus interruptus (CI) in Drosophila, and its 
homologs – the glioblastoma-associated (GLI) factors – GLI2 and GLI3, in amniotes, as 
described in more detail below (Alexandre et al. 1996; Aza-Blanc et al. 1997; Sasaki et al. 
1999). 
1.8.2. Transduction of the HH signal 
The core of the canonical SHH signalling cascade is similar in flies and vertebrates. Below is 
presented a description of the Drosophila HH pathway with comments on its differences in 
vertebrates. In the absence of hh ligand, the transmembrane receptor patched (PTCH) inhibits 
the heptahelical transmembrane protein smoothened (SMO and prevents its localization to 
the plasma membrane (Beachy et al. 2010), perhaps by modulating the levels of 
phosphatidylinositol-4-phosphate (PI4P) (Yavari et al. 2010). Smoothened is essential for 
activation of hh signaling in both flies and vertebrates (van den Heuvel and Ingham 1996; 
Varga et al. 2001; Zhang et al. 2001). In these conditions, the serine/threonine kinases protein 
kinase A (PKA), glycogen synthase kinase 3 (GSK3) and casein kinase I (CKI) 
phosphorylate and target Cubitus Interruptus, or GLI in vertebrates, for proteasomal 
processing into a repressor form – CI-R, or GLI-R, respectively (Jia et al. 2005; Price and 
Kalderon 2002; Tempe et al. 2006). These repressor forms enter the nucleus where they 
silence the expression of SHH-target genes.  
A key role in recruiting the kinases to CI/GLI is played by the motor protein Costal 2, 
COS2, (or KIF7 in vertebrates), which forms a complex with SMO, CI/GLI, PKA, GSK3 and 
CKI in the absence of hh (Endoh-Yamagami et al. 2009; Sisson et al. 1997). However, 
binding of HH to PTCH, which is assisted by the transmembrane proteins IHOG and BOI 
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(and their vertebrate orthologs - CDO and BOC, respectively) (Tenzen et al. 2006; Zheng et 
al. 2010), allows SMO to be translocated to the cell surface (Liu et al. 2007). This 
translocation appears to depend on the activity of another serine/threonine kinase – fused, 
FU, that phosphorylates COS2 at Ser572 resulting in the dissociation of CI/GLI from the 
COS2-PKA-GSK3-CKI complex and preventing the generation of CI-R/GLI-R (Liu et al. 
2007; Ruel et al. 2007). Upon HH reception, Fused also phosphorylates Suppressor-of-fused, 
SUFU, permitting the release of full length CI/GLI from an inhibitory CI/GLI-sufu complex 
in the cytoplasm, and its subsequent translocation into the nucleus where it activates HH-
responsive genes (Methot and Basler 2000; Wang et al. 2000).  
Despite the described similarities with Drosophila, vertebrate HH signaling features 
some differences. For instance, instead of a single Ptch gene, vertebrate genomes encode two 
paralogs – Ptch1 and Ptch2 (Carpenter et al. 1998; Lewis et al. 1999; Motoyama et al. 1998). 
Also, vertebrate SUFU is required for GLI processing into a repressor form via recruitment 
of GSK3β to the PKA-CKI-KIF7 complex, in addition to inhibiting the release and nuclear 
translocation of full-length GLI (Cooper et al. 2005; Humke et al. 2010; Kise et al. 2009). 
Importantly, vertebrate HH signaling depends on the primary cilium (Corbit et al. 2005; Kim 
et al. 2010). In the absence of SHH, patched is present in the cilium where it blocks the 
ciliary accumulation of smoothened, while when present SHH causes eviction of patched 
from the cilium and accumulation of SMO and the GLI-SUFU complex, followed by release 
of full-length GLI (Rohatgi et al. 2007; Tukachinsky et al. 2010). The SHH-triggered 
translocation of GLI to the cilium requires KIF7, whereas in the absence of SHH, KIF7 
localises to the basal body of the cilium which is enriched in PKA and proteasomal 
complexes (Ingham et al. 2011; Liem et al. 2009). In summary, the organisation of the HH 
signaling cascade is largely conserved between flies and vertebrates, where HH reception by 
patched blocks its inhibitory effect on smoothened which prevents the formation of CI-
R/GLI-R forms, hence allowing the generation of CI-A/GLI-A and HH-target gene activation 
(Huangfu and Anderson 2005). 
1.8.3. The GLI transcription factors are mediators of HH signaling in vertebrates 
The mammalian genome encodes three paralogs of the GLI family – GLI1, GLI2 and GLI3 
which are Zn-finger domain-containing DNA-binding transcription factors (Matise and 
Joyner 1999). GLI2 and GLI3 are bifunctional as they exist as either activator or repressor 
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forms depending on the presence or absence of HH ligands, whereas GLI1 possesses only 
activator properties (Hui and Angers 2011). The repressor ability of GLI2 and GLI3 is 
determined by an N-terminal repressor domain, which is absent in GLI1, while all three 
proteins have a C-terminal trans-activation domain, with the Zn-finger DNA-binding domain 
located in between (Ruiz i Altaba et al. 1999; Sasaki et al. 1999). In addition, GLI2 and GLI3 
harbour, like CI, a processing determinant domain (PDD) which is necessary for limited 
proteolysis and generation of GLI-R forms (Smelkinson et al. 2007; Wang and Li 2006). 
 Genetic studies in mice have demonstrated that GLI2 and GLI3 are the major 
mediators of SHH signaling in mammals and are essential for normal embryogenesis, with 
GLI2 acting primarily as an activator, and GLI3 acting primarily as a repressor of HH target 
genes (Ding et al. 1998; McDermot et al. 2005; Motoyama et al. 1998; Persson et al. 2002). 
The cause for the predominantly activator function of GLI2 appears to be a less potent PDD 
than the one in GLI3, resulting in complete proteasomal degradation upon phosphorylation 
by PKA, GSK3-beta and CKI, such that very small amount of GLI2-R is produced (Pan and 
Wang 2007). Gli1 gene expression is induced upon HH pathway activation, and is thought to 
amplify the target cell response to HH signaling, but appears to be dispensable for murine 
development (Bai et al. 2002; Bai et al. 2004; Park et al. 2000). However, in vertebrates like 
zebrafish and Xenopus, Gli1 rather than Gli2a/b is the main activator of Hh signaling in early 
development (Karlstrom et al. 2003; Lee et al. 1997). Interestingly, other post-translational 
modifications also modulate GLI factor activity. Deacetylation of acetylated GLI1 and GLI2 
in NIH3T3 cells by HDAC1 promotes their trans-activatory potential (Canettieri et al. 2010), 
analogous to the effects of SUMO-ylation of GLI1/2/3 in the chicken neural tube catalyzed 
by the SUMO E3 ligase PIAS1 (Cox et al. 2010). 
 All three GLI transcription factors bind to DNA with similar affinity at the consensus 
motif  5’-TGGGTGGTC-3’ using Cys2His2 Zn-fingers 4 and 5 of their DNA-binding domain 
(Kinzler and Vogelstein 1990; Hallikas et al. 2006; Pavletich and Pabo 1993). However, 
genome-wide studies of GLI occupancy in cell culture and in vivo revealed the presence of 
non-canonical GLI binding motifs, and that indirect binding of GLI to DNA mediated by 
protein-protein interactions is not unlikely (Vokes et al. 2007; Vokes et al. 2008). GLI target 
genes comprise both universal targets that are regulated in all HH-responsive tissues and 
these include Ptch1, Ptch2, Gli1, Hhip, Boc and Cdo (Chuang and McMahon 1999; Lee et al. 
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2010; Tenzen et al. 2006), and specific targets that are regulated in particular tissues only, 
such as the Foxa2 gene in the floor plate, Gremlin and Hand2 in the limb buds, and Myf5 and 
Lama1 in somites (Anderson et al. 2009; Borycki et al. 1999; Sasaki et al. 1997; Vokes et al. 
2008). 
1.8.4. SHH and dorso-ventral patterning of the neural tube 
Initially secreted from the notochord, and then from the floor plate, the lipidated and 
multimeric SHH-N establishes a dynamic gradient directed along the dorso-ventral (DV) axis 
of the neural tube, where the spread and stability of SHH is negatively influenced by binding 
to atched and HHIP1, and positively affected by interactions with HSPGs, CDO, BOC and 
GAS1 (Echerald et al. 1993; Incardona et al. 2002; Martinelli and Fan 2007; Rubin et al. 
2002). The ventral-to-dorsal gradient of SHH establishes six distinct progenitor domains in 
the ventral neural tube – floor plate, p3, pMN, p2, p1 and p0, by regulating the spatial 
expression of multiple homeodomain (HD) and basic helix-loop-helix (bHLH) transcription 
factors (Briscoe et al. 2000). The target genes of SHH signaling in the neural tube belong to 
two classes: Class I genes are repressed by SHH and these include Pax3, Pax6, Pax7, Irx3 
among others (Ericson et al. 1997; Mansouri et al. 1998), while Class II targets - like Foxa2, 
Olig2, Nkx2.2, Nkx6.1, Dbx1, Dbx2 (Briscoe et al. 1999; Sander et al. 2000; Sasaki et al. 
1997), are activated by SHH (Jessell 2000). Thus, graded SHH generates distinct expression 
domains of HD and bHLH factors with sharp boundaries, which are maintained by cross-
regulatory interactions between the two classes of targets, and the combinatorial expression 
of different factors spatially defines the progenitor cell domains (Dessaud et al. 2008). 
 
SHH patterns the neural tube via a gradient of GLI activity 
Graded SHH signalling patterns the ventral neural tube by generating a parallel gradient of 
GLI activity, where GLI repressor potential is progressively attenuated, while GLI activator 
function is promoted in ventral-to-dorsal direction (Jacob and Briscoe 2003). Each GLI 
protein contributes to the sum gradient of GLI activity and this combined input determines 
the gene expression response of target cells to SHH signaling (Ribes and Briscoe 2013). 
Thus, the specific role of individual GLI factors is determined by their expression pattern and 
levels in the neuroepithelium, by their inherent transcriptional regulatory activity and by their 
post-translational regulation by SHH (Dessaud et al. 2008).   
 
 
  
29 
Expression of GLI 1, 2 and 3 in the murine neuroectoderm initiates slightly before 
E7.5 when all three genes are expressed uniformly along the dorso-ventral (DV) axis of the 
neural tube (Hui et al. 1994). At E9.5 GLI1 is restricted to the ventral half of the tube, GLI2 
is expressed ubiquitously (but is excluded from the floor plate) with slightly higher 
expression in the dorsal neural tube, whereas GLI3 is restricted to intermediate and dorsal 
levels, and this pattern is maintained at later stages but limited to the ventricular zone (Hui et 
al. 1994; Lee et al. 1997; Sasaki et al. 1997). Zebrafish gli genes are similarly expressed 
along the DV axis of the neural tube. At early stages, gli2a and gli3 mRNA transcription 
initiates throughout the neuroectoderm, but by 15 hpf they become restricted to the dorsal 
neural tube, while gli1 expression displays a complementary pattern with high mRNA levels 
in the ventral neural tube and absence of expression in the floor plate and dorsal neural tube 
(Karlstrom et al., 1999; Karlstrom et al., 2003; Tyurina et al., 2005; Vanderlaan et al., 2005). 
Interestingly, there are distinct requirements for GLI proteins during dorso-ventral 
patterning of the neural tube. In amniotes, GLI2 predominantly functions as a transcriptional 
activator and appears to be essential for generating the highest SHH signalling response for 
Gli2
-/-
 mutant mouse embryos failed to specify the floor plate cells and V3 interneurons in 
the ventral-most domain of the tube (Ding et al. 1998). GLI1 appears more or less 
dispensable for neural tube patterning by SHH for Gli1-defficient mice are viable and display 
no behavioral abnormalities, indicating that its absence is compensated by another GLI factor 
(Park et al. 2000). In fact, Gli1;Gli2 double mutants die perinatally and have multiple defects 
including loss of ventral spinal cord fates (Park et al. 2000), whereas replacement of Gli2 
with Gli1 rescues the Gli2-null phenotype suggesting that it is the GLI activator function that 
is required for ventral NT patterning (Bai and Joyner 2001). In contrast, GLI3 operates 
mostly as a repressor for Gli3
-/- 
embryos display dorsal expansion of intermediate neural 
progenitors (Persson et al. 2002), while combined inactivation of Gli3 and Shh leads to 
normal specification of ventral progenitor domains except for the floor plate an V3 
interneuron identities (Litingtung and Chiang 2000).  
Thus, a model is proposed according to which SHH is required for motor neuron and 
V0-2 interneuron specification by removal of GLI3 repressor function resulting in de-
repression of target genes, while patterning of V3 interneuron and floor plate identities by 
SHH depends on GLI2 activator inputs (Ribes and Briscoe 2009). 
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Dorso-ventral patterning of the zebrafish neural tube is also effected by Shh-regulated 
Gli transcription factor activity, although the exact role of each Gli factor is slightly distinct 
than in amniotes. In gli1-deficient fish (in the detour (dtr) mutants), induction of the cranial 
motor neurons fails, but spinal cord motor neurons are unaffected (Chandrasekhar et al. 1999; 
Karlstrom et al. 1996). The yot (you-too) mutants express a dominant repressor form of gli2a 
and feature severe reduction of motor neurons in the brain and spinal cord (Karlstrom et al. 
1999). Application of gli3 morpholinos leads to profound decrease in the number of cranial 
and spinal motor neurons, as well as retinal ganglional cells, and to ectopic activation of gli1 
and fkd4 in the dorsal neural tube at 24 hpf (Tyurina et al. 2005; Vanderlaan et al. 2005). 
Taken together, these observations reveal that both Gli1 and Gli3 activator are required for 
ventral neural tube patterning in zebrafish, while Gli2a and Gli3 repressor forms are needed 
to oppose the activation of Shh target genes in the dorsal neural tube (Karlstrom et al. 2003; 
Tyurina e t al. 2005; Vanderlaan et al. 2005).  
 
1.9. Transcription-regulatory elements 
The precise control of developmental gene expression in time and space is ensured by the 
combinatorial binding of transcription factors to multiple, relatively short (100 bp - 1 kb) 
genomic regions called transcription-regulatory elements (TREs) (Lagha et al. 2012) which, 
apart from promoters, also include enhancers, silencers, insulators, locus control regions 
(LCRs), tethering elements, etc (Davidson 2006). Below is provided a brief description of the 
main classes of TREs, namely the core promoter, enhancers, silencers and insulators. 
 
1.9.1. The core promoter 
By definition, the core promoter is the minimal set of sequence motifs required for the 
initiation of gene transcription by RNA pol II (Watson et al. 2004). Core promoters can be 
focused or dispersed, differing in the number and distribution of transcription start sites: 
focused promoters initiate transcription from a single site or from a small cluster of start sites 
spread over few nucleotides; dispersed promoters harbour several start sites dispersed over a 
region of 50 – 100 base pairs (Muller and Tora 2013). Focused promoters are composed of a 
combination of sequence motifs including the TATA-box, Inr (initiator), BRE (TFIIB 
recognition element), DPE (downstream ptomoter element), MTE (motif ten element), and 
others, while dispersed promoters often correlate with CpG islands (Juven-Gershon et al. 
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2008). Importantly, core promoters serve as binding sites for the general transcription factors 
(GTFs) which recruit RNA polymerase II (RNA pol II), and together establish the pre-
initiation complex poised for transcriptional initiation (Muller and Tora 2013).  
 However, efficient gene transcription in vivo often requires additional inputs from 
transcription factors bound to other regulatory elements, often located hundreds or thousands 
of base pairs away from the core promoter, which modulate the rate of transcription initiation 
through a variety of mechanisms (Watson et al. 2004). 
 
1.9.2. Transcriptional enhancers 
Transcriptional enhancers are classically defined as genomic regions that enhance 
transcription initiation from a promoter in a distance- and orientation-independent manner 
when tested on plasmids constructs (Bulger and Groudine 2011), although there are examples 
of enhancer-like elements whose activity is orientation-dependent or diminishes with 
increasing the distance to the target promoter (Hozumi et al. 2013; Swanson et al. 2010). 
Enhancers are located in the introns of their target genes, or upstream or downstream of the 
target promoters, often at huge distances – up to 1 Mb in the case of the ZPA-enhancer of the 
mammalian Shh gene (Lettice et al. 2003). Enhancer elements have diverse sequences, which 
in many cases feature high substitution rates during evolution (Taher et al. 2012), and serve 
as combinatorial-binding platforms for tissue-specific transcription factors (Laga et al. 2012). 
As such, transcriptional enhancers are central components of developmental gene regulatory 
networks and play important role in the evolution of organismal complexity (Davidson 2006; 
Levine 2010; Wittkop and Kalay 2011).  
 Mechanistically, enhancers modulate the transcription rate of their target genes 
through direct or indirect interactions of the enhancer-bound transcription factors with the 
transcription machinery at the core promoter (Faro-Trindade and Cook 2006; Fuda et al. 
2009). There is also evidence that transcriptional activators at enhancers can recruit histone 
modifying and chromatin remodelling complexes that create a transcription-permissive 
environment by changing nucleosome conformation and distribution along DNA (Bulger and 
Groudine 2011), and that many enhancers are themselves transcribed as non-coding RNAs 
(Natoli and Andrau 2012). Further details on enhancer function and evolution are provided in 
the discussions of the result chapters of this study. 
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1.9.3. Transcriptional silencers 
Transcriptional silencers are regulatory elements bound by transcriptional repressor proteins 
that negatively affect expression of their target genes by either directly interfering with the 
transcription machinery at a promoter, or by suppressing the activity of some enhancers 
(Ogbourne and Antalis 1998), which is often achieved by the induction of a repressive 
chromatin state at the target gene (Gaston and Jayaraman 2003; Talbert and Henikoff 2006). 
Similarly to enhancers, silencers can be located up- or downstream, or in the introns of their 
target genes, and some exhibit orientation-dependent behaviour (Shei and Broach 1995; 
Ogbourne and Antalis 1998). Well studied silencer elements are the PREs (Polycomb 
Response Elements), associated with the repressive function of the polycomb group proteins 
(Bantignies and Cavalli 2011), and the NRSE (Neuron-Restrictive Silencer Element) that 
binds the REST repressor and is involved in the silencing of neuronal gene transcription 
(Mori et al. 1992) (discussed in Section 7.4.5)  
 
1.9.4. Insulators 
For precise regulation of developmental gene expression it is essential that the enhancers of a 
particular gene do not interfere with the expression of other genes nearby. This is ensured by 
the CTCF (CCCTC-binding factor)-bound insulator elements which are a class of regulatory 
sequences that are able to insulate the promoter of a gene from the activity of nearby 
enhancers when located between the promoter and enhancers (Gaszner and Felsenfeld 2006), 
while other insulators act as boundary elements that prevent the spreading of repressive or 
activating chromatin states in neighbouring genomic regions with opposite chromatin states 
(Essafi et al. 2011). One of the models of enhancer-blocking insulator function postulates that 
insulators prevent the activation of neighbouring genes by the enhancers of another gene 
through the formation of chromosome loops where several insulator elements within a 
genomic region interact with each other (Herold 2012). There is evidence that the change in 
chromosome conformation is facilitated by the cohesin complex (Wendt et al. 2008), which 
can physically interact with CTCF (CCCTC-binding factor) and is essential for long-distance 
chromatin contacts (Nativio et al. 2009). According to this model, one of the insulators must 
be positioned in between the enhancer and the insulated genes (Gaszner and Felsenfeld 
2006), which brings the enhancer in a chromosome loop that, by some unclear mechanism, 
prevents it from acting on genes located outside of the loop. This is the mechanism thought to 
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block expression of the maternal copy of the Igf2 gene in mice (Kanduri et al. 2000; Kurukuti 
et al. 2006) and the process thought to mediate the function of the Fab insulators in the 
Drosophila bithorax complex of homeotic genes (Kyrchanova et al. 2011; Maeda and Karch 
2006). In addition, there is also evidence that CTCF-bound insulators can physically 
associate with enhancers (Handoko et al. 2011) presenting another possible mechanism of 
enhancer-blocking activity by insulators. 
1.10. Methods for the prediction of transcription-regulatory elements 
The prediction of transcription-regulatory elements is generally more difficult compared to 
prediction of the coding portions of the genome due to the relatively small size, lack of 
ATG/stop codon marks and exon-intron boundaries, and the low level of sequence 
conservation in regulatory elements (Elgar 2009). However, several approaches exist, 
grouped in two categories – direct and indirect, which allow the prediction of putative TREs 
(Nelson and Wardle 2013).  
1.10.1. Direct (biochemical) methods  
Currently, the most frequently employed direct approaches include chromatin 
immunoprecipitation (ChIP) and DNaseI hypersensitivity (DHS) assays which, when 
combined with next-generation DNA sequencing methods, enable genome-wide prediction of 
TREs. Both methods are described in more detail below. 
1.10.1.1. Prediction of TREs based on transcription factor occupancy and/or histone 
modifications as revealed by ChIP-seq 
Mechanistically, TREs serve as scaffolds for the combinatorial binding of transcription 
factors to short binding motifs within the nucleotide sequence of the element (Davidson, 
2006). The detection of such motifs in a sequence of interest forms the basis of the 
computational prediction of TREs. However, such prediction is not an indication of 
biochemical potential or the ability of the motif to be recognised and bound by its cognate 
transcription factor in vivo. Moreover, the binding of a particular TF to its motif depends on 
the tissue type and/or developmental stage (Levine, 2010). Chromatin immunoprecipitation 
allows for the identification of transcription factor binding sites of interest through-out the 
whole genome (ChIP-seq) in different tissues, stages and conditions (Park 2009). However, 
this method requires the availability of tested antibodies against the transcription factor of 
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interest. Due to the limited availability of GLI antibodies, ChIP is therefore not a preferred 
method for the prediction of Lama1’s TREs, in regard to this study. 
However, the ChIP-seq method can be used to catalogue the genome-wide 
distribution of specific post-translational histone modifications like lysine mono-, di- or 
trimethylation on histone 3 and histone 4 (Rea et al. 2000; Martin et al. 2005), lysine 
acetylation on on all four core histones (Hebbes et al. 2000), serine phosphorylation on 
histone 3 (Mahadevan et al. 1991; Nowak et al. 2004), mono-ubiquitylation of H2A and H2B 
(Wang et al. 2004), etc. Importantly, many of these modifications are inherently plastic, or 
reversible, with specifically dedicated enzymes performing the opposite reactions (Shi et al. 
2004; Kurdistani et al. 2003). Moreover, the same locus can harbour different histone marks 
in different tissues or developmental stages (Rada-Iglesias et al. 2011; Cotney et al. 2012). In 
effect, the combinatorial pattern of diverse histone marks is thought to substantially affect the 
regulation of gene transcription and chromosome organisation (Stock et al. 2007; Munshi et 
al. 2009).  
Several studies have demonstrated that particular genomic regions like promoters, 
coding sequences and enhancers are enriched for certain types of histone modifications 
(Kimura 2013). For instance, the promoters of activated genes are generally marked by 
H3K27ac (acetylation of lysine 27 in histone 3) and H3K4me3 (tri-methylation of lysine 4 in 
histone 3) (Heintzman et al. 2007); the bodies of actively transcribed gene loci associate with 
H3K36me3 (Wagner 2012); active enhancers are enriched for H3K27ac and H3K4me1 
(Rada-Iglesias et al. 2011; Spicuglia et al. 2012), while silenced regions are marked by 
H3K9me3 or H3K27me3 (Kim et al. 2012; Young et al. 2011). Thus, these modifications can 
serve as markers for the prediction of un-annotated regulatory elements, which is clearly 
demonstrated by the identification of 2489 putative melanocyte enhancer elements in a ChIP-
seq assay for H3K4me1 enrichment in murine melanocytes (Gorkin et al. 2012).  
In addition, the ChIP-seq method can also uncover enhancers characterised by the 
recruitment of the p300/CBP histone acetyltransferase co-activator to DNA-bound 
transcriptional activators (Imhof et al. 1997; Holmqvist et al. 2013). Consistent with this, a 
ChIP-seq assay of p300 binding in E11.5 mouse embryo heart tissue identified more than     
3, 000 putative enhancers which show shallow evolutionary conservation and could not be 
isolated by phylogenetic footprinting (Blow et al. 2010). Remarkably, lacZ reporter 
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transgenesis revealed that 81 of the 130 tested sequences were active in the developing heart, 
clearly indicating the utility of using p300 as a marker of putative enhancer regions, 
especially divergent ones (Blow et al. 2010). Thus, unexplored genomic regions enriched for 
p300 binding are good candidates for enhancer function (Visel et al. 2009). 
In summary, the ChIP-seq approach is a powerful method that is not only restricted to 
the confirmation of direct binding of transcription factors to their targets in vivo, but can also 
be used to identify previously unknown tissue-specific regulatory elements. 
1.10.1.2. Prediction of TREs in DNaseI hypersensitive domains 
A complementary approach for whole-genome discovery of putative regulatory elements is 
the DNaseI hypersensitivity (DHS) assay combined with next-generation sequencing 
platforms – DNase-seq (Boyle 2008). The DNaseI hypersensitivity assay relies on the 
identification of genomic regions with less compact nucleosome configuration which renders 
DNA more accessible (hypersensitive) to digestion by DNaseI (Ballare et al. 2013) as 
compared to DNA in tightly packed chromatin. It is believed that such “open chromatin” 
regions mark functionally active sites in the genome involved in the regulation of gene 
transcription (Thurman et al. 2012). In fact, multiple studies have shown that DNaseI 
hypersensitive sites correlate with various functional types of TREs. For instance, an 
extensive survey for hypersensitive sites in the intergenic region upstream of the IL-3 gene in 
humans, identified a complex cluster of both constitutive and inducible hypersensitive sites 
which corresponded to hitherto unknown enhancers of IL-3 that are required for precise in 
vivo expression of this gene in T-cells, myeloid progenitors and mast cells (Baxter et al. 
2012). Other studies have revealed that DNaseI hypersensitivity marks not only enhancer and 
promoter elements but also locus control regions (Fu et al. 2002; Kim et al. 2010; Kim et al. 
2013), silencers (Feng et al. 2005; Zarnegar et al. 2010) and insulators (Chen et al. 2001; 
Sultana et al. 2011; Follows et al. 2012).  
Taken together, these observations illustrate the utility of DHS assays for uncovering 
transcriptional regulatory elements. Moreover, meta-analysis of genome-wide DNaseI 
hypersensitivity and ChIP studies have revealed significant overlap between hypersensitive 
sites and various histone modifications (Shu et al. 2011). This demonstrates that the 
combination of data from both DHS and ChIP assays is a powerful strategy for the prediction 
of developmentally relevant transcriptional regulatory elements.  
 
 
  
36 
1.10.2. Indirect methods  
The indirect methods for prediction of transcription-regulatory elements rely on 
computational analyses in silico using genomic sequence information alone. There are two 
main approaches to in silico analyses. The most popular and straightforward strategy, 
phylogenetic footprinting, consists in performing multi-species genomic comparisons with 
the aim of identifying discrete evolutionary-conserved non-coding regions, which might 
possess characteristics of TREs (Blanchette and Tompa 2002). The other strategy employs a 
relatively novel technique which does not require sequence conservation, but predicts 
putative TREs using a model of the pattern of transcription factor binding sites (TFBSs), or 
motif grammar, that defines a particular functional class of regulatory elements (Spitz and 
Furlong 2012), as described below. 
1.10.2.1. Computational prediction of TREs based on sequence organisation/pattern, 
irrespective of overall conservation 
An increasing number of studies report on TREs with divergent sequence yet retaining 
similar or identical function across species (Fisher et al. 2006; Nelson and Wardle 2013). 
Such elements evade prediction by the methods based on evolutionary conservation of 
sequence, like phylogenetic footprinting (Blow et al. 2010), described later. In recent years 
however, new computational developments were designed to address this problem building 
on the idea that each TRE features a specific organisational pattern or architecture 
represented by a particular composition, number, order and spacing of TFBSs (Davidson 
2006; Evans et al. 2012). In the cases where functionally conserved TREs lack overt 
sequence conservation, they may still retain corresponding individual TFBSs or clusters of 
TFBSs. This allows one to derive a picture of the pattern of TFBSs or “regulatory grammar” 
that characterises a particular functional class of TREs (Senger et al. 2004), which then can 
be used to predict novel TREs by probing the genome for the existence of regions with 
similar organisation. This approach has been successfully deployed in a small number of 
studies. For instance, Senger et al. (2004) performed SELEX (Systematic Evolution of 
Ligands for Exponential Enrichment) assays to characterise the TFBSs of REL and GATA 
factors (two classes of transcription factors involved in the activation of innate immunity 
genes in Drosophila) followed by computational analysis of the 5’-flanking regions of 50 of 
the innate immunity genes. Interestingly, it was revealed that more than half of these genes 
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harbour a shared REL-GATA module with fixed/constrained organisation (distance and 
orientation between the REL and GATA motifs), features that appear to be essential for the 
regulatory activity (Senger et al. 2004). 
In another genome-wide comparison between human and zebrafish combined with 
TFBSs-pattern identification analysis, Taher et al. (2011) demonstrated the existence of 
hundreds of divergent but corresponding non-coding regions in the human/zebrafish genome. 
Importantly, despite the lack of overt sequence conservation, the pairs of human/zebrafish 
elements displayed shared pattern of TFBSs architecture, suggestive of a conserved function. 
Consistent with this idea, many of the human sequences overlapped with sites where the 
transcriptional coactivator p300 is enriched, strongly hinting for roles in transcriptional 
regulation. In fact, 8 out of 18 human sequences displayed tissue-specific enhancer activity in 
transgenic zebrafish embryos, which was remarkably similar to the activity displayed by their 
orthologous sequences from zebrafish. Thus, a computational approach, based on the 
presence of common regulatory encryption, is able to successfully uncover functionally-
conserved cryptic TREs (called “covert” elements) despite the lack of overall sequence 
similarity (Taher et al, 2011). 
However, it is also true that many functionally-similar transcription-regulatory 
elements lack recognizable motif grammar; instead, they display considerable variation in the 
content, order, spacing and orientation of the TFBSs, yet generating the same output, as is the 
case with the regulation of the RET gene in human and zebrafish (Fisher 2006), the cardiac 
TREs in Drosophila (Junion 2012) and the promoters of ribosomal protein (RP) genes in 
yeasts (Hogues 2008). The latter case is particularly striking for S. cerevisiae uses a 
completely different set of transcription factors to regulate its ribosomal gene promoters 
compared to C. albicans. In the former species, the promoters of the RP genes are controlled 
by Rap1, Fhl1 and Ifh1, while in the latter the same function is performed by Tbf1 and Cbf1 
(Hogues 2008). 
Altogether, this flexibility in TFBSs composition and configuration renders many 
TREs difficult to predict computationally, especially in the absence of sequence conservation 
(Bery 2013). 
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1.10.2.2. Comparative genomics and TRE prediction 
Comparative genomics consists in the alignment of genomic sequences from two or several 
different species, and relies on the conservation of functionally-relevant regions. This 
strategy is widely applied in the annotation of coding genes in newly-sequenced genomes, 
and in the reconstruction of organismal phylogenies (Ureta-Vida et al. 2003). Notably, 
comparative genomics can be used for the prediction of transcription-regulatory elements, in 
a procedure known as “phylogenetic footprinting”. The latter method consists in aligning 
orthologous genomic regions from different species which results in the identification of 
evolutionary conserved non-coding elements (or CNEs) in the sequences. The phylogenetic 
footprinting rests on the classic molecular evolution paradigm that mutations (base-pair 
substitutions, indels, translocations) in functionally-important genomic regions are likely to 
be deleterious and subject to negative (purifying) selection leading to lower rates of change 
compared to functionally-neutral sequences (Blanchette and Tompa 2002). In effect, the 
conserved elements appear as “footprints” in the neutrally-evolving background (Zhang and 
Gerstein 2003). 
The output of a phylogenetic footprinting analysis strongly depends on the choice of 
species for comparison (comparators), or the scope. Comparisons between highly divergent 
species (for instance, between mouse and zebrafish, whose last common ancestor lived more 
than 419 million years ago (Zhu et al. 2009)) would yield elements that are shared across 
deep phylogenies. Conversely, in a variant approach called “phylogenetic shadowing” 
(Berezikov et al. 2005), genomic alignments between closely related species could be used to 
uncover short species-specific differences (instead of similarities) embedded in long stretches 
of highly homologous sequence. Importantly, a phylogenetic footprinting study which 
combines both phylogenetically close and disparate comparators allows for the identification 
of clade-specific conserved non-coding elements (CNEs) (Müller et al. 2002).  
Phylogenetic footprinting analyses can be deployed at different scales - genome-wide 
(Woolfe et al. 2005; Pennachio et al. 2006), chromosome-specific (Royo et al. 2011) or gene-
centric (Uchikawa et al. 2003; Navratilova et al. 2009; Sato et al. 2012). The number of 
CNEs that is usually retrieved in a phylogenetic footprinting study depends on the scale of 
analysis, the phylogenetic distance between the compared species and the stringency 
parameters of the alignment algorithm and can vary from tens – in gene-centric alignments, 
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to several hundred thousand – in whole-genome alignments of placental mammals (Haeussler 
2011; Bejerano et al. 2004; Visel et al. 2007). 
The phylogenetic footprinting approach is advantageous over other methods for TRE 
prediction (such as ChIP-seq, DNaseI HS and the motif grammar-based methods) as it does 
not require prior knowledge on transcription-factor binding or the design of complicated 
motif-grammar algorithms, and can be used with pre-computed whole-genome alignments 
(Ureta-Vidal et al. 2003), thus enabling rapid identification of conserved elements. A major 
limitation of the phylogenetic footprinting is the difficulty or inability to identify 
functionally-conserved TREs that are highly divergent in sequence (Nelson and Wardle 
2013). Consequently, phylogenetic footprinting may fail to detect rapidly-evolving, but still 
genuine TREs. Nevertheless, this method has been effectively used in several model species 
for the prediction of enhancers and other regulatory elements that were subsequently 
functionally validated in vivo, as described in Section 4.2. 
 
1.11. Functional validation of candidate transcription-regulatory elements 
Once a candidate transcription-regulatory element has been predicted either biochemically or 
computationally, the next step is validation of its putative activity. This can be achieved 
using reporter gene constructs in cell culture and/or in transgenic animals (in vivo) (Carey 
and Smale 2000). The cell culture approach, together with its advantages and limitations, is 
discussed in Chapter 5.  
The best environment for functional validation of a predicted TRE is the whole 
embryo, ideally from the same biological species as the species-of-origin of the candidate 
element. This is so, for the whole embryo could potentially provide all signalling molecules 
and transcription factors necessary for the activity of the candidate TRE, and thus to enable 
the examination of the element’s function in specific tissues and developmental stages 
(Haeussler and Joly 2011). 
 
1.11.1. Zebrafish as a tool for the validation of candidate TREs 
In order to examine in vivo the putative regulatory function of a genomic region, a CNE for 
instance, the tested element is cloned upstream of a minimal promoter driving a reporter 
gene, usually the bacterial lacZ gene (McGregor et al. 1991), or the GFP gene from the 
hydrozoan Aequorea victoria (Amsterdam et al. 1995; Chalfie et al. 1994), followed by 
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micro-injection the CNE::reporter constructs in 1-cell stage embryos. The ideal strategy for 
candidate mammalian TREs is to inject a CNE::lacZ construct in mouse oocytes and then 
assay for lacZ activity in the transgenic embryos (Nagy et al. 2003).  
However, the latter approach is both laborious and expensive especially for screening 
a large number of elements. Moreover, the analyses can only be performed at one temporal 
stage at a time due to the intra-uterine nature of mouse development. Therefore, a faster and 
financially less demanding strategy is necessary for the initial screening of mammalian 
elements. Such an alternative is the analysis of these elements in transiently transgenic 
zebrafish embryos where a tested element regulates the expression of a fluorescent protein 
reporter gene, such as GFP (Amsterdam et al. 1995). Although this strategy leads to 
mosaicism, the reproducibility in reporter gene expression, combined with the large number 
of fertilized eggs, the extra-maternal nature of early zebrafish development, and the optical 
transparency of the embryos, renders monitoring the activity of putative regulatory elements 
possible in real time and across multiple stages (Higashijima et al. 1997; Nüsslein-Volhard 
and Dahm 2002). 
Numerous studies have exploited this approach to uncover enhancers of 
developmental genes in mice and humans (Sacilotto et al. 2013; Oksenberg et al. 2013; 
Tamplin et al  2011; Hernandez-Vega et al. 2011; Ghiasvand et al. 2011; Amigo et al. 2011; 
Shin et al. 2005; Abbasi et al. 2007). For instance, a GFP-based reporter screen in transient 
transgenic zebrafish and mouse embryos revealed neural tube-specific enhancer activity of 
conserved intronic regions in the autism-associated human AUTS2 gene (Oksenberg et al. 
2013). Another investigation into the notochord-specific targets of the FOXA2 transcription 
factor in mice combined cell sorting, microarray-based gene expression screening and ChIP 
to identify the cis-regulatory modules that bind FOXA2 (Tamplin et al. 2011). The putative 
mouse regulatory regions were subsequently tested for their ability to direct notochord-
specific GFP reporter expression in zebrafish embryos which resulted in the identification of 
7 elements, whose activity requires intact FOXA2 sites. Importantly, these mouse enhancers 
are not conserved in zebrafish and could not have been detected on the basis of phylogenetic 
sequence comparisons (Tamplin et al. 2011). Thus, despite the lack of sequence 
conservation, murine regulatory elements were able to respond to the notochord-specific 
trans-environment in the zebrafish embryo and directed reporter expression according to the 
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expected pattern. This study, together with the discovery of functionally conserved but 
sequence-divergent enhancers of the RET gene in human and zebrafish (Fisher et al. 2006), 
illustrates well the power of the zebrafish model system to analyse the putative activity of 
non-conserved mammalian elements. 
Importantly, the preliminary validation of a tissue-specific transcriptional enhancer in 
transiently transgenic zebrafish must be supported by a demonstration of its activity in stable 
lines (Ishibashi et al. 2013). Usually, several lines are generated and analysed for a common 
issue in enhancer screens is the “variability of position effects” (Roberts et al. 2014), that is 
the variation in reporter’s expression pattern among transgenic lines due to different 
integration sites of the enhancer::reporter construct (Roberts et al. 2014; Ishibashi et al. 
2013). The latter phenomenon is a combined result of: 1) the potential influence of cryptic 
TREs nearby the integration site that can enhance, attenuate or ectopically modify the 
reporter’s gene expression; and 2) the random integration of the enhancer::reporter construct 
in the host genome (Ishibashi et al. 2013). Fortunately, Roberts et al. (2014) have recently 
provided an effective solution to this problem showing that stable lines generated via PhiC31 
integrase-mediated targeted transgene integration exhibited nearly identical tissue-specific 
enhancer-driven reporter expression. 
In conclusion, the zebrafish embryo is a well suited vertebrate model for the 
functional validation of candidate transcription-regulatory elements, including those 
predicted in mammalian genomes. 
 
1.12. Objectives of the current study 
Regulation of the tissue-specific expression pattern of the murine Lama1 gene is poorly 
known. As described earlier, previous studies in our laboratory found that SHH is essential 
for Lama1 expression in the somites and neural tube of mouse embryos, but did not inform 
about whether the control is direct, via the GLI transcription factors, or indirect – via 
intermediary factors in the gene network. Therefore, the main objective of the current study 
is to elucidate the link between SHH and Lama1 transcription, by testing the hypothesis of a 
direct role of SHH in Lama1 expression in the neural tube and somites, mediated by GLI 
binding to transcription-regulatory elements (TREs) in the vicinity of the Lama1 locus. 
To address the proposed hypothesis, I aim at the following specific objectives: 
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1) Identification of candidate TREs of the murine Lama1 gene using comparative 
genomics approaches, based on the assumption that the conserved expression of Lama1 
mRNA across vertebrates is due to conserved regulatory mechanisms. 
2) Functional screening of the set of identified candidate TREs in mammalian cell 
culture. 
3) Functional screening of a subset of the identified candidate TREs in transgenic 
zebrafish embryos, relying on the assumption that the tested murine elements could be 
functional in zebrafish, which is supported by the similarities in Lama1 expression pattern 
and the role of HH signaling between mouse and zebrafish. 
5) In case none of the tested elements display transcriptional-enhancer properties, an 
alternative approach could be used to predict candidate TREs of Lama1, based on available 
data for transcription factor occupancy and enhancer-enriched histone marks at the murine 
Lama1 locus. 
4) Detailed analyses of the tissue-specific activity of promising candidate TREs in 
transgenic zebrafish embryos, including examination of the responsiveness of the tested 
elements to perturbations in Hh signaling.  
 
 
 
 
 
 
 
 
 
 
 
 
\ 
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Chapter 2 
Materials and methods  
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2.1. Mouse embryo techniques 
2.1.1. Mouse strains and embryo collection 
Mouse embryos for whole-mount in situ hybridisation were harvested from the C57BL/6J 
and Shh (Anderson et al. 2009) strains. Pregnant females were euthanized by an overdose of 
anaesthetic followed by cervical dislocation. The embryos were harvested via hysterectomy 
and immediately placed in RNase-free qPBS solution, followed by removal of the yolk sacs 
and overnight fixation at 4°C in 4% HCHO + 2 mM EDTA in qPBS. Embryos were staged 
according to Kauffman (1992). 
2.1.2. Embryo genotyping 
DNA from embryos from the Shh strain was isolated via lysis of the yolk sacs in 100 uL tail 
mix solution at 95C for 20 minutes, followed by the addition of 100 µL 40 mM Tris HCl 
(Sigma Aldrich). 1 L of the lysis mix was used for a PCR at 58C annealing temperature 
using Shh-P5, Shh-P6 and Shh-PGK primers (see Table 2.2) (Anderson et al. 2009). PCR 
products were analasyed with gel electrophoresis using 1.2% agarose/TAE gel. 
 
a1-NSE::lacZ transient transgenic mouse embryos were genotyped from yolk sac material by 
our collaborator Dr. Norris Ray Dunn (IMB, Singapore) using the Generic LacZ F and LacZ 
R primers (Table 2.2) to generate a 315 bp lacZ transgene fragment (Figure 2.1). The Mcc 
gene was used as a positive internal control (Young et al. 2011). 
2.1.3. Whole-mount in situ hybridization (WMISH) 
Overnight-fixed embryos were rinsed and washed 3 x 15 minutes with 1 x PTW buffer and 
treated with 20 g/mL Proteinase K in 1mL Proteinase K buffer at 37C according to their 
stage, followed by 3 x rinses in 1 mL PTW buffer. Then, the embryos were post-fixed in 1 
mL 4% HCHO + 0.1% glutaraldehyde in PTW for 20 minutes at room temperature, followed 
by 3x rinses and 3x washes with PTW for 5 minutes. Next, the embryos were rinsed in 1 mL 
1:1 PTW:hybridisation buffer solution, replaced by 1 mL hybridisation buffer and stored at – 
20C. On the day of WMISH, the embryos were incubated with 1 mL hybridization buffer 
for 2 hours at 69C. Then, the old buffer was replaced with 1 mL fresh hybridization buffer,  
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Figure 2.1. Genotyping results for the nine b-Gal-positive embryos, as obtained by Dr. Norris Ray Dunn (IMB, 
Singapore). All nine embryos carry the lacZ transgene represented by the upper of the two fragments on the 
electrophoretogram. 
immediately followed by the addition of 3 uL 1 ug/mL DIG-labelled RNA probe, and the 
embryos were incubated at 69C overnight. On the next morning, the old hybridization buffer 
+ RNA probe were discarded and the embryos were quickly rinsed twice with 1 mL fresh 
hybridization buffer at 69C, followed by two washes 30 minutes each with new 1 mL of 
hybridization buffer at 69C. Then, the embryos were washed once with 1:1 hybridisation 
buffer:TBST buffer for 20 minutes at 69C, followed by two 30 minutes washes in TBST at 
room temperature. Next, the embryos were rinsed 2 x in MABT buffer and incubated in 1 mL 
blocking solution for 2 hours at room temperature. Then, the old blocking solution was 
replaced with fresh one and 0.5 L of anti-digoxigenin alkaline-phosphatase antibody 
(Roche) was added. The embryos were incubated at 4C overnight. The following day, 
embryos were extensively washed with MABT, followed by 2 x 30 minutes washes with 
NTMT at room temperature. Staining was developed by the addition of 3.5 l 5-bromo-4-
chloro-3-indolyl phosphate (BCIP; Roche) and 4.5 l 4-Nitro blue tetrazolium chloride 
(NBT; Roche) to 1 ml NTMT and incubating the embryos in the dark at room 
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temperature/4C. The staining was terminated by rinsing embryos in PTW, followed by 20 
minutes post-fixation at room temperature and 3x 15 mines washes in PTW. 
2.1.4. β-galactosidase staining 
Embryos were stained following a protocol kindly provided by our collaborator Dr. Ray 
Dunn (IMB, Singapore). Newly-harvested embryos were cleaned from the extra-embryonic 
membranes and fixed with 4% paraformaldehyde in PBS for 2 hours at 4C, and then rinsed 
3 x and washed 3 x 10 minutes in PBS at room temperature. Embryos were incubated in 1 
mL staining solution (5 mM K3Fe(CN)6 + 5 mM  K4Fe(CN)6  + 2 mM MgCl2 + 1 mg/mL X-
gal + 0.02% NP-40 in PBS) at 37C overnight. Stained embryos were extensively washed 
with PBS at room temperature. The E9.5 and E10.5 transgenic embryos were sectioned by 
the Histology and Pathology facility in IMCB, Singapore, and were counter-stained with 
eosin. The E12.5 and E13.5 transgenics were sectioned via a cryostat as described in 2.1.6. 
2.1.5. Vibratome sectioning 
Embryos stained according to the WMISH protocol were embedded in 2% agarose in PBS 
and kept at 4C overnight. Blocks were cut out of the gel and glued to a chuck using 
SuperGlue (Bostik), and 80-100 m sections were obtained using Vibratome 1500 sectioning 
apparatus (Vibratome

). The sections were collected in 80% glycerol and mounted to a glass 
slide using Glycergel mounting medium (Dako). 
2.1.6. Cryostat sectioning 
Stained embryos were incubated in 15% sucrose solution and embedded in OCT medium 
(BDH) on plastic mounting boats, immediately followed by transfer of the boats on dry ice-
chilled 100% ethanol until freezing of the OCT medium. The embedded embryos were stored 
at -80C. For sectioning, the embedded embryos were mounted on pre-chilled chucks via 
OCT medium, and cut into 30 m sections using a cryostat (Bright Instruments). Sections 
were collected on superfrost slides (Menzel-Glaser) and left to dry for 1 hour at room 
temperature, and then kept at -20C before use. Before use, sections were left at room 
temperature for 30 minutes, followed by 15 minutes rehydration with PBS, and mounted 
using Glycergel mouning medium (Dako). 
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2.1.7. Imaging 
Whole-mount embryos were visualized using a MZ12.5 steromicroscope (Leica) and images 
were captured by a SPOT

 INSIGHT Colour camera using SPOT Advanced software 
(Diagnostic Instruments). Embryo sections were visualized using Leica DMR microscope 
(Leica) and images were captured via DMR DC300FX digital camera (Leica) using Leica 
IM50 Image software vl.20 (Leica). The obtained images were processed by Photoshop CS5 
(Adobe). 
2.1.8. Mouse oocyte injections 
The a1-NSE::lacZ reporter plasmid was sent (dissolved in Milli-Q water) to the Mouse 
Transgenesis Group in IMCB, Singapore, where it was linearized with SacII releasing a 4.8 
kb linear fragment containing the a1-NSE::lacZ construct, which was injected into oocytes 
from the FVB/N mouse strain. The day of injection was counted as E0 but embryos were 
harvested a day later than the desired stage to allow for delays in development as is often the 
case with transient transgenic mouse embryos (personal communication with Dr. Ray Dunn 
(IMB, Singapore)). 
2.2. Chicken embryo techniques 
2.2.1. Embryo incubation 
Fertilised chicken eggs were obtained from local farms and incubated at 39C until the 
desired embryonic stage, according to Hamburger and Hamilton (1951).  
2.2.2. Embryo collection 
At the desired embryonic stage, eggs were opened at the wider end and the embryos were 
dissected and temporarily kept in RNase-free qPBS on ice, immediately followed by fixation 
according to the protocol applied to mouse embryos and described earlier. Chicken embryos 
were staged according to Hamburger and Hamilton (1951). 
2.2.3. WMISH, sectioning and imaging  
Chicken embryos were processed for WMISH, vibratome sectioning and imaging following 
the protocols applied to mouse embryos, as described above. 
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2.3. Zebrafish husbandry and embryo techniques 
2.3.1. Zebrafish lines and embryo collection 
Zebrafish were kept at 28C at 14 hours light/10 hours dark cycle. Fish embryos were 
collected from the wild type AB strain (IMCB, Singapore), from the Tg(olig2:EGFP) line 
kindly provided by Dr. Vladimir Korzh lab (IMCB, Singapore), and from the smo
hi1640Tg
 line 
provided by Dr. Sudipto Roy (IMCB, Singapore). Embryos were harvested from paired 
matings in the mornings and kept at 28C in E3 embryo medium. 
2.3.2. Generation of CNE:: EGFP-reporter constructs 
CNEs were amplified from mouse genomic DNA (C57BL/6J) using the primer pairs in Table 
2.2. The primers harboured HindIII linkers, which enabled cloning in the HindIII site of the 
EGFP reporter vector (McDonald et al. 2010; Yu et al. 2011). Successful CNE::EGFP 
reporter construct generation was confirmed via sequencing with the M13 forward and M13 
reverse primers (See Table 2.2). 
2.3.3. Microinjection and embryo maintenance 
Embryos were obtained from paired matings in the mornings immediately before 
microinjection. Embryos were injected at the 1-cell stage using with ~ 1 nL plasmid (or 
plasmid + RNA) solution that also contained 0.05% Phenol Red (stock: 0.5% in DPBS, 
Sigma) in Milli-Q water. Following injection, the embryos were transferred at 28C in E3 
embryo medium and periodically monitored for reporter gene expression until the 96 hpf 
stage. All dead embryos were regularly discarded and the water was renewed every 24 hours. 
2.3.4. Fixation and immunohistochemistry 
Embryos with interesting reporter gene expression pattern were set aside and dechorionated 
with 0.5 mg/ml Pronase (stock 10mg/ml dissolved in water, Roche Applied Sciences) for 30 
minutes at room temperature. Then, embryos were fixed with 4% PFA (Sigma-Aldrich) in 
PBS (Sigma-Aldrich) at 4C on a shaker, overnight (~14 hours). On the following day, 
embryos were rinsed once and washed twice (10 minutes each) in PBTX buffer at room 
temperature, with agitation, followed by a single wash in 50% methanol (Merck) in PBTX. 
Finally, the embryos were kept in methanol and stored at -20°C. 
 Embryos for immunostaining were rehydrated by a rinse and a single wash in 50% 
methanol in PBTX, followed by two washes in PBTX. Then, embryos were incubated with 
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PBDT buffer for 1 hour at room temperature. Subsequently, the embryos were incubated with 
the primary antibody diluted in PBDT (1:1000) at 4°C, overnight, with agitation. On the next 
day, the embryos were rinsed once followed by two washes (30 minutes each) with fresh 
PBDT at room temperature, with agitation. Next, the embryos were incubated with the 
secondary antibody diluted in PBDT (1:5000), at 4C overnight. On the following day, the 
embryos were rinsed once and washed two times in PBDT with DAPI (Invitrogen) added at 
one of the washing steps. Shortly before imaging, the PBDT buffer was replaced by 80% 
glycerol (Invitrogen) in PBTX. 
 
Antibodies used 
(1:800) anti-GFP rabbit polyclonal antibody, Alexa Fluor® 488 conjugate, Life Technologies 
(Invitrogen). 
(1:200) anti-pax3/pax7 mouse monoclonal antibody, DSHB 
(1:800) anti-mCherry, rabbit polyclonal DsRed antibody, Clontech 
(1:1000) Alexa Fluor 546 goat anti-mouse IgG, Life Technologies (Invitrogen) 
(1:1000) Alexa Fluor 568 goat anti-rabbit IgG, Life Technologies (Invitrogen) 
(1:20) anti-Pax7 mouse monoclonal antibody (DSHB) 
2.3.5. Cryosectioning 
Whole-mount immunostained embryos were transferred from 80% glycerol to O.C.T. 
medium where they were embedded in the desired orientation, followed by rapid freezing in 
cooling bath of ethanol on dry ice. The O.C.T. blocks were stored at -80°C. For sectioning, 
the O.C.T. blocks were mounted to pre-chilled chucks and 12 m sections were obtained 
using a cryostat (Bright Instruments). Sections were collected on Marienfeld-Superior glass 
slides, followed shortly after that by mounting using Vectashield medium (Vector 
Laboratories). 
2.3.6. Imaging 
Whole-mount embryos in 80% glycerol in PBTX were visualized via a Zeiss Axio Imager. 
M2 microscope equipped with Zeiss AxioCam HRc camera, and images were captured with 
the AxioVison v. 4.7.2 software. Confocal images were captured via Olympus BX61 
microscope using the FV10-ASW software. 
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2.4. Luciferase reporter assays in cell culture 
2.4.1. Reporter construct generation 
CNEs were isolated from mouse genomic DNA using primer pairs in Table 2.2 (see section 
2.5.1), and first cloned into the TOPO vector (see see section 2.5.2). CNEs cloned into the 
TOPO vector (Invitrogen) were excised with KpnI and XhoI and sub-cloned into the KpnI- 
and XhoI-sites of the multiple cloning region in the pGL3-Promoter vector (pGL3 Luciferase 
Reporter Vectors (Technical Manual, Promega 2007). Some CNEs were generated with 
primers harbouring KpnI-linkers, and were similarly cloned into the KpnI site of pGL3 
(sections 2.5.3 – 2.5.5). Successful construct generation was confirmed via diagnostic 
digestion and sequencing using the pGL3 seq primer (see Table 2.2) 
2.4.2. Cell culture maintenance 
The C3H10T1/2 mouse embryonic fibroblast cell line was employed in all transient 
transfection assays of CNE function. Cells stored at liquid nitrogen were rapidly defrosted in 
water bath at 37°C and added to 5 ml pre-warmed DMEM medium (Gibco) containing 10% 
FBS (Gibco) and 1% PSF (Gibco), simply referred to as “medium” in this study. The cells 
were centrifuged at 1000 x g for 5 min and the pellet was re-suspended in 1 ml growth 
medium. Then, 0.1 ml cell suspension was added to 5 ml pre-warmed medium in 25 cm
3 
Nunc flasks, which were kept in conditioned incubators at 37°C and 5% CO2. On the next 
day, the old medium was replaced with fresh one and the cells were subsequently passaged 
every 2 days after reaching 80-90% confluence. For passaging, the old medium was 
discarded and the cells in each 25 cm
3
 flask were rinsed 3 times with 0.5 ml pre-warmed  1 x 
DPBS buffer without Ca
2+
 and Mg
2+
 (Life Technologies) followed by 5 minutes incubation 
with 1 x Trypsin-EDTA, Phenol Red (Life Technologies) at 37°C. The dissociated cells were 
collected in 5 ml growth pre-warmed growth medium and then pelleted by centrifugation at 1 
x 10
3
 for 5 min at RT. The supernatant was discarded and the cell pellet was re-suspended in 
1ml growth medium. Finally, 0.1 l cell suspension was added to a flask with fresh growth 
medium and cultured at the conditions described above until reaching 80-90% confluence 
when the passaging was repeated. Note that the cells were not maintained beyond the 20
th
 
passage to avoid the accumulation of aberrations. Thus all experiments were performed with 
cells between the 3
rd
 (after reconstitution of frozen cells) and the 20
th
 passage. 
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2.4.3. Transient cell transfection 
Cells were transiently transfected via lipofection using Lipofectamine 2000 (Invitrogen) in 
Opti-MEM transfection medium (Life Technologies). The transfections were performed in 6 
well-plates (Thermo Scientific) with 6x10
5
 cells per well. On Day 1, the old growth medium 
from each well was discarded and the cell monolayer was washed 3 times with 1 ml of pre-
warmed DPBS, followed by incubation of the cells with 1 ml pre-warmed Opti-MEM 
medium for 10-15 minutes at 37°C. Meanwhile, the transfection mix was prepared by the 
combination of two fractions. The first fraction was made by the addition of 3 g DNA 
(containing the reporter plasmid, control plasmid and carrier DNA; see below*) to 0.3 ml 
Opti-MEM in 2 ml eppendorf tubes (one tube per well). For the second fraction, 4 µl 
Lipofectamine 2000 were added to 0.3 ml Opti-MEM in separate 2 ml eppendorf tubes (one 
tube per well) and incubated for 5 minutes at RT. Immediately after that, the two fractions 
were combined and left at RT for 30 minutes with gentle agitation every 10 minutes. In the 
meantime, the old Opti-MEM medium was discarded and 0.4 ml fresh pre-warmed Opti-
MEM medium was put in each well with cells, followed by addition of the transfection mix 
(containing the DNA:Lipofectamine 2000 complex). The plate was gently rocked and left in 
the incubator. Three hours after transfection, the cells were supplemented with another 
1ml/well pre-warmed Opti-MEM medium followed by overnight incubation. On Day 2, the 
old Opti-MEM transfection medium was removed and replaced with 3ml/well growth 
medium 
*The total amount of DNA added to each well was 3 µg and it included 260 ng CNE::pGL3 reporter plasmid, 
60 ng pRL reporter vector and 2.68 µg pcDNA3 plasmid (used as carrier DNA). 
2.4.4. Preparation of cell lysates and quantification of protein concentration 
On Day 3, approximately 48 hours post-transfection, the old growth medium was removed 
and the cells were lysed by adding 0.5 ml/well 1x Passive Lysis Buffer (Promega) followed 
by incubation for 15 minutes at RT with agitation. In order to avoid errors in the luciferase 
assay due to unequal protein amount between a test CNE::pGL3 construct lysate and the 
control lysate, the total protein concentration in each lysate was estimated first using the 
Bradford protein method. For this, a standard curve was prepared using BSA (Promega) 
samples with known concentration: 0.125, 0.25, 0.5, 1, 2 and 5 mg/ml, where 20 l of each 
protein sample was incubated with 980 l 1 x Quick Start™ Bradford Dye Reagent (BioRad) 
for 10 minutes at RT, immediately followed by measurements of the light absorbance of the 
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samples at 595 nm on a spectrophotometre. The results were used to prepare a standard 
curve. Next, in analogous way, 20 l of each cell lysate were mixed with 980 l of the 
Bradford reagent and light absorbance was measured accordingly. The absorbance data from 
the lysates were plotted on the standard curve and the protein concentration was estimated for 
each lysate. Then, the concentrations of all lysates were standardised to 0.22 mg/ml (with 
Passive Lysis Buffer) and this was used in the subsequent luciferase reporter assays. 
2.4.5. Dual Luciferase Reporter Assay 
The activities of the two luciferases expressed in the transfected cells – the experimental 
luciferase (from the firefly Photinus pyralis) and the control luciferase (from the sea pansy 
Renilla reniformis), were measured using the Dual-Luciferase Reporter® (DLR™) Assay 
system (Promega) in luminometre at RT. At the onset, 10 µl of each lysate (after 
standardizing the concentrations to 0.22 mg/ml) were dispensed into the individual wells of 
Hard-Shell
®
 Low-Profile Thin-Wall 96-well microplates (BioRad). The activities of the two 
luciferases were recorded sequentially beginning with the measurement of firefly luciferase 
activity. For this, 50 µl Luciferase Assay Reagent II (containing luciferin, the substrate of 
firefly luciferase) to each well followed by programmed agitation of the whole plate for 3 
seconds. Then, another 3 seconds of programmed pre-read delay were included before the 
actual measurements of firefly luciferase activity. Upon completion of the recordings, the 
firefly luciferase was quickly quenched by the addition of 50 µl Stop & Glo® Reagent 
(which also includes coelenterazine – the substrate of the Renilla luciferase), followed by 3 
seconds of plate agitation and 3 seconds of pre-read delay before the measurements of 
Renilla luciferase activity were taken (Promega). 
2.5. Molecular biology techniques 
2.5.1. Polymerase chain reaction (PCR) 
2.5.1.1. Primer design 
PCR primers were designed using the Primer Premier 5 or NetPrimer tools 
(www.premierbiosoft.com), to be between 19-26 nucleotides long, with similar A/T and G/C 
content, to possess at least one G/C nucleotide at the 3’-end, and to have Tm of 57-63°C. 
Primers harbouring linkers for restriction enzymes were designed similarly with reference to 
“Cleavage Activity Near DNA Termini” (Stratagene). 
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2.5.1.2. PCR reaction settings 
The GoTaq® DNA Polymerase kit (Promega) was used for the amplification of sequences 
with size ≤ 1 kb and for standard genotyping procedures. The GoTaq polymerase requires 1 
minute per kb during the extension phases. The reactions were performed in a 20 µl volume, 
including: 
 
10 l Green GoTaq® Reaction 2 x buffer 
0.4 µl dNTP-mix (10 mM each) 
0.8 µl F-primer (20 µM) 
0.8 µl R-primer (20 µM) 
0.1 µl GoTaq® DNA Polymerase (5 u/µl) 
1 µl DNA template (30-100 ng/µl) 
6.9 µl Milli-Q H2O 
 
Cycle conditions: 
Intial denaturation 95°C 2 min 
Denaturation 95°C 1 min 
Annealing 1 min 
Extension 72°C 1 min/kb 
Repeat steps 2-4 34 times 
Final extension 72°C 5 min 
Keep 4°C indefinitely 
 
The iProof™ High-Fidelity DNA Polymerase kit (Bio-Rad Laboratories) was used for highly 
accurate amplification of sequences with size ≤ 2 kb. iProof™ High-Fidelity DNA 
Polymerase requires 30 seconds per kb during the extension phases. The reactions were 
performed in a 50 µl volume, including. 
 
10 µl iProof HF 5 x buffer 
1 µl dNTP-mix (25 mM each) 
1 µl F-primer (20 µM) 
1 µl R-primer (20 µM) 
1 µl MgCl2 (50 mM) 
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1 µl DNA template (100 ng/µl) 
0.5 µl iProof DNA Polymerase (2 u/µl) 
34.5 l Milli-Q H2O 
 
Cycle conditions: 
Initial Denaturation 98°C 30 sec 
Denaturation 98°C 10 sec 
Annealing at T°C + 3°C above the primer with the lowest Tm 30 sec 
Extension 72°C 30 sec/kb 
Repeat steps 2-4 34 times 
Final extension 72°C 10 min 
Keep 4°C indefinitely 
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Primer name Sequence 
Shh-P5 GTTGTTACTGCATCCCTTCCATC 
Shh-P6 GGCTAGCTCAGTGCTTGCAAG 
Shh-PGK-R GGATGTGGAATGTGTGCGAG 
CNE3 F CATAGCGTGGAGGTGGAGAGAGC 
CNE3 R CCCTGGCTCTGGAAACCTAACTC 
CNE4 F CTGTCCCGAAGTCACTCTGTATTTG 
CNE4 R GCCGTGAGTGTCTCTGCTGTG 
CNE5 F CCAGTTGATGTCACAGCAGTAGC 
CNE5 R GCTCCACACTTGAGATGCTGCC 
CNE6 F CCTGGGAGGACCAAGATGAAG 
CNE6 R TCAGAGAGGGTGGGAAAGGAC 
CNE7 F CACTGGGAGCCATTAGGAGGG 
CNE7 R CGTGTGCTTTTCTGTCTCAGTAAC 
CNE9 F GACTCTGCTCAAGGGTATGTGTTCC 
CNE9 R GGTCAAGGAGCCTGGAAATCTGTC 
CNE10 F CCTTCGGAGACTTCTGGCTTTC 
CNE10 R GCTGTGACCCTGATTGTATCTGTATG 
CNE13 F CGATTTAGCCCTGCCCTGC 
CNE13 R GGGCAAAGCATCCAGTAGGC 
CNE14 F CACAGTGGAGACAAACACGAGGC 
CNE14 R CTGGTAGGGGTGATTTGGACGG 
CNE15 F GGAGACGCTGGGAGATTTGGAC 
CNE15 R GATTTGAAGGCACAGGCAGACC 
CNE19 F GTGACAGTCTTGCTTTCTGATAGGG 
CNE19 R GGTTTCGTTAGGTTCTTTCAGGG 
CNE21 F CTGCTCTGGCATTTCCGACC 
CNE21 R GCTCAGGTAGACACAGGAACGG 
CNE22 F CCAGAAGTCCCAGAAGAGAATGC 
CNE22 R GCGTTCCTTAATAGTATTAGTC 
CNE23 F CCACAATAGGTAAGAGACAGGTAGGG 
CNE23 R CCAGTGGCTTCCCAGTCAGG 
CNE24 F CAGCATTCTCCCTCTGAACATACAC 
CNE24 R GACAGAAACCTTGAGAGAAATCCC 
a1-NSE F TCTGACTCTAGGGGTCACCTGCTT 
a1-NSE R GGTCACTTTCAGCAACCTCACAG 
np1230 seq CTATGACCATGATTACGCCAAGC 
pGL3 seq CAAAATAGGCTGTCCCCAGTGC 
M13 F GTTTTCCCAGTCACGAC 
M13 R CAGGAAACAGCTATGAC 
LacZ F ATCCTCTGCATGGTCAGGTC 
LacZ R CGTGGCCTGATTCATTCC 
 
Table 2.1. Primer sequences used in this study. All but Shh-P5, Shh-P6, Shh-PGK, M13 F, M13R, LacZ F and 
LacZ R were designed in this study. 
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2.5.2. TOPO cloning of PCR products 
The TOPO® TA Cloning® Kit (Invitrogen, Life Sciences) was used for rapid cloning of 
Taq-polymerase generated PCR products. 1 µl PCR product was incubated with 1 µl Salt 
Solution, 3 µl Milli-Q H2O and 1 µl pCR™II-TOPO® vector for 5 minutes at RT, followed 
by transfer on ice for 20 minutes. Next, 2ul of the cloning reaction were added to 40 µl of 
TOP10F’ chemically-competent cells (Invitrogen) and the mixture was incubated on ice for 
30 minutes. The cells were heat-shocked for 30 seconds at 42°C and immediately placed on 
ice for 2 minutes, followed by the addition of 250 µl S.O.C medium and 1 hour incubation at 
37°C with agitation (200 rpm). Finally, 40 -100 l of each transformation were spread on a 
pre-warmed agar plate containing the appropriate antibiotic. Prior to spreading the cells, the 
plates had been coated with 40 µl of 40 mg/ml X-gal (Promega) and 40 µl of 100 mg/ml 
IPTG (Sigma-Aldrich) for blue/white screening of bacterial colonies. 10-15 promising clones 
– white colonies, were selected for further analysis of miniprep DNA. 
2.5.3. DNA digestion with restriction enzymes 
Digestion of DNA was performed in 100 µl reaction volume with the appropriate restriction 
endonuclease (RE, from New Engalnd Biolabs). For plasmid DNA, 5 g were incubated with 
10 µl 10 x Reaction Buffer (New Engalnd Biolabs) and 1.5-2 µl RE enzyme (1u/µl). 10 l  
10 x BSA (New England Biolabs) were also added where required. The reaction was 
incubated for 2 hours at 37°C.  
 
Digestion of PCR amplicons with linkers was performed in 50 µl reaction volume. 5 µl 10 x 
Reaction Buffer and 1µl RE (1 u/µl) were added to 30 µl of purified PCR product in Milli-Q 
H2O. 5 µl 10 x BSA were added where required and the reaction was incubated overnight at 
37°C. 
2.5.4. Vector dephosphorylation 
Prior to ligation with DNA fragments, the plasmid vector was dephosphorylated using the 
Calf Intestinal Alkaline Phosphatase (New England BioLabs), in order to prevent self-
ligation of the vector DNA ends. The reaction volume was set up at 50 µl, where 5 µl NEB 
Buffer 3 and 1 µl phosphatase (10u/µl) were added to 30 µl solution of linearised plasmid in 
Milli-Q H2O. The reaction was incubated for 15 minutes at 37°C, followed by 15 minutes 
incubation at 50°C. 
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2.5.5. Ligation 
DNA fragments and vector were ligated using the T4 DNA Ligase (Promega) in 1:3 or 1:1 
molar ratio of vector to insert. The ligations were performed in 10 l reaction volume.  The 
appropriate volume of insert and vector solutions (both in Milli-Q H2O) were incubated with 
5 ul of 2 x Ligase Buffer and 1ul of T4 DNA Ligase at 4°C overnight.  
2.5.6. Bacterial transformation 
2 l of ligation reaction or 2 l of plasmid (20-100 ng/l) were added to 50 µl of chemically-
competent E.coli cells (strain) and incubated on ice for 30 minutes. Then, the mixture was 
heat-shocked at 42°C for 30 seconds followed by immediate transfer on ice for 2 minutes. 
400 µl of S.O.C medium were added and the cells were incubated with agitation (200 rpm) at 
37°C for 1 hour. Finally, 80 µl of bacterial suspension were streaked on a pre-warmed LB 
agar plate containing the appropriate antibiotic (100 µg/ml Ampicillin, 25 µg/ml Kanamycin 
or 50 µg/ml Chloramphenicol (Sigma-Aldrich)) and incubated overnight at 37°C. On the 
following day, 10-20 bacterial colonies were picked up and used to prepare minicultures. 
2.5.7. Plasmid miniprep 
Preparation of plasmid DNA from bacterial minicultures (4 ml) was performed using the 
AxyPrep™ Plasmid Miniprep Kit (Axygen Biosciences). 3 ml of overnight LB culture were 
centrifuged at 12 x 10
3
 rcf for 1 minute (repeated 2 times). The supernatant was discarded 
and the bacterial pellet resuspended in 250 l of cold Buffer S1. Then, the cells were lysed 
with 250 l Buffer S2 for 3 min at RT, followed by the addition of 350 l Buffer S3, which 
neutralized the reaction. The sample was centrifuged at 12 x 10
3
 rcf for 10 minutes to pellet 
the precipitate and the clear supernatant was transferred to an AxyPrep column. The loaded 
column was centrifuged for 1 minute at 12 x1 0
3
 rcf and then washed 2 x with Buffer W2 
followed by another step of 1-minute centrifugation at 12 x 10
3
 rcf to remove residual buffer. 
At the end, the DNA was eluted with 60 µl of Milli-Q H2O and stored at -20°C. 
2.5.8. Plasmid midiprep 
Preparation of plasmid DNA from bacterial midicultures (50 ml) was performed using the 
HiSpeed® Plasmid Midi Kit (QIAGEN). 50 ml of overnight LB culture were centrifuged at 6 
x 10
3
 rcf for 15 minutes at 4°C. The bacterial pellet was re-suspended in 6 ml Buffer P1 
followed by the addition of 6 ml Buffer P2 (lysis buffer) and incubated at RT for 5 minutes. 
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Then, the reaction was neutralized with 6 ml chilled Buffer P3 after which the lysate was 
immediately added to a QIAfilter Cartridge and incubated for 10 minutes at RT. Next, the 
lysate was pressure-filtered from the cartridge and simultaneously loaded in a HiSpeed Midi 
Tip which has been equilibrated with 4 ml Buffer QBT. The tip was washed with 20 ml 
Buffer QC followed by elution of the DNA with 5 ml Buffer QF. The DNA was precipitated 
with 3.5 ml isopropanol (Merck) at RT for 5 minutes. The eluate/isopropanol mixture was 
pressure-filtered through a QIAprecipitator Midi Module and the flow-through was 
discarded. Next, the QIAprecipitator was washed with 2 ml 70% ethanol. Finally, the DNA 
was eluted with 1ml MilliQ-H2O and stored at -20°C. 
2.5.9. Synthesis of digoxigenin-labelled RNA probes 
Riboprobes were synthesized by in vitro transcription in 20µl reaction volume, containing: 
 
1 µl linearised DNA (1 µg/µl) 
4 µl 5 x TSC buffer (Promega) 
2 µl 10 x DIG RNA Labeling Mix (Roche) 
0.5 µl 50 mM DTT (Sigma Aldrich) 
1 µl RNasin (Promega)  
1.5 µl RNA polymerase (20 u/µl) (Promega) 
10 µl DEPC-treated Milli-Q H2O 
 
The reaction was incubated at 37°C for 2 hours. The DNA template was removed by the 
addition of 2 µl of RQ1 DNase I (Promega) and further incubation at 37°C for 30 minutes. 
To precipitate the RNA, 2 µl 200 mM EDTA, 2.5 ul 4 M LiCl and 70 µl 100% RNAse-free 
ethanol (Sigma Aldrich) were added and the mixture was kept at -80°C for 1 hour. Then, the 
RNA was pelleted by centrigugation at 13 x 10
3
 rpm for 30 minutes at 4°C; the supernatant 
was discarded and the pellet washed with 100 µl 70% RNAse-free ethanol followed by 
another centrifugation at 13 x 10
3
 rpm for 10 minutes at at 4°C. The supernatant was 
discarded and the pellet was vacuum-dried at RT for 2-3 minutes. Finally, the RNA was 
resuspended in 50 µl DEPC-treated Milli-Q H2O, with the addition of 1.5 µl RNasin and 0.5 
µl 100 mM DTT. The probes were stored at -20°C. 
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plasmid restriction 
enzyme 
RNA polymerase 
Lama1-pCRII TOPO
a
 EcoRV Sp6 
Lamb1-pCRII TOPO
b
 EcoRV Sp6 
Lamc1-pCRII TOPO
a
 EcoRV Sp6 
cLama1-pBluescript II KS + SacI T3 
 
Table 2.2. RNA probes used in this study. Indicated are the restriction enzyme used to linearise the plasmid 
template, and the RNA polymerase used for probe synthesis. 
a plasmids were kindly provided by Claire Anderson (Anderson et al. 2009) 
b plasmid was generated by Ms. Katherine Long 
 
Chicken Lama1 probe was synthesized form EST clone ChEST869c13 from the Source 
Bioscience (Life Sciences). 
2.5.10. Capped-RNA synthesis 
Capped RNA was synthesised using the mMESSAGE mMACHINE® Kit (Ambion), using 
appropriate RNA polymerase and linearised DNA template, depending on the vector and the 
insert orientation. The reaction was performed in 20 µl volume, where 1 µl of linearised 
DNA template (1 µg/µl), 10 µl 2 x NTP/CAP mix, 2 µl 10x Reaction Buffer, 2 µl appropriate 
RNA polymeraze (Enzyme Mix) and 5 µl Nuclease-free H2O were mixed together and 
incubated at 37°C for 2 hours. Then, DNA template was removed by the addition of 1 µl 
RQ1 DNase I (Promega) and further incubation at 37°C for 15 minutes. The reaction was 
stopped and RNA precipitated by the addition of 30 µl Nuclease-free H2O and 30 µl LiCl 
Precipitation Solution (7.5 M LiCl, 50 mM EDTA) followed by 1 hour incubation at -20°C. 
The precipitate was collected by centrifugation at 13 x 10
3
 rpm for 15 minutes at 4°C; the 
supernatant was discarded and the pellet washed once with 1 ml of 70% RNase-free ethanol, 
and re-centrifuged at the same settings. Finally, the RNA was resuspended in Milli-Q H2O, 
aliquoted in small volumes and kept at -80°C. 
 
RNA Vector 
RE for template 
linearisation 
RNA polymerase 
Tol2 pDB600 XbaI T3 
dnPKA pCS2+ NotI Sp6 
H2B-mCherry pCS2+ KpnI Sp6 
Shh pSP64T BamHI SP6 
 
Table 2.3. Capped RNAs used in this study. Shown are the encoding plasmids, the restriction enzyme (RE) used 
for plasmid linearization and the RNA polymerase used for transcription. 
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2.5.11. Estimation of DNA/RNA sequence size 
DNA/RNA samples were loaded on 400 nM Ethidium Bromide 1% Agarose gel in TAE 
buffer, along with 3 l of GeneRuler 1 kb Ladder (Fermentas Life Sciences). Size of 
DNA/RNA was determined by comparison of the distance travelled by the sample’s band(s) 
with the bands on the ladder of known size. 
2.5.12. Estimation of DNA/RNA concentration 
2 l of DNA/RNA sample (either in TE buffer or Milli-Q H2O) were loaded on NanoDrop 
ND-1000 Spectrophotometer (Thermo Scientific) and concentration was measured against a 
blank sample (TE buffer or Milli-Q H2O only). 
2.5.13. Gel Extraction 
DNA fragments were recovered from agarose gels using the Zymoclean™ Gel DNA 
Recovery Kit (Zymo Research). Agarose gel slices containing the desired fragment were 
excised from the rest of the gel and dissolved in ADB Buffer at 55°C for 10 minutes. The 
solution was loaded on Zymo-Spin™ I Columns and subsequently washed twice with DNA 
Wash Buffer. The DNA was eluted with Milli-Q H2O. 
2.5.14. Phenol/chloroform DNA extraction 
One volume of phenol (molecular biology grade, Sigma-Aldrich) was added to 1 volume of 
DNA solution and the mixtire was vortexed for 15 minutes, followed by centrifugation at for 
10 minutes. The top aqueous phase containing the DNA was transferred to a new tube. 0.5 
volume of phenol and 0.5 volume of chloroform/isoamyl alcohol (CIA, ratio 24:1) were 
added and the sample was vortexed for 15 minutes, followed by centrifugation at 13x10
3
 rpm 
for 10 minutes. The top layer was transferred to a new tube and 200 µl of CIA were added, 
followed by 1 minute of vortexing and 5 minutes of centrifugation. Finally, the DNA-
enriched top phase was transferred to a clean tube and prepared for alcohol precipitation. 
2.5.15. DNA precipitation 
DNA was precipitated by adding 2 volumes of 100% ethanol (DNAase-free, Sigma Aldrich), 
1/10 volume of 3 M sodium acetate (pH 5.3) (Sigma Aldrich) and 1 µl of glycogen (Sigma 
Aldrich). The sample was then incubated at -20°C overnight. Then, the sample was 
centrifuged at 13 x 10
3
 rpm at 4°C for 30 minutes. After removal of the supernatant, the DNA 
pellet was washed with 100 l of 70% DNAase-free ethanol and centrifuged at 13 x 103 rpm 
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at 4°C for 10 minutes. The supernatant was removed, the pellet was air-dried or vacuum-
dried at 40°C for 3 minutes and re-suspended in Milli-Q H2O at the required concentration. 
2.5.16. RNA precipitation 
RNA was precipitated by adding 3 volumes of 100% ethanol (RNA grade, Sigma-Aldrich), 
1/20 volume of 4 M LiCl (Sigma-Aldrich) and 1 µl of glycogen (Roche Applied Sciences). 
The sample was then incubated at -80°C for 1 hour. Then, the sample was centrifuged at 13 x 
10
3
 rpm at 4°C for 30 minutes. After removal of the supernatant, the RNA pellet was washed 
with 100 µl of 70% RNA-grade ethanol and centrifuged at 13 x 10
3
 rpm at 4°C for 10 
minutes. The supernatant was removed, the pellet was air-dried and re-suspended in DEPC-
treated H2O at the required concentration. 
2.6. in silico analyses 
2.6.1. Genomic sequence retrieval 
Genomic sequence information was retrieved from the Ensembl project database 
(www.ensembl.org), and from the UCSC Genome Bioinformatics database 
(www.genome.ucsc.edu). 
2.6.2. Gene expression information retrieval 
Information on the expression pattern of genes in the mouse, chicken and zebrafish was 
obtained from the Mouse Genome Informatics (MGI, www.informatics.jax.org), the Gallus 
Expression In Situ Hybridization Analysis (GEISHA, www.geisha.arizona.edu), and The 
Zebrafish Model Organism (ZFIN, www.zfin.org) databases. 
2.6.3. Analysis of sequence conservation 
Identification of conserved non-coding elements in the vicinity of the murine Lama1 
locus was performed using the ECR Browser (www.ecrbrowser.decode.org), the UCSC 
Genome Browser (www.genome.ucsc.edu), and the VISTA Browser 
(www.pipeline.lbl.gov/cgi-bin/gateway2).   
The ECR Browser tool performs and visualises comparative multispecies whole-genome 
alignments in a dynamic way enabling the rapid identification of candidate TREs. In short, 
the ECR Browser aligns genomic sequences retrieved from the UCSC Genome Browser after 
masking of repetitive elements followed by construction of large-scale syntenic relationships. 
To facilitate synteny mapping, the browser initially aligns each species’s genome to all others 
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in a pair-wise fashion (Ovcharenko 2004). By aligning the base genome to the genome 
sequences of selected species, the ECR generates a conservation profile, which is displayed 
in a 2D graphical format (Figure 4.1B; Figure 4.3B). There, the x-axis schematically 
represents the position in the base genome sequence while the y-axis represents the identity 
(in percentage, %) between the base and the aligned genome sequences at the specific 
position. Those segments of the alignment with significant length (in base pairs) which have 
equal to or higher percentage identity than a minimum custom-defined threshold appear as 
highlighted peaks, defined as evolutionary-conserved regions. All of the ECRs identified in 
this study are abbreviated as CNEs (Conserved Non-coding Elements) reflecting the fact that 
all of them are located in genomic regions with no known protein-coding potential. The rest 
of the aligned sequence which have bp length and percentage identity lower than the set-up 
thresholds does not appear as peaks and such regions are considered more or less neutrally 
evolving.  
Customised multiple alignments in of the Lama1-containing genomic region from mouse, 
human, opossum, chicken and zebrafish were performed in mVISTA using the Shuffle-
LAGAN algorithm. The aligned genomic sequences were manually retrieved from the 
Ensembl database; each sequence spans from the 3’-end of Ptprm locus to the 5’-end 
(transcription start site) of Arhgap28 locus. Identification of peaks in the mouse/zebrafish 
alignment was achieved using the low stringency parametres of minimum 50% sequence 
identity over a 50 bp window, maximising the identification of conserved, albeit short, 
regions between the genomes of mouse and zebrafish. 
2.6.4. Analysis of transcription factor binding motif presence and conservation 
Detailed analyses of the transcription factor binding motifs content of CNEs and a1-NSE 
were performed using the rVISTA 2.0 (www.rvista.dcode.org), MatInspector and 
FrameWorker tools (Cartharius et al. 2005; www.genomatix.de). The rVISTA tool enables 
the computational prediction of TFBSs using PWMs (Positional Weight Matrices) from the 
TRANSFAC database, using a combination of pattern recognition and comparative sequence 
analysis. Such approach significantly reduces the number of false positive matches by 95% 
while maintaining sensitivity of the search. After the TFBSs are localised in both sequences, 
rVISTA proceeds with the identification of pairs of aligned TFBSs which are further tested 
for sequence conservation. To be regarded as conserved, the aligned TFBSs must meet the 
 
 
  
63 
requirement of at least 80% sequence identity over a 20bp-sliding window encompassing the 
core of the binding site (Loots and Ovcharenko 2004). Despite the fact that a significant 
fraction of the predicted TFBSs are not functionally relevant, the rVISTA tool is nevertheless 
efficient in providing a set of limited number of putative TFBSs which can be further 
examined by functional studies. Each of the identified CNEs was individually submitted for 
analysis in the rVISTA 2.0 tool using default parameters: the “Vertebrates” set from the 
TRANSFAC professional V10.2 library and the “Optimized for function” option from the 
“Matrix similarity” parameter. In the next section, the programme was set up to screen the 
CNE sequence using the PWMs for all available TF families, including the Gli family.  
2.6.5. Analyses of chromatin features 
Information on histone marks, transcription factor occupancy and DNaseI hypersensitivity 
was obtained using the UCSC ENCODE Browser/database (Rosenbloom et al. 2012; 
www.genome.ucsc.edu). 
2.6.6. Design of mutations in the Gli motifs within a1-NSE 
Base pair substitutions in the Gli motifs of a1-NSE were designed using the SequenceShaper 
tool from Genomatix (www.genomatix.de). 
2.6.7. Sequence visualization and manipulation 
All sequence files were stored and manipulated in the ApE (A plasmid editor v1.10.4) 
software tool (www.biologylabs.utah.edu/jorgensen/wayned/ape/). 
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Solution or buffer Composition 
Blocking solution 2% Blocking reagent (Roche), 10% Horse serum, 0.1% Tween 20 in DEPC H2O 
E3 embryo medium 
15mM NaCl, 0.5mM KCl, 1mM CaCl2, 1.5mM KH2PO4, 0.05mM Na2HPO4, 1mM 
MgSO4, 0.7mM NaHCO3 and 3-4 drops per litre of methylene blue 
Genius 3 100mM Tris HCl, 50mM MgCl2, 150mM NaCl 
Hybridisation buffer 
50% Formamide, 1.3x SSC, 5mM EDTA, 50ug/mL tRNA, 0.2% Tween 20, 0.5% 
CHAPS, 100ug/mL in DEPC H2O, pH7.5 
LB agar 10g/L Tryptone, 5g/L yeast extract, 10g/L NaCl, 15g/L agar in deionised H2O, pH7.0 
LB broth 10g/L Tryptone, 5g/L yeast extract, 10g/L NaCl in deionised H2O, pH7.0 
MABT 100mM Tris HCl, 150mM NaCl, 0.1% Tween 20 in DEPC H2O 
NTMT 1% Tween 20 in Genius 3 solution, pH7.5 
PBDT 1% BSA (Sigma-Aldrich), 1% DMSO (Merck), 0.5% Triton X-100 in PBS 
PBTX 0.1% Triton X-100 (BDH Chemicals) in PBS 
Proteinase K buffer 100mM Tris HCl, 50mM EDTA in DEPC H2O, pH8.0 
PTW 0.1% Tween 20 in qPBS 
qPBS 
137mM NaCl, 5.37mM KCl, 0.14mM CaCl2, 1.25mM MgSO4, 1.1mM KH2PO4, 
1.1mM Na2HPO4 in DEPC H2O 
 
Tail mix solution 25mM NaOH, 0.2mM EDTA 
TBST (10x) 0.4M NaCl, 0.2mM KCl, 0.25M Tris HCl, 1% Tween 20 in DEPC H2O, pH7.5 
 
Table 2.4. Composition of solutions and buffers used in this study. 
 
reporter construct “parent” vector cloning site sequencing primerc 
CNE::pGL3 pGL3 Promoter KpnI or KnpI/XhoI pGL3 seq 
CNE::EGFP EGFP (-)a HindIII M13 F and M13 R 
a1-NSE::EGFP EGFP (-)a HindIII M13 F and M13 R 
a1-NSE::lacZ np1230b KpnI/XhoI np1230 seq 
 
Table 2.5. Reporter constructs generated in this study. 
a, the EGFP (-) vector was kindly provided by Harriet Jackson (University of Sheffield) and is based on   
McDonald et al. (2010) and Yu et al. (2011). 
b, the np1230 vector was developed by Dr. Sarah Coy during her Thesis project (Coy et al. 2011) and is based 
on Yee and Rigby (1993).c, all sequencing primers are indicated in Table 2.2
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Chapter 3 
Laminin 1 expression in the amniote embryo
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3.1. Hypothesis and Aims 
As described earlier in Chapter 1, previous research in our laboratory revealed that SHH is 
required for Lama1 expression in the neural tube and somites of E9.5 mouse embryos, where 
absence of Lama1 mRNA correlates with failure to assemble the myotomal basement 
membrane culminating in defective morphogenesis and cell fate specification of the 
myotome (Anderson et al. 2009). However, it was unclear whether SHH acts as an activating 
or maintaining factor for Lama1 expression in the neural tube and somites. Thus, I performed 
whole-mount in situ hybridization (WMISH) to examine Lama1 mRNA expression in Shh-
deficient embryos at an earlier stage, at E8.5. Another unanswered question related to the 
expression of the Lamb1 and Lamc1 genes in Shh
-/-
 embryos. Was their expression disturbed 
similarly to that of Lama1? I addressed this question by studying the mRNA expression 
pattern of Lamb1 and Lamc1 in Shh-mutant embryos. Finally, I hypothesized that the 
expression pattern of Lama1 is conserved across vertebrates, based on existing knowledge in 
the mouse and zebrafish models, and to demonstrate this  I investigated Lama1 expression in 
a third vertebrate species – the embryo of the domestic chicken. 
3.2. Results 
First, I confirmed our previous observations on the expression of Lama1 in E9.5 wild type 
and Shh
-/- 
embryos, using a 950 bp digoxigenin-labelled antisense RNA probe 
complementary to a region of the murine Lama1 mRNA spanning from position 4, 193 to 
position 5, 142 relative to the transcription start site (Claire Anderson’s Thesis 2009). 
In wild type embryos (here labelled as Shh
+/+
), the most prominent sites of Lama1 
expression were the neural tube, presomitic mesoderm and somites, the mesonephros, optic 
and otic vesicles, and the head mesenchyme (Figure 3.1A-F). Notably, Lama1 expression in 
the neural tube and somites was completely obliterated in Shh-deficient embryos, while 
expression in the presomitic mesoderm, and to some extent in the head mesenchyme, 
remained unaffected (Figure 3.1G-L). This result is in agreement with earlier studies in our 
lab (Anderson et al. 2009).  
Further examination of Lama1 expression in E10.25-E10.5 wild type embryos 
showed little change from E9.5. Similarly, Lama1 transcripts were abundant along the neural 
tube, in the head mesenchyme, in the presomitic mesoderm and differentiating sclerotomes,   
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Figure 3.1. Expression of Lama1 mRNA in E9.5 wild type and Shh mutant mouse embryos. Lama1 expression in 
E9.5 Shh
+/+ 
(A-F) (n=3), and Shh
-/-
 (G-I) (n=2) mouse embryos was analysed by whole-mount in situ 
hybridisation. (A) Note that Lama1 expression extends throughout the entire neural tube. (B) In the head, 
Lama1 is detected in all divisions of the brain and in the surrounding head mesenchyme (section in D). (C) High 
magnification of the tail region showing high levels of Lama1 expression in the presomitic mesoderm and 
posterior somites. (E) and (F) are sections through the flank and tail regions, respectively, showing strong 
expression in the neural tube (orange arrowheads in E) and PSM (black arrow in F), and weak expression in 
the sclerotome (black arrow in E). (G) Note the absence of expression in the neural tube and somites of the Shh
-
/-
 embryo. (H) Absence of Lama1 expression in all brain divisions, but not in the head mesenchyme, is observed 
in the Shh mutant embryo (section in J). (I) High magnification of the tail region showing the complete absence 
of Lama1 transcripts in all somites (orange arrows) but not in the presomitic mesoderm. (K) and (L) are 
sections through the trunk and tail regions of the Shh
-/-
embryo revealing the lack of Lama1 expression in the 
neural tube (oranhe arrowheads) and somites (K), while expression in the presomitic mesoderm remains intact 
(black arrow in L). Abbreviations: de, diencephalon; dmm, dermomyotome; hm, head mesenchyme; mb, 
midbrain; met, metencephalon; mye, myelencephalon; nt, neural tube; psm, presomitic mesoderm; sc, 
sclerotome; te, telencephalon. 
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Figure 3.2. Expression of Lama1 mRNA in E10.25 wild type mouse embryos. Lama1 expression in E10.25 wild 
type (A-F) (n=3) mouse embryos was analysed by whole mount in situ hybridisation. (A) Note the strong 
expression of Lama1 in the entire neural tube. (B) High magnification of the left side of the facial region 
showing Lama1 expression between the 1
st
 and 2
nd
pharyngeal arches (white arrow). (C) Magnified dorsal view 
of the tail bud showing high Lama1 expression in the presomitic mesoderm and weaker expression in the 
somites. (D-F) Horizontal sections through the head where anterior is up, posterior is down. Lama1 is expressed 
in the brain and surrounding head mesenchyme (D, E) and in the 1
st
 pharyngeal pouch (indicated by a black 
arrow in F). (G-J) Transverse sections through the trunk and tail regions. Lama1 is expressed in the condensing 
sclerotome and in the ventral neural tube, but not in the dermomyotome (G) and dorsal root ganglia (I). (H) 
Expression in the mesonephric tubules is very prominent. Note the higher levels of Lama1 expression in the 
ventricular zone of the neural tube (orange arrows at E, G and I). Abbreviations: de, diencephalon; dmm, 
dermomyotome; drg, dorsal root ganglion; ha, hyoid arch (2
nd
 pharyngeal arch); hb, hindbrain; hm, head 
mesenchyme; ma, mandibular arch (1
st
 pharyngeal arch); msn, mesonephros; nt, neural tube; ov, otic vesicle; 
ph, pharynx; psm, presomitic mesoderm; sI, somite I (designates a newly formed somite); sc, sclerotome. 
 
and in the mesonephros (Figure 3.2). Notably, Lama1 expression in the neural tube was 
confined to the ventricular zone in the ventral half of the tube (Figure 3.2E, G and I). 
Interestingly, a new domain of expression has appeared in the endodermal lining of the 1
st
 
pharyngeal pouch (Figure 3.2B and F). 
3.2.1. Shh is required for Lama1 transcription in the somites, but not in the neural tube, 
of E8.5 embryos 
Shh is essential for Lama1expression in the neural tube and somites of E9.5 mouse embryos. 
However, it is unclear whether SHH initiates or maintains Lama1 transcription. To address 
this question, I studied Lama1 expression at an earlier stage, in E8.5 Shh
+/+ 
and Shh
-/- 
mouse 
embryos. Lama1 is already expressed in the neural tube, presomitic mesoderm and somites of 
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E8.5 Shh
+/ +
embryos (Figure 3.3A-D). In Shh
-/- 
embryos, Lama1 transcripts are absent from 
somites (Figure 3.3E, F, G), but maintained in the presomitic mesoderm (Figure 3.3H), as in 
E9.5 Shh
-/-
 embryos. However, in contrast to E9.5 Shh-null embryos, Lama1 expression in 
the neural tube of E8.5 Shh
-/- 
embryos was largely unaffected (Figure 3.3E, F, G), except for 
the posterior-most region of the neural tube where it was absent. These observations suggest 
that SHH is required for the initiation of Lama1 expression in the somites. In contrast, SHH 
appears to function in the maintenance of Lama1 expression in the neural tube and not in its 
initiation. Altogether, these observations reveal distinct requirements for SHH in Lama1 
expression in the neural tube and somites, and raise interesting questions about the molecular 
mechanisms governing Lama1 transcription in these tissues. 
 
Figure 3.3. Expression of Lama1 mRNA in E8.5 wild type and Shh mutant mouse embryos. Lama1 expression in 
E8.5 Shh
+/+ 
(A-D) (n=3), and Shh
-/-
 (E-H) (n=3) mouse embryos was analysed by whole- mount in situ 
hybridisation. (A) and (E) present dorsal views of the whole embryo, while (B-D) and (F-H) are transverse 
sections. Lama1 is expressed throughout the neural tube and somites (A, B, C, D), and presomitic mesoderm 
(D) of the wild-type embryo. In the Shh
-/- 
embryo there is lack of expression in the somites (E; black arrow in F 
and G), but not in the neural tube (E, F, G) and presomitic mesoderm (H). The orange arrow in (A) and (E) 
signify the position of a newly-formed somite, sI. Abbreviations: nt, neural tube; psm, presomitic mesoderm; 
som, somite. 
3.2.2. Expression of Lamb1 and Lamc1 is unaffected in Shh-deficient mouse embryos 
According to the current model in our lab, the failure in myotomal basement membrane 
assembly in Shh
-/-
 mouse embryos is caused by the loss of Lama1 expression in the somites, 
which leads to inability to secrete the laminin-111 trimer that is critical to initiate the 
assembly of the myotomal basement membrane (Anderson et al. 2009). However, the 
question of whether expression of Lamb1 and Lamc1, encoding the other two subunits of 
laminin-111, is also affected in Shh-null embryos, particularly in the neural tube and somites, 
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remained unanswered. Therefore, I investigated the expression of these laminin genes in wild 
type and Shh mutant embryos. Consistent with earlier reports (Tunggal et al. 2000), I 
observed ubiquitous expression of both Lamb1 and Lamc1 in Shh
+/+
embryos (Figure 3.4A-C 
and Figure 3.5A, B, respectively). Transcripts were detected in the neural tube, somites, 
presomitic mesoderm, pharyngeal arches, etc. A notable difference between the expression 
pattern of Lamb1 and Lamc1 in Shh
+/+
 mice was the absence of Lamb1 transcripts from the 
heart, while Lamc1 was expressed there (Figure 3.4A and Figure 3.5A). However, most 
importantly, the expression of both Lamb1 and Lamc1 was unaffected in the Shh
-/-
 embryos, 
and the staining in the neural tube and somites, in particular, did not significantly differ from 
that observed in wild type embryos (Figure 3.4D-F and Figure 3.5C, D).  
 
Figure 3.4. Expression of Lamb1 mRNA in E9.25 wild type and Shh mutant mouse embryos. Lamb1 expression 
in E9.25 Shh
+/+ 
(A-C) (n=2), and Shh
-/-
 (D-F) (n=2) mouse embryos was analysed by whole- mount in situ 
hybridisation. (A) and (D) are images of the whole embryo, (B) and (E) are horizontal sections through the head 
region, while (C) and (F) are transverse sections through the trunk. (A) Lamb1 mRNA is expressed in most 
tissues, but not in the heart (A) and the ectoderm of the pharyngeal arches (black arrowheads in B, E). (C) Both 
the neural tube and somites express Lamb1. (D) The pattern of Lamb1 expression is largely unchanged in Shh
-/-
embryos, and particularly in the head (E), as well as in the neural tube and somites (F). Abbreviations: de, 
diencephalon; ha, hyoid arch (2
nd
 pharyngeal arch); hb, hindbrain; hg, hindgut; ht, heart; ma, mandibular arch 
(1
st
 pharyngeal arch); mb, midbrain; nt, neural tube; som, somite. 
This indicates that SHH is not required for the expression of Lamb1 and Lamc1 at the 
examined stages and further supports the model that it is the lack of Lama1 transcription that 
is mainly responsible for the failure to assemble the myotomal basement membrane in Shh-
deficient embryos. 
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Figure 3.5. Expression of Lamc1 mRNA in E9.75 wild type and Shh mutant mouse embryos. Lamc1 expression 
in E9.75 Shh
+/+ 
(A, B) (n=2), and Shh
-/-
 (C, D) (n=2) mouse embryos was analysed by whole- mount in situ 
hybridisation. (A) and (C) images of the whole embryo; (B) and (D) lateral view of the right side of the head. 
(A) and (B) Lamc1 is expressed throughout the body of the wild type embryo, including the heart, all brain 
divisions, the future spinal cord (orange arrow), the somites (orange arrowhead), pharyngeal arches and otic 
vesicle (outlined in white). (C) and (D) Notably, the expression of Lamc1 is unaffected in Shh mutant embryos. 
Abbreviations: ce, cerebellum; ma, mandibular arch (1
st
 pharyngeal arch); mb, midbrain; mye, myelencephalon; 
ov, otic vesicle; te, telencephalon. 
3.2.3. Lama1 transcription in the chicken embryo 
Considering the conserved pattern of Lama1 expression between mouse and zebrafish 
embryos, I was eager to learn whether this phenomenon is a general characteristic of 
vertebrates. Therefore, I decided to examine Lama1 mRNA expression in a third vertebrate 
embryo – that of the domestic chicken (Gallus gallus dom.). 
The expression pattern of the chicken Lama1 gene (cLama1) is poorly documented. 
Zagris et al. (2000) performed in situ hybridization studies with radiolabelled anti-sense RNA 
probes to chicken Lama1 mRNA in embryos from pre-gastrulation Hamburger-Hamilton 
stage 1 (HH1) until 10-somites stage (HH11). The authors reported strong expression in both 
the epiblast and hypoblast at HH1, and at the stage of primitive streak formation (HH3-4) 
Lama1 was strongly expressed by mesenchymal cells ingressing through the primitive groove 
and more weakly by the ectoderm. During head fold development (HH5-6), intensive Lama1 
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staining appeared in the neuroectoderm and lateral mesoderm. Curiously, Zagris et al. (2000) 
failed to detect Lama1 expression in the neural tube and sclerotome of 10-13-somites stage 
embryos (HH10-11). Instead, they reported high expression in the pronephros, weaker 
expression in the dermomyotome and absence of Lama1 in the sclerotome. This lack of 
Lama1 transcripts in the early avian neural tube contrasts with data from the rodent 
(Anderson et al. 2009; Miner et al. 2004) and zebrafish (Figure 1.3; Joseph Pickering’s 
Thesis 2012; Zinkevich et al. 2006) models where, in the case of the mouse embryo, Lama1 
is highly expressed in the neural tube even at early stages of somitogenesis at E8.9 (this 
study). Moreover, during murine somite maturation Lama1 transcripts disappear from the 
dermomyotome, while expression is maintained at low levels in the sclerotome (Anderson et 
al. 2009; this study), which is opposite to the report from Zagris et al. (2000).   
However, there were several issues with the latter study. First, the authors used mouse 
embryo cDNA to generate their “anti-chicken Lama1 mRNA” probes which could 
theoretically have an effect on the probe’s ability to correctly recognize the avian Lama1 
mRNA, and hence generate trustful staining. Second, their data for the lack of neural tube 
and sclerotomal expression is derived from only a single HH10-11 chicken embryo. Thus, it 
could be argued that the lack of Lama1 expression in these tissues is a random artifact of the 
assay and does not represent the true pattern.  
 Therefore, I decided to re-analyse the expression of the chicken Lama1 and add data 
for later stages as well, which were not covered by Zagris et al. (2000). To achieve this, I 
generated a 819 bp digoxigenin-labelled antisense RNA probe that was complementary to a 
region of the chicken Lama1 mRNA spanning from position 506 to position 1, 324 relative to 
the transcription start site. This probe was then used to examine the expression pattern of the 
cLama1 gene. 
cLama1 displays a tissue-specific but dynamic expression pattern. At the earliest 
stage investigated – Hamburger-Hamilton stage 4 (or HH4, 18 h of incubation), cLama1 
transcripts are restricted to ingressing mesodermal cells that have invaded the space between 
the ectoderm and endoderm (Figure 3.6A-D). Later, at HH8 (28 h of incubation), the pattern 
dramatically changes with high levels of cLama1 expression in the forming neural tube 
anteriorly and the neural plate posteriorly, while expression in most of the mesoderm is 
diminished (Figure 3.7A-F). Interestingly, there is a domain of cLama1 expression restricted  
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Figure 3.6. Expression of cLama1 mRNA in HH4 chicken embryos. cLama1 expression in HH4 chicken 
embryos (n=2) was analysed by whole-mount in situ hybridization. (A) Dorsal view of the whole embryo 
showing the fully developed primitive streak (black arrowheads) with the Hensen’s node (black arrow) at its 
anterior-most end. Expression of cLama1 is evident in the ingressed mesoderm. (B-D) Transverse sections 
showing high expression in the mesoderm and low or absent expression in the ectoderm and endoderm. 
Abbreviations: ect, ectoderm; end, endoderm; mes, mesoderm; pf, primitive fold; pg, primitive groove.  
 
to the floor of the foregut endoderm and in what appears to be the posterior-most edge of the 
unsegmented cranial paraxial mesoderm (anterior to somite 1) (Figure 3.7B and H). Most 
posteriorly, where gastrulation movements are still proceeding, there is only speckled 
expression in the mesoderm (Figure 3.7G).  
By HH15 (51 h of incubation), new domains of cLama1 transcription have appeared 
(Figure 3.8A-H). At this stage, prominent sites of cLama1 expression are the somites, 
nephrogenic mesenchyme, posterior lateral plate mesoderm and the tail bud (Figure 3.8B, D, 
F, H). Similar to the mouse, cLama1 was expressed throughout the epithelium in newly 
formed somites, but in more mature somites cLama1 mRNA is restricted to the sclerotome, 
while expression in the dermomyotome is extinguished (Figure 3.8D, E). Surprisingly, in 
contrast to the situation in mouse and zebrafish embryos, there is a conspicuous lack of 
cLama1 transcripts in the presomitic mesoderm (Figure 3.8B, F). Expression in the neural 
tube continues and spans the whole length of this structure. Interestingly, in the posterior 
neural tube cLama1 expression extends through the whole medio-lateral width of the  
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neuroepithelium, while anteriorly it is restricted to the ventricular zone of the ventral half of 
the neural tube (Figure 3.8C, F). Another curious detail is the lack of cLama1 transcripts in 
the nephric duct while high levels are detected in the nephrogenic mesenchyme that will 
subsequently generate the mesonephric tubules (Figure 3.8D).  
 
Figure 3.7. Expression of cLama1 mRNA in HH8 chicken embryos. cLama1 expression in HH8 chicken 
embryos (n=3) was analysed by whole-mount in situ hybridization. (A, H) Dorsal views. (B-G) Transverse 
sections. (A) cLama1 mRNA is abundant in the closing neural tube and in the neural plate at the posterior of the 
body (A, E, F), as well as in the posterior-most edge of the unsegmented cranial paraxial mesoderm (black 
arrow in A and H). Low levels of expression are observed in the 1
st
 somte (H). The dotted orange lines 
delineate the intersomitic clefts. Note the higher expression of cLama1 in the ventricular zone of the neural tube 
(orange arrows in B, C and D). The floor of the foregut also expresses cLama1 (black arrowheads in B). 
Abbreviations, ect, ectoderm; end, endoderm; fg, foregut; hm, unsegmented head mesoderm; mes, mesoderm; 
nf, neural fold; ng, neural groove; np, neural plate; nt, neural tube; pg, primitive groove; s1, 1
st
 somite; s2, 2
nd
 
somite; som, somite. 
 
At the latest examined stage, at HH18 (67 h of incubation), cLama1 continues to be 
expressed in the somites, neural tube, mesonephros and posterior lateral plate mesoderm with 
no expression in the presomitic mesoderm (Figure 3.9A-D). Similar to HH15, expression in 
mature somites is restricted to the sclerotome, while in the neural tube cLama1 RNA is 
confined to the ventricular zone in the ventral half of the tube (Figure 3.9D). The nephric 
duct is devoid of cLama1 expression in contrast to the nephrogenic mesenchyme, congruent 
to the pattern at HH15 (Figure 3.9D’). 
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Figure 3.8. Expression of cLama1 mRNA in HH15 
chicken embryos. cLama1 expression in HH15 chicken 
embryos (n=3) was analysed by whole-mount in situ 
hybridization. (A) Dorso-lateral view of a whole 
embryo showing expression in the neural tube, somites, 
nephric mesoderm and lateral plate mesoderm. (B) High 
magnification of the posterior half of the embryo (dorsal 
view, anterior is to the top); a green arrow indicates 
cLama1 expression in a newly-forming somite (s0) in 
the rostral-most edge of the presomitic mesoderm. (B, 
F) Note the absence of cLama1 mRNA from most of the 
presomitic mesoderm. (H) High magnification of the tail 
bud region (dorsal view, anterior is to the top). (C-G) 
Transverse sections. (C, F) cLama1 transcripts are 
enriched in the ventricular zone of the neural tube 
(orange arrows). (E, D, D’) cLama1 is expressed in the 
nephrogenic mesenchyme (black arrow), but not in the 
nephric duct (black arrowhead). (F, H’) Note the 
presence of cLama1 mRNA in the posterior lateral plate 
mesoderm. Abbreviations: dmm, dermomyotome; lpm, 
lateral plate mesoderm; nc, notochord; mt, myotome; nt, 
neural tube; sc, sclerotome; sI, somite I (designates a 
newly formed somite); som, somite; psm, presomitic 
mesoderm; tb, tail bud. 
 
 
 
 
 
In summary, contrary to Zagris et al. (2000), I observed high expression of Lama1 in 
the chicken neural tube, weaker signal in the sclerotome, absent from the dermomyotome, 
and curiously, also absent from the presomitic mesoderm, unlike the situation in mouse and 
zebrafish.  
Overall, the expression pattern of the chicken Lama1 gene is highly similar to that in 
the mouse and zebrafish embryos, suggesting conserved mechanisms of transcriptional 
control on Lama1. Importantly, this hints for the possibility that SHH signaling is similarly 
involved in the regulation of Lama1 expression in the ventral neural tube and somites across 
vertebrates. 
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Figure 3.9. Expression of cLama1 mRNA in HH18 chicken embryos. cLama1 expression in HH18 chicken 
embryos (n=2) was analysed by whole-mount in situ hybridization. (A) Dorsal view of the whole embryo 
showing intense cLama1 expression in the future brain and spinal cord, somites and nephrogenic mesenchyme. 
(B) and (C) High magnification of the trunk at the forelimb level and of the tail bud region, respectively (dorsal 
views, anterior is to the top). (D, D’) A transverse section through the interlimb region indicating strong 
cLama1 expression in the ventricular zone of the ventral neural tube (orange arrow) and nephrogenic 
mesenchyme, lower levels of expression the sclerotome, and absence in the nepric duct. Abbreviations: dmm, 
dermomyotome; flb, forelimb bud; hlb, hindlimb bud; lpm, lateral plate mesoderm; nd, nephric duct; nm, 
nephrogenic mesenchyme; nt, neural tube; sc, sclerotome; sI, somite I (designates a newly formed somite); som, 
somites. 
3.3. Discussion 
I examined the expression pattern of the Lama1 gene in rodent and avian embryos. Prominent 
sites of expression in the mouse embryo are the neural tube, somites, presomitic mesoderm, 
nephric structures and head mesenchyme, which is consistent with older reports. Confirming 
previous findings from our laboratory, I found that Lama1 transcription in the neural tube and 
somites was lost in Shh-deficient E9.5 mouse embryos, while expression in the presomitic 
mesoderm was unaffected. Interestingly, SHH was not required for Lama1 expression in the 
neural tube of E8.5 embryos, in contrast to such requirement in the somites. I also showed 
that expression of Lamb1 and Lamc1 genes is not affected in Shh-null mouse embryos. 
Finally, I studied the expression pattern of the chicken Lama1 gene and found that it is 
strongly expressed in the neural tube, nephric mesoderm, cranial mesenchyme and somites, 
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but not in the presomitic mesoderm, and concluded that the expression pattern of the Lama1 
gene in vertebrates is largely conserved.  
3.3.1. Lama1 expression in the neural tube of mouse and chicken embryos. 
In agreement with prior studies, I found that Lama1 is characteristically expressed along the 
neural tube (from the ventral telencephalon to most posterior region of the spinal cord) in 
mouse embryos and I also showed that expression in this structure is conserved in the 
chicken. 
3.3.1.1. SHH is not required for Lama1 gene activation in the neural tube 
Intriguingly, Shh-defficient E8.5 embryos displayed persistent Lama1 expression in the 
neural tube but not in the somites (Figure 3.3), in contrast to the situation in E9.5 Shh
-/-
 
animals where both the CNS and somites were devoid of Lama1 mRNA. Interestingly, a 
similar relationship exists in zebrafish, where expression of lama1 in the neural tube is 
unaffected in early smo
-/-
 or cyclopamine-treated wild type embryos (12-15 somites stage), 
while it is reduced in the brain of cyclopamine-treated zebrafish at 27 hpf (Table 1.2; Joseph 
Pickering’s Thesis 2012). 
The observations in the mouse embryo suggest that: 1) Lama1 expression in the 
somites and neural tube is governed by distinct cis-regulatory elements, and 2) SHH plays a 
role in the maintenance of Lama1 transcription in the CNS rather than in its initial activation 
there, similarly to the WNT3a-dependent maintenance, but not initiation, of brachyury gene 
transcription in the paraxial mesoderm (Galceran et al. 2001).  
The latter conclusion also hints to the existence of separate enhancers controlling the 
activation and the maintenance of Lama1 expression in the neural tube. Such scenario is 
consistent with studies reporting the presence of distinct enhancers dedicated to either 
activation or maintenance of developmental gene expression. For instance, the modulation of 
Pax2 expression in the murine midbrain-hindbrain boundary (MHB) is governed by two 
enhancers (Pfeffer et al. 2002). A POU5f1-dependent 120 bp element, termed the 
“activation” enhancer, is sufficient and required to activate Pax2 expression in the anterior 
neural plate at late gastrulation. Another 410 bp enhancer with functional PAX2/5/8 binding 
motifs is both sufficient and necessary to maintain Pax2 expression in the MHB at later 
stages, indicating a positive feedback by PAX2 on its own gene’s transcription (Pfeffer et al. 
2002). Similarly, investigation of the complex transcriptional regulation of the Myf5-Mrf4 
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locus identified separate enhancers for activation and maintenance of Myf5 expression in the 
pharyngeal arches, as well as in the axial muscles (Carvajal et al. 2001).  
Alternatively, both activation and maintenance of Lama1 expression within the mouse 
neural tube could be controlled by a single enhancer, which would require distinct inputs 
from different transcription factors and signaling pathways at early (activation) and later 
(maintenance) stages. This is the case of the orthodenticle (otd) gene in Drosophila that is 
essential for ocellar development. Expression of otd in the eye-antennal disc is controlled by 
a single enhancer – ocelliless, which is initially activated by inputs from the Wingless and 
Hedgehog signalling pathways, while its later activity is maintained by autoregulatory inputs 
by the Otd transcription factor itself (Blanco et al. 2009). 
3.3.1.2. Laminins and neural progenitor cells 
Interestingly, Lama1 expression accumulates in the ventricular zone (VZ) of the neural tube, 
particularly in the anterior neural tube at E8.5, 9.5 and 10.25 in the mouse (Figure 3.1D; 
Figure 3.2E; Figure 3.3B, F) and at HH8/HH15 in the chicken (Figure 3.7B, C; Figure 3.8C), 
while in later stage embryos (Figure 3.2G and Figure 3.9D) this ventricular enrichment is 
also observed in the posterior neural tube. This suggests that Lama1 is predominantly 
transcribed by the pool of proliferating neural progenitor cells located in the ventricular zone 
and is down-regulated in post-mitotic neural or glial cells. Thus, it is possible that laminin 
α1-containing laminins play a role in modulating the behavior of neural progenitor cells. 
Consistent with this possibility, several studies have reported the effects of laminins on the 
maintenance of neural stem cells (Flanagan et al. 2006; Hall et al. 2008), and led to the 
concept that laminins may be an essential component of the ECM in the neural stem cell 
niche (Lathia et al. 2007), as described in more detail in Chapter 1. 
3.3.1.3. Laminins in cortical morphogenesis and axonal growth and migration. 
The pattern of Lama1 expression in both the mouse and chick embryos is also consistent with 
roles of this laminin subunit in glial development and cortical morphogenesis, and multiple 
studies have elucidated critical functions of the laminin α1, α2 and γ1 subunits in axonal 
migration, fasciculation, and glial development in the CNS, as described in Chapter 1. The 
Lama1-knockout studies by Heng et al. (2011) and Ichikawa-Tomikawa et al. (2012) were 
especially important for they demonstrated a critical role of the laminin α1-containing pial 
basement membrane in cerebellar development. These findings are consistent with my 
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observations that Lama1 is transcribed in the embryonic neuroepithelium, and also in 
mesenchymal cells aggregated at the basal surface of the neural tube (Figure 3.2D, E, G). 
These cells form the meninges of the forebrain and spinal cord and are derived from the 
cranial neural crest and the sclerotome, respectively (Couly et al. 1993; Christ et al. 2007). 
Future studies using conditional inactivation of Lama1 in specific neural cell populations at 
different temporal stages would be instrumental in elucidating the plethora of unknown 
functions of Lama1 in the developing nervous system. 
3.3.2. Laminins and neural crest cells 
Laminin α1 expressed by the neural tube and somites may also participate in the migration of 
neural crest (NC) cells along basement membranes of the neural tube, dermomyotome and 
myotome, as described in Chapter 1 where it was highlighted that neural crest cells up-
regulate laminin synthesis at the onset of ganglia formation (Duband and Thiery 1988). It 
would be interesting to determine the laminin isoform present within the condensing ganglia, 
although laminin α1 is a unlikely candidate as I found no Lama1 expression of this subunit in 
the dorsal root ganglia (Figure 3.2G). However, laminin-111 synthesised by sclerotomal cells 
may be utilized by aggregating NC cells. 
3.3.3. Lama1 expression in somites and presomitic mesoderm 
Lama1 is expressed in the somites of all three vertebrates analysed to date – in mouse, 
zebrafish and chicken. While expression is uniform in newly-formed somites of mouse and 
chicken embryos (Figure 3.3C), Lama1 expression is down-regulated in the dermomyotome 
upon or before epithelial-to-mesenchymal transition of the ventral somitic half (Figure 3.8E), 
but remains expressed in the mesenchymal sclerotome (Figure 3.1E; Figure 3.2G, I; Figure 
3.8D). A similar pattern is observed in zebrafish embryos (Figure 1.3; Joseph Pickering’s 
Thesis 2012). 
Lama1 expression in the mouse somites is required for proper myotomal 
morphogenesis and differentiation and, directly or not, for trunk neural neural crest 
migration, through the involvement of laminin α1 in the formation of the myotomal basement 
membrane (Anderson et al. 2009). It is likely that chicken laminin α1 performs similar 
functions. This could be tested via antibody-mediated blocking of laminin α1 interactions 
with cellular receptors like integrin and/or dystroglycan, or by siRNA-mediated down-
regulation of cLama1 mRNA expression in the paraxial mesoderm.  
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3.3.3.1. The requirement for SHH in the presomitic mesoderm and somites is different 
in mouse and zebrafish 
Here, I confirmed previous studies from our lab (Anderson et al. 2009) demonstrating the 
requirement for SHH in the expression of Lama1 in the mouse somites and neural tube at 
E9.5 (Figure 3.1), but not in the presomitic mesoderm. I also provided evidence suggesting 
that Shh is required for the initiation of Lama1 expression in somites, whereas expression in 
the presomitic mesoderm is independent of SHH signalling (Figure 3.3). Interestingly, the 
opposite is true in zebrafish, as lama1 expression requires Hh signalling in the presomitic 
mesoderm, but not in the somites. Indeed, 27 hpf smoothened-deficient fish embryos 
displayed a strong reduction of lama1 mRNA in the presomitic mesoderm, but not in the 
somites (Table 1.2; Joseph Pickering’s Thesis 2012). 
These observations suggest that distinct signalling mechanisms control Lama1 
expression in the somites and in the presomitic mesoderm. One may speculate that Lama1 
transcription in these structures is controlled 1) via a single “paraxial mesoderm” enhancer, 
or alternatively, 2) via separate “somite” and “PSM”-dedicated enhancers. The first scenario 
would assume that the availability of some transcription factors differs between the somites 
and presomitic mesoderm. For instance, GLI are not expressed in the murine PSM but are 
expressed in the somites, while in zebrafish they are expressed in both tissues (Hui et al. 
1994; Thisse et al. 2004), suggesting that the mouse PSM employs an alternative GLI-
independent mechanism to induce Lama1. According to the second scenario, the somite 
enhancer(s) of the murine Lama1 gene would be expected to be SHH-responsive, while the 
PSM enhancer(s) would not. The opposite would be true for zebrafish lama1, although 
constitutive activation of Hh signaling is sufficient to up-regulate lama1 in zebrafish somites 
(Table 1.2; Joseph Pickering’s Thesis 2012), suggesting that a somite-specific regulatory 
element(s) which is Hh-responsive is present in the zebrafish lama1 locus. In fact, what 
appears to be a lack of requirement for Hh in the somitic expression of fish lama1 could be 
due to combinatorial regulation by other signaling pathways and their downstream 
transcription factors, whose combined inputs form an “OR” logic processing gate, instead of 
an “AND” one in the control of lama1 transcription in the fish somites (Davidson 2006). The 
same could be true for the presomitic mesoderm in the mouse. 
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Based on this, one can envision a hypothetical scenario where somitic and presomitic 
expression of Lama1 in the last common ancestor of zebrafish and mouse was modulated by 
two regulatory elements, one for the somite and one for the PSM, both of which receiving 
inputs from HH signaling, perhaps in the form of direct binding by GLI factors (Figure 3.10). 
Beside the GLI inputs, other inputs – from factor X in the somite enhancer and from factor Y 
in the PSM enhancer, acted in a combinatorial, quasi-redundant manner with the GLI factors 
to drive Lama1 expression in these tissues. Upon divergence of the actinopterygian (leading 
to zebrafish) and sarcopterygian (leading to mouse) lineages nearly 419 million years ago 
(Zhu et al. 2009), one may hypothesise that the two enhancers underwent independent loss of 
transcription factor inputs, such that the fish lineage lost input Y from the PSM enhancer, 
while the mouse lineage lost input X from the somite enhancer (Figure 3.10). In effect, the 
losses rendered the zebrafish PSM enhancer and the mouse somite enhancer dependent on 
GLI inputs, and these dependencies were revealed upon experimental perturbation of the HH 
signaling pathway. In contrast, the murine PSM- and fish somite enhancers were insensitive 
to HH signaling deficiencies for they still harbored the quasi-redundant Y and X inputs, 
respectively (Figure 3.10). 
 
Figure 3.10. A hypothetical scenario for the evolution of the putative somite and presomitic mesoderm enhancers of Lama1. 
A schematic diagram illustrating the hypothetical presence of separate somite and presomitic mesoderm (PSM) enhancers of 
Lama1 in the last common ancestor of teleosts and mammals, which were driven by semi- (quasi-) redundant inputs from 
GLI combined with X or Y factors in the somite and PSM enhancer, respectively. After divergence of the sarcopterygian 
and actinopterygian lineages, the somite enhancer lost the binding site for factor X in the lineage lieading to mouse, whereas 
the zebrafish lineage lost the binding site for factor Y in the PSM enhancer. Thus, the murine somite enhancer and the fish 
PSM enhancer were rendered strongly dependent on Hh signaling (as discussed in the text). Legend: magenta triangles, Gli 
factors; cyan shape, factor Y; brown shape, factor X; red rectangles, GLI binding sites; green rectangles, factor Y binding 
sites; yellow rectangles, factor X binding sites; green asterisks, lost factor Y binding site; yellow asterisks, lost factor X 
binding site. 
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A striking example is provided by the eve stripe 2 enhancer (es2E) in Drosophila 
melanogaster, which is regulated by inputs from products of the hunchback, bicoid, kruppel 
and giant genes, where some of the binding motifs appear to be redundant indicated by the 
lack of qualitative changes in the expression pattern driven by mutant variants of es2E 
(Arnosti et al. 1996; Lagha et al. 2012). Similarly, Drewell (2011) investigated the pattern of 
distribution of Kruppel and Hunchback transcription factor binding sites (TFBSs) within the 
BX-C (bithorax complex) in D. melanogaster and concluded that clustering of TFBSs allows 
for extensive functional redundancy such that losses of individual sites do not result in 
obvious phenotypic changes (Drewel 2011). This suggests that enhancers can tolerate 
extensive sequence turnover with gain and losses of TFBSs without overt effects on the 
regulatory output of the elements, perhaps because of quasi-redundancy between particular 
TFBSs (Weirauch and Hughes 2010). 
3.3.3.2. Putative functions of laminin α1 in the presomitic mesoderm (PSM) 
It is possible that laminin-111 synthesised in the murine PSM incorporates into the basement 
membrane surrounding the neural tube, which could explain the presence of laminin α1 
protein on the pial surface of the neural tube even in Shh
-/-
 embryos, as hypothesized by 
Anderson et al. (2009).  
 In regard to functions within the PSM, laminin-111 is in a position of hypothetically 
modulating various aspects of somitogenesis, from survival of PSM cells to clefting and 
budding of epithelial somites, similarly to the requirement for fibronectin in the formation of 
chicken somites (Rifes et al. 2007). The putative function of laminin α1 in the murine 
presomitic mesoderm could be addressed by soaking cultured mouse embryos in the presence 
of antibodies that prevent the interaction of laminin a1 with cell surface receptors, or by Cre-
based conditional deletion of the Lama1 gene within the cells of the presomitic mesoderm 
(Marinic et al. 2013). 
However, the avian presomitic mesoderm was largely devoid of cLama1 mRNA 
(Figure 3.8A, B, F), in striking contrast to the mouse and zebrafish embryos. This suggests 
that cLama1 expression in the presomitic mesoderm was lost in the avian lineage at some 
point after the great sauropsid/synapsid dichotomy nearly 310 million years ago (Benton 
2005; van Tuinen and Hadly 2004). An alternative, but less parsimonious scenario is that 
Lama1 expression in the presomitic mesoderm was independently invented by teleosts and 
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mammals. Nevertheless, I observed cLama1 in the anterior-most end of the chicken PSM 
where the newly formed somites bud off from (green arrowhead in Figure 3.8B). This pattern 
is very intriguing as it suggests some unique function for laminin α1 at this very rostral end 
of the PSM, as hypothesised above for the mouse. Strikingly, despite the lack of cLama1 
mRNA expression through most of the avian PSM, a recent study provided detailed 3-
dimentional view of the laminin and fibronectin protein matrices within and around the avian 
presomitic mesoderm (Rifes and Thorsteinsdottir 2012). Interestingly, both matrices display 
progressive increase in structural organization in a caudal-to-rostral direction, where laminin 
in particular is presented by small patches within the less mature posterior PSM while in the 
anterior half of the PSM, where somitic epithelialization and budding occur, laminin is 
deposited as a fenestrated meshwork on the surface of the mesodermal cell (Rifes and 
Thorsteinsdottir 2012), again hinting to functions in PSM morphogenesis. 
But if the chicken PSM does not transcribe cLama1 then which cells provide laminin 
to the PSM? One possibility is that the neural tube provides laminin-111 for cLama1 is 
expressed there. Alternatively, the absence of cLama1 expression in the avian presomitic 
mesoderm may be compensated by the expression of another alpha laminin subunit, most 
likely laminin α5, which appears to be present in the chicken presomitic mesoderm (Coles et 
al. 2005) but not in the murine PSM (Anderson et al. 2009). Thus, the putative function of 
laminin in the development of the PSM might be performed by different isoforms in the 
mouse and chicken embryos.  
Moreover, another unreported aspect of avian cLama1 expression pattern is the 
domain at the very caudal edge of the unsegmented cranial paraxial mesoderm (black arrow 
in Figure 3.7A, H). It could be speculated that laminin α1 plays a role in the initial separation 
of the cranial from presomitic paraxial mesoderm. These scenarios can be addressed either by 
interfering with the stability of cLama1 mRNA or by blocking antibodies against laminin α1, 
as mentioned previously.  
3.3.4. Lama1 expression in the nephrogenic mesoderm 
Another conserved domain of Lama1 expression is the nephrogenic mesoderm. The results 
from my studies on Lama1 mRNA expression in the mouse embryo (Figure 3.1E; Figure 
3.2H) are consistent with previous reports on Lama1 expression in the developing nephric 
systems (Anderson et al. 2009; Miner et al. 1997; Miner et al. 2004; Sorokin et al. 1997), as 
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described in Chapter 1. Interestingly, I found that in the avian embryo cLama1 mRNAs are 
present only in the nephrogenic mesenchyme but not in the nephric duct (Figure 3.8D, D’; 
Figure 3.9D, D’), at least at the examined stages. Perhaps, the minor difference in the 
expression pattern of the chicken and murine Lama1 has species-specific functional 
consequences for nephric development. However, Ekblom et al. (1990) reported that, 
nevertheless, in the mouse embryo, laminin α1 disappears from the ureters and collecting 
ducts (which are derivatives of the nephric duct) by day 16 of gestation and remains only in 
the proximal tubules of the nephrons (derived from the nephrogenic mesenchyme) where it 
also down-regulated eventually (Ekblom et al. 1990). Despite these minor differences, the 
transient expression of Lama1 in the developing kidneys suggests important functions of 
laminin α1 in kidney morphogenesis, as described in Chapter 1. 
3.3.5. Other domains of Lama1 expression 
Intriguingly, I observed Lama1 mRNA expression in the floor of the foregut of HH8 chicken 
embryos (black arrowheads Figure 3.7B) as well as in the endoderm of the 1
st
 pharyngeal 
pouch and pharynx of mouse embryos at E10.25 (Figure 3.2B, F). It is possible that laminin 
α1, in the form of laminin-111, could perform a role in the complex processes of epithelial 
sheet folding during pharyngeal pouch and thyroid diverticulum evagination. In this respect, 
the observation that blocking the interaction between laminin γ1 and nidogen leads to a 
severe reduction in branching morphogenesis of the submandibular salivary gland in E13 
mouse embryos (Kadoya et al. 1997), suggests that the presence of assembled Laminin 
network is required for branching/folding of epithelia. A study in Caenorhabditis elegans 
uncovered the involvement of laminin in the apical localization of the PAR-3 protein in 
pharyngeal precursors that is required for establishment of the apical-basal polarity of the 
nematode pharynx epithelium, independent from laminin’s incorporation in basement 
membranes (Rasmussen et al. 2012). Thus, expression of Lama1 in the pharyngeal endoderm 
of mouse and chicken embryos hints for hitherto unknown functions of laminins in this 
region of the embryo, which can be addressed by the application of blocking antibodies to 
laminin α1 and/or its receptors in cultured embryos or by RNAi-mediated down-regulation of 
Lama1 translation. 
Another interesting domain of cLama1 mRNA expression is in the ingressing 
mesoderm in HH4 chick embryos (Figure 3.6), which is consistent with the observations 
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from Zagris et al. (2000). However, the functional significance of this expression by the 
newly formed mesoderm is unclear, especially in consideration of the requirement for 
basement membrane breakdown at the site of the primitive groove, where epiblast cells 
undergo epithelial-to-mesenchymal transition (EMT) and turn into mesoderm (Nakaya et al. 
2008). In relation to this, the EMT marker Snail2 was up-regulated and mesodermal 
differentiation accelerated in Lamc1
-/- 
embryoid bodies which also, expectedly, lacked 
basement membrane (Fujiwara et al. 2007), again demonstrating the negative relationship 
between Laminins and mesodermal ingression in gastrulation. 
Although I did not examine cLama1 expression in pre-gastrulation chicken embryos 
(stages 1-2), it was reported to be expressesed by the epiblast and more intensively by the 
hypoblast (Zagris and Chung 1990; Zagris et al. 2000) at that stage, and culturing chicken 
embryos in solution containing laminin antibodies perturbed the adhesion and migration 
directionality of epiblast cells during formation of the primitive streak, which eventually 
culminated in disintegration of the whole area pelucida (Zagris and Chung 1990), thus 
revealing important roles for laminin-111 in early avian embryogenesis. This is reminiscent 
to the essential functions of laminin α1 in murine epiblast differentiation and extraembryonic 
membrane stability (Miner et al. 2004). 
3.3.6. Lamb1 and Lamc1 mRNA expression is unaffected by the absence of Shh 
The absence of Shh did not have an effect on the expression of Lamb1 and Lamc1 at E9.5. 
This further consolidates the model in our laboratory that the failure of myotomal basement 
membrane (MBM) assembly is a result of perturbed Lama1, but not other Laminin genes’ 
transcription (Anderson et al. 2009). However, Anderson et al. (2009) detected patches of 
laminin β1 protein in the somites of Shh-/- embryos, which were not organized in a continuous 
sheet as in wild type animals. It is not implausible that laminin β1 in these patches could be 
part of residual laminin-111 produced before somitogenesis, in the presomitic mesoderm, that 
failed to polymerise due to perturbation of Lama1 transcription in the somites of Shh-null 
embryos, illustrating that dosage of laminin α1, and hence – laminin-111, is important for 
effective assembly of the myotomal basement membrane (Anderson et al. 2009). In fact, 
synthesis of the alpha subunits and interaction with the beta-gamma dimer is considered 
essential for secretion of the whole laminin heterotrimer from laminin-producing cells 
(Yurchenco et al. 1997). However, a more likely explanation is that the laminin β1+ patches 
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of unassembled laminin are formed by laminin-511 instead, as Lama5 expression was 
unaffected in the somites of Shh-defficient embryos (Anderson et al. 2009), and therefore 
could have facilitated the secretion of a laminin β1-containing trimer. 
 
 In summary, I confirmed our previous finding that SHH is required for Lama1 
expression in the somites and neural tube of E9.5 mouse embryos. I reported a differential 
requirement for SHH signaling in the somites and neural tube for the initiation and 
maintenance of Lama1 expression, respectively. Finally, I investigated the expression pattern 
of the chicken Lama1 gene and concluded that its expression is largely conserved with that of 
its mouse and zebrafish orthologs, hinting to the conservation of signaling and transcription-
regulatory mechanisms. This has led me to hypothesise that Lama1 expression in the murine 
somites and neural tube is directly regulated by SHH via binding of GLI transcription factors 
to cis-regulatory elements in the vicinity of the Lama1 locus. Moreover, based on the 
conserved expression of Lama1 across vertebrates, particularly in the neural tube and 
somites, it is highly plausible that the SHH-responsive regulatory elements are conserved, 
which may aid their identification via in silico approaches, as described in the next chapter. 
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Chapter 4 
in silico identification of conserved non-coding elements in 
the vicinity of the Lama1 locus in mice 
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4.1. Hypothesis and Aims 
Previous research in our laboratory implicated the SHH signalling pathway and GLI2/GLI3 
transcription factors in the regulation of Lama1 expression in the neural tube and somites of 
mouse embryos (Anderson et al. 2009). Based on this, I hypothesised that SHH exerts a 
direct control on Lama1 transcription, mediated by binding of the GLI transcription factors to 
regulatory elements in the vicinity of the Lama1 locus. Here, I attempted to identify putative 
GLI-binding-sites-containing regulatory elements in the mouse Lama1 locus using the 
method of phylogenetic footprinting. 
4.2. Introduction 
 
4.2.1. Phylogenetic footprinting and regulation of developmental gene expression 
An emerging picture from genome-wide studies is that most conserved-non coding elements 
(CNEs) predominantly map to regions flanking genes implicated in embryonic development 
(Dermitzakis et al. 2002; Bejerano et al. 2004; Woolfe et al. 2005; Pennacchio et al. 2006; 
Elgar 2009). This hints for a role of CNEs as modulators of gene transcription. For instance, 
such a role was suggested by Bejerano et al. (2004), who uncovered 481 ultraconserved 
elements (defined as displaying 100% sequence identity over a ≥ 200 bp window) in 
phylogenetic footprinting between human, rat and mouse whole genome sequences. Notably, 
111 of these elements mapped to exonic portions of known human genes predominantly 
involved in RNA binding and splicing, but the majority were located in the introns or 
intergenic territories around genes with known roles in transcriptional control and 
development (Bejerano et al. 2004). Indeed, numerous in vivo studies at different scales and 
scopes have demonstrated that a substantial fraction of CNEs have gene regulatory potential 
(Dickmeis et al. 2004; Poulin et al. 2005), as revealed for the murine endothelial and neural 
enhancers of the Scl gene (Gottgens et al. 2000) for instance, illustrating the power of 
phylogenetic footprinting to detect putative TREs, as detailed below. 
Despite the low level of sequence conservation of vertebrate CNEs with those 
identified in flies or nematodes, suggesting that these elements are perhaps phylum-specific 
and related to the establishment of the bauplan (Vavouri and Lehner 2009; Elgar 2009; 
Woolfe et al. 2005), a recent study by Clarke et al. (2012) provided the first example of 
functional pan-bilaterian CNEs that span the deuterostome-protostome dichotomy. Two such 
elements with enhancer activity were detected in alignments between human, zebrafish, sea 
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urchin, owl limpet, sea hare and tick genomic sequences and were named Bicores, for 
Bilaterian Conserved Regulatory Elements. Bicore 1 and 2 were mapped upstream of the 
orthologs of the Id2 and Zn503 genes, respectively. In all of the above metazoans, Bicore 1 
and 2 displayed 60-65% sequence identity over ~100 bp in the vertebrate/protostome 
comparisons. Remarkably, despite the vast phylogenetic distance, the Bicores from different 
species drove similar spatio-temporal patterns of GFP reporter expression in the CNS of 
transgenic zebrafish, corresponding to the domains of endogenous Id2 and Zn503 gene 
activity (Clarke et al. 2012). 
Importantly, mammal/teleost comparisons proved to be highly informative and 
effective in detecting functional CNEs as evident from a genome-wide comparison between 
human and pufferfish, which recovered 3,100 CNEs with at least 70% identity (Pennacchio et 
al. 2006). 167 of the top-ranking human fragments were further examined in a high-
throughput mouse transgenesis approach, which revealed that 75 behaved as transcriptional 
enhancers driving lacZ reporter gene expression predominantly in the central and peripheral 
nervous system (Pennacchio et al. 2006). Curiously, more than 50% of the candidate regions 
did not exhibit enhancer activity which could be due to species-specific differences in the 
transcription-factor milieu, to the fact that some of these CNEs are not enhancers, and/or to 
technical limitations of the study, such as terminating reporter expression screening prior to 
the stage of enhancers’ activity. 
Similarly, another study with a narrower phylogenetic scope demonstrated the power 
of phylogenetic footprinting to uncover CNEs with pan-vertebrate conserved function. 
Navratilova et al. (2009) performed human/zebrafish alignments and catalogued several 
highly-conserved non-coding elements (HCNEs) with at least 70% identity over ≥ 100bp 
sequence window in the SOX3 and PAX6 loci of the human genome. Notably, upon reporter 
construct injection in zebrafish embryos, most of the HCNEs (80%) generated reproducible 
patterns of GFP fluorescence in tissues that correspond to domains of sox3 and pax6 mRNA 
expression. Furthermore, some of the human and fish HCNEs showed similar functional 
properties, i.e. the expression driven by the orthologous elements was remarkably congruent 
and consistent with previous functional analyses of some of the human regions around PAX6 
in transgenic mice (Navratilova et al. 2009; Kleinjan et al. 2001; Kleinjan et al. 2006). This 
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demonstrates the potency of zebrafish as a useful system to test the activity of mammalian 
non-coding elements. 
In some exceptional, gene-centric investigations, phylogenetic footprinting has 
succeeded in the identification of the almost complete set of tissue-specific enhancers of a 
gene, as is the case of the murine Six1 gene. There, Sato et al. (2012) compared the mouse 
genome with those of the opossum, chicken, Xenopus and teleosts and detected 15 CNEs 
flanking the Six1 locus. The elements ranged in size from 0.1 to 0.7 kb in length and showed 
at least 50% identity over 100bp among mouse/chicken. Notably, subsequent in vivo analyses 
in chicken and mouse embryos revealed that 7/15 of the sequences exhibit distinct enhancer 
activities in the cranial placodes, dorsal root ganglia, somites, notochord and cranial 
mesoderm, which in sum covered the major domains of Six1 expression (Sato 2012). 
Nevertheless, although CNEs are frequently associated with enhancer properties in 
vivo, CNEs may also belong to other types of transcription-regulatory elements such as 
silencers, insulators (Royo et al. 2011), locus control regions, miRNA binding sites, or even 
non-coding RNAs (Birney et al. 2007). 
Considering the efficiency of phylogenetic footprinting combined with the 
availability of web-based automated programmes allowing relatively rapid customised 
multispecies genome comparisons, I decided to use this approach for the detection of 
conserved non-coding elements in the murine Lama1 locus, some of which I predicted would 
harbour Gli-binding sites if Shh directly controls Lama1 (Anderson et al. 2009). 
4.3. Results 
4.3.1. in silico identification of CNEs in the Lama1 locus region 
There are few web-based bioinformatics tools which perform multi-species genome 
alignments combined with graphical display of sequence conservation, namely the UCSC 
Genome Browser (Kent et al. 2002), the VISTA Genome Browser (Frazer et al. 2004) and 
the ECR Browser (Ovcharenko et al. 2004). I chose to use the ECR (for Evolutionary 
Conserved Regions) Browser over the other alternative tools for the following advantages 
(see section 2.3.3 for detailed description of the ECR Browser): 
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1. It affords dynamic and interactive visualization of conservation profiles across 
multiple species. 
2. It allows the inclusion of phylogenetically critical species, such as the opossum 
Monodelphis domestica, which are not available in alternative programmes. 
3. It automatically highlights regions meeting the stringency criteria, which enables 
faster screening of the alignments. 
4. It provides a direct link to the rVISTA tool (Loots and Ovcharenko 2004) for rapid 
examination of TFBSs present in the CNE sequences. 
 
The ECR Browser also allows the adjustment of conservation parameters according to 
the user’s needs. In this study, two such parameters, minimum window length (in base pairs) 
and minimum sequence identity (in percentage, %) were customized at 100 bp and 60%, 
respectively. Such level of stringency, ≥ 60% identity over a 100 bp window, was chosen for 
it has been previously shown in comparisons between chicken and mammalian genomes that 
these stringency settings are effective in the identification of CNEs with important regulatory 
functions (Uchikawa et al. 2003, Coy et al. 2011), and they decrease the frequency of false 
positives, providing a manageable number of CNEs for subsequent experimental studies. The 
100 bp window was chosen for, although the average size of transcriptional enhancers is 500 
bp (Loot 2008), these elements can range in size from 100 bp (Krebsbach et al. 1996; Loot 
2008) to few kilobases (Danielian et al. 1997), whereas the 60% stringency cut off would 
enable the detection of candidate enhancers that might be more weakly conserved than the 
reported > 95% and > 70% sequence identity of putative TREs derived from human/rodent 
and human/teleost sequence comparisons, respectively (Bejerano et al. 2004; Sandelin et al. 
2004; Woolfe et al. 2005). 
Based on this approach and parameter settings, I aligned the mouse genomic region 
harboring the Lama1 locus with the corresponding genomic regions from several other 
vertebrate species: human, cow, opossum, chicken, Xenopus, zebrafish and fugu (Figure 4.1). 
The mouse/human and mouse/cow alignments generated too high number of peaks, due to 
close evolutionary relationship, most of which are perhaps functionally irrelevant. In 
contrast, the mouse/chicken, mouse/Xenopus and mouse/teleosts comparisons produced 
either too few or no conserved elements, suggesting too stringent conservation parametres.
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Figure 4.1. Phylogenetic footprinting analysis of the Lama1 locus on mouse chromosome 17. (A) Schematic representation of the murine Lama1 locus (shown in green) and its 
nearest neighbouring genes on chromosome 17: Arhgap28 (salmon), Lrrc30 (purple) and Ptprm (blue). The centromere of chromosome 17 is further down on the left, while the 
scale bar above indicates the length of the mouse Lama1 gene (125kb) in kilobases and the distance (394kb) between Lama1 and the Ptprm gene. Curved arrows represent the 
transcriptional start site of the gene and the direction of transcription. Straight grey lines connect genes from the schematic representation in (A) to their corresponding positions in 
the ECR Browser output in (B). (B) Conservation plot of the genomic region shown in (A), generated by the ECR Genome Browser. Each row of the plot represents the alignment 
of the mouse sequence with the genome of a comparator species with decreasing phylogenetic relatedness moving from bottom (mouse/human alignment) to top (mouse/fugu 
alignment). Conserved genomic regions meeting or exceeding the stringency criteria (≥60% identity over at least 100bp) appear as colour-coded peaks: blue (exons), yellow 
(UTRs), salmon (introns), green (repeats) and red (intergenic non-coding sequence).Note the decrease in peaks number or absence thereof in the alignments with Xenopus and 
teleots fish, respectively. A scale bar of 100 kb is shown below the graph. 
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Therefore, I repeated the same ECR Browser alignment but decreased the stringency 
down to 30% identity over a 30 bp window. However, even under these relaxed conditions, 
the ECR Browser failed again to display any conserved sequence in the mouse/Xenopus and 
mouse/teleost alignments, not even in exonic regions, contrary to expectations as blastn 
comparisons of Lama1 cDNA sequences (Ensembl) from mouse and zebrafish revealed 72% 
identity (E-value = 0.0). I suspected that the local alignment method applied by the ECR 
Browser is not optimal for the detection of conserved elements between highly divergent 
sequences that have undergone rearrangements and inversions (Brudno et al. 2003), and/or 
there were issues with the quality of the compared genomic sequences as the ECR Browser 
authomatically selects the aligned sequences. To circumvent this problem, I used the Shuffle-
LAGAN (a hybrid global-local, or glocal alignment) algorithm at mVISTA, and performed 
customised comparisons of the genomic region containing the Ptprm, Lrrc30, Lama1 and 
Arhgap28 loci from mouse, human, opossum, chicken and zebrafish (see Chapter 2 for 
details of the analysis). This approach succeeded in the detection of conserved peaks in all of 
the alignments, including in the mouse/zebrafish comparison (Figure 4.2). In the latter 
alignment, most of the peaks correspond to conserved exons from the Ptprm, Lrrc30, Lama1 
and Arhgap28 genes, while two of the identified peaks correspond to unique sequences in the 
non-coding regions, and were named here as CNEa and b (Figure 4.2; Table 4.1). Notably, 
CNEb is located within the 3
rd
 intron of the Lama1 gene. 
The most informative alignment in the ECR Browser, in terms of the number of 
CNEs detected, was the mouse/opossum one. Therefore, I focused my studies on that 
comparison. Based on it, I identified 24 CNEs in the mouse sequence, numbered from 1 to 24 
(Figure 4.3; Figure 4.4). CNE1 is positioned most proximally to the Lama1 transcription start 
site and CNE24 is the most distal one. Interestingly, no CNE was identified within the 
intronic sequences of Lama1 or in the intergenic space downstream of the Lama1 3’ UTR. 
Instead, all CNEs are interspersed in a 361 kb interval upstream of the Lama1 transcription 
start site. CNEs 1-3 are located in the intergenic space between Lama1 and the Lrrc30 gene, 
CNEs 4-22 are situated in the region between Lrrc30 and the Ptprm gene while, notably, 
CNEs 23 and 24 are found in the first intron of Ptprm (Figure 4.3). The search for additional 
CNEs was not extended further downstream of the Ptprm1 intron 1 for enough number of 
CNEs were already recovered for subsequent analyses. 
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Figure 4.2. Identification of CNEs in the vicinity of the Lama1 locus in a mouse/zebrafish alignment. 
Comparison of the Lama1-containing genomic region, spanning from the 3’-end of Ptprm locus to the 5’-end of 
Arhgap28, from mouse and zebrafish, as generated in mVISTA. A) Full view of the alignment. Elements 
characterized with sequence identity ≥ 30% over a 30 bp window are displayed in pink colour. Most of the 
colored peaks correspond to exonic sequences. Dark bars above and yellow shadowing within the alignment 
plot indicate the extent of each gene locus. B) Detailed views of CNEa and b. CNEa corresponds to the 5’-end 
of CNE24, located in the 1
st
 intron of Ptprm, while CNEb is located in the 3
rd
 intron of the Lama1 locus (see 
Table 4.1). 
 
The pattern of distribution of some of the CNEs necessitates more detailed 
description. Accordingly, CNE1 is the nearest CNE to Lama1 locus, situated 33.5 kb 
upstream of the Lama1 transcription start site, or approximately 30 kb upstream of the known 
transcription-regulatory elements of Lama1 (Niimi et al. 2003, 2004; Piccinni et al. 2004). 
CNE2, 3 and 4 are located close (within 10 kb) to the Lrrc30 gene with CNE3 positioned 
only 12 bp 5’ to the Lrrc30 transcription start site, while CNE2 and 4 flank the Lrrc30 gene 
(Figure 4.3). The close proximity of CNE3 to this poorly explored gene combined with 
results from the current study (see Chapter 6) raises interesting questions regarding CNE3’s 
function. 
Further upstream of the Lama1 locus, CNEs 11-16 form a loose cluster where each 
CNE is separated from its nearest neighbour by less than 10 kb, while CNE22 is located 
about 6 kb 5’ of the transcription start site of the Ptprm gene. Finally, as mentioned earlier, 
CNEs 23 and 24 are positioned within the first intron of Ptprm (Figure 4.3). 
In terms of size (length of base pairs), the identified CNEs range from 137 bp to 953 
bp which is consistent with the size reported in the literature (Elgar 2009; Pennacchio et al. 
2006; Woolfe et al. 2005). It is important to indicate that in cases where two or more 
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promising peaks on the ECR Browser plot were separated by less than 150 bp of non-
conserved sequence, the peaks together with the intervening regions were considered as part 
of one CNE, as is the case for CNEs 4, 5 and 13 (Figure 4.3; Figure 4.4). Based on the fact 
that transcription-regulatory elements may contain regions of high and low sequence 
conservation (Clarke et al. 2012), selecting only for the most highly-conserved regions could 
result in spurious activity during the functional assays, which would not reflect the genuine 
function of the entire regulatory element. 
The ECR Browser-identified CNEs differ at the extent of sequence conservation, with 
CNE4 being the least conserved (62.1%) while CNEs 20 and 24 are the most conserved with 
78.4% and 81.4% identity, respectively (Figure 4.4; Table 4.1). These percentages of 
sequence identity are the result of the mouse/opossum genome sequence alignment. Notably, 
however, CNEs 9, 14, 19, 23 and 24 do also appear conserved in the mouse/chicken 
comparison, indicating that the extent of sequence identity of these particular CNEs, shared 
between the mammalian and avian species, meets the established stringency criteria. In 
contrast, the rest of the CNEs are not identified in comparisons of the mouse with non-
mammalian species sequences, and their description is based on the mouse/opossum 
alignment as stated earlier. 
 
Figure 4.3. Distribution of conserved non-coding elements (CNEs) in the vicinity of the mouse Lama1 gene 
based on the analysis from the ECR Browser. (A) A diagram of the genomic region containing the CNEs 
identified in this study. To ease subsequent visualization in panel B, the whole region is divided in seven 
viewing windows shown as light-grey boxes and numbered from I to VII with Roman numerals. (B) A detailed 
view of the comparison between the mouse sequence and the genome of the opossum M. domestica and the 
chicken G. gallus, generated in the ECR Browser. On the left are shown the viewing windows (I – VII) with 
each window corresponding to a section of the mouse genomic region in (A) that is aligned with the opossum 
(bottom row) and chicken (upper row) (see Legend at the bottom). The percentages on the right reflect sequence 
conservation in the alignments. All CNEs identified in this study are highlighted in cyan (mouse/opossum) or 
light-green (mouse/chicken) in the alignment plots. Their position in the whole genomic region is indicated by 
gray lines that map the highlighted peaks from the alignments onto the diagrams of the genomic region, placed 
between windows I-II, III-IV and V-VI. The CNEs are numbered with Arabic numerals, from 1 to 24, depicted 
next to the connecting grey lines. At the bottom left is provided a scale bar of 10 kb to ease distance estimation 
in the ECR Browser plots. Below is shown a Legend that explains the meaning of the color code used in the 
Figure (see page 97). 
 
 
 
 
 
  
96 
 
 
Figure 4.3. Distribution of conserved non-coding elements (CNEs) in the vicinity of the mouse Lama1 gene 
based on the analysis from the ECR Browser. Description is provided on the previous page (p. 95).  
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CNE 
genomic coordinates on 
chromosome 171 
length (in bp) 
% sequence 
identity2 
a 67,302,811-67,302,924 114 80.0 
b 67,719,841-67,719,952 112 68.8 
1 67,663,410-67,663,687 278 71.9 
2 67,638,755-67,638,982 228 67.1 
3 67,632,731-67,633,050 320 68.8 
4 67,628,306-67,629,259 953 62.1 
5 67,613,886-67,614,330 444 64 
6 67,603,803-67,604,119 317 77.6 
7 67,585,118-67,585,462 345 68.5 
8 67,566,070-67,566,263 194 65.5 
9 67,552,672-67,553,105 434 72.4 
10 67,532,119-67,532,491 373 73.2 
11 67,514,616-67,514,817 202 65.8 
12 67,512,661-67,513,331 671 64.7 
13 67,505,209-67,506,030 822 64.8 
14 67,500,119-67,500,500 382 67.3 
15 67,495,323-67,495,591 269 70.6 
16 67,493,075-67,493,309 235 63.4 
17 67,466,906-67,467,545 640 66.6 
18 67,433,815-67,434,304 490 67.6 
19 67,424,809-67,424,945 137 75.9 
20 67,371,939-67,372,109 171 78.4 
21 67,368,753-67,369,379 627 72.1 
22 67,360,683-67,361,162 480 65.6 
23 67,323,788-67,324,481 694 70.2 
24 67,302,361-67,303,096 736 81.4 
 
Table 4.1. Features of the identified CNEs .
1
The coordinates are according to the GRCm38 assembly of the 
mouse genome (mm10 in the UCSC Browser). 
2
The percentages reflect the conservation of the mouse elements 
with the corresponding opossum sequences (for CNEs 1-24) or zebrafish sequences (for CNEs a and b). 
4.3.2. Some CNEs contain binding sequence motifs for GLI and ZIC factors 
Each of the CNEs is characterised by a unique nucleotide sequence which contains potential 
motifs (sites) for interaction with DNA-binding proteins. The group of DNA-binding proteins 
of particular importance for this study is the GLI family of transcription factors. According to 
my hypothesis for a direct role of SHH signalling in the regulation of Lama1 transcription, I 
predicted the existence of GLI-binding sites within the Lama1 locus and/or its vicinity, and 
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specifically within CNEs, as CNEs have been reported to be a preferential hub for TFBS with 
regulatory functions (Hemberg et al. 2012; Sato et al. 2012).  
 
Figure 4.4. Conservation profile of individual CNEs (1-24) based on the mouse/opossum genome comparison 
from the ECR Browser. (A) A map of the location of the 24 CNEs in relation to the mouse Lama1 locus and 
neighbouring loci (black arrows show direction of transcription). (B) Detailed conservation plots for each CNE 
as generated by the ECR Browser for alignments of the mouse and opossum genomes. The percentages on the 
right reflect sequence conservation in the alignment. CNEs highlighted in light-green (4, 7, 13, 22, 23 and 24) 
contain one or more GLI/ZIC binding motifs, as discussed in the text. Below is shown a Legend that explains 
the meaning of the color code used in the Figure. Note that the lengths of the CNEs are not to scale; for detailed 
information on CNEs’ lengths see Table 4.1. 
 
To test this possibility, I submitted the pre-computed mouse/zebrafish and 
mouse/opossum alignments of each CNE for processing in the rVISTA2.0 tool (Loots and 
Ovcharenko 2004; see section 2.6.4 for details). This approach predicted the presence of GLI 
binding motifs in CNEs 13, 23 and 24 (see Table 4.2 and Figure 4.4). Notably, some of the 
GLI binding motifs in CNEs 13 and 23 overlapped with motifs for the ZIC transcription 
factors. This is not unexpected as previous studies have revealed that the minimal consensus 
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binding sequence of the ZIC transcription factors (5’-GGGTGGTC-3’) is nearly identical to 
the consensus binding sequence of the GLI factors (5’-TGGGTGGTC-3’) (Kinzler and 
Vogelstein 1990; Mizugishi et al. 2001). Moreover, gel shift assays demonstrated the ability 
of ZIC factors to bind to the consensus Gli-binding sequence albeit with lower affinity than 
the GLI factors (Aruga et al. 1994; Mizugishi et al. 2001). These highly similar binding 
properties could be explained by the fact that ZIC transcription factors contain a Zn-finger 
DNA binding domain with five Cys2His2 finger motifs, which is highly-homologous to the 
Zn-finger DNA-binding domain of the GLI factors (Aruga et al. 1996). Interestingly, the 
rVISTA tool also predicted that CNEs 4, 7 and 22 contain a ZIC motif but not a GLI one 
(Table 4.2).  
CNE 
GLI/ZIC 
motif 
position in 
CNE 
Expected ± SD 
Over 
representation 
Z-score 
Gli/Zic motif 
presence in 
opossum 
Gli/Zic motif 
conservation 
4 ZIC 890-904 (+) 0.37 ± 0.61 2.70 0.21 no no 
7 ZIC 153-167 (+) 0.09 ± 0.31 10.53 1.31 no no 
13 GLI 
GLI 
GLI 
68-82 (-) 
295-309 (-) 
759-773 (-) 
0.98 ± 0.99 3.07 1.54 GLI (127-138) (+) no 
22 ZIC 412-426 (+) 0.18 ± 0.42 5.64 0.77 ZIC (324-332) (-) yes 
23 GLI 
GLI 
146-160 (-) 
273-287 (-) 
0.71 ± 0.84 2.84 0.95 ZIC (545-553) (-) no 
24 GLI 
GLI 
71-85 (-) 
345-359 (+) 
0.75 ± 0.86 2.67 0.87 no no 
 
Table 4.2. Presence and conservation of GLI/ZIC motifs in some of the CNEs. The current table lists the 
prediction of GLI/ZIC binding motifs within some of the CNEs, together with relevant statistics information, as 
obtained using the “Over-represented TFBSs” tool from Genomatix and rVISTA. The “Position in CNE” 
column shows the location of the motif in the mouse CNE sequence and the DNA strand, “+” (sense) and        
“–“ (antisense). The “Expected ± SD” column displays the expected number of a given motif matches in an 
equally sized random genomic region, together with the standard deviation (SD). The “Over-representation” 
column indicates the fold factor of match numbers in the analysed sequence compared to an equally sized 
genomic region from the background, or found versus expected matches number. The “Z-score” is a measure of 
the statistical significance of the over-representation ratio; a Z-score above 2 or below -2 is considered 
statistically significant, corresponding to a p-value of ~ 0.05 (Genomatix; Sue et al. 2005). The “GLI/ZIC motif 
presense in opossum” column shows the presence and location of GLI/ZIC motifs within the opossum CNE 
sequence. The last column indicates conservation of GLI/ZIC motifs between mouse and opossum. Note that 
the ZIC motif in CNE22 is conserved. 
 
However, none of the predicted binding motifs for GLI and ZIC factors are 
significantly over-represented in the CNEs relative to the genomic background (Table 4.2). 
Also, most of these GLI/ZIC motifs are not conserved in the mouse/opossum alignment, i.e. 
they do not meet the stringency criteria of the rVISTA algorithm described earlier (both in 
terms of position within the CNE and motif’s sequence), and are identified only in the base 
 
 
  
100 
genome – that of the mouse (Table 4.2). An important exception is the ZIC binding site in 
CNE22, which shows both conserved motif sequence and position. Interestingly, despite the 
lack of conservation, the orthologous sequences of CNE13 and CNE23 in the opossum 
genome do harbor a GLI or a ZIC motif, respectively, but in a shuffled position within the 
CNE (see Table 4.2). 
4.4. Discussion 
Here, using phylogenetic footprinting, I reported on the identification of evolutionary 
conserved non-coding elements (CNEs), which may have putative regulatory functions, 
distributed in the genomic region of the mouse Lama1 locus. Notably, some of these 
elements harbour GLI and/or ZIC binding motifs, which makes them candidates for 
mediating the control role of Lama1 transcription by SHH signalling (Anderson et al. 2009). 
4.4.1. Few of the identified CNEs are conserved with zebrafish sequences 
Analysis of the Lama1-containing genomic region using the ECR Browser failed to identify 
conserved elements (even exons) in the mouse/zebrafish and mouse/fugu comparisons, even 
at low stringency settings (minimum 30% sequence identity over a minimum of 30 bp 
window) (Figure 4.1). Perhaps, this is due to the local alignment algorithm used by the ECR 
Browser, which is not suitable for the detection of conservation between highly divergent 
sequences (Brudno et al. 2003). In contrast, an alternative mouse/zebrafish glocal alignment 
using mVISTA under relaxed stringency, succeeded in detection of the conserved exons of 
Ptprm, Lrrc30, Arhgap28 and Lama1 genes, as well as in the identification of two CNEs, a 
and b, located in the 1
st
 intron of the Ptprm gene and in the 3
rd
 intron of the Lama1 gene, 
respectively (Figure 4.2; Table 4.1). Thus, CNE a and b are candidates for regulatory 
elements of Lama1.  
The scarcity of CNEs between mouse and zebrafish in the Lama1-containing genomic 
region is intriguing, when one considers the highly similar pattern of Lama1 mRNA 
expression in the embryos of these species (Anderson et al. 2009; Zinkevich et al. 2006; 
Joseph Pickering’s Thesis 2012) (Figures 1.3 and 1.4; Table 1.2; Figure 3.1). However, 
conservation of function does not necessarily correlate with or require conservation of 
sequence, as discussed later.  
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4.4.2. Some CNEs may represent long-range enhancers of Lama1 
All of the CNEs identified in this study, except for CNEb, are located 5’ from the 
transcription start site of the Lama1 gene. The most proximal CNE to Lama1 – CNE1, is ~ 
33.5 kb upstream from the previously described basal promoter of the gene (Niimi et al. 
2003, 2004; Piccinni et al. 2004), while the most distal element – CNEa (overlapping with 
the 5’- end of CNE24), is nearly 395 kb upstream of Lama1. Such distances from the Lama1 
locus do not negate the possibility that the CNEs may function as transcription-regulatory 
elements of Lama1 for numerous studies have provided examples of regulatory elements, 
particularly enhancers, positioned tens or hundreds of kilobases away from their target genes 
(Gottgens et al. 2000; Uchikawa et al. 2003; Kundu et al. 2013). In an extreme case, the 
enhancer responsible for ZPA-specific expression of the Shh gene is situated nearly 1 Mb 
away from the Shh locus in intron 5 of the Lmbr1 gene (Lettice et al. 2002; Lettice et al. 
2003). Notably, CNEs 23 and 24, and CNEa, are located in intron 1 of the Ptprm gene, which 
is not inconsistent with a role in Lama1 transcriptional regulation considering the case of the 
PZA Shh enhancer and the Pax9 enhancer driving expression in the medial nasal process of 
the mouse embryo, which was found 8kb downstream of the last exon of Pax9 - in the 7
th
 
intron of the Slc25a21 gene (Santagati et al. 2003). Alternatively, these and other CNEs may 
be involved in the control of Ptprm and/or Lrrc30 expression, instead, as discussed in 
Chapters 5 and 6. The remoteness of many enhancers from their target promoters hints for 
long-distance mechanisms of interactions that involve the establishment of physical contacts 
(chromatin looping) between the enhancer and the promoter (Lower et al. 2009; Dean 2011; 
Gibcus 2013). Hence, it is plausible that some of the CNEs detected in my study may 
function as long-range enhancer elements to modulate Lama1 transcription. 
4.4.3. Some CNEs may represent other classes of regulatory elements and/or ncRNA 
genes 
Not all conserved non-coding sequences have enhancer properties. For instance, a conserved 
element may perform insulator functions as shown for the CTCF-dependent insulators 
flanking the mouse and human β-globin clusters (Farrell 2002), or the pan-vertebrate 
insulator shielding the Hoxd complex in mouse, chicken and zebrafish from the influence of 
the nervous system-specific enhancers of the Evx2 gene (Kmita et al. 2002). Similarly, 
Glazko et al. (2003) found that nearly 11% of strongly conserved regions in mouse/human 
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alignments correspond to predicted matrix-attachment regions (MARs), huge fraction of 
which preceded the 5’ ends of genes, suggesting a role in transcriptional regulation (Glazko 
et al. 2003). Alternatively, a CNE may exert a rather large-scale chromatin organisation 
function in chromosome condensation or replication (Cremer and Cremer 2001).  
There is also a possibility that some of the CNEs in the vicinity of Lama1 may 
operate via a RNA intermediate, i.e. that some CNEs are actually transcribed as non-coding 
RNAs (ncRNAs), which then embark on transcriptional regulation of target genes, as shown 
for the 2.2 kb ncRNA HOTAIR from the human HOXC locus which represses HOXD 
transcription in trans (Rinn et al. 2007). Such scenario for some of the identified CNEs in 
this study is plausible and consistent with the finding of pervasive non-coding transcription 
through-out the human genome (Birney et al. 2007). However, applying a novel algorithm 
for analysis of RNA-seq, ChIP-seq and DNaseI hypersensitivity data from human and mouse 
cell lines, Hemberg et al. (2012) reported that conserved elements are four times more likely 
to correspond to clusters of TFBSs than to unannotated ncRNAs, although it is also true that 
many of the TFBSs clusters were transcribed as low-abundant unspliced and non-
polyadenylated RNAs (Hemberg 2012). In fact, this is consistent with recent studies which 
found that some enhancers are transcribed as enhancer RNA (eRNA) that appear not to be a 
by-product of accessible chromatin but to perform active function in enhancer-promoter 
looping, at least in the case of the oestrogen receptor α (ER-α) transcription factor and its 
target genes (Li et al. 2013). 
Therefore, it is possible that some of the conserved elements that I have identified may 
not be bona fide enhancers but instead function as insulators, silencers, MARs or even 
ncRNA. 
4.4.4. CNEs and gene synteny 
That some of the identified CNEs might function as transcription-regulatory elements is 
suggested by the preservation of gene content and order in the surroundings of the Lama1 
locus across vertebrate phylogeny, a phenomenon known as “shared synteny” (Moreno-
Hagelsieb et al. 2001). The constraints that impede synteny breakage could be a result of the 
requirements for regulatory elements in the transcriptional control of one or more genes in 
the cluster, which would impose negative selection pressure on any translocation event that 
separates a dependent gene from its regulatory elements (Ahituv et al. 2005; Engstrom et al. 
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2007; Irimia et al. 2012). The practical implication of this phenomenon for locus-specific 
TRE identification is that there is a much higher probability for a TRE of a gene of interest to 
reside in the syntenic block than outside of it (Haeussler 2011). Such scenario is plausible, 
especially when the expression pattern of the genes in the block is evolutionary conserved, as 
is the case for Lama1 mRNA expression among mouse, zebrafish and chicken (Chapter 3 of 
this study; Joseph Pickering’s Thesis 2012; Zinkevich et al. 2006). Shared synteny, combined 
with conserved expression pattern, suggest that some or all of the TREs controlling Lama1 
expression may reside in the vicinity of Lama1. Moreover, as mentioned earlier, CNEs 11-16 
form a cluster in the territory between the Lrrc30 and Ptprm loci (Figure 4.3). This is in 
agreement with the non-uniform distribution of ultraconserved elements in the mouse and 
human genomes (Bejerano et al. 2004) and with the clustering of developmentally-active 
conserved enhancers on the 3
rd
 chromosome in Drosophila (Kundu et al. 2013), raising the 
possibility of similar regulatory properties for CNEs 11-16. 
4.4.5. GLI binding motif-containing CNEs are candidate SHH-responsive enhancers  
Most important in this study is the identification of several CNEs (CNEs 13, 23 and 24) that 
contain GLI binding motifs (Figure 4.4; Table 4.2), as these may represent the transcription-
regulatory elements mediating the response to SHH signalling in the somites and neural tube 
(Anderson et al. 2009). Notably, few of the CNEs harbour binding motifs for the ZIC 
transcription factors (CNEs 4, 7, and 22) which have a highly homologous Zn-finger DNA 
binding domain compared to the GLI factors (Aruga et al. 1996). Given the fact that the 
binding motif for ZIC factors (5’-GGGTGGTC-3’) is almost identical to the consensus motif 
for the GLI proteins (5’-TGGGTGGTC-3’) (Kinzler and Vogelstein 1990; Mizugishi et al. 
2001), it is not unlikely that the GLI TFs may have the potency to occupy both motifs in vivo. 
Therefore, CNEs 4, 7 and 22 are also candidates for the regulatory elements mediating the 
SHH signal in the mouse somites and neural tube. However, it is important to note that none 
of the identified GLI/ZIC motifs is significantly over-represented in the CNEs (Table 4.2), 
relative to genomic back-ground. Therefore the presence of GLI/ZIC motifs in CNEs 4, 7, 
13, 22, 23 and 24 is not considered a strong indicator of their putative role as mediators of the 
SHH effects on Lama1 transcription. 
It is noteworthy to mention that despite the lack of conserved GLI/ZIC binding 
motifs, the orthologous sequences of CNE13 and CNE23 in the opossum genome do harbor a 
 
 
  
104 
GLI or a ZIC motif, respectively (see Table 4.2), albeit at a different position compared to 
the mouse orthologs. It is likely that during evolution, the exact place of the GLI/ZIC motif 
has shifted (shuffled) in the mouse or opossum genomes without necessarily affecting the 
putative regulatory function these CNEs might have. Such reorganization of TFBSs in 
developmental enhancers is well documented in the even-skipped (eve) stripe 2 enhancer 
(es2E) among multiple Drosophila species. There, the distribution and number of sites for 
the Bicoid, Hunchback, Krüppel, Knirps and Giant transcription factors have changed in the 
different species without changes in the regulatory output of the enhancer (Ludwig et al. 
1998; Ludwig et al. 2000). 
 
The identification of several conserved non-coding elements around the murine Lama1 
locus suggests that they may be involved in the transcriptional regulation of Lama1 
expression, functioning as enhancers, insulators, or silencers, among other possibilities. 
Notably, some CNEs contain GLI and/or ZIC binding motifs, although not significantly over-
represented. Nevertheless, compared to the other CNEs, the GLI/ZIC motif-containing CNEs 
are putative candidates for the SHH-responsive somitic and neural enhancers of Lama1. 
Testing these hypotheses requires experimental examination of CNE function, as described in 
Chapters 5 and 6. 
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Chapter 5 
in vitro analysis of CNE activity 
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5.1. Hypothesis and Aims 
Numerous studies in various species have demonstrated the involvement of predicted 
conserved non-coding elements (CNEs) in the transcriptional regulation of nearby genes. 
Therefore, I hypothesised that the CNEs identified in the vicinity of the murine Lama1 locus 
have transcriptional activities. I tested this in a cell culture system by performing transient 
cell transfections of reporter gene constructs driven by the CNEs, followed by measurements 
of reporter gene activity. 
5.2. Introduction: transient cell transfection for analysis of CNE function 
Once a candidate regulatory element has been predicted either by indirect computational 
methods based on sequence conservation or by direct biochemical profiling of chromatin 
states across the genome, the next essential step is the demonstration of its ability to 
modulate gene transcription. 
A frequently employed method for relatively rapid screening of the functional 
properties of conserved (or non-conserved) non-coding sequences is the transient cell 
transfection assay, where reporter plasmids containing the candidate elements are introduced 
in cells maintained in culture (Naylor 1999). The activity of the tested element is assayed by 
its effect on the rate of transcription of the reporter gene, which in most protocols is inferred 
indirectly by measuring the concentration or enzymatic activity of the reporter’s gene protein 
product (Bronstein et al. 1994). This approach is considered transient since the introduced 
plasmids remain episomal and rarely integrate into the host genome, which necessitates that 
the measurements of reporter activity must be taken within 24 – 72 hours post transfection 
(Carey and Smale 2000).  
It is important to note that the host cells should maximally represent the tissue type 
where the putative element is expected to act considering the expression pattern of the 
endogenous gene of interest. This is especially relevant to assays of CNE function for it 
increases the probability that the host cells would express the full complement of 
transcription factors necessary for the activity of the candidate element (Carey and Smale 
2000). In transfection experiments, the preferred path for introducing reporter plasmids in 
cells is via lipofection, where DNA is complexed with cationinc lipid compounds (Felgner et 
al. 1987). The most frequently used reporter encodes the firefly luciferase enzyme from 
Photinus pyralis (deWet et al 1987). The enzyme is active in cell lysates and catalyzes the 
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oxidation of exogenously supplied D-luciferin, which is accompanied by the release of light 
that can be quantified (Allard et al. 2008). The luciferase assay is very sensitive and spreads 
over a linear range of more than 7 orders of magnitude of luciferase concentration, which 
allows convenient measurements of a broad range of enzyme activities (TM040, Promega).  
Numerous studies have employed the luciferase reporter system to examine the 
functional potential of putative TREs, including the few studies on the basal promoter and 
proximal enhancers of the murine and human Lama1 gene (Niimi et al. 2003, Niimi et al. 
2004; Piccinni et al. 2004; Niimi et al. 2006). Luciferase reporter-based analyses in cell 
culture are not limited to the identification of enhancers but can also reveal the function of 
silencer elements as demonstrated for a conserved repressor motif in the chicken cardiac 
troponin T gene (Tidyman et al. 2003) and the conserved Polycomb-dependent silencer 
region D11.12 between the human HOXD11 and HOXD12 genes (Woo et al. 2010). 
These results illustrate that the highly sensitive and relatively rapid luciferase 
reporter-based assay is well suited for initial screening of the activity of candidate TREs in 
transient cell transfections. Nevertheless, several factors can influence the outcome of such 
an experiment (Table 5.1), leading to limitations, such as the requirement for high number of 
experimental replicates, the need to use endogenous promoters in the appropriate cell lines, 
as well as the difficulty of studying candidate enhancers that cannot function in isolation 
and/or elements requiring chromosomal integration and a particular chromatin environment 
(Carey and Smale 2000). However, some of these limitations can be mitigated with the 
appropriate controls (Table 5.1). 
5.3. Results 
5.3.1. Analysis of CNE function via transient cell transfection of luciferase reporter 
constructs 
I decided to employ the transient cell transfection assay combined with luciferase reporters as 
an approach to screen several of the identified CNEs for potential enhancer activity. I 
focused my analyses on all CNEs containing GLI/ZIC binding motifs (CNEs 4, 7, 13, 22, 23 
and 24) but also included CNEs 3, 5, 10, 15 and 19 (which do not harbor GLI/ZIC motifs) for 
these exhibited high sequence conservation in the mouse/opossum phylogenetic footprinting 
comparisons (see Table 4.1). Each of the selected CNEs was amplified from mouse genomic 
DNA (from the C57BL/6J mouse strain) in a standard PCR protocol and cloned upstream of 
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the SV40 promoter in the pGL3- Promoter plasmid (Promega), which harbours a modified 
firefly luciferase reporter gene luc+. It is important to note that the orientation of the CNEs 
in the reporter plasmid was maintained according to their orientation relative to the Lama1 
transcription start site on mouse chromosome 17 (Figure 5.1) 
 
Factors leading to limitations of 
the assay 
Controlled by Controlled in this study 
1.  inefficient cell transfection 
normalisation of the test reporter signal to 
the signal from a 2
nd
 reporter plasmid 
(internal control), e. g. taking the ratio of 
firefly luciferase activity to Renilla 
luciferase activity. 
yes 
2. variation in cell proliferation, 
death and lysis between samples 
using the same total cell lysate protein 
concentration in each assay 
yes 
3. inappropriate cell type 
using a cell line that represents one or 
more of the tissue types normally 
expressing the gene of interest in vivo; 
ideally, the cell line should express the 
gene of interest. 
yes/no 
4. inapproapriate promoter 
using the endogenous promoter of the 
gene of interest. 
no 
5. non-specific promoter induction 
Comparing the activity of the tested 
candidate enhancer to the activity of a 
random genomic region. 
no 
6. reprorter-plasmid independent, 
endogenous luciferase activity 
examining the luciferase activity in a 
lysate from non-transfected cells. 
yes 
7. aberrant transcription initiation 
from cryptic sites in the vector’s 
backbone. 
insertion of a polyA signal immediately 
up-stream of the promoter. 
yes 
8. promoter/promoter or 
enhancer/promoter interference or 
crosstalk 
using an internal control plasmid with a 
different promoter or, ideally, by testing 
the candidate enhancer in stably 
transfected cells. 
 
no 
 
Table 5.1. Potential factors that can influence the outcome of a transient cell transfection-based assay of 
candidate TREs. Here are listed some of the most pertinent factors that can affect the results from a transient 
cell-transfection-based analysis of candidate TREs, together with proposed controls (Carey and Smale 2000; 
Schagat et al. 2007). The third column shows whether the relevant factors have been controlled for in the 
current study. Factors 3, 4, 5 and 8 are discussed in more detail in Section 5.4 of this chapter. 
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Figure 5.1. A schematic diagram of CNE::pGL3 reporter plasmid constructs. The top half of the diagram 
shows the arrangement of important functional elements in the firefly luciferase reporter plasmid pGL3-
Promoter, including the location of the cloned CNE. Below is shown a diagram of the relationship of a CNE to 
the Lama1 locus in terms of directionality (indicated by a solid black arrow above the blue CNE box). This 
feature was kept unchanged in the CNE::pGL3 constructs. 
The pGL3-Promoter plasmid is well suited for identification of mammalian elements 
with enhancer properties. The advantages of this reporter vector include optimized codon 
content of the luc+ gene for efficient translation in mammalian cells, elimination of 
consensus transcription factor binding motifs from the coding sequence of luc+ and, most 
importantly, the presence of a poly (A) site upstream of the tested element which serves as a 
transcription-pause signal to prevent background transcription initiation events from 
sequences in the vector’s backbone (Promega 2008) (Figure 5.1).  
 I transfected each CNE::pGL3 reporter plasmid individually into the mouse 
embryonic fibroblast cell line C3H10T1/2 (step 1 on Figure 5.2). This cell line has properties 
of mesenchymal multipotent stem cells, is SHH-responsive (Kinto et al. 1997), and can be 
directed into skeletal muscle, smooth muscle, osteogenic, chondrogenic and adipogenic cell 
lineages under different protocols (Haas et al. 2000; Bostrom et al. 2000; Shea et al. 2003; 
Tang et al. 2004). Notably, these cell types are also generated in vivo by progenitors 
descending from the somites (Christ and Scaal 2008). Therefore, the C3H10T1/2 line is a 
good in vitro model system to investigate mammalian somitic cell specification and 
differentiation. These advantages are especially relevant to the current study, which 
investigates the control of Lama1 transcription by SHH in the murine somites and neural 
tube.  
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Figure 5.2. A schematic diagram of the transient cell transfection procedure and the double luciferase assay 
used to screen for CNE activity. (1) – (6) designate consecutive steps in the experimental and analytical 
approach accompanied with a short description of each step. The empty-pGL3 control plasmid and the lysate 
derived from cells transfected with this plasmid are highlighted in red; the CNE::pGL3 test plasmid and the 
lysate derived from cells transfected with this plasmid are highlighted in blue. The curved arrows emanating 
from the plates at steps (4) and (5) represent the recordings from the two luciferases, the firefly luciferase (FL) 
and Renilla luciferase (RL), respectively. A Legend panel is provided at the left bottom quadrant with 
explanation of used abbreviations. RLUs, Relative Light Units, are the units of measurement of luciferase 
activity. 
In order to control for transfection efficiency, pipetting inconsistencies and toxicity, 
each CNE::pGL3 test reporter plasmid was co-transfected with the pRL-SV40 control 
reporter plasmid which encodes the Renilla sea pansy luciferase (Schagat et al. 2007). This 
enzyme uses a different substrate – coelenterazine (Matthews et al. 1977), than the firefly 
luciferase, allowing for the sequential recording of the activities of both enzymes in the same 
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sample (see Chapter 2 for details on the procedure). This permits the normalization of each 
sample by computing the ratio of test reporter activity (the firefly luciferase from 
CNE::pGL3) to internal control reporter activity (the Renilla luciferase from pRL). The latter 
approach minimizes or excludes sample-to-sample variability and enables comparisons of 
test reporter activity between cell samples transfected with CNE::pGL3 and samples 
transfected with the empty-pGL3 (the parent pGL3 plasmid which does not contain any 
CNE) (Figure 5.2) 
 The activity of the luciferase reporters (measured in Relative Light Units, or RLUs) 
was recorded sequentially in the lysates from each CNE::pGL3 sample. At least three 
replicate transfections were performed for every CNE::pGL3 construct including the empty-
pGL3 control plasmid. In each replicate, I conducted two independent luciferase assays with 
separate aliquots from every cell lysate (step 3 on Figure 5.2). Then, I averaged the 
calculated FL/RL ratios for each CNE (LC in Figure 5.2) and compared these to the FL/RL 
values from the empty-pGL3 control sample (LE in Figure 5.2) to obtain the 
CNE::pGL3/empty-pGL3 ratios (LC/LE in Figure 5.2). This approach allowed me to 
determine the normalized fold change in activity between a CNE::pGL3 construct and the 
empty-pGL3 control.  
 Next, I performed one-way analysis of variance (ANOVA) followed by a Dunnett’s 
post-test using the log10 of the LC/LE ratios, which enabled the comparison of the mean of 
every LC/LE value to the LE/LE value (which equals 1). The fold change in luciferase 
activity and the results from the statistical analysis are shown in Figure 5.3.  
Notably, several of the examined CNEs exhibited either higher or lower fold change 
in luciferase activity relative to the empty-pGL3 control (Figure 5.3). CNEs 10, 19, 21, 22 
and 23 displayed increased luciferase activity. In contrast, CNEs 7 and 13 displayed 
decreased luciferase activity hinting for silencer-like properties (Figure 5.3). It is important to 
note that the ANOVA statistical analysis did not reveal significant differences between the 
mean RLUs of the tested CNE::pGL3 constructs versus the empty-pGL3, except for 
CNE7::pGL3. The lack of statistical significance in the case of CNEs 10, 19, 21, 22 and 23 is 
likely the result of a small sample size (small number of replicates). To improve the data, 
higher number of replicates is needed. 
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Figure 5.3. Fold change in firefly luciferase activity driven by the tested CNEs. A plot of the fold change in 
firefly luciferase activity (as measured in RLUs) driven by each CNE (shown by individual blue columns) 
compared to the activity of the empty-pGL3 control (red column), which equals 1. Black bars associated with 
each blue column represent the standard error of the mean (SEM) Statistical analyses were performed using 
One-Way ANOVA followed by Dunnett’s post-test (P<0.0001).  
In summary, the results from the transient cell transfections of CNE::pGL3 luciferase 
reporter constructs in C3H10T1/2 cells do not suggest that some of the conserved elements 
possess transcriptional activity, except perhaps for CNE7 (Figure 5.3). The putative causes 
behind these results are discussed in more detail in Section 5.4. 
5.3.2. in silico analysis of CNE correlation with molecular markers of chromatin state 
and TFBSs 
Despite the weak or absent activity of the CNEs when tested in isolation from the rest of the 
genome, I decided to examine whether the CNEs associate with diagnostic characteristics of 
TREs, in particular with marks of occupied transcription factor binding sites, specific histone 
modifications and DNaseI hypersensitivity sites, while in their genomic context. First, I 
analysed the distribution of such marks in the genomic region encompassing all CNEs 
identified in this study, using the UCSC Genome Browser. Notably, several chromatin marks 
exhibit discrete, discontinuous enrichment along the entire locus; however, the majority of 
these marks do not co-localise with the CNEs identified in the current study (Figure 5.4). 
Intriguingly, Lama1-expressing organs (like brain and kidney) display similar chromatin 
mark profiles that are distinct from the mark profile of Lama1-non-expressing organs (such 
as spleen) (Figure 5.4).  
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Figure 5.4. Distribution of chromatin state marks in the genomic region including all 24 CNEs. Description is provided on the next page (p. 114). 
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Figure 5.4. Distribution of chromatin state marks in the genomic region including all 24 CNEs. The 
distribution of RNA Pol II and CTCF binding, DNaseI hypersensitive sites, and H3K4me1 and H3K4me3 
marks was analysed across the entire genomic region containing the identified CNEs, using the UCSC Genome 
Browser. The graph in the top row indicates sequence conservation generated by PhastCons. The plots on the 
subsequent rows display chromatin mark enrichment in brain, kidney and spleen. Notable peaks of most marks 
are observed in the promoter regions of Lama1 and Ptprm. Interestingly, additional peaks of H3K4me1 and 
DNaseI hypersensitivity (DNaseI HS) are seen within the Lama1 locus, whereas several peaks of CTCF 
enrichment and DNaseI HS are also found in the intergenic space between the Lama1 and Ptprm loci. 
Importantly, of all CNEs identified in this study only CNE7 and CNE23 co-localise with enrichment peaks 
higher than 15% above background level (see Figures 5.5 and 5.6; Table 5.2). The rest of the CNEs show lower 
than 15% or no enrichment relative to background. The positions of CNE1 and CNE24 are indicated in cyan 
boxes on the sequence conservation row (see the previous page 113). 
 
Next, I examined in more detail the association of each of the CNEs (1-24 and CNEa 
and b) with various chromatin marks. Here, I report on the findings made with CNEs 7 and 
23 (Table 5.2) for the analyses of the other CNEs did not reveal significant enrichment for 
any transcription factor binding, histone modification or DNaseI hypersensitivity. 
CNE7 is especially interesting (Figure 5.5 and Table 5.2) as its genomic position 
correlates with a high peak of CTCF (CCCTC-binding factor) occupancy in various organs 
such as the embryonic E14.5 brain and limb buds, adult cortex, kidney and heart, and with a 
somewhat lower CTCF peak in adult lung and cerebellum. This contrasts with the low or 
background levels of CTCF occupancy in the adult liver, small intestine, spleen, bone 
marrow, testes and mouse embryonic fibroblasts (Table 5.2 and Figure 5.5). Intriguingly, 
CNE7 also overlaps with DNaseI hypersensitive sites particularly in the adult heart, skeletal 
muscle, kidney and brain, as well as in the embryonic E11.5 mesoderm, forelimb and 
hindlimb buds, and the E14.5 brain. There are very low or no DNaseI peaks in the adult liver, 
colon, lung, cerebellum, adipose tissue, spleen and thymus (Table 5.2 and Figure 5.5). The 
putative implications of these features on CNE7’s function are discussed later. 
 Analyses of CNE23 revealed the presence of the H3K4me1 histone modification 
associated with it in the adult olfactory bulb and kidney, and in the embryonic E14.5 brain 
and limbs (Table 5.2 and Figure 5.6). In addition, CNE23 correlates with DNaseI 
hypersensitive sites in the neonatal retina (highest peak), E14.5 brain, E11.5 mesoderm, 
E11.5 forelimb and hindlimb buds and the adult kidney. 
Overall, the results from the in silico analyses of CNEs 7 and 23 hint for putative in 
vivo transcription-regulatory functions of these elements. 
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  CNE7 CNE23 
organ/tissue CTCFa DNaseIb H3K4me1c DNaseIb 
E11.5 
mesoderm 
  ++   + 
E11.5 FL and 
HL buds 
  ++   + 
E14.5 limb 
buds 
++   +   
E14.5 brain ++ + + + 
kidney 8w ++ + + + 
skeletal 
muscle 8w 
  ++     
heart 8w ++ ++ +   
embryonic 
fibroblasts 8w 
+/-       
bone marrow 
8w 
+/-       
thymus 8w   +/-     
spleen 8w +/- +/-     
adipose tissue 
8w 
  +/-     
brown adipose 
tissue 24w 
    +   
testis 8w +/-       
liver 8w +/- +/-     
colon 8w   +/-     
small intestine 
8w 
+/-   +   
lung 8w + +/-     
retina 1d       ++ 
cortex 8w ++ +     
olfactory bulb 
8w 
    ++   
cerebellum 8w + +/-     
 
Table 5.2. Correlation of TFBSs occupancy, histone modifications and nucleosome accessibility with CNEs 7 
and 23 in embryonic and adult tissues and organs. Legend: ++, high or moderate levels; +, low levels; +/-, very 
low levels or signal approaching background noise. Abbreviations: FL, forelimb; HL, hindlimb; 1d, 1 day 
postnatal; 8w, 8 weeks postnatal; 24w, 24 weeks postnatal; H3K4me1, monomethylation of Lysine 4 in histone 
3; H3K27ac, acetylation of Lysine 4 in histone 3. 
 
a 
data for TFBSs by ChIP-seq from the ENCODE/LICR track in the UCSC Browser. 
b 
data for DNaseI hypersensitive sites by Digital DnaseI from the ENCODE/UW track in the UCSC Browser. 
c 
data for histone modifications by ChIP-seq from the ENCODE/LICR track in the UCSC Browser. 
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Figure 5.5. Association of CNE7 with CTCF transcription factor occupancy and DNaseI hypersensitive sites as 
shown by the UCSC Genome Browser. A graphical display of CNE7 sequence conservation, CTCF occupancy 
and DNaseI hypersensitivity generated by the UCSC Browser using the NCBI37/mm9 assembly of the mouse 
genome. Each row (or data track) from top to bottom presents features associated with the sequence at the 
corresponding genomic position (indicated by the coordinates at the top of the display). The subsets of tracks 
with thematically similar data (sequence conservation, CTCF enrichment and DNaseI hypersensitivity) are 
indicated on the right side of the diagram. The extent (in base pairs) of CNE7 is shown by the thick grey bar at 
the top of the display and highlighted in light orange along all data tracks. 
 
 
 
 
 
 
  
117 
 
Figure 5.6. Association of CNE23 with enhancer-enriched histone marks and DNaseI hypersensitive sites as 
shown by the UCSC Genome Browser. A graphical display of CNE23 sequence conservation, histone 
modifications and DNaseI hypersensitivity generated by the UCSC Browser using the NCBI37/mm9 assembly 
of the mouse genome. Each row (or data track) from top to bottom presents features associated with the 
sequence at the corresponding genomic position (indicated by the coordinates at the top of the display). The 
subsets of tracks with thematically similar data (sequence conservation, histone modifications and DNaseI 
hypersensitivity) are indicated on the right side of the diagram. The extent (in base pairs) of CNE23 is shown by 
the thick grey bar at the top of the display and highlighted in light green along all data tracks. 
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5.4. Discussion 
Here, I examined the transcriptional activity of CNEs 3, 4, 5, 7, 10, 13, 15, 19, 21, 22, 23 and 
24 using a transient cell transfection approach combined with recordings of the activity of a 
firefly luciferase reporter driven by the CNEs (Figures 5.1, 5.2 and 5.3). Several of the 
CNEs, in particular CNE7, 10, 19, 21, 22 and 23, changed weakly the activity of the 
luciferase reporter compared to the negative control (Figure 5.3). However, it remains 
unclear whether this change is a result of genuine enhancer-like properties of the CNEs, or it 
is a stochastic effect of the CNEs on the SV40 promoter due to possible opportunistic 
interactions between transcription factors bound to the CNE and the RNA pol II machinery at 
the SV40 promoter. A control assay with a similarly-sized random genomic fragment is 
required in order to test the latter possibility, in which case a significantly higher activity is 
expected from the CNE, provided it is an enhancer, as compared to the random fragment. In 
addition, the ANOVA analyses of the mean fold change for each CNE did not show 
statistically significant differences from the empty pGL3 negative control (except for CNE7), 
which is a result of the weak and highly variable activity of the tested CNEs. Therefore, the 
current data do not provide a strong argument for the putative transcription regulatory 
activity of the tested CNEs, except for CNE7. Several factors may have contributed to this 
outcome, as discussed below.  
 
5.4.1. CNEs and their transcription-regulatory activity in cell culture 
The low luciferase activity driven by the tested CNEs (Figure 5.3), compared to results from 
other similar studies (Niimi et al. 2003; Hlawatsch et al. 2013), raises some questions about 
the experimental parametres and design.  
One possibility for the low performance of the CNEs is that they might require the 
endogenous Lama1 promoter for optimal activity. This is due to the phenomenon of 
enhancer-promoter specificity whereby the enhancers of one gene are incompatible with the 
promoters of other, neighbouring genes, and can direct transcription only from their target 
gene’s promoter (Butler and Kadonaga 2001). Such enhancer/promoter dependency was 
previously demonstrated for the adjacent but divergently transcribed gooseberry (gsb) and 
gooseberry neuro (gsbn) genes, as well as for the dpp gene in Drosophila (Li and Noll, 1994; 
Merli et al. 1996). Using an enhancer-trap approach in Drosophila, Butler and Kadonaga 
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(2001) demonstrated that some transcriptional enhancers can direct reporter expression from 
a DPE-dependent core promoter, but not from a TATA-dependent core promoter, and vice 
versa, showing a preference for particular core promoter motifs. Specific enhancer-promoter 
preferences have also been described in yeast (Li et al. 2002) and sea urchins (Kobayashi et 
al. 2007). It is hypothesised that such specificity may enable some enhancers to activate 
transcription from the correct promoter in gene-dense genomic regions, or when the enhancer 
is located far (in tens or hundreds of kilobases) from the target gene (Butler and Kadonaga 
2001).   
Thus, it is possible that the weak or absent activity of the tested CNEs may be a result 
of their inability to effectively interact with the SV40 promoter in the pGL3 vector, as 
opposed to a putaive productive interaction with the endogenous Lama1 promoter, because 
of promoter-specific sequence motif differences. Consistent with such an idea, the SV40 and 
Lama1 promoters are composed of distinct sequence motifs - a TATA-box and a CpG island, 
respectively (Byrne et al. 1983; Piccinni et al. 2004). It can be hypothesised that some of the 
tested CNEs are transcriptional enhancers that have adapted to operate in conjunction with a 
CpG-rich promoters, but not with a TATA-box ones, analogously to the observations in 
Drosophila (Butler and Kadonaga 2001). Therefore, a better approach to testing the CNEs 
for enhancer-like properties is to design new CNE::reporter constructs where the reporter 
gene is driven by the endogenous Lama1 promoter. 
Second, the low activity of the tested CNEs might be due to the requirement for 
specific transcription factors and/or inducing signals that were not presented in the 
C3H10T1/2 cell culture system. As mentioned above, analyses of the existing literature 
suggested that C3H10T1/2 cells exhibit properties of mesoderm-derived cells (Haas and 
Tuan 2000; Bostrom et al. 2000; Shea et al. 2003; Tang et al. 2004), such that they are 
perhaps an optimal environment for preliminary identification of the mesodermally-active 
Lama1 enhancers. Additional support for the choice of C3H10T1/2 cells could be provided 
by a demonstration of their ability to endogenously express Lama1 mRNA. Furthermore, 
C3H10T1/2 cells may not be the ideal system to assess the transcription regulatory activity of 
CNEs with non-mesodermal tissue-specificity, such as candidate enchancers operating in the 
neural tube. The use of other cell lines, combined with transgenesis assays, would be the 
most efficient strategy to address this limitation. 
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Another possible explanation is that some of the tested CNEs might have other roles 
than that of enhancers or silencers, like matrix attachment regions (MARs) or locus control 
regions (LCRs), for instance, the properties of which are difficult to demonstrate in transient 
assays for such demonstration requires chromosomal integration of the tested construct 
(Dean 2011; Fraser and Grosveld, 1998). This scenario is consistent with the observed lack 
of enrichment for enhancer-associated chromatin marks on most CNEs (Section 5.3.2). In 
regard to LCRs, these genomic regions are defined based on their ability to confer high levels 
of integration-site independent expression of a linked transgene (Fraser and Grosveld 1998). 
As previously suggested (Carey and Smale, 2000), the most effective way to uncover the 
function of putative LCRs is to generate several independent stable cell lines or transgenic 
animal lines where it is expected that each one has integrated the transgene construct at 
random locations in the genome. If the candidate element acts as a locus control region, then 
more lines (in principle, all of them) should express the transgene than would have been 
expected for an enhancer element. This is so for LCRs confer protection from 
heterochromatic modifications that could silence the transgene (Kioussis and Festenstein, 
1997). Therefore, a further examination of some CNEs in transgenic animals or stable cell 
lines in culture would address this possibility. 
 Also, the low activity of tested CNEs might be a result of interference or cross-talk 
between the enhancer and/or promoter on the test plasmid (the pGL3) and the promoter on 
the internal control plasmid (the pRL). The high copy number of reporter plasmids may have 
led to competition for transcription factors present at limited quantities, which in turn may 
have resulted in low level occupancy of their binding sites and inefficient reporter gene 
transcription (Carey and Smale 2000; Mercola et al. 1985; Promega 2008). However, 
examination of the FL and RL activities does not indicate that such interference has occurred 
in the current study. Perhaps, the best way to circumvent this limitation is to test each 
CNE::reporter construct in stably-transfected C3H10T1/2 cells (Carey and Smale 2000). 
 In summary, one or a combination of several uncontrolled factors may have 
contributed to the weak activity of the CNEs when tested in transient transfection conditions 
(Table 5.1). Therefore, the data could be improved by substituting the SV40 promoter for the 
endogenous Lama1 promoter, by the use of other cell lines, by increasing the number of 
experimental replicates, and by the inclusion of a comparison with random genomic 
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elements. Alternatively, the CNEs could be tested in stable cell lines or in transgenic animals, 
as described in Chapter 6. 
5.4.2. CNE7 and its silencer properties in cell culture 
Interestingly, CNE7 significantly decreased the activity of the luciferase reporter compared 
to the empty-pGL3 control (Figure 5.3). This behavior hints to putative silencer properties 
for CNE7. If this were the case, CNE7 would be expected to operate via a long-range 
mechanism in vivo (Hampsey et al. 2011), as its nearest potential target, the Lrrc30 gene, is 
situated nearly 46 kb away from CNE7. Such a scenario is consistent with previous luciferase 
reporter studies combined with a C3 (or Chromosome Conformation Capture) assay, which 
revealed the existence of silencer elements in the vicinity of the human MECP2 gene that are 
able to directly interact with the MECP2 promoter despite it being located ~130 kb away of 
the silencers (Liu and Francke 2006). There is evidence that long-distance interactions 
between silencers and target promoters are facilitated by DNA looping mediated by the 
Ume6 and TFIIB factors, which are responsible for the recruitment of the repressively-acting 
Isw2 chromatin remodeler to target promoters in S. cerevisiae (Yadon et al. 2013). It would 
be interesting to see whether CNE7 acts via a long-range chromosome looping mechanism 
and which sequence it targets. Are there any target sequences within or nearby the Lama1 
promoter? Both questions could be addressed by the circular chromosome conformation 
capture (4C) technique (Zhao et al. 2006). 
It is also important to note that CNE7 harbours a ZIC binding motif, although not a 
significantly over-represented one (Chapter 4, Table 4.2), and it is possible that the silencer 
properties of CNE7 might be mediated by the binding of a ZIC- and/or GLI-repressors forms. 
This putative dependence on the ZIC motif can be addressed by generating mutant versions 
of CNE7 with substitutions in the ZIC motif combined with over-activation or down-
regulation of the hedgehog signalling pathway. 
5.4.3. CNE7 and CTCF occupancy 
Another interesting finding about CNE7 was its association with CTCF occupancy in several 
organs and tissues (Figure 5.4 and Table 5.2). Consistent with these findings, further 
examination of CNE7 by the MatInspector and FrameWorker in silico tools (Cartharius et al. 
2005) revealed the presence of a CTCF binding motif on CNE7 that is conserved across 
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therian mammals (placentals and marsupials), which is indicated on Figure 5.7. However, 
this motif does not appear to be significantly over-represented in CNE7 compared to the 
genomic background (Number of matches: 1; Expected: 0.28±0.53; Over-representation: 
3.54; Z-score: 0.41; see Legend to Table 4.2 for details on Z-scores). Nonetheless, the peak 
of CTCF enrichment (as well as the peak of DNaseI hypersensitivity) is centered on the 
conserved block of CNE7 that harbours the CTCF motif (compare Figure 5.7 with Figure 
5.5). These observations hint for a possible role of CTCF in the activity of CNE7 and such 
hypothesis could be tested in cell transfection experiments with a mutant CNE7 which lacks 
the CTCF binding motif. 
 
Figure 5.7. The CTCF binding motif in CNE7 is conserved across mammals. A display of the sequence 
conservation along CNE7 as generated in the UCSC Browser using the NCBI37/mm9 assembly of the mouse 
genome. The extent of CNE7 is indicated by a thick grey bar at the top of the diagram. The conserved sub-
region of CNE7 that contains the CTCF binding motif (highlighted in pink) is shown enlarged at the bottom half 
of the figure. The core of the CTCF motif is highlighted in grey and is derived from sequence analysis of CNE7 
using the MatInspector tool from the Genomatix Software Suit (Cartharius et al. 2005). 
 
CTCF is a Zn-finger domain containing protein (Burcin et al. 1997) that binds DNA 
in a sequence-specific manner to motifs with the core consensus CCCTC (Lobanenkov et al. 
1990), and is the only known factor that mediates insulator function in vertebrates (Bell et al. 
1999; Bell and Felsenfeld, 2000). Genome wide studies of CTCF binding often reveal its 
localization at the boundaries of transcriptionally active and repressed chromatin (Barski et 
al. 2007; Cuddapah et al. 2009), and some observations suggest that CTCF exerts its 
insulator functions by changing chromosome conformation, facilitated by interactions with 
the cohesin complex (Nativio et al. 2009; Wendt et al. 2008). In addition, there is also 
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evidence that CTCF -bound insulators can physically associate with enhancers (Handoko et 
al. 2011) presenting another possible mechanism of enhancer-blocking activity by insulators. 
However, in my study CNE7 was cloned only 10 bp 5’ of the SV40 promoter in the 
pGL3 plasmid. Therefore, it is unlikely that CNE7 acted as a classical insulator in this case.  
Rather, CNE7 would be expected to directly interfere with transcription initiation from the 
nearby SV40 promoter. Therefore, one can envision a hypothetical scenario, where a CTCF -
bound CNE7 directly interacts with its target promoter to silence it in vivo, analogously to the 
repressive interaction of a CTCF -bound CpG-rich element with the mouse Pax6 P0 
promoter prior to glial differentiation of embryonic stem cells (Gao et al. 2011). Whatever 
the case, it would be interesting to examine whether a CTCF-dependent cohesin-mediated 
looping process is responsible for the silencing effect of CNE7 on luc+ expression. This can 
be tested by a ChIP assay with antibodies against CTCF and the cohesin components SA2 or 
SMC1/3 (Xiao et al. 2011), in conjunction with the circular chromosome conformation 
capture method in a C3H10T1/2 cell line stably-transfected with either the wild type 
CNE7::pGL3 construct or a version of it with loss-of-function mutations in the CTCF 
binding motif. 
 
The levels of CTCF occupancy at CNE7 differ in different tissues 
It is intriguing that CTCF occupancy of CNE7 varies in different organs and developmental 
stages. As can be seen in Figure 5.5 and Table 5.2, CTCF levels are higher in the E14.5 
embryonic brain and limbs, and in the adult heart and kidneys as compared to the low levels 
in the adult liver and thymus. If CTCF directly binds to its motif in CNE7, then the binding 
affinity and/or the activity of bound CTCF may differ in different tissues, and this may affect 
the putative insulator/silencer activity of CNE7. This is consistent with studies showing that 
CTCF binding to insulators can be negatively influenced by methylation of cytosines in the 
binding sites (Hark et al. 2000; Engel et al. 2006), and that the activity of CTCF can be 
modulated through physical interactions with co-factors, such as CP190 and the thyroid 
hormone receptor (Lutz et al. 2003; Weth et al. 2010; Wood et al. 2011). 
The high levels of CTCF enrichment in the embryonic E14.5 brain and adult kidney, 
where Lama1 is expressed (Miner et al. 2004; Sorokin et al. 1997), are puzzling. It is possible 
that in these structures CNE7 might positively affect Lama1 expression in vivo, as suggested 
by a recent demonstration of the ability of CTCF /cohesin complexes to bind both the 
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promoter and enhancers regions of the human PCDHA gene facilitating chromatin loop 
formation and subsequent transcriptional activation (Guo et al. 2012). Alternatively, and in 
line with the observed silencer properties of CNE7 in culture, this element might in fact 
function as a CTCF -dependent silencer in vivo to quantitatively modulate the rate of 
transcription from the Lama1 promoter in tissues where Lama1 is expressed (embryonic 
brain, kidney). This is not unlikely for Lum and Lee (2001) showed the presence of a silencer 
element immediately upstream of the strong TATA-less promoter of the human HMGB1 
gene, which was able to reduce by nearly 6-fold the activity of the highly potent promoter, 
thus keeping in check the ubiquitous basal levels of HMGB1 expression in non-proliferating 
cells (Lum and Lee, 2001). 
In summary, the emergent picture of CTCF is that of a multifunctional factor engaged 
in diverse nuclear activities not only in enhancer-blocking processes and chromatin boundary 
demarcation but also in transcriptional activation and repression (Phillips and Corces, 2009; 
Nikolaev 2009). Such diverse roles can be achieved by post-translational modifications of 
CTCF, like sumoylation (Kitchen and Schoenherr, 2010), by interactions with different co-
factors (Lutz et al. 2000; Wood et al. 2011), and by modulating the access to its binding 
motifs on DNA (Hark et al. 2000), for instance. A comprehensive in vivo study that combines 
BAC-reporter transgenesis, transcription factor binding site mutagenesis and chromosome 
conformation capture analyses will provide detailed understanding of the precise mechanisms 
of CNE7 action in a chromosomal context and the role of CTCF. 
5.4.4. CNE7 and DNaseI hypersensitivity 
CNE7 is also characterised by a peak of DNaseI hypersensitivity. As mentioned earlier, such 
hypersensitivity marks not only enhancer and promoters but also insulators and silencers 
(Boyle 2008), which is consistent with the silencer-like behavior of CNE7 in culture. That 
silencer elements feature such hypersensitivity is demonstrated by a study, which combined 
phylogenetic footprinting, DNaseI hypersensitivity and luciferase reporter assays to describe 
the regulatory elements of the human FSHR gene, which is specifically expressed in the 
testicular Sertoli and ovarian granulosa cells (Hermann and Heckert, 2005). Four 
hypersensitive sites (DHS1-4) were identified, the third of which corresponding to an OCT-
1-dependent silencer element in the first intron of FSHR, which represses FSHR expression 
in non-gonadal cells (Hermann and Heckert, 2005). 
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Another interesting aspect of CNE7 is the differential pattern of DNaseI 
hypersensitivity across different tissues and organs (Figure 5.5 and Table 5.2). For instance, 
CNE7 features a high peak of hypersensitivity in the embryonic E14.5 brain, E11.5 
mesoderm, E11.5 fore- and hindlimb buds and adult skeletal muscles, but a low peak of 
hypersensitivity in the adult heart, liver and thymus (Figure 5.5 and Table 5.2). The variation 
in DNaseI hypersensitivity between these structures may reflect the extent of CNE7’s activity 
in vivo. As described by Boyle et al. (2008), DNaseI hypersensitivity is not a binary property 
but represents a continuous range of chromatin accessibility, with the same region showing 
different “levels” of hypersensitivity in different tissues and conditions. In agreement to this, 
low or non-expressed genes in CD4+ T-cells showed weaker hypersensitivity at their 
transcription start sites compared to highly expressed genes (Boyle et al. 2008). 
Remarkably, the tissue pattern of DNaseI hypersentivity at CNE7 corresponds to the 
pattern of CTCF occupancy in different tissue. Hence, tissues/organs with high levels of 
CTCF occupancy like the embryonic limbs and brain have also higher hypersensitivity 
(Figure 5.5). It is tempting to hypothesize that CTCF binding on CNE7 depends on 
chromatin accessibility which might require the binding of a pioneer transcription factor. For 
instance, binding of PU.1 to an intronic enhancer in Pax5 leads to reduced nucleosomal 
occupancy at the locus and up-regulation of Pax5 expression in B-cell development (Decker 
et al. 2009; Guertin et al. 2013). 
5.4.5. CNE23 and its target gene 
Although CNE23 did not significantly enhance reporter gene expression in vitro (Figure 5.3), 
an analysis of this CNE in the UCSC Browser revealed association with the enhancer-
enriched histone mark H3K4me1 (Heintzman 2007), as well as overlap with DNaseI 
hypersensitive sites in diverse embryonic and adult organs and tissues (Figure 5.6 and Table 
5.2). The location of CNE23 in the first intron of the Ptprm gene suggests the possibility that 
this element might be devoted to the transcriptional regulation of Ptprm, rather than to the 
regulation of Lama1. Such an assumption is consistent with numerous studies in the mouse 
and other metazoans that have mapped the location of tissue-specific enhancers in the first 
intron of their target genes. For instance, in the mouse, a 499 bp N-box-dependent enhancer 
activates acetylcholinesterase (AChE) gene expression in skeletal muscle cells (Chan et al. 
1999); a SOX9-dependent element drives Col11a2 activity in cartilage (Liu et al. 2000);        
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a 1.7 kb TBX1-, NKX2.5-, ISLET1-dpendent region directs Foxa10 expression in the 
anterior heart field (Watanabe et al. 2012), while a GATA3-dependent enhancer ensures N-
myc gene expression in the branchial arches (Potvin et al. 2010). Studies of transcriptional 
regulation in other species also provide examples for enhancers located in the first intron of 
their target genes: a cartilage-specific enhancer of the col2a1 gene in Xenopus (Kerney et al. 
2010); a photoreceptor-specific enhancer of the CiPax6 gene driving expression in the 
sensory vesicle of Ciona intestinalis (Irvine et al. 2008), and a 334 bp enhancer for early 
embryonic expression of the HpOtxL gene (a member of the orthodenticle-related gene 
family) in the sea urchin Hemicentrotus pulcherrimus (Hayashibara et al. 2004). Thus, 
CNE23 could display tissue-specific activity, in particular in the heart, as suggested by the 
location of CNE23 in the first intron of the Ptprm gene and the endogenous expression of 
Ptprm in the adult myocardium (Koop et al. 2003). However, as evident from Figure 5.6, the 
peak height for H3K4me1 and p300 coactivator enrichment in both embryonic and adult 
hearts is not convincingly high to suggest cardiac activity. Moreover, the acetylation mark 
H3K27ac, which is associated with active enhancers (Rada-Iglesias et al. 2011; Cotney et al. 
2012) is absent at CNE23 in the heart (Figure 5.6), which further argues against cardiac-
specific function of this CNE.  
Alternatively, CNE23 might be involved in the regulation of Lama1, as cases exist of 
genes being regulated by intronic enhancers positioned in another gene located up to a 1 Mb 
away (Lettice et al. 2003). BAC-reporter studies combined with deletion analyses and a 
chromosome conformation capture experiment in several relevant cell types will help to 
uncover the target, or targets, of CNE23. 
5.4.6. CNE23 and chromatin features 
The presence of H3K4me1 marks not restricted to a specific tissue/organ, but observed in 
various structures derived from all three germ layers like the embryonic limb, the olfactory 
bulbs and small intestine (Figure 5.6), makes it difficult to deduce the putative expression 
pattern driven by CNE23 in vivo. Perhaps, CNE23’s role is to boost the activity of tissue-
specific elements, as previously shown for some regulatory modules of the sea urchin genes 
endo16 and cyIIIa (Kirchhamer et al. 1996; Coffman and Davidson 2001; Davidson 2006).  
Nevertheless, the combined profile of relatively low peaks of H3K4me1, H3K27ac 
and DNaseI hypersensitivity suggests that CNE23 might be a genuine regulatory element in 
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vivo, with enhancer-like properties, but it also suggests that in most tissues CNE23 is not in 
an active state, except perhaps in the adult olfactory bulbs (Figure 5.6). The latter structures 
are characterised by high H3K4me1 occupancy combined with relatively higher levels of 
H3K27ac than in the rest of the tissues, and the joint presence of these two marks hints for 
active state of CNE23 in the olfactory bulbs. Interestingly, while there are no reports of 
Ptprm expression in the brain (Koop et al. 2003), Lama1expression is observed in the murine 
embryonic brain well into the E14.5 stage (Miner et al. 2004). Thus, a Lama1-devoted 
function of CNE23 cannot be ruled out. 
It is plausible that in the majority of the tissues, CNE23 is kept in an inactive, or 
poised state (Calo and Wysocka 2013), which is characterised by an enrichment for 
H3K4me1, p300 and H3K27me3 occupancy, and the absence H3K27ac marks (Creyghton et 
al. 2010; Rada-Iglesias et al. 2011) and is observed in enhancers regulating forelimb- versus 
hindlimb-specific developmental genes, for instance (Cotney et al. 2012). Interestingly, 
poised enhancers become enriched in H3K27ac marks and depleted in H3K27me3 marks 
upon cell specification and differentiation (Creyghton et al. 2010; Rada-Iglesias et al. 2011). 
Thus, one possibility is that CNE23 is in a poised state in most tissues. 
Finally, an appropriate in vivo transgenesis assay with a CNE23-driven gene reporter 
would potentially address the question of the transcription-regulatory potential of CNE23. 
 
In this study, I performed transient cell transfections of CNE::reporter constructs in 
cell culture to screen for putative regulatory functions of the conserved elements. The assay’s 
results however, do not convincingly support the hypothesis that the tested CNEs are 
enhancers or silencers in vitro, perhaps except for CNE7, and the speculated causes for these 
results were discussed. In addition, database analyses of CNEs’ chromatin state do not 
indicate correlation of the CNEs with transcription-regulatory element marks, except for 
CNEs 7 and 23. However, the lack of such correlation might be due to the fact that the 
chromatin state data have been obtained mostly from adult tissues and cell cultures, 
conditions under which an embryonic TRE might be inactive and difficult to predict. 
Therefore, in order to test the putative regulatory activity of the CNEs in more native 
environment, I adopted a different strategy, namely the examination of CNE function in vivo, 
in transgenic animals, as described in the next Chapter. Such an approach provides the 
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additional advantage of informing about the spatio-temporal activity of the candidate 
elements. 
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Chapter 6 
Functional screening of mouse CNEs in transiently-
transgenic zebrafish embryos
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6.1. Hypothesis and aims 
The analyses of CNE function in cell culture suggested a weak putative silencer activity of 
CNE7, but failed to convincingly demonstrate enhancer/silencer properties of the rest of the 
tested CNEs. Also, this assay did not provide information about tissue-specificity of the 
tested candidate regions. Furthermore, as the optimal activity of many transcription 
regulatory elements requires the integration of inputs from several signalling pathways 
(Davidson 2006), which can only be recapitulated in vivo, it is possible that my in vitro assay 
may have failed to detect the putative activity of the tested CNEs. To address this, a GFP 
reporter-based screening of a subset of the mouse CNEs was performed in transient 
transgenic zebrafish embryos. Such strategy is promising for, despite the lack of 
mouse/zebrafish conserved elements at the Lama locus, this gene features a largely 
conserved expression pattern in both species (this study; Anderson et al. 2009; Joseph 
Pickering’s Thesis 2012). This suggests that conserved trans-acting inputs regulate Lama1 in 
the mouse and zebrafish, implying that the murine CNEs may be able to respond to the 
transcription factor milieu in the fish embryo (Chatterjee et al. 2011; Fisher et al. 2006).  
6.2. Introduction 
6.2.1. The Tol2 transposon system in the analysis of TREs in vivo 
There are several strategies for the generation of transgenic zebrafish expressing fluorescent 
protein reporter genes. The simplest one relies on the injection of plasmid DNA carrying the 
reporter construct into fertilized eggs, which leads to high mosaicism in F0 and low 
frequency of germ line transmission of the transgene - about 5% of injected fish produce 
transgenic offspring (Stuart et al. 1988; Long et al. 1997). A more efficient method relies on 
the injection of pseudotyped retroviral vectors at the blastula stage, which results in nearly 
100% of the injected fish becoming founders (Lin et al. 1994). However, the handling and 
modifying of retroviral vectors is laborious making this approach unsuitable for the rapid 
screening of a large number of candidate regulatory elementsin transiently transgenic fish 
embryos (Kawakami, 2007). Another highly efficient and relatively simple strategy for 
zebrafish transgenesis uses the autonomous Tol2 DNA transposon from the medaka fish 
(Oryzias latipes) (Kawakami et al. 1998).The Tol2 element is nearly 4.7 kb in length and 
encodes a transposase consisting of 649 amino acid residues (Kawakami and Shima. 1999; 
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Kawakami et al. 2000). The enzyme is functional in all tested vertebrate models (zebrafish, 
Xenopus, chicken, mouse) and is able to mobilise non-autonomous Tol2 elements lacking the 
transposase gene but retaining the two termini at the ends of the transposon (Kawakami et al. 
2000; Kawakami et al. 2004; Sato et al. 2007; Kawakami and Noda 2004). Tol2 is transposed 
via a “cut-and-paste” mechanism - the transposase catalyses excision of the element from its 
original site followed by random integration at a new site of the genome (Kawakami et al. 
2000). The minimal 200 bp and 150 bp sequences at the left and right termini flanking the 
Tol2 transposase gene, respectively, are critical in this process. These termini contain 12 bp 
terminal inverted repeats and subterminal regions which are necessary and sufficient for 
transposition (Urasaki et al. 2006). Thus, any foreign DNA that is cloned in between the 
minimal sequences can be mobilized and integrated into the host genome, via co-injection of 
the Tol2-based construct with Tol2 transposase mRNA into one cell-stage embryos 
(Kawakami 2007).  
This is especially advantageous in examining the activity of candidate regulatory 
elements driving GFP reporter expression in transient assays for it results in early integration 
of the foreign construct into the host genome, which minimizes transgene mosaicism 
eventually leading to more consistent pattern of tissue- and/or stage-specific activation of the 
reporter gene (Fisher et al. 2006). Several studies have demonstrated the efficiency of the 
Tol2 system for testing putative regulatory elements in zebrafish embryos (Navratilova et a. 
2009; Royo et al. 2011; Zelenchuk and Bruses 2011; Ikle et al. 2012; Ritter et al. 2012). For 
instance, Ikle et al. (2012) used in silico approaches followed by Tol2-mediated transgenesis 
in zebrafish to identify mouse and fish enhancers of Hand2 that modulate its expression in 
the ventral pharyngeal arches, while Ritter et al. (2012) employed the Tol2 strategy to 
investigate the function of candidate TREs in stable zebrafish lines based on phylogenetic 
comparisons between the human and zebrafish genomes. Interestingly, the combined 
analyses revealed the existence of tissue-specific enhancers located in the protein-coding 
regions of their target genes (Ritter et al. 2012). Remarkably, the exonic enhancers were 
characterized by H3K4me1 enrichment similarly to the typical intergenic non-coding 
enhancers and are three times more likely to harbor this modification as compared to the rest 
of the exonic non-enhancer sequence (Ritter et al. 2012).  
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In summary, the use of GFP reporter-based transient analysis aided by Tol2-mediated 
reporter construct integration in zebrafish embryos is an effective strategy for the rapid 
screening of mouse candidate transcription regulatory elements. 
6.3. Results. 
Based on the successful results from the studies described above, I decided to employ 
transient transgenesis with mouse CNE::GFP reporter constructs in the zebrafish embryo to 
test in vivo the performance of a subset of the identified CNEs. I chose to analyse the activity 
of CNEs 3, 6, 7, 9, 10, 14, 19, 21, 23 and 24 either because they were examined in the in 
vitro tests (CNEs 7, 10, 19, 21, 23 and 24) (Figure 5.3), or because they displayed 
conservation not only with the opossum sequence but with the chicken as well, and as such 
are candidates for transcription regulatory elements (CNEs 3, 6, 9 and 14). 
 
Figure 6.1. A schematic diagram of a portion of the CNE::EGFP reporter constructs. The individual functional 
elements in the reporter construct are depicted as colored rectangular boxes. The arrow above the “CNE” box 
indicates the orientation of the CNE according to its genomic orientation relative to the Lama1 transcription 
start site. The curved arrow at the start of the “EGFP” box signifies the direction of transcription. Note that the 
whole “CNE::β-globin promoter::EGFP” unit is flanked by the minimal terminal elements of the Tol2 
transposon (orange boxes). 
Each CNE was individually cloned in its original genomic orientation (relative to the 
Lama1 transcription start site) into an EGFP-reporter plasmid (McDonald et al. 2010; Yu et 
al. 2011), immediately upstream of the minimal human β-globin promoter (β-globinP), which 
is used to drive expression of the EGFP reporter gene (Figure 6.1). Importantly, the reporter 
vector contains the minimal Tol2 terminal elements flanking the CNE::EGFP construct 
(Figure 6.1), which ensures that the whole CNE::β-globinP::EGFP unit can be efficiently 
integrated into the host embryo genome upon co-injection of the CNE::EGFP plasmids with 
Tol2 transposase mRNA. Before injection of the CNE::EGFP plasmids, I confirmed that the 
empty EGFP-reporter plasmid exhibits no cryptic enhancer activity (Figure 6.2; n=157). 
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Figure 6.2. The “empty” EGFP construct does not activate reporter gene expression. Shown is an embryo at 
31 hpf (n=157) that has been injected with “empty” EGFP plasmid, which does not contain any CNE. The 
embryo shows no EGFP expression, demonstrating the utility of the construct to reliably assess the activity of 
candidate enhancer elements. Abbreviations: de, diencephalon; hb, hindbrain; mb, midbrain; sc, spinal cord. 
Two independent injections in zebrafish embryos at the one-cell stage were 
performed for each CNE::EGFP plasmid (two preps of each were tested), followed by the 
analysis of EGFP expression in a total of 300 to 500 injected embryos at 6, 24, 31, 48 and 72 
hours post fertilization (hpf). The results of the experiments are summarized in Table 6.1 and 
Figure 6.3. Surprisingly, most of the screened CNEs, except for CNE3, directed weak and 
highly mosaic reporter expression: the few EGFP-marked cells were not restricted to a single 
tissue (with very few exceptions, as described in Table 6.1) but were dispersed through the 
whole body in the positive embryos, in a highly variable (inconsistent) pattern between the 
embryos. Based on these data, I concluded that CNEs 6, 7, 9, 10, 14, 19, 21, 23 and 24 were 
unable to function as tissue-specific transcriptional enhancers, at least in the current study 
(Table 6.1; Figure 6.3). The putative causes behind these results are discussed in Section 6.4. 
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 CNE3 CNE6 CNE7 CNE9 CNE10 CNE14 CNE19 CNE21 CNE23 CNE24 
Total number of 
analysed 
embryos# 
511 396 412 324 370 435 387 369 401 422 
Number of EGFP 
positive 
embryos* 
292 3 1 13 3 6 10 2 8 9 
Number of 
embryos with 
tissue-specific 
EGFP 
expression¥ 
289 0 0 1 1 0 0 0 0 2 
Number of EGFP 
negative embryos 
219 393 411 311 367 429 377 367 393 413 
 
Table 6.1. Numbers of CNE-injected embryos. # indicates the total number of analysed injected embryos, 
excluding the dead ones. * indicates that although the constructs with CNEs 6, 7, 9, 10, 14, 19, 21, 23 and 24 
produced EGFP-positive embryos, the reporter’s expression in these embryos was weak, restricted to few cells 
in different tissues and was highly variable between embryos. In contrast, CNE3 directed strong tissue-specific 
EGFP expression in the skeletal muscles in ~ 57% (289) of the analysed embryos (511); only 3 out of the 292 
postive CNE3-injected embryos showed weak and highly mosaic EGFP expression (not indicated in the Table). 
¥ indicates the number of embryos with tissue-specific EGFP expression. Most of the EGFP
+
 CNE3-injected 
embryos featured tissue-specific reporter expression in the skeletal musculature; only one of the EGFP
+
 CNE9-
injected embryos showed restricted expression in the gut; one EGFP
+
 CNE10-injected embryo had notochord-
specific reporter expression; and only two of the EGFP
+
 CNE24-injected embryos exhibited specific expression 
in the heart and skeletal muscles, respectively. 
 
 
Figure 6.3. Summary of the analyses of CNEs in transiently transgenic zebrafish. A graphical representation (in 
percentages) of the results from Table 6.1. Note that most of the EGFP
+
 CNE3-injected embryos feature tissue-
specific EGFP expression, while the remaining CNEs directed weak, highly mosaic and variable expression in a 
few of the injected embryos. 
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Of all murine CNEs that were tested in the zebrafish embryo, only CNE3 directed 
strong and consistent tissue-specific expression of the EGFP reporter gene, particularly in the 
skeletal muscle cells (Table 6.1; Figure 6.3; Figure 6.4). At 24 hpf, reporter gene expression 
driven by CNE3 was weak in the myotome (data not shown). However, a moderate reporter 
signal was first observed at 24 hpf in the myotome alone but by 72 hpf, strong EGFP 
expression was observed in both myotomal and cranial skeletal muscles (Figure 6.4).  
 
Figure 6.4. CNE3 directs EGFP expression in the skeletal muscles of zebrafish embryos. Panels A and B 
present the pattern of EGFP activity driven by CNE3 in the anterior and posterior halves of the same F0 
embryo, respectively, at 60 hpf. A’ and B’ show magnified views of A and B. EGFP is specifically observed in 
the myotomal (white arrowheads) and cranial (white arrows) skeletal muscle cells. 
 
Such muscle-specific activity prompted me to perform further in silico analyses of 
CNE3 for the presence of binding motifs for the myogenic regulatory factors (MRFs), which 
would explain the in vivo activity of CNE3. Remarkably, both rVISTA and MatInspector 
results showed the presence of overlapping binding motifs containing a conserved pan-
amniote E-box with the sequence 5’-CAGCTG-3’ for the basic helix-loop-helix myogenic 
regulatory transcription factors MyoD and Myog (Murre et al. 1989; Chaudhary and Skinner, 
1999) (Figure 6.5). However, this MRF binding motif is not significantly over-represented in 
CNE3 relative to genomic background (Number of matches: 2; Expected: 0.49±0.70; Over-
representation: 4.10; Z-score: 1.45; see Legend to Table 4.2 for details on Z-scores).   
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Intriguingly, detailed examination of CNE3 in the UCSC Genome Browser revealed that 
CNE3 overlaps with high peaks of MyoD and Myogenin occupancy in the C2C12 mouse 
myoblast cell line, and with a broad peak of DNaseI hypersensitivity in adult mouse skeletal 
muscles (Figure 6.6). In contrast, there is no DNaseI hypersensitivity over CNE3 in non-
skeletal muscle tissues, like the adult heart, retina and cerebellum, which is in agreement 
with the absence of EGFP expression in these structures in the transiently-transgenic fish 
embryos (Figure 6.4; Figure 6.6). 
 
Figure 6.5. CNE3 harbours a conserved E-box containing binding motif for myogenic regulatory factors 
(MRFs). A display of the sequence conservation along CNE3 as generated in the UCSC Browser. The extent of 
CNE3 is indicated by a thick grey bar at the top of the diagram. The conserved sub-region of CNE3 that 
contains the E-box and the MRF binding motif is shown magnified at the bottom half of the figure. The 
conserved “CAGCTG” E-box is highlighted in yellow and is derived from sequence analysis of CNE3 using the 
rVISTA tool (Ovcharenko et al. 2004). Predicted binding sites for MYOD and myogenin are indicated in green 
and pink rectangles, respectively. 
6.4. Discussion 
The in vivo EGFP reporter-based screen in zebrafish of a subset of the CNEs near the murine 
Lama1 locus revealed that CNE3 has skeletal muscle-specific enhancer properties (Figure 
6.4), while the remaining of the analysed CNEs failed to display strong and consistent 
reporter gene expression (Table 6.1; Figure 6.3). Nevertheless, one or two of the zebrafish 
embryos injected with CNEs 9, 10 and 24 displayed tissue-specific EGFP expression. The 
latter observation is most likely unrelated to the CNE but is an enhancer-trapping effect 
where the β-globin promoter has fallen under the control of a nearby enhancer at the 
integration site. The lack of enhancer activity of mouse CNEs 6, 7, 9, 10, 14, 19, 21, 23 and 
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24 in zebrafish embryos raises questions about the putative function of these CNEs in their 
genomic context in the mouse and about the nature of the transcription factor environment in 
the host species, as discussed later.  
 
Figure 6.6. Association of CNE3 with myogenic regulatory factors (MRFs) and DNaseI hypersensitive sites.    
A graphical display of CNE3 sequence conservation, transcription factor occupancy and DNaseI 
hypersensitivity generated in the UCSC Browser using the NCBI37/mm9 assembly of the mouse genome. Each 
row (or data track) from top to bottom presents features associated with the sequence at the corresponding 
genomic position (indicated by the coordinates at the top of the display). The subsets of tracks with thematically 
similar data (sequence conservation, transcription factors and DNaseI hypersensitivity) are indicated on the 
right side of the diagram. The extent (in base pairs) of CNE3 is shown by the thick grey bar at the top of the 
display and highlighted in light blue along all data tracks. 
 
In contrast to the other tested CNEs, CNE3 specifically up-regulated EGFP 
expression in both myotomal and cranial skeletal muscle cells in ~ 57% of the injected 
embryos (Figure 6.3; Figure 6.4). Notably, CNE3 harbours an evolutionary conserved E-box 
sequence and is occupied by the myogenic regulatory factors MYOD and myogenin in the 
murine C2C12 myoblast cell line, and also maintains an open chromatin configuration in 
adult skeletal muscles that is suggestive of transcription-regulatory activity in the CNE3 
locus (Figure 6.5; Figure 6.6). Taken together, the results from the in vivo and in silico 
analyses suggest that CNE3 may act as a muscle-specific enhancer in the mouse. 
6.4.1. Most of the tested CNEs failed to drive EGFP expression in transient transgenesis 
in the zebrafish 
As described earlier, mouse CNEs 6, 7, 9, 10, 14, 19, 21, 23 and 24 failed to drive strong and 
consistent expression of the EGFP reporter in transgenic zebrafish embryos (Table 6.1; 
Figure 6.3). Several factors could explain these results. 
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1) One possibility, which was discussed in Chapter 5, is that some regulatory 
elements are selective in terms of promoter specificity and perform optimally only in 
conjunction with the endogenous promoter of their target gene, as shown in Drosophila      
(Li and Noll 1994; Merli et al. 1996). Consistent with this explanation, the human β-globin 
promoter in the EGFP (-) vector is dissimilar to the Lama1 promoter: the former contains 
TATA- and CACCC-boxes, whereas the latter is comprised of a CpG-rich sequence (Piccinni 
et al. 2004). Thus, the tested CNEs might have a preference to the Lama1-promoter, instead 
of the β-globin promoter. To address this issue, the β-globin promoter could be substituted 
for the basal promoter of the murine Lama1 gene (Niimi et al. 2003; Piccinni et al. 2004) and 
new transgenic analyses could be performed in the zebrafish. 
2) Another possibility is that some elements cannot function in isolation, that is - 
when tested individually outside of their genomic context, and require synergistic 
interactions with additional elements to fine-tune enhancer output. Such mechanism has been 
demonstrated for the enhancers modulating hypothalamic expression of shh in zebrafish 
(Ertzer et al. 2007), the enhancers controlling the troponin I genes in mice (Guerrero et al. 
2010), as well as for the booster-like proximal regulatory region (PRR) that cooperates with 
the distal regulatory region (DRR) of the murine MyoD gene to provide high levels of 
skeletal muscle-specific expression (Tapscott et al. 1992). Perhaps the most comprehensive 
way to address this issue is to employ transgenesis with BAC constructs harbouring  
deletions of individual CNEs. 
3) Alternatively, as discussed in Chapter 5, some CNEs may not function as 
enhancers but as insulators or silencers. For instance, Royo et al. (2011) characterized three 
insulators from the human IRXB genomic cluster in transgenic zebrafish. However, the 
EGFP reporter construct used for the in vivo analyses in my study is not adequate to detect 
such elements as the empty vector generates basal (almost undetected) levels of transcription 
(Figure 6.2). Instead, an EGFP reporter driven by a strong enhancer (like the mid-brain-
specific Z48 enhancer of the cardiac actin gene) could be employed for the identification of 
insulator elements, where the candidate insulator is cloned between the enhancer and the 
minimal promoter (Bessa et al. 2009). 
4) It is also plausible that the tested CNEs, which are not conserved in the zebrafish 
genome, are clade-specific and can function only in mammalian tissues, implying that the 
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trans-environment in zebrafish embryos is unable to provide regulatory inputs to these 
CNEs. This phenomenon is thought to be a consequence of long evolutionary divergence 
times (as between teleosts and mammals) leading to lineage specific cis-trans coevolution, or 
developmental system drift (Gordon and Ruvinsky 2012; True and Haag 2001). This results 
in genes, with otherwise conserved expression pattern between two species, being regulated 
by divergent cis-regulatory elements and divergent transcription factor inputs. In effect, an 
enhancer-swap experiment may lead to failure of reporter expression because the host trans 
environment is unable to properly interpret the donor's cis information (Ariza-Cosano et al. 
2012). Such cis-trans compensatory coevolution has been suggested from studies of the 
neurogenic ectoderm enhancers (NEEs) in drosophilid flies, where each species – 
melanogaster, pseudoobscura and virilis, has accumulated adaptive parallel species-specific 
changes in their neurogenic ectoderm enhancers, most likely in response to changes in the 
transcription factor milieu of each species (Crocker et al. 2008). For instance, the eve stripe 2 
enhancer from D. yacuba, D. erecta and D. pseudoobscura directed lacZ reporter expression 
patterns in transgenic D. melanogaster embryos that are identical to the pattern driven by the 
D. melanogaster eve stripe 2 enhancer (Ludwig et al. 1998). However, the orthologs of the 
eve stripe enhancers from the phylogenetically distant sepsid flies did not precisely 
recapitulate the drosophilid pattern when tested in D. melanogaster (Hare et al. 2008). If this 
were the case with CNEs 6, 7, 9, 10, 14, 19, 21, 23 and 24, it would be more appropriate to 
test their activity in transgenic mouse embryos, instead.  
5) Finally, some of the CNEs might be active only at later developmental stages that 
were not covered by the 3 days period of screening. It could be that during the assay period 
of 72 hours, some CNEs were in an inactive state due to repressive chromatin configuration 
for instance, which is remodeled at later stages thus allowing the regulatory element to 
interact with various transcription factors. Such a phenomenon was observed in the 
regulation of the immunoglobulin J (IGJ) gene during the antigen-driven stages of B-cell 
development, where the IL-2 cytokine induces opening of the enhancer chromatin, which 
enables STAT5 to bind to its motifs and activate the IGJ gene (Kang et al, 1998). Similarly, 
the ontogenetic progressive activation and repression of the genes in the human β-globin 
cluster depend on stage-specific regulatory elements in their promoters and the nearby locus 
control region (LCR) (Levings and Bungert 2002; Orkin 1995). If this is the case with the 
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tested CNEs, a longer monitoring in transgenic fish might be required to detect any potential 
enhancer activity. 
6.4.2. CNE3 acts as a muscle-specific enhancer 
As reported above, CNE3 contains a conserved E-box that is bound by the MYOD and 
myogenin transcription factors in myoblast culture (Figure 6.5; Figure 6.6). MYOD and 
myogenin, together with MYF5 and MYF6 (MRF4), are myogenic basic helix-loop-helix 
(bHLH) transcription factors, well known for their roles in vertebrate skeletal muscle cell 
commitment and differentiation (Buckingham et al. 2003; Pownall et al. 2002). MYOD is a 
powerful activator of the myogenic programme as its forced expression is sufficient to 
convert not only fibroblasts but also liver, pigment and neuronal cultured cells into skeletal 
muscle (Weintraub et al. 1989), while myogenin functions downstream of MyoD and is 
essential for the activation of skeletal muscle differentiation genes and muscle formation in 
vivo, as shown by the severe reduction of all skeletal muscles and neonatal lethality in Myog-
deficient mice (Hasty et al. 1993; Nabeshima et al. 1993). 
MYOD, as well as the other bHLH myogenic factors, binds to the consensus 
CANNTG E-box sequence (Chaudhary and Skinner 1999). MYOD strongly activates 
reporter constructs carrying a pair of E-boxes partly due to inter-protein interactions that 
stabilise the MYOD-DNA complex (Weintraub et al., 1990), and the nearly ubiquitous E-
proteins (like TCF3) have been shown to participate in such oligomerisation with MYOD via 
the HLH domains (Lassar et al. 1991). It is particularly interesting and relevant to this study 
that binding sites for non-bHLH proteins like MEIS1, SP1 and MEF2 can substitute for the 
second E-box, and thus contribute to the stability of the bound MYOD-DNA complex 
(Tapscott 2005; Knoepfler et al. 1999; Biesiada et al. 1999). Remarkably, CNE3 contains a 
conserved MEIS1 binding site that partially overlaps the E-box, as analysed by rVISTA, 
suggesting the possibility that the transcription factor activity of the E-box-bound 
MYOD/myogenin is augmented by cooperative heterotypic interaction with MEIS1 
(Knoepfler et al. 1999). It would be interesting to test whether CNE3’s muscle-specific 
activity requires the conserved E-box and the MEIS1 binding motif by performing reporter 
analyses using mutant versions of CNE3 with loss-of-function substitutions at these sites. 
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6.4.3. CNE3 and its putative target gene 
The pattern of reporter gene expression driven by CNE3 raises the puzzling question about 
its target gene in the murine genome. Indeed, mine and previous studies in our laboratory 
have shown that the major domains of Lama1 expression in the mouse embryo are the neural 
tube, the meso- and metanephric kidneys, the presomitic mesoderm and the somitic 
sclerotome (Chapter 3 of this study; Anderson et al. 2009; Miner et al. 2004). Lama1 mRNAs 
are observed throughout the somite in the newly formed 2-3 somites, but in mature somites 
Lama1 expression is down-regulated in the dermomyotome and remains expressed at low 
levels in the sclerotome (Andersone et al. 2009; see also Chapter 3 of this study). Therefore, 
there is so far no indication of Lama1expression associated with skeletal muscles in the 
embryo, although laminin α1 has been observed associated with the myotube ends in 
developing intercostal muscles at E11.5 and E15.5 (Patton et al. 1997). However, this study 
did not provide information on the cell type expressing Lama1 at the muscle/rib junction, 
leaving the possibility that laminin α1 may be produced by the costal or tendon cells (both 
derived largely from the sclerotome (Christ and Scaal 2008)), but accumulates at the surface 
of the myocytes, putatively interacting with integrin and dystroglycan receptors (Anderson et 
al. 2009; Bajanca et al. 2006). As for expression in the adult, Falk et al. (1999) and Patton et 
al. (1997) report that laminin α1 is undetectable in adult skeletal muscles. However, contrary 
to these reports, recent studies in our laboratory detected laminin α1 expression at the sites of 
activated satellite cells in injured adult skeletal muscles (Shantisree Rayagiri, unpublished 
data), raising the possibility that CNE3 may be involved in the transcriptional activation of 
Lama1 in regenerating adult muscles.  
Alternatively, CNE3’s close proximity to the transcription start site of the poorly 
characterized Lrrc30 gene (the two loci are just 12 bp away) (Figure 4.3), hints for a possible 
role of CNE3 in the control of skeletal muscle expression of Lrrc30. In relation to such 
scenario, it is interesting to note that adult human skeletal muscles express LRRC30 mRNA, 
as inferred from RNA-seq data in the Illumina Body Map project (GeneCards
®
), and also the 
zebrafish lrrc30 gene is clearly expressed in the myotome (Thisse et al. 2004). The latter 
observation is particularly intriguing, as it implies that the murine CNE3 may be responsible 
for the activation/maintenance of a skeletal-muscle specific pattern of Lrrc30 expression that 
is conserved across vertebrates. In order to support this view, it would be necessary to 
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examine Lrrc30 mRNA expression in the mouse and test whether CNE3 up-regulates 
reporter gene expression in the skeletal muscles of transgenic mouse embryos. The latter 
experiment is important for previous studies have demonstrated that although conserved with 
fish, some human enhancers generate different expression patterns when tested in zebrafish 
and mice, which might indicate the existence of evolutionary divergent trans-environments 
(Ariza-Cosano et al. 2012).  
It cannot be excluded that CNE3 might also function as a shared enhancer, driving 
transcriptional activation from the promoters of both the Lrrc30 and Lama1 genes. Such 
mechanism has been previously reported for the salivary gland-specific expression of the pig-
1 and sgs-4 genes in Drosophila, which share a SEBP1-binding enhancer (Hofmann and 
Lehmann, 1998), for the co-expression of achaete and scute genes in the proneural clusters of 
Drosophila (Gomez-Skarmeta et al. 1995), and suggested for the synchronic co-expression of 
the Myf5 and Mrf4 genes in the most ventral part of the murine thoracic somites (Carvajal et 
al. 2001). Performing circular chromosome conformation capture experiments (4C) will 
facilitate answering the question of CNE3’s target genes. Alternatively, one may generate 
transgenic mouse embryos carrying a BAC clone which spans the Lrrc30-Lama1 region, 
including CNE3, where two different reporter genes – lacZ and PALP (human placental 
alkaline phosphatase gene), are inserted downstream of the Lrrc30 and Lama1 promoters, 
respectively. Deleting CNE3 from the BAC construct and assaying reporters’ expression 
would enable to determine whether Lama1 or Lrrc30, or both, are regulated by CNE3. Such 
method has been employed to examine the complex cis-regulatory apparatus of the murine 
Mrf4-Myf5 locus, for instance (Carvajal et al. 2008) 
 
The results from the in vivo analysis of CNEs around the murine Lama1 locus in 
transgenic zebrafish revealed that only one of the elements, CNE3, has tissue-specific 
enhancer properties, while the rest of the sequences failed to drive strong and consistent 
reporter expression. This poor activity is similar to the results from the in vitro luciferase 
assays and could be due to endogenous promoter requirements, the need for synergistic 
interactions with other elements, the divergent transcription environment of the host, activity 
at later developmental stages, or because the CNEs are not transcriptional enhancers but 
silencers or insulators. Importantly, the outcome of this assay did not succeed in informing 
about the transcription regulatory elements of Lama1 that mediate its expression under the 
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influence of SHH. Therefore, another approach is necessary to unravel these elements as 
described in the next chapter.  
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Chapter 7 
 
Identification of a neural-specific enhancer 
in intron 1 of the murine Lama1 gene 
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7.1. Hypothesis and Aims 
Transgenic analyses in zebrafish of conserved non-coding elements from the vicinity of the 
murine Lama1 locus did not reveal any candidate enhancers except for CNE3. Importantly, 
none of the tested CNEs directed reporter expression in the neural tube or early somites, two 
sites where Lama1 transcription requires SHH signals in the mouse embryo (Anderson et al. 
2009; this study). Consequently, I hypothesized that the SHH-sensitive enhancers directing 
Lama1 transcription in the neural tube and somites might not be conserved. To uncover these 
elements, I employed an alternative approach that does not depend on sequence conservation 
but involves the association of genomic sequence with particular chromatin features such as 
occupied transcription factor binding sites, specific histone modifications and DNaseI 
hypersensitivity. Here, I report on the analysis of available data from ChIP-based studies, 
which led me to identify an enhancer element in intron 1 of mouse Lama1. 
7.2. Introduction 
The correlation of DNaseI hypersensitivity and particular histone modifications with active 
developmental enhancers has been used effectively for identification of the latter, as 
described in Chapter 1. Therefore, in order to identify potential SHH-regulated enhancers of 
the murine Lama1 gene, I carried out an investigation of the available literature focusing on 
studies of the genomic occupancy of GLI transcription factors.  
In search of direct target genes of SHH involved in distal autopod development, 
Vokes et al. (2008) performed chromatin immunoprecipitation with E11.5 mouse embryo 
limb buds that expressed conditionally a Flag-tagged version of GLI3, GLI3
Flag
. 5274 
GLI3
Flag
-bound genomic regions (GBRs) with mean length of 854 base pairs were identified, 
followed by demonstration that some of the regions mediated GLI-dependent transcriptional 
regulation of Prdm1, Gli1, Gremlin and Hand2 in the limb buds of transgenic mouse 
embryos (Vokes et al. 2008). Surprisingly, 16 of the GBRs corresponded to a subset of 25 
GLI1-occupied neural-specific enhancers that have been described earlier in neuralised 
embryoid bodies by the same team (Vokes et al. 2007). Interestingly, these enhancers were 
non-functional in the limb buds as they were enriched for the repressive chromatin mark 
H3K27me3, and none of their target genes - Nkx2.1, Nkx2.2 or Foxa2, were expressed in the 
limb buds of wild type or Gli3
-/- 
embryos. This led the authors to conclude that although 
GLI3 is not involved in silencing of these SHH-dependent neural enhancers in the limbs, it 
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was nonetheless able to gain access to the GLI motifs in their DNA sequence (Vokes et al. 
2008), suggesting that GLI activator and GLI repressor forms, as well as different GLI 
factors, exhibit similar binding specificities in vivo. 
7.3. Results 
7.3.1. Identification of a GLI-bound region in the 1
st
 intron of the murine Lama1 gene 
Encouraged by the observation of GLI3
Flag’s ability to bind otherwise inactive neural 
enhancers in the developing limbs, I screened the full list of 5274 GLI3
Flag
-bound genomic 
regions that was provided in the Supplementary Data Set 1 document by Vokes et al. (2008). 
I identified a 907 base pair peak with Rank No. 1926 located within intron 1 of the murine 
Lama1 locus, approximately 200 bp downstream of the 3’-end of exon 1, and containing not 
one but three GLI binding motifs (Figure 7.1) (SuppDataSet1, Vokes et al. 2008). Detailed 
sequence analyses with MatInspector (Cartharius et al. 2005) revealed the presence of 
another two putative GLI-binding sites within this 907 bp region (Figure 7.1). The latter 
motifs however were not reported in Vokes’s study. Thus, this intronic region harbours five 
GLI binding motifs in total, where motifs 1, 2 and 5 were annotated by Vokes et al. (2008), 
while motifs 3 and 4 were found in this study. 
Based on the fact that a ~1 kb region within the 1
st
 intron of Lama1 contains five GLI 
binding motifs, some or all which are occupied by GLI3 in vivo, I hypothesized that this 
region might be a functional transcription-regulatory element, and even more, that it could be 
a promising candidate for mediating the effects of SHH on Lama1 transcription in the mouse 
somites and/or neural tube. Thus, I performed PCR with mouse genomic DNA to isolate a 
1038 bp amplicon (which I named “a1-NSE”, for reasons explained below) containing the 
907 bp GLI-bound element, followed by cloning of a1-NSE into the same Tol2-based EGFP-
reporter vector used for the functional screening of CNEs described in the previous chapter 
(Figure 7.2).  
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Figure 7.1. Identification of a GLI-occupied region in intron 1 of the murine Lama1 gene. Panel A displays the 5’ end of the Lama1 gene with its first exon and 
part of the 19.3 kb-long intron 1 harbouring the a1-NSE element, as analysed in the UCSC Genome Browser. Below the locus is presented a phastCons plot of 
sequence conservation over the whole genomic region. Panel B is a schematic representation of a1-NSE indicating the relative positions of individual GLI 
binding motifs (1-5) and their sequence. Motifs 1, 2 and 5 were annotated by Vokes et al. (2008) and are indicated in dark green, while motifs 3 and 4 uncovered 
in this study are highlighted in orange. * GLI motif 4 is on the opposite strand relative to the other four GLI motifs. The GLI binding motif consensus sequence 
is indicated below. 
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Figure 7.2. A schematic representation of the a1-NSE::EGFP reporter construct. a1-NSE (blue box) is cloned 
upstream of the human β-globin promoter:EGFP reporter cassette, in the same orientation as the direction of 
transcription in the Lama1 locus (indicated by a straight grey arrow above the blue box). A curved grey arrow 
at the beginning of the EGFP gene indicates the direction of EGFP transcription. mini3’- and mini5’-Tol2 
elements (orange boxes) flank the a1-NSE::EGFP construct and enable its integration in the zebrafish genome 
by Tol2 transposase. 
7.3.2. Activity of a1-NSE in transgenic zebrafish 
I microinjected 30 ng/µL a1-NSE::EGFP construct, together with 20 ng/µL Tol2 mRNA, in 
1-cell stage wild type zebrafish embryos and examined its activity in transient transgenic 
zebrafish (F0) at different developmental time-points. In total, 413 injected embryos were 
analysed, 259 of which were EGFP-positive. The majority, 254, exhibited consistent 
expression restricted to the ventral neural tube only (Figure 7.3), whereas the remaining of 
the EGFP
+
 embryos had weak and highly mosaic expression in varios organs, including the 
neural tube (Table 7.1). Those F0 fish that showed consistent tissue-specific expression of 
EGFP in the ventral neural tube (n= 254) were selected and left to develop until sexual 
maturity, when 40 of them were screened in paired out-crosses with wild type fish for germ-
line transmission of the a1-NSE::EGFP construct. Only 4 of the screened adults (10%) 
generated EGFP
+
 F1 clutches, in which the frequency of reporter-expressing embryos was 
25-35%, depending on the clutch. Importantly however, all of the EGFP
+
 F1 embryos 
displayed reporter expression restricted to the ventral neural tube; no expression was 
observed in any other organ.  
Here, I report on the enhancer activity of a1-NSE as observed in F1 transgenic 
zebrafish for the reporter pattern in F1 embryos (Figures 7.4 and 7.5) was highly similar to 
that in F0 transient transgenic embryos (Figure 7.3), although less mosaic and less intensive, 
which is usually encountered in enhancer transgenic experiments in zebrafish (compare 
Figures 7.3 and 7.4).  
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Figure 7.3. a1-NSE directs EGFP expression in the neural tube of F0 transgenic zebrafish embryos. 
Abbreviations: de, diencephalon; hb, hindbrain; te, telencephalon. 
 
Total number of analysed injected embryos 413 
Total number of EGFP
+
 embryos 259 
Number of embryos with weak and variable EGFP expression 5 
Number of embryos with strong EGFP signal in the NT 254 
Number of embryos with strong EGFP signal in the ventral NT 254 
Number of injected fish grown to adulthood 230 
Number of F0 screened 40 
Number of F0 founders 4 
Total number of EGFP
+
 embryos in F1 112 
Frequency of EGFP
+
 embryos in F1 25 – 35% 
 
Table 7.1. Quantitative data from the Tol2 transposase-mediated transgenesis of the a1-NSE::EGFP construct 
in zebrafish. The “Total number of analysed injected embryos” excludes the dead ones. “Strong EGFP signal in 
NT” indicates high number of cells expressing high levels of EGFP in the neural tube (NT), as contrasted to the 
five EGFP
+ 
embryos featuring only weak reporter expression in a small number of cells in multiple locations in 
the body. 
 
In F1 embryos, faint EGFP signal was detected at ~ 24 hpf only in the anterior neural 
tube, but by 31 hpf reporter expression has intensified and was observed only in the neural 
tube, spanning from the rostral tip of the diencephalon anteriorly and continuing posteriorly 
into a narrow longitudinal stripe of EGFP
+
 cells in the spinal cord (Figure 7.4). Curiously, the 
EGFP signal was restricted to the ventral half of the neural tube and was absent from the 
telencephalon. Transverse cross sections of the brain revealed that EGFP was expressed by a 
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dorso-ventral patch of cells that was merely 2-3 cells thick (Figure 7.4). Later on, at 52 hpf, 
EGFP expression expanded dorsally consistent with the dorso-ventral growth of the brain and 
spinal cord but was, interestingly, restricted to the ventricular zone of the neural tube (Figure 
7.5). 
 
Figure 7.4. EGFP expression in the neural tube of 31 hpf F1 a1-NSE::EGFP-transgenic zebrafish embryos 
(n=63). (A, B) whole-mount images, (C, D) transverse sections through the optic (C) and otic (D) levels of the 
brain as shown in (B). White arrowheads in (A, C, D) indicate the expression of EGFP in the ventral 
diencephalon, midbrain and hindbrain; white arrows in (A) show the continuation of EGFP expression in the 
ventral spinal cord. White asterisk in (A) highlights the absence of EGFP signal in the telencephalon 
Abbreviations: de, diencephalon; hb, hindbrain; hy, hypothalamus; mb, midbrain; ov, otic vesicle; sc, spinal 
cord; te, telencephalon; tc, tectum.  
Thus, the mouse a1-NSE non-coding element behaves as a neural-specific enhancer when 
tested in a heterologous system – the zebrafish embryo. Hence, a1-NSE received its current name 
for its position in intron 1 of Lama1 (a1-) and the fact that it harbours Neural-Specific Enhancer 
properties. 
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Figure 7.5. EGFP expression in the neural tube of 52 
hpf F1 a1-NSE::EGFP-transgenic zebrafish embryos 
(n=49). (A, B) whole-mount images, (C, D) transverse 
sections through the optic (C) and posterior hindbrain 
(D) levels of the brain as shown in (B). White 
arrowheads in (A, C, D) indicate the expression of 
EGFP in the ventricular zone of the brain; white arrows 
in (A) show the continuation of EGFP expression in the 
ventral spinal cord. White asterisk in (A) highlights the 
absence of EGFP signal in the telencephalon. 
Abbreviations: hb, hindbrain; hy, hypothalamus; sc, 
spinal cord; te, telencephalon; tg, tegmentum; tc, 
tectum.  
7.3.3. Activity of a1-NSE in transgenic 
mouse embryos 
The activity of the murine a1-NSE element in 
zebrafish embryos is reminiscent of Lama1 
mRNA expression in the mouse neural tube 
(see Figures 3.1 and 3.2), leading me to examine a1-NSE function in its endogenous 
environment in the mouse embryo. For this, I cloned a1-NSE upstream of the lacZ reporter 
gene driven by the minimal human β-globin promoter (Figure 7.6). The lacZ cassette encodes 
a β-galactosidase (β-Gal) reporter with nuclear localization signal enabling more precise 
labeling of lacZ-expresing cell, while the human β-globin promoter has lower basal 
transcriptional activity compared to alternative promoters 
 
Figure 7.6. A schematic representation of the a1-NSE::lacZ reporter construct. a1-NSE (blue box) is cloned 
upstream of the human β-globin promoter:lacZ reporter cassette, in the same orientation as the direction of 
transcription in the Lama1 locus (indicated by a straight grey arrow above the blue box). A curved grey arrow at 
the beginning of the lacZ gene indicates the direction of lacZ transcription. β-galactosidase is targeted to the 
nucleus as a result of a nuclear localisation signal sequence at the 5’-end of lacZ (light green box). 
(like the thymidine kinase promoter), thus reducing the probability of stochastic non-specific 
reporter expression (Coy et al. 2011; Yee and Rigby 1993). 
The linearized a1-NSE::lacZ construct was introduced into mouse oocytes via pro-
nuclear microinjection, performed by our collaborators in IMCB Singapore, according to  
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Figure 7.7. β-Gal expression in the 
neural tube of E9.0 (n=1) and E9.25 
(n=3) a1-NSE::lacZ-transgenic 
mouse embryos. (A) whole-mount 
lateral view of the E9.0 transgenic 
embryo. (B) magnified lateral view 
of the head region of the same 
embryo indicating the presence of β-
Gal in the CNS but not the 1
st
 
pharyngeal arch and heart. (C) dorsal 
view of the same embryo as in (A) 
showing reporter expression in the 
neural tube but not in somites. (D, E, 
F) whole-mount lateral views of 
E9.25 embryos No. 1, 2 and 3, 
respectively, showing consistent β-
Gal expression in the diencephalon, 
mesencephalon, hindbrain and neural 
tube, but not in the telencephalon. 
Black arrow in (B, D, E and F) 
indicates weaker β-Gal expression at 
the midbrain/hindbrain boundary. 
Abbreviations: de, diencephalon; hb, 
hindbrain; hrt, heart; mes, mesencephalon; nt, neural tube; pa1, 1
st
 pharyngeal arch; psm, presomitic mesoderm; 
som, somites; spc, spinal cord; te, telencephalon. 
 
standard mouse transgenesis procedures (Brown and Corbin 2002), and the resultant 
transgenic embryos were analysed at several developmental stages. The earliest transgenic 
embryo obtained was at stage E8.5-E9.0 (n=1). Remarkably, a1-NSE drove β-Gal expression 
solely in the neural tube, as in transgenic zebrafish (Figure 7.7A-C). Similar expression was 
observed at E9.25 (n=3) (Figure 7.7D-F), and at E9.5 (n=1) (Figure 7.8). At E9.5, the 
transgenic embryo displayed β-Gal staining in the diencephalon, mesencephalon, hindbrain 
and along the neural tube, but absent from the telencephalon, the caudal-most end of the tube 
and curiously, from the isthmic region between mesencephalon and hindbrain. Moreover, 
somites, presomitic mesoderm, neprhric tissues and head mesenchyme, which all express 
Lama1, lacked β-Gal staining (Figure 7.8), further corroborating the neural specificity of a1-
NSE. 
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Figure 7.8. β-Gal expression in the 
neural tube of E9.5 (n=1) a1-
NSE::lacZ-transgenic mouse embryo. 
(A-G) whole-mount images. (H) and (I) 
are near-horizontal sections of the head, 
while (J) is a transverse section at the 
forelimb level. (A) a lateral view of the 
whole embryo; (B) magnified view of 
the head region showing β-Gal 
expression in the diencephalon, 
mesencephalon and hindbrain but not in 
the telencephalon and the pharyngeal 
arches. (C) frontal view of the head 
indicating the characteristic ventro-
lateral stripes (orange arrows) of β-Gal 
signal in the diencephalon. (D) dorsal 
view of the head showing absence of 
reporter expression in the floor-plate 
and at the midbrain/hindbrain boundary 
(black arrows). (E) dorsal view of the 
trunk region revealing that β-Gal is 
confined to the neural tube and is 
absent from somites. (F) dorsal view of 
the caudal end of the embryo, showing 
similar pattern as in (E). (G) magnified 
lateral view of the caudal region 
showing the posterior limit of β-Gal 
expression and absence of the latter 
from the paraxial mesoderm; the 
newly-formed somite (sI) is outlined. 
Sections (H) and (I) reveal that reporter expression is indeed restricted to CNS as head mesenchyme is devoid 
of signal. (J) β-Gal expression is absent from the dorsal neural tube (indicated by a black arrow), and the 
somites. Abbreviations: coe, coelom; doa, dorsal aorta; de, diencephalon; dmm, dermomyotome; flp, floor-
plate; ha, hyoid arch; hb, hindbrain; hm, head mesenchyme; hrt, heart; ma, mandibular arch; mes, 
mesencephalon; nt, neural tube; ops, optic stalk; opv, optic vesicle; psm, presomitic mesoderm; sc, sclerotome; 
sI, newly formed somite; som, somites; te, telencephalon; tev, telencephalic vesicle. 
 
At E10.5 (n=1), the activity of a1-NSE in the neural tube remained similar to that 
observed at earlier stages, with strong β-Gal expression in all regions of the CNS except the 
telencephalon, dorsal isthmus and caudal neural tube (Figure 7.9). However, I observed 
additional expression in several non-neural domains like the heart, sclerotomes, the 1
st
 
pharyngeal pouch, in the limb bud mesenchyme and cloacal area (Figure 7.9B, E, H), raising 
the possibility that reporter expression in these domains might also be under the control of 
a1-NSE. However, examination of later stage transgenic mouse embryos, revealed that this is 
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unlikely to be the case as these embryos featured β-Gal expression mainly in neural 
structures, but not in the heart or in any somitic derivatives (Figure 7.10). Thus, an E12.5 
embryo (n=1) exhibited a weaker but nevertheless CNS-restricted β-Gal staining in all 
regions of the brain and spinal cord, except for the telencephalon and caudal-most end of the 
neural tube, respectively (Figure 7.10A-C). 
Figure 7.9. β-Gal expression in the neural tube of E10.5 (n=1) a1-NSE::lacZ-transgenic mouse embryo.      
(A-H) whole-mount images. (I-K) sections as indicated in (A). (A) a side view of the whole embryo, indicating 
the consistent pattern of β-Gal 
expression in the central nervous 
system similar to that observed at 
earlier stages (compare with Figure 
7.7 and 7.6). (B) frontal view of 
the whole embryo. (C) 
magnifiedlateral view of the head 
region. β-Gal is expressed in the 
diencephalon, mesencephalon and 
hindbrain, but not in the 
telencephalon. Intriguingly, the 
first pharyngeal cleft is also 
positive. (D) dorsal view of the 
head showing the absence of 
reporter expression in the floor-
plate. (E) side view of the inter-
limb region showing expression in 
the neural tube and in the 
sclerotome (black arrowheads). (F) 
dorsal view of the inter-limb 
region. (G) Dorsal view of the 
tailbud region; the location of the 
newly formed somite (sI) is 
outlined. (H) side view of the 
tailbud region, showing expression 
in the ectoderm of the cloacal area. 
In panels (E, F, I and J) anterior is 
to the top. (I) horizontal section 
through the head revealing β-Gal 
expression in the neural tube but 
not in the head mesenchyme or otic 
vesicles. (J) horizontal section 
through the pharyngeal region 
showing β-Gal expression in the 
endoderm of the first pharyngeal pouch (green arrows). (K) transverse section at the forelimb level. β-Gal 
staining is present in the neural tube where it appears to be reduced in the mantle layer (white asterisk), and is 
absent from the floor-plate and the dorsal neural tube (black arrow); the vertebral mesenchyme (derived from 
the sclerotome) below the neural tube also expresses β-Gal, while the rest of the somitic derivatives lack 
reporter expression. Abbreviations: cla, cloacal area; doa, dorsal aorta; de, diencephalon; flb, forelimb bud; flp, 
floor-plate; ha, hyoid arch; hb, hindbrain; hm, head mesenchyme; hrt, heart; ma, mandibular arch; mes, 
mesencephalon; mtm, myotome; nt, neural tube;ov, otic vesicles;phc1, 1
st
 pharyngeal cleft; php1, 1
st
 pharyngeal 
pouch; psm, presomitic mesoderm; sI, newly formed somite; som, somites; te, telencephalon; vrtm, vertebral 
mesenchyme. 
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Figure 7.10. β-Gal expression in 
the neural tube of E12.5 (n=1) and 
E13.5 a1-NSE::lacZ-transgenic 
mouse embryos. (A-D) whole-
mount images and transverse 
section of the E12.5 embryo.(A) 
lateral, (B) frontal and (C) dorsal 
views of the whole embryo, 
showing β-Gal expression restricted 
to the post-telencephalic central 
nervous system. (D) transverse 
section at the forelimb level 
revealing reporter expression 
restricted to the ventricular zone of 
the ventral half of the spinal cord 
(black arrow). (E-J) and (K-R) are 
image sets from E13.5 embryos 
No.1 and 2, respectively. (E, K) 
lateral, (F, L) frontal and (G, M) 
dorsal views of the embryos. (H) 
frontal section through the head of 
embryo No. 1 as indicated in (E); β-
Gal is expressed at multiple sites in 
the telencephalon, eyes and jaws. 
(N) frontal section through the head of embryo No. 2 revealing reporter expression in the telencephalon that is complementary to the pattern observed in embryo No. 1 (H). (I) and 
(J) are transverse sections of the trunk of embryo No. 1 at forelimb and hindlimb levels, respectively. β-Gal is expressed not only in the ventricular zone, but also in the mantle 
layer of the spinal cord; in addition, the dorsal root ganglia are also β-Gal-positive. (O) and (P) are transverse sections of the trunk of embryo No. 2 at forelimb and interlimb 
levels, respectively. Similarly to embryo No. 1 (I, J), β-Gal is present in both the ventricular zone and in the mantle layer of the spinal cord. However, in contrast to embryo No. 1, 
there is no reporter expression in dorsal root ganglia. (Q) and (R), proximal and distal, respectively, transverse sections of embryo No. 2 at the level of the tail. Abbreviations: amg, 
amygdala; ctx, neocortex, drg, dorsal root ganglia; epl, ependimal layer of spinal cord; hi, hippocampus; lge, lateral ganglionic eminence; lns, lens;mes, mesencephalon; meo, 
medulla oblongata;mntl, mantle layer of spinal cord; mrgl, marginal layer of spinal cord; poa, postoptic area of hypothalamus; rtn, retina; spc, spinal cord; te, telencephalon; th, 
thalamus;tng,tongue;vrtc,vertebral-condensation.
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Interestingly, the β-Gal signal in the spinal cord of the E12.5 embryo was limited to 
the ventricular zone (Figure 7.10D), reminiscent to a1-NSE’s activity in transgenic fish and 
to the endogenous Lama1 mRNA expression pattern. Similarly, E13.5 embryos (the latest 
stage examined; n=2) displayed strong expression in all regions of the CNS including, 
surprisingly, parts of the telencephalon (Figure 7.10E-G and K-M). However, the 
telencephalic β-Gal staining was not identical but rather complementary in the two littermate 
embryos – one of the transgenics showed staining in the neocortex and hippocampus but 
lacked β-Gal in the amygdala (Figure 7.10N), while the opposite pattern was observed in the 
second embryo (Figure 7.10H), which also showed heavy β-Gal expression in the dorsal root 
ganglia, cranial nerves, retina and the lens (Figure 7.10G, H, I). Otherwise, β-Gal staining in 
the post-telencephalic CNS was largely consistent between the two E13.5 embryos (Figure 
7.10I-J and O-R). This suggests that β-Gal expression observed in the telencephalon and non-
CNS structures in the two E13.5 and the single E10.5 transgenic embryos is due to transgene-
integration-site effects, as it is common in such types of assays in the mouse. However, one 
domain of β-Gal expression was consistent among all nine transgenic embryos – that of the 
post-telencephalic CNS, and it was highly similar to the pattern of Lama1 mRNA expression 
in wild type mouse embryos. 
In summary, a1-NSE behaves as a tissue-specific enhancer directing reporter gene 
expression specifically in the central nervous system of transgenic mouse and zebrafish 
embryos. The results of these functional assays combined with the presence of occupied GLI 
binding motifs, suggest that a1-NSE may operate as a CNS-specific enhancer of the murine 
Lama1 gene in vivo, and that perhaps its activity is modulated by SHH.  
7.3.4. in silico analyses of a1-NSE 
To gain additional knowledge about the mechanisms underlying a1-NSE’s tissue-specific 
transcriptional control, I performed detailed in silico sequence analyses using MatInspector, 
the VISTA Genome Browser and the Mouse Genome Informatics database. MatInspector 
revealed the presence of 240 transcription factor binding motifs within a1-NSE. Interestingly, 
in addition to five GLI motifs described above, a1- NSE harbours putative binding sites for 
several other transcription factors with prominent roles in neural development like the bHLH 
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proteins MASH1 and neurogenin, the HMG-box-containing SOX3, SOX6 and SOX9 factors, 
the POU-domain transcriptional activators, the homeodomain protein LHX3 and the Zn-
finger transcriptional repressor REST (also known as NRSF), among many others (Figure 
7.11; Table 7.2).  
 
Motif Number of 
matches 
Expected ± 
SD 
Over -
representation 
Z-score 
GLI1/2/3 5 1.05 ± 1.03 4.74 3.36 
FOXH1 4 1.95 ± 1.4 2.05 1.11 
FOXJ1 4 8.38 ± 2.88 0.48 -1.69 
HMX1/2 5 9.5 ± 3.07 0.53 -1.63 
LEF1 2 3.46 ± 1.86 0.58 -1.05 
LHX3 1 7.07 ± 2.65 0.14 -2.48 
MASH1/NEUROG 2 1.38 ± 1.17 1.45 0.1 
PAX3 2 0.94 ± 0.97 2.13 0.58 
PAX6 2 2.09 ± 1.44 0.96 -0.41 
POU2F1/3F3 4 7.59 ± 2.74 0.53 -1.49 
POU3F2/4F1 4 7.89 ± 2.8 0.51 -1.57 
POU6F1 3 4.73 ± 2.17 0.63 -1.03 
REST 1 0.69 ± 0.83 1.45 -0.23 
RXRA/B/G 5 3.16 ± 1.78 1.58 0.75 
SOX3/6/9 15 8.65 ± 2.93 1.73 2 
 
Table 7.2. Binding motifs within a1-NSE of transcription factors involved in CNS development. The current 
table lists the binding motifs of transcription factors with roles in CNS development, together with relevant 
statistics information, as obtained using the “Over-represented TFBSs” tool from Genomatix. Note that most 
motifs are presented more than once within the a1-NSE sequence (e.g. GLI), and that in some of these cases 
more than one paralog from a particular TF family is considered by Genomatix in the analysis (e.g. GLI, RXR, 
POU factors, etc). The “Expected ± SD” column displays the expected number of a given motif matches in an 
equally sized random genomic region, together with the standard deviation (SD). The “Over-representation” 
column indicates the fold factor of match numbers in the analysed sequence compared to an equally sized 
genomic region from the background, or found versus expected matches number. The “Z-score” is a measure of 
the statistical significance of the over-representation ratio; a Z-score above 2 or below -2 is considered 
statistically significant, corresponding to a p-value of ~ 0.05 (Genomatix; Sue et al. 2005). 
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Figure 7.11. Map of transcription factor binding motifs in a1-NSE. A schematic representation of a1-NSE as a 
dark blue bar with relative locations of individual binding motifs for transcription factors with important roles in 
neural development shown bellow in different colours. Numbers above the bar indicate the position of the first 
base pair of each motif relative to the beginning (1) and end (1038) of a1-NSE. 
 
Notably, a1-NSE, and as a matter of fact – the whole Lama1’s intron 1, does not 
display high sequence conservation across vertebrates, and even across Mammalia. 
Customized glocal alignment of the murine Lama1’s intron 1 sequence with the 
corresponding sequences from human, opossum, chicken and zebrafish revealed limited 
conservation in the mouse/human and mouse/opossum comparisons, whereas no 
conservation was detected with chicken and zebrafish, even at very low stringency conditions 
– 70% sequence identity over a 30 bp window (Figure 7.12A, B). Despite the limited 
sequence conservation or lack of it, the 1
st
 introns of the mouse, human, chicken and 
zebrafish Lama1 orthologs share some common TFBSs (Table 7.3). 
Although the murine Lama1’s intron 1 exhibits low total conservation with the 
corresponding human and opossum sequences, some discrete regions appear to be conserved 
in the mouse/human alignment, including regions within a1-NSE (Figure 7.12A, B, C). 
DiAlign TF analyses (Genomatix) showed that none of these regions contain conserved GLI-
binding motifs. The same analyses however, revealed that a1-NSE harbors several other 
conserved transcription factor binding motifs, some of which are putative binding sites for 
factors involved in vertebrate CNS development, such as FOXH1, HBP1, NMYC, PAX6/8, 
POU3F2, POU3F3, POU4F1, RXRA/B/G and SOX9 (Table 7.4). 
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Figure 7.12. Phylogenetic footprinting analysis of Lama1’s intron 1. The 1st 
intron of the murine Lama1 gene was aligned with the corresponding 1st 
intron of the Lama1 orthologs from human, opossum, chicken and zebrafish 
using the mVISTA tool. (A) An alignment performed under default 
stringency settings (minimum 70% sequence identity over a minimum of 
100 bp window). (B)  In order to allow for the detection of short conserved 
sequences in the size range of individual transcription factor binding motifs, 
the same alignment was repeated under decreased stringency settings 
(minimum 70% sequence identity over a minimum of 30 bp window). Note 
the absence of sequence conservation in the mouse/chicken and 
mouse/zebrafish alignments. (C) A close-up view of the first 1, 350 base 
pairs of the murine Lama1’s intron 1, containing the a1-NSE element, 
aligned with human and opossum sequences under low stringency settings 
(minimum 70% sequence identity over a minimum of 30 bp window). A 
dark blue bar with labeling on top indicates the extent of a1-NSE in the 
alignments in panels (A), (B) and (C). A black scale bar is provided below 
the alignments. 
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A. 
Binding motif p-value Common  mouse human chicken zebrafish 
DDIT3 (DNA-damage inducible transcript 3) 6.50E-05 4 1 21 2 3 
ZFP628 (zinc finger protein 628) 7.99E-05 4 4 9 4 1 
NFE2L1 (nuclear factor, erythroid derived 2,-like 1) 9.36E-05 4 4 6 3 3 
PAX1 (paired box 1) 0.000101 4 2 3 3 2 
ATF4 (activating transcription factor 4) 0.000105 4 5 14 5 2 
HINFP (histone H4 transcription factor) 0.000113 4 1 9 1 1 
ABL1 (c-abl oncogene 1, non-receptor tyrosine kinase) 0.000117 4 10 14 3 4 
HOMEZ (homeodomain leucine zipper-encoding gene) 0.000117 4 5 6 3 1 
SALL1 (spalt-like transcription factor 1) 0.000155 4 2 20 3 4 
GTF3C (general transcription factor III C) 0.000267 3 0 4 1 1 
PAX9 (paired box 9) 0.000340 4 3 7 7 1 
THAP1 (THAP domain containing, apoptosis associated 
protein 1) 
0.000340 4 4 14 5 1 
TAF (TATA box binding protein (TBP)-associated factor) 0.000409 4 3 5 5 7 
ZFP110 (zinc finger protein 110) 0.000480 2 1 0 1 0 
MLX (MAX-like protein X) 0.000488 4 6 5 2 3 
ZBTB26 (zinc finger and BTB domain containing 26) 0.000538 4 3 5 5 1 
ZBTB7A (zinc finger and BTB domain containing 7a) 0.000538 4 8 9 2 2 
ZBTB33 (zinc finger and BTB domain containing 33) 0.000564 4 6 10 7 7 
OSR (odd-skipped related) 0.000678 4 6 4 8 1 
ZSCAN21 (zinc finger and SCAN domain containing 21) 0.002370 4 6 12 15 6 
B. 
Binding motif p-value Common mouse human chicken zebrafish 
PAX 4, 6, 7 (paired box 4, 6 and 7) 0.003675 4 11 39 20 27 
ZIC (zinc finger protein of the cerebellum family 
member) 
0.006014 4 8 22 6 5 
PAX3 (paired box 3) 0.022713 4 19 32 18 9 
REST (RE1-silencing transcription factor) 0.027427 4 21 25 11 4 
NKX6.1 (NK6 homeobox 1) 0.036085 4 44 101 63 78 
SMAD (SMAD family member) 0.036885 4 21 49 11 6 
ETS (E26 avian leukemia oncogene family member) 0.040725 4 92 153 73 30 
GLI (GLI-Kruppel family member) 0.043061 4 34 48 16 3 
NEUROD (neurogenic differentiation family member) 0.043905 4 20 32 20 10 
 
Table 7.3. Transcription factors binding motifs common to the 1
st
 introns of Lama1 from  mouse, human, 
chicken and zebrafish. The 1
st
 introns of the Lama1genes from mouse, human, chicken and zebrafish were 
analysed for common TF binding motifs. A) The top 20 statistically significant common motifs matches are 
displayed only, out of 37 significant motif matches in total. B) Some of the statistically significant common 
motifs matches are for TFs with roles in vertebrate CNS development, although these motifs matches are not 
included in top 20. The p-value indicates “the probability to obtain an equal or greater number of sequences 
with a motif match from a randomly drawn sample of the same size as the set of input sequences. The lower the 
p-value, the higher is the statistical significance (importance) of the observed common motif match” 
(Genomatix). The “Common” column shows the number of input sequences (4 input sequences in this study) 
with a common motif. The columns named “mouse”, “human”, “chicken”, and “zebrafish” show the number of 
individual motif matches within the input sequence from each species. 
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Binding motif Position 
FOXH1 (forkhead box H1) 934 – 950 (-) 
GATA1 (GATA binding protein 1) 945 – 957 (-) 
HBP1 (high mobility group box transcription factor 1) 
178 - 202 (+) 
674 –  698 (+) 
825 – 849 (-) 
HIC1 (hypermethylated in cancer 1) 787 – 799 (-) 
HMGA (high mobility group AT-hook) 
561 – 585 (+) 
837 – 861 (-) 
932 – 956 (+) 
HNF1B (HNF1 homeobox b) 940 – 956 (+) 
IKZF1 (IKAROS family zinc finger 1) 706 – 718 (-) 
MECOM (MDS1 and EVI1 complex locus) 604 – 620 (+) 
Nanog (Nanog homeobox) 
179 – 197 (+) 
831 -849 (-) 
NFIL3 (nuclear factor, interleukin 3, regulated) 934 – 954 (-) 
NMYC (v-myc myelocytomatosis viral related oncogene, 
neuroblastoma derived) 
765 – 781 (+) 
PAX6 (paired box 6) 839 – 857 (+) 
PAX8 (paired box 8) 828 – 856 (-) 
POU2F1 (POU domain, class 2, transcription factor 1) 828 – 842 (+) 
POU3F2 (POU domain, class 3, transcription factor 2) 839 – 857 (+) 
POU3F3 (POU domain, class 3, transcription factor 3) 838 – 852 (-) 
POU4F1 (POU domain, class 4, transcription factor 1) 843 – 861 (+) 
RREB1 (ras responsive element binding protein 1) 781 – 795 (-) 
RXR (retinoid X receptor) 205 - 229 (-) 
SOX9 (SRY (sex determining region Y)-box 9) 781 – 805 (-) 
SPIC (Spi-C transcription factor (Spi-1/PU.1 related) 928 – 948 (+) 
USF1 (upstream transcription factor 1) 686 – 702 (-) 
 
Table 7.4. Transcription factor binding motifs within a1-NSE that are conserved between mouse and human. 
Here are listed the transcription factor binding motifs that are identified as sequence conserved within a1-NSE, 
as obtained from the mouse/human alignment (displayed at figure 7.11C) using the DiAlign TF tool 
(Genomatix). The “Position” column shows the location of each putative motif within a1-NSE as base-pair 
coordinates; the (+) and (-) signs refer to the “sense” and “antisense” strand, respectively. TFs highlighted in 
cyan feature roles in vertebrate CNS development. 
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Figure 7.13. Chromatin state profile of a1-NSE in different cell types/organs and developmental stages.         
a1-NSE features high and broad peaks of H3K4me1 H3K27ac histone marks, as well as RNA pol II occupation 
and DNaseI hypersensitivity in brain tissue but not in other organs, as revealed by analysis in the UCSC 
Genome Browser. Horizontal black arrows point at the peak of DNaseI hypersensitivity that gradually 
attenuates with progression of development. 
 
An important insight into a1-NSE’s function is provided by its association with 
certain chromatin features, as revealed by the examination of a1-NSE in the UCSC Genome 
Browser. Remarkably, a1-NSE correlates with a broad peak of H3K4me1 and H3K27ac 
histone modifications, which mark active enhancers (Creyghton et al. 2010; Rada-Iglesias et 
al. 2011), in the brain of E14.5 mouse embryos but not in embryonic fibroblasts, small 
intestine or spleen (Figure 7.13). This further supports the idea that a1-NSE is a neural-
specific enhancer. Moreover, there is a peak of DNaseI hypersensitivity over a1-NSE whose 
pattern undergoes progressive temporal changes suggesting that the a1-NSE locus is more 
accessible to nuclease digestion at E14.5 but becomes virtually inaccessible in the adult brain 
(black arrows in Figure 7.13). Another curious finding is the enrichment for RNA Pol II 
binding not only around the Lama1 promoter but also in a1-NSA itself, and this is only 
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observed in the brain but not in other tissues/organs. Taken together, the data gained through 
in silico analyses strongly suggest that a1-NSE operates as a neural-specific enhancer of the 
murine Lama1 gene that is active during central nervous systems development (CNS). 
 
7.4. Discussion 
Here I reported on the identification of a GLI-bound enhancer element, a1-NSE, located in 
the 1
st
 intron of the mouse Lama1 gene, which drives neural-specific reporter expression in 
the CNS of transgenic zebrafish and mouse embryos, suggesting conserved transcription 
factor environments in both species. Consistent with this, a1-NSE contains binding sites for 
transcription factors implicated in vertebrate neural development, and also features chromatin 
marks of active enhancers in the brain but not in non-neural tissues. Yet, a1-NSE displays no 
sequence conservation between mouse and zebrafish, although intron 1 of the mouse Lama1 
gene shares common TF binding motifs with that of zebrafish. 
7.4.1. GLI-binding sites and a1-NSE’s function 
a1-NSE harbours a cluster of five GLI-binding motifs within ~ 1 kb of sequence, some or all 
of which are probably occupied by GLI factors in the developing neural tube. Each of the 
five motifs closely resembles the GLI consensus “TGGGTGGTC” sequence (Kinzler and 
Vogelstein 1990) but none is a perfect match to it (Figure 7.1), which is not unusual as most 
transcription factors bind to a spectrum of related sequences (Zhang et al. 2006). Motifs 3 
and 4 were not annotated by Vokes et al. (2008) but were predicted by MatInspector. 
Perhaps, any of the three GLI factors in the mouse could bind to any of the 5 sites, as 
GLI1/2/3 show very similar binding affinities in vitro (Hallikas et al. 2006). Interestingly, 
Vokes et al. (2007) reported that 24% of GLI1-target genes in neural cell cultures contain 
their GLI1-ocuppied sites within the first or second intron, which is consistent with the 
location of the five GLI motifs of a1-NSE in the first intron of Lama1 (Figure 7.1). 
Moreover, the density of GLI binding sites within a1-NSE is significantly higher than 
what is expected by random distribution of GLI motifs in the genome (Z-score = 3.36, see 
Table 7.1; Hallikas et al. 2006; Vokes et al. 2008), which hints for their possible functional 
significance in a1-NSE activity. In fact, this phenomenon - the presence of multiple binding 
motifs for the same transcription factor within a regulatory element, is known as “homotypic 
clustering”, and is proposed to increase the thermodynamic probability of transcription factor 
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binding in the process of one-dimensional diffusion of transcription factors along DNA 
(Gorman and Greene 2008). Interestingly, Gotea et al. (2010) reported that homotypic 
clusters are 25-times over-represented in developmental enhancers, and it is suggested that 
clustering may facilitate cooperative interactions between the DNA-bound factors, which 
serves to reduce gene expression noise by increasing the number of required transcriptional 
activation steps (Segal et al. 2008), resulting in sharper gene expression patterns. This model 
is supported by the inability of Bicoid (K57R) mutant to engage in homotypic protein-protein 
cooperative interactions which lead to failure in establishing the sharp posterior boundary of 
hunchback gene expression and gross morphological defects in the head and thorax of mutant 
Drosophia flies (Lebrecht et al. 2005). 
The presence of occupied GLI motifs in a1-NSE suggests that GLI proteins 
participate in its neural-specific enhancer function. Such assumption is supported by the 
conserved expression pattern of Gli genes in the vertebrate neural tube of, where all Gli are 
expressed throughout the neuroectoderm in early stages of development, before Gli1 mRNA 
becomes restricted to the ventral half of the neural tube (excluding the floor plate), and Gli2 
and Gli3 to the dorsal half of the tube (Hui et al. 1994; Sasaki et al. 1997; Vanderlaan et al. 
2005). To test whether some or all of the GLI motifs are required for the activity of a1-NSE, 
loss-of-function base pair substitutions were introduced and the effects examined in transient 
transgenic zebrafish embryos, as described in the next chapter. 
7.4.2. ZIC transcription factors and a1-NSE 
It is also plausible that the activity of GLI proteins bound to their motifs in a1-NSE could be 
modulated by ZIC (zinc finger protein of the cerebellum) transcription factors. ZIC proteins 
(ZIC 1-5) bind the GLI consensus motif sequence in vitro (Mizugishi et al. 2001), due to a 
(Cys2His2)5 Zn-finger DNA-binding domain of ZIC that is highly homologous to the DNA-
binding domain of GLI (Aruga et al. 1996) as discussed in Chapter 4. ZIC and GLI proteins 
can also physically interact through Zn-fingers 3-5 of their DNA-binding domains and this 
interaction facilitates the nuclear translocation of GLI proteins (Koyabu et al. 2001). 
Interestingly, cell culture assays indicate that once in the nucleus, ZIC and GLI proteins 
synergistically enhance each other’s ability to trans-activate reporter gene expression, which 
is again dependent on Zn-fingers 3-5 in both proteins (Koyabu et al. 2001).  
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Thus, a model has emerged where ZIC factors are modulators of GLI-mediated SHH 
signaling responses in vivo. For instance, in the central nervous system Zic1, Zic2 and Zic3 
genes promote early neuroectoderm specification in Xenopus (Mizuseki et al. 1998; Nakata 
et al. 1998), Zic2, Zic3 and Zic5 are essential for neuropore closure in mice (Nagai et al. 
2000; Inoue et al. 2004), and Zic2 function is required for division of the prosencephalon 
(Brown et al. 1998; Nagai et al. 2000), for proper proliferation of granule cell precursors in 
the anterior cerebellum (Aruga et al. 1998; 2002), and for correct contralateral projection of 
retinal ganglion cells (Herrera et al. 2003). This plethora of functions is reflected in the 
expression of Zic genes during neural development where all Zic1-5 have similar expression 
pattern restricted to the dorsal ½ or 1/3 of the midbrain, hindbrain and spinal cord, and to the 
allar plates of the telencephalon (Nagai et al. 1997).  
Studies in zebrafish, Xenopus, chick and mouse embryos reveal that both antagonistic 
and cooperative interactions exist between GLI and ZIC factors, and the particular mode of 
interaction is probably determined by cell lineage, extracellular signals and/or by intrinsic 
propensities of different ZIC factors to activate some GLI proteins but to inhibit others upon 
physical contact when bound to DNA (Aruga et al. 1993; Aruga et al. 1999; Brewster et al. 
1998). Based on this, it is possible that ZIC could bind to one or more GLI motifs in a1-NSE 
and contribute to its neural enhancer function through direct interaction with GLI factors. 
The close proximity between GLI motifs 3-5 in a1-NSE favours such a model, which can be 
tested by immunoprecipitating ZIC bound to a1-NSE in a ChIP experiment in vivo, or by an 
electrophoretic mobility shift assay (EMSA) in vitro. 
7.4.3. a1-NSE exhibits chromatin features of a tissue-specific enhancer 
Inspection of a1-NSE in the UCSC Genome Browser revealed that in brain tissue a1-NSE is 
enriched for the histone modifications H3K4me1 and H3K27ac and displays opened 
chromatin configuration as shown by the peak of DNaseI hypersensitivity at E14.5 
embryonic brain but not in other cell types/organs (Figure 7.13). As discussed in Section 
5.4.6., H3K4me1 is over-represented in both poised and active enhancers (May et al. 2011), 
while H3K27ac is considered as a reliable mark of active versus poised state of 
developmental enhancers (Creyghton et al. 2010; Rada-Iglesias et al. 2011). A peak of 
DNaseI hypersensitivity within a1-NSE spans conserved sub-regions 4-5, indicating that this 
particular part of a1-NSE is in a more accessible chromatin state (black arrows in Figure 
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7.13). Remarkably, however, the peak gradually disappears as development proceeds. This is 
consistent with the idea that the accessibility of regulatory regions varies in time and in 
different tissues, depending on the presence/absence of pioneer transcription factors which 
can elicit chromatin decompaction and facilitate the binding of other transcription factors 
(Guertin and Lis 2013). The temporal pattern of a1-NSE accessibility is also consistent with 
the expression pattern of Lama1 mRNA, which is transcribed in the embryonic and foetal 
central nervous system but gradually disappears at later stages (Miner et al. 2004). 
The low levels or absence of chromatin features in other cells/organs – embryonic 
fibroblasts, intestine and spleen (Figure 7.13), suggests strongly that a1-NSE is a 
developmentally-regulated neural-specific enhancer, and this is consistent with results from a 
genome-wide study of the chromatin states of promoters, insulators and enhancers in various 
human cell types, revealing that chromatin signatures of promoters and insulators are largely 
invariant across different tissues, while enhancers exhibit high cell-type-specific histone 
modification patterns (Heintzman et al. 2009). 
Another intriguing feature of a1-NSE is its enrichment for bound RNA Pol II (Figure 
7.13). Several recent studies have demonstrated that some enhancers associate with Pol II 
and are transcribed as non-coding RNA called “enhancer” RNA (eRNAs) (Koch et al. 2011). 
However, it is unclear whether all eRNAs are functionally relevant or are by-products of 
stochastic initiation events due to random collision of Pol II with accessible chromatin 
(Natoli and Andrau 2012; Struhl 2007). Nevertheless, there are studies, which hint or 
demonstrate important biological roles for some eRNAs. For instance, Evf-2 is a spliced, 
multi-exonic ncRNA that is transcribed from the ultraconserved enhancer element ei located 
between the Dlx5 and Dlx6 loci in the mouse genome, and is induced by SHH signaling 
(Feng et al. 2006). Evf-2eRNA appears to act in trans by forming a complex with DLX2 
leading to enhancement of its transactivation potential. In turn, the Evf-2-bound DLX2 
promotes the activation of the Dlx5/6 genes by binding to the same ultraconserved element, 
ei, that encodes Evf-2. Thus, it appears that Evf-2 acts in feed-forward regulatory loop (Feng 
et al. 2006). Another key study on a genome-wide scale uncovered signal-induced 
transcription of thousands of CBP-bound enhancers in murine cortical neurons (Kim et al. 
2010). These neuronal enhancers associate with RNA pol II in an activity-dependent manner 
leading to bi-directional transcription, the levels of which correlate with the levels of mRNA 
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synthesis from nearby genes, suggesting that transcription at enhancers promotes target gene 
expression (Kim et al. 2010). Thus, it is plausible that the neural-specific activity of a1-NSE 
might be mediated by an eRNA intermediate. It would be highly interesting to investigate 
this possibility further, by injecting a1-NSE::EGFP-transgenic zebrafish embryos with 
siRNA and morpholinos complementary to the sense- or antisense strands of a1-NSE. 
 
7.4.4. a1-NSE and the entire intron 1 of Lama1 display limited sequence conservation 
Intron 1 of the murine Lama1 gene, together with a1-NSE, are not conserved in the 
mouse/chicken and mouse/zebrafish comparisons, whereas the mouse/human and 
mouse/opossum alignments show some conserved regions (Figure 7.12). The lack of 
conservation with zebrafish lama1’s intron 1 is intriguing, especially in light of the similar 
function of a1-NSE when tested in zebrafish and mouse embryos, and because the 1
st
 intron 
of zebrafish lama1 contains CNS-active enhancer sequences (Joseph Pickering’s Thesis 
2012). However, evolutionary conservation of enhancer function despite interspecific 
sequence divergence appears to be a relatively common phenomenon, as introdiced in 
Section 1.10.2.1 and elaborated further on in Section 9.2, and could be explained by the co-
occurrence of common TFBSs establishing “regulatory grammar” (Senger et al. 2004). 
Consistent with this, the 1
st
 introns of mouse and zebrafish Lama1 orthologs share common 
binding motifs of many TFs, some of which are involved in neural development, including 
GLI, ZIC, NEUROD and PAX proteins (Table 7.3B). Therefore, one can hypothesise that 
when tested in transgenic zebrafish embryos, a1-NSE displays a neural-specific activity that 
is similar to the activity in transgenic mouse embryos, for the TF environment in the 
developing zebrafish CNS is similar to the TF environment in the murine CNS, despite the 
lack of a recognisable “a1-NSE orthologous element” in the 1st intron of fish lama1. This 
hypothesis predicts that a reporter gene would exhibit neural expression in transgenic mouse 
embryos when driven by intron 1 of the zebrafish lama1, and this could be tested 
experimentally. 
7.4.5. Neural specificity of a1-NSE function 
The presence of GLI binding motifs cannot alone explain the neural specificity of a1-NSE, as 
a GFP reporter driven only by a cluster of eight tandem consensus GLI binding sites 
efficiently activates reporter expression upon HH pathway activation not only in neural 
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lineages but also in other SHH-responsive cells, such as the somitic cells (Stamataki et al. 
2005; Kahane et al. 2013). Therefore, additional transcription factor inputs must be present to 
restrict a1-NSE’s activity to the neural tube, and not to the somites, limb buds or cranial 
mesenchyme, which are also dependent on HH signaling (Borycki et al. 1998; Hu and Helms 
1999; McGlinn and Tabin 2006). Consistent with this idea, a1-NSE harbours putative 
binding sites for transcription factors with established functions in CNS development (Table 
7.2; Guillemot 2007; Stolt and Wegner 2010). Some of the putative sites appear to be 
conserved between mouse and human (Table 7.4).  
However, most of the predicted TFBSs do not exhibit statistically significant over- 
(or under-) representation in a1-NSE, except for the GLI, and SOX3/6/9 motifs (Table 7.2), 
hinting for potential in vivo function of these motifs. Interestingly, the LHX3 motif features 
significant under-representation – instead of 7 expected LHX3 motifs, a1-NSE contains only 
a single such motif (Table 7.2), suggesting for some functional importance of the exclusion 
of LHX3 motifs from a1-NSE. Despite the lack of statistical significance for the majority of 
CNS-development-related motifs in a1-NSE, the motifs could still be genuine TFBSs in vivo, 
for many transcription factors engage in physical interactions between each other and the 
bound regulatory DNA element, modulating target gene transcription in a combinatory 
manner (Davidson 2006). Therefore, although individual TF binding motifs are not 
significantly over-represented in a1-NSE, the combination of several different motifs could 
be.  
a1-NSE contains binding motifs for the proneural basic helix-loop-helix transcription 
factors neurogenin and MASH1, as well as for several SOX and POU-domain proteins 
(Figure.7.11). Neurogenins 1, 2 and 3 and MASH1 are predominantly expressed in the 
ventricular zone of the prospective spinal cord and brain starting from E8.5 in mouse 
development (Guillemot and Joyner 1993; Sommer et al. 1996), and the SOXB1 class of 
proteins (SOX1, 2, 3) are specifically expressed in the ventricular zone of the mouse neural 
tube together with many POU factors (He et al. 1989; Uchikawa et al. 1999). Notably, these 
transcriptions factors are known to synergise in the regulation of target genes. For instance, 
SOX1/2/3 and POU3F2 are essential for the synergistic activation of the 30 bp neural 
enhancer of the nestin gene in the developing murine spinal cord via binding to adjacent sites 
in the regulatory element (Tanaka et al. 2004). Analogously, synergistic interaction between 
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MASH1 and the Class III POU proteins POU3F2 and POU3F2 is requied for the expression 
of Delta1 in the murine dorsal spinal cord and telencephalon (Castro et al. 2006). In addition, 
cross-regulatory interactions exist between these transcription factors. For instance, 
neurogenins and MASH1 trigger neuronal differentiation by first repressing the transcription 
of the SOXB1 class of genes, which are required for maintenance of pluripotency and self-
renewal in neural stem cells (Bylund et al. 2003).  
Thus, one can envision a model where combinatorial inputs from GLI and/or ZIC, 
proneural bHLH, POU domain, SOX and homeodomain transcription factors contribute 
synergistically to the neural specificity of a1-NSE. This model can be tested by deletion of 
the motifs for SOX, POU or bHLH transcription factors from a1-NSE and examining the 
effects in transient transgenic zebrafish injected with the mutant a1-NSE-reporter construct. 
However, in addition to cooperative interactions between transcriptional activators, 
the specificity of a1-NSE could be also determined by the binding of a global repressor, as it 
is often the case in embryonic patterning (Davidson 2006). Consistent with this, a1-NSE 
contains a binding motif for the RE1-silencing transcription factor, or REST (also known as 
NRSF) (Table 7.2). REST is a repressor of neuronal genes in non-neural tissues and in 
undifferentiated neural precursor cells (Lunyak and Rosenfeld 2005). Inactivation of Rest in 
mouse embryos or over-expression of a dominant negative form of REST (dnREST) in 
chicken embryos leads to ectopic activation of neuronal marker genes in the myotome, 
epicardium and in the limb ectoderm, or to premature activation of neural differentiation 
genes in the ventricular zone of the spinal cord (Chen et al. 1998).  
REST acts via binding to the relatively long and rare 21 bp repressor element-1 (RE1) 
motif, also known as NRSE (Neuron-Restrictive Silencer Element) (Mori et al. 1992), in the 
promoters or enhancers of genes encoding proteins of differentiated neurons (Brivanlou 
1998; Sun et al. 2005). REST recruits a complex that adds repressive marks to the associated 
chromatin (Andres et al. 1999; Lakowski et al. 2006). In effect, this results in silencing of the 
REST-bound promoter or enhancer and repression of target gene transcription. Expression of 
Rest is also consistent with its role as major repressor of neuronal genes in non-neural tissues, 
as it is ubiquitously expressed at E8.5 and E9.5 in mouse embryos (Chen et al. 1998), but in 
neural tissues its levels are strongly down-regulated in the transition between stem- and 
intermediate progenitors with complete dissociation from RE1 motifs at the onset of neuronal 
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differentiation (Ballas et al. 2005). Surprisingly, a role of Rest in modulation of Hh signaling 
in zebrafish neural tube patterning was described by Gates et al. (2010). Zebrafish embryos 
treated with morpholinos against rest exhibit moderate ventralisation of the neural tube, with 
dorsal expansion of ptch1, foxa2, and nkx2.2a expression, reminiscent of up-regulated Hh 
signaling. Analysis of gli gene expression in rest morphants uncovered that gli2a was 
overexpressed, indicating that rest acts on the Hh pathway by repressing gli2a expression 
(Gates et al. 2010). 
Thus, it is plausible that the neural-specific activity of a1-NSE is, at least in part, 
conferred by REST-mediated silencing in non-neural tissues, while a1-NSE is active in the 
CNS due to down-regulation of REST expression or inhibition of its binding to the RE1 
motif on a1-NSE. This assumption can be tested by deletion of the RE1 motif from a1-NSE 
and observing the effects on EGFP reporter expression in transient transgenic zebrafish. 
In summary, the neural-specific pattern of a1-NSE activity is most likely determined 
by the combined effects of neural-specific transcriptional activators and global, ubiquitous 
repressors whose activity is however downregulated in the central nervous system. 
 
7.4.6. a1-NSE’s activity in transgenic zebrafish 
The Tol2 transposase-mediated transient transgenesis of a1-NSE::EGFP into F0 zebrafish 
embryos appears to have been successful for nearly 62% of the analysed injected embryos 
were EGFP-positive, an yield that is consistent with previous reports (Navratilova et al. 
2009; Royo et al. 2011; Ikle et al. 2012). However, only 4 founders were found among the 
screened EGFP
+
 fish (n=40), resulting in germ-line transmission rate of 10%, which is lower 
than the reported average rate of 30 – 70% for Tol2-based transgenesis (Kawakami 2007), 
suggesting for reduced activity of the a1-NSE enhancer in the F1 generation. A possible 
cause behind this reduction in activity could be a transgene silencing phenomenon previously 
described in zebrafish (Akitake et al. 2011; Goll et al. 2009), where CpG-rich sequences in 
the transgene construct are particularly susceptible to DNA methylation leading to epigenetic 
silencing of transgene expression (Goll et al. 2009). Interestingly, the first 200 base pairs of 
a1-NSE are part of an extensive 717 bp long CpG island (Figure 7.14), suggesting the 
possibility that the a1-NSE::EGFP transgene might have been subjected to DNA methylation 
in some of the F0 zebrafish, hence the low rate of detected founders (10%).  
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 Nevertheless, the 4 founders gave rise to F1 clutches where the frequency of EGFP
+
 
embryos ranged from 25% to 35%, which is in the range of the 0.3-100% frequency reported 
in other studies (Kawakami et al. 2004; Kawakami 2007; Urasaki et al. 2006). Notably, all 
EGFP
+
 F1 embryos featured reporter expression restricted only to the ventral neural tube, 
with no expression observed in other structures, suggesting that a1-NSE’s activity is resistant 
to the potential influence of by-stander enhancers at the genome integration sites in different 
F1 embryos.  
 
Figure 7.14. a1-NSE partially overlaps with a CpG-rich sequence at the start of the murine Lama1 gene. The 
pink shading indicates the extent of a1-NSE. 
7.4.7. a1-NSE activity and Lama1 expression 
The reporter expression pattern driven by the murine a1-NSE in transgenic mouse and 
zebrafish embryos is very similar to the neural expression pattern of endogenous Lama1 in 
mouse and zebrafish embryos (this study; Joseph Pickering Thesis 2012) (Figure 7.15). 
Lama1 is transcribed at higher levels by cells in the ventricular/subventricular zone (V/SVZ) 
of the neural tube in zebrafish and mouse, and in the mouse embryo this expression becomes 
progressively ventrally restricted, such that Lama1 mRNA is eventually excluded from the 
dorsal neural tube, as well as from the floor plate (Figure 3.1; Figure 3.2). Remarkably, the 
pattern of β-Gal signal in the a1-NSE::lacZ transgenic mouse embryos is very similar to that 
of endogenous Lama1, although there was a somewhat broader reporter signal that spanned 
the whole medio-lateral width of the neural tube (Figure 7.15A-D; Figure 7.8J; Figure 7.9K). 
This could be due to the high stability of β-galactosidase protein (β-Gal) (or alternatively – to 
the stability of the color product), which may have marked cells at the ventricular zone 
initially, but was subsequently transmitted to daughter cells that migrated radially to form the 
mantlelayer of the neural tube (Kriegstein and Alvarez-Buylla 2009). Consistent with such 
explanation, the E10.5 transgenic mouse embryo featured weaker expression of β-Gal in the 
mantle layer as compared to the E9.5 embryo (white asterisk in Figure 7.9K), and in the 
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E12.5 transgenic embryo reporter expression was confined solely to the ventricular zone 
(black arrow in Figure 7.10D), reminiscent to the endogenous expression of Lama1 mRNA at 
that stage (Miner et al. 2004), and this is most likely consequence of the eventual degradation 
of the β-Gal protein or a dilution effect. 
 
Figure 7.15. The a1-NSE-driven reporter expression pattern is very similar to the neural expression pattern of endogenous 
Lama1. Comparison between the a1-NSE::lacZ E9.5 transgenic (A, B) and a wild type E9.5 mouse embryo stained for 
Lama1 mRNA (C, D). (B) and (D) are sections at forelimb level. (E) The a1-NSE-driven EGFP expression pattern in a 28 
hpf transiently transgenic zebrafish embryo is similar to the endogenous lama1 mRNA expression pattern in the anterior 
neural tube of a 25 hpf wild type zebrafish embryo. There is significant overlap between the pattern of β-Gal staining (A) 
and Lama1 mRNA expression (C) along the murine neuraxis, except for the telencephalon, where a1-NSE is inactive, while 
endogenous Lama1 is expressed there. Note the absence of reporter expression in non-neural tissues (like the sclerotome and 
presomitic mesoderm) in both transgenic mouse and zebrafish embryos. Abbreviations: de, diencephalon; dmm, 
dermomyotome; hb, hindbrain; mes, mesencephalon; nt, neural tube; psm, presomitic mesoderm; sc, sclerotome; spc, spinal 
cord; psm, presomitic mesoderm; te, telencephalon; wt, wild type. (Image in F is kindly provided by Dr. Joseph B. 
Pickering, University of Sheffield) 
Alternatively, the expanded β-Gal signal could be a result of the absence of binding 
sites in a1-NSE for putative repressors, which might function to silence endogenous Lama1 
expression in the mantle layer, resulting in persistent lacZ reporter expression beyond the 
V/SVZ. In relation to this, I observed a complex expression pattern of β-Gal in multiple sites 
in the mantle layer of the spinal cord in the two E13.5 transgenic embryos (Figure 7.10I-J, O-
P), where Lama1 mRNA does not appear to be expressed (Miner et al. 2004). This could 
again be an outcome of the lack of essential repressor inputs on a1-NSE. Given the presence 
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of potential binding sites for numerous proneural transcriptional activators (Figure 7.11), it is 
possible that the ectopic lacZ expression results from permissive conditions. 
Similar reasons may explain the expression of β-Gal in the telencephalon of the two 
E13.5 embryos (Figure 7.10E-H, K-N), as a1-NSE does not appear to possess telencephalic 
activity since none of the transgenic embryos at the earlier stages showed expression of β-Gal 
in the telencephalon (Figures 7.7, 7.8 and 7.9). Also, this staining is inconsistent between the 
two E13.5 embryos (Figure 7.10H and N), and may result from the usurpation of the β-globin 
promoter in the a1-NSE::lacZ construct by the enhancers of a bystander gene at the 
integration site. This second possibility is hinted by the suspicious β-Gal signal in the dorsal 
root ganglia and in the trigeminal ganglion, two sites where endogenous Lama1 mRNA is not 
detected (Figure 3.2; Anderson et al. 2009; Miner et al. 2004), in one of the E13.5 
transgenics. In this case, the transgene has probably integrated in the vicinity of a neural 
crest-specific developmental enhancer, as ganglia in the peripheral nervous system are 
derived from the neural crest (D’amico-Martel and Noden 1983). Alternatively, a1-NSE may 
harbour genuine telencephalic activity at E13.5, as endogenous Lama1 is expressed in the 
cortex at that stage (Miner et al. 2004), and examination of additional E13.5 or later 
transgenic embryos may clarify this issue. 
Similarly, the E10.5 transgenic embryo also displayed non-CNS β-Gal expression in 
the heart, sclerotomes, first pharyngeal pouch, and limb mesenchyme. Although Lama1 is 
expressed in the sclerotome and first pharyngeal pouch at E10.25 (Figure 3.2), it is unlikely 
that β-Gal expression in these structures corresponds to a real transcriptional activity of a1-
NSE as none of the other transgenics showed lacZ activity in these domains. Most likely, 
expression at these sites is due to integration effects, or to the absence of repressor motifs on 
a1-NSE that would normally prevent a1-NSE activity there. 
The pattern of β-Gal expression along the neural tube of a1-NSE-transgenic mouse 
and zebrafish embryos (Figures 7.7, 7.8A-C, 7.9A) coincides strikingly to the antero-
posterior expression pattern of Shh along the neuraxis (Echelard et al. 1993; Krauss et al. 
1993). In the presumptive spinal cord and hindbrain of mouse embryos, Shh transcription is 
limited to the ventral midline, while in the midbrain and forebrain it extends ventro-laterally.  
This is particularly evident in the forebrain at E9.5, as Shh is expressed as two ventro-lateral 
stripes in the rostral diencephalon (Echelard et al. 1993). This very specific expression 
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domain overlaps with the pattern of β-Gal expression in the E9.5 transgenic mouse embryo 
(orange arrows in Figure 7.8C), suggesting that a1-NSE, like endogenous Lama1, may be 
responsive to Shh signals secreted from the ventral neural tube (Figures 3.1, 3.2 and 3.3; 
Anderson et al. 2009). Thus, a1-NSE may be the regulatory element mediating the Shh 
effects on Lama1 expression in the neural tube. 
The pattern of EGFP driven by a1-NSE in the zebrafish ventral neural tube is 
reminiscent to the expression pattern of genes that are positive targets (or Class II genes) of 
Hh signaling, such as nkx2.2a, olig2 and nkx6.1 (Gates et al. 2010; Guner et al. 2007; Park et 
al. 2002) (Figure 7.4). Moreover, the activity of a1-NSE in transgenic zebrafish is similar to 
the pattern of endogenous Lama1 expression in both mouse and fish embryos, and this is 
particularly evident at stage 52 hpf transgenic zebrafish where EGFP signal is confined 
largely to the ventricular zone of the brain (Figure 7.5). Interestingly, as mentioned earlier, in 
both species, reporter expression is excluded from the dorsal neural tube (Figures 7.4 and 
7.5; black arrows in Figures 7.8J; 7.9K; 7.10D) and this is most likely due to repressive 
inputs by GLI3 repressor form in the mouse and by both Gli2a and Gli3 repressor forms in 
zebrafish, which although expressed throughout the dorsoventral extent of the neural tube at 
early stages, later become confined to the dorsal half of the tube where they repress Shh-
target genes (Persson et al. 2002; Tyurina et al. 2005; Vanderlaan et al. 2005). It is also 
possible that BMP signaling in the dorsal neural tube contributes to silencing of a1-NSE. 
Indeed SMAD proteins have been shown to physically interact with the GLI3 repressor form 
in cultured mouse cells (Liu et al. 1998) and with Gli2a repressor during zebrafish somite 
patterning (Maurya et al. 2011). 
In summary, the neural-specific activity of the murine a1-NSE in transgenic mouse 
and zebrafish embryos resembles the endogenous expression of Lama1 in both species, 
suggesting that a1-NSE may be the cis-regulatory element responsible for directing Lama1 
transcription in the murine central nervous system. Moreover, the fact that a1-NSE can 
operate in a homologous manner when tested in fish and mammals hints for conservation of 
the signaling pathways and transcription factor inputs impinging on a1-NSE. The presence of 
GLI binding motifs combined with the characteristic activity of a1-NSE along the neuraxis 
that parallels the expression of Shh in the notochord and floor plate, strongly suggest that 
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SHH signaling might be a modulator of a1-NSE’s function, and this hypothesis is addressed 
in the next chapter. 
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Chapter 8 
 
Regulation of a1-NSE’s transcriptional activity  
by the Hh signalling pathway 
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8.1. Hypothesis and aims 
The presence of five GLI binding motifs, and the GLI3 binding at a1-NSE in vivo (Vokes et 
al. 2008), combined with the specific reporter expression pattern in the neural tube of 
transgenic mouse and zebrafish embryos, raises the hypothesis that the activity of a1-NSE 
might be regulated by the HH signalling pathway. Here, I examined this assumption by 
performing Hh signalling loss- and gain-of-function experiments in transient transgenic 
zebrafish embryos that express EGFP under the control of the murine a1-NSE enhancer. In 
addition, I tested whether the activity of a1-NSE depends on intact GLI binding motifs by 
performing transient transgenesis in zebrafish embryos using a mutated version of a1-NSE 
(mut a1-NSE).  
8.2. Cyclopamine treatment abolishes the activity of a1-NSE 
Treatment of whole embryos, tissue explants or cells in culture with small molecule 
inhibitors of the Hh signalling pathway is a straightforward initial approach to address 
whether the function of a particular transcription regulatory element depends on active Hh 
signalling. Cyclopamine is the oldest and most widely used antagonist of HH signalling, 
which at certain concentrations can effectively block Hh signal transduction when added to 
zebrafish embryo medium water (Wolff et al., 2003). Therefore, I decided to treat zebrafish 
embryos injected with the a1-NSE::EGFP construct with cyclopamine in order to examine 
whether the function of a1-NSE requires active HH signalling. 
8.2.1. Introduction 
Cyclopamine is a steroidal alkaloid first isolated from the lilly Veratrum californicum 
following an investigation on the etiology of cyclopia epidemic in sheep during the 1950’s in 
the United States (Binns et al., 1963; Keeler and Binns, 1968). Subsequently, it was revealed 
that administration of cyclopamine to gastrulation-stage amniote embryos triggered a 
complex set of midline facial and neurological defects ranging from microcephaly, ocular 
hypotelorism (closer than normal midline proximity of the eyes) to fusion of the olfactory 
placodes, synopthalmia and alobar holoprosencephaly (undivided prosencephalon), which 
characterise the cyclopic condition (Keeler and Binns, 1968; Incardona et al., 1998). Notably, 
these disruptions were highly similar to the midfacial and brain malformations observed in 
Shh-deficient mouse embryos (Chiang et al. 1996) and human patients with mutations in the 
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SHH gene (Roessler et al. 1996).  Eventually, it was demonstrated that the teratogenic effects 
of cyclopamine were caused by attenuation of Hh signalling, which was evidenced by 
perturbations of the dorsal-ventral patterning of the neural tube and somites in chicken 
embryos (Cooper et al. 1998; Incardona et al. 1998), and cyclopia, loss of the horizontal 
myoseptum and pectoral fin patterning disruptions in zebrafish (Neumann et al. 1999). 
Cyclopamine exerts its antagonistic effects on Hh signalling by direct binding to the 
transmembrane heptahelical bundle of smoothened (SMO), which is thought to trigger 
inhibitory conformational changes in SMO structure (Chen et al., 2002). Although, it remains 
elusive how cyclopamine mechanistically affects downstream functions of smoothened, it 
appears this is not through inhibition of SMO trafficking to the primary cilium (Wilson et al., 
2009).  
Multiple studies in zebrafish have effectively used cyclopamine to down-regulate the 
Hh signalling pathway (Neumann et al. 1999; Neumann et al. 2000; Wolff et al. 2003; Gering 
et al. 2005). For instance, Wolff et al. (2003) showed that increasing concentrations of 
administered cyclopamine lead to perturbations in myotomal cell fate acquisition of 
progressively more superficial fibres. For instance, the differentiation of the medially-located 
muscle pioneers, which are most sensitive to Hh signalling, can be blocked by 5 uM 
cyclopamine, whereas the differentiation of the superficial slow fibers (SSFs) is only affected 
at 20-30 uM cyclopamine (Wolff et al. 2003), indicating that muscle pioneer progenitors 
require higher levels of Hh activity than the SSF progenitors (Jackson and Ingham, 2013). 
8.2.2. Results 
Prior to cyclopamine treatment of a1-NSE::EGFP-injected zebrafish, I first tested the 
potency of the cyclopamine stock solution I used. To do this, I divided a population of wild 
type (AB strain) zebrafish embryos at the 30%-epiboly stage (equivalent to ~ 5 hpf stage) 
into two groups. One group (n=193) was incubated in 50 µM cyclopamine solution in 
embryo medium, while the second group (n=227) served as a negative control where, instead 
of cyclopamine an equivalent volume of 98% ethanol was added to the embryo medium. The 
experiment was terminated after 24 hours, or at the prim-16 stage (31 hpf) followed by 
analysis of the embryos’ morphology. 
Notably, the cyclopamine-treated embryos displayed typical morphological 
abnormalities, indicating attenuated Hh signalling, such as microcephaly, ocular 
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hypotelorism (medial ocular proximity), aberrant shape of the prosencephalon, deficient 
retinal pigmentation and U-shaped myotomes (Brand et al. 1996; Chen et al. 2001) (Figure 
8.1E, F, G and H). In contrast, all control embryos appeared normal (Figure 8.1A, B, C and 
D). These preliminary observations indicate that 50 uM cyclopamine disrupts effectively Hh 
signalling in zebrafish embryos. Thus, similar concentration can be used to treat a1-
NSE::EGFP-injected embryos. 
 
Figure 8.1. Treatment of zebrafish 
embryos with 50 µM cyclopamine is 
sufficient to disrupt Hh signalling. (A-D) 
control embryos (n=193) and (E-H) 
cyclopamine-treated embryos (n=227) 
were analysed at 31hpf for the presence 
of Hh-mediated effects. Treatment of 
wild type fish with 50uM cyclopamine 
effectively disrupts Hh signalling as 
indicated by microcephaly (double-
headed arrow in E), lack of retina 
pigmentation (arrows in F), aberrant 
prosencephalon morphology 
(arrowheads in G) and U-shaped 
somites (an asterisk and outline of an 
individual somite in H). In contrast, the 
control treated embryos showed normal 
phenotype (A-D). 
 
 
 
 
In order to test whether cyclopamine treatment affects the activity of a1-NSE, I 
microinjected the a1-NSE::EGFP plasmid together with Tol2 mRNA in 1-cell stage wild 
type zebrafish embryos (see Chapter 7). Approximately five hours after injection, at the 30%-
epiboly stage, the total population of injected embryos was divided in two groups. One group 
was incubated in 50 µM cyclopamine solution in E3 embryo medium, while the second 
group served as a negative control and incubated with an equivalent volume of 98% ethanol 
added to the embryo medium. The treatment was carried out for 24 hours until the prim-16 
stage, or 31 hpf, when the experiment was terminated, and the fish embryos were fixed and 
prepared for analysis. The results of the experiment are shown in Table 8.1 and Figures 8.2 
and 8.3.  
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Remarkably, most of the cyclopamine treated embryos exhibited complete absence of 
EGFP signal; instead, 6.5%  showed only fragmentary (patchy) EGFP staining with reduced 
intensity remaining only in the anterior CNS (Figure 8.2B and B’ and Figure 8.3). 
Importantly, none of the embryos displayed the specific a1-NSE-driven EGFP expression 
pattern restricted to the ventral half of the neural tube, and extending from the tip of the 
rostral diencephalon to the caudal spinal cord (see also Figure 7.4 and 7.5), to which I refer 
here as the “normal” or “wild type, wt” expression pattern (compare Figure 8.2A and A’ with 
Figure 8.2B and B’; Figure 8.3). In contrast, 63.1% of the control embryos exhibited normal 
expression of EGFP in the ventral half of the brain, while only 4.6% of control embryos 
showing patchy/reduced reporter expression (Figure 8.2A, A’; Figure 8.3).  
These results indicate that cyclopamine interferes with the activity of the murine a1-
NSE in transient transgenic zebrafish embryos, and strongly suggest that the interference is 
due to failure in the activation of the Hh signalling pathway. 
 
 repeat 1 repeat 2 
 control cyclopamine control cyclopamine 
Total No. of embryos 244 187 213 205 
No. of embryos with normal 
expression 
159 0 130 0 
No. of embryos with 
patchy/reduced expression 
11 16 10 9 
% embryos with normal 
expression 
65.16 0 61.03 0 
% embryos with reduced 
expression 
4.51 8.56 4.69 4.39 
% embryos with no 
expression 
30.33 91.44 34.28 95.61 
 
Table 8.1. Numbers and percentages of control and cyclopamine-treated zebrafish embryos with normal or 
patchy/reduced a1-NSE-driven EGFP expression from two independent replicate experiments. 
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Figure 8.2. Treatment of zebrafish embryos with 50 µM cyclopamine disrupts a1-NSE’s activity. EGFP 
fluorescence from control (A, A’) and cyclopamine treated zebrafish embryos (B,B’) at 31 hpf. Note the severe 
reduction in EGFP expression in the brain of cyclopamine-treated fish (white arrows B). Higher magnification 
reveals a small patch of residual EGFP signal in the ventral mesencephalon and anterior hindbrain (B’). 
Abbreviations: ce, cerebellum; de, diencephalon; hb, hindbrain; tc, tectum. 
 
Figure 8.3. Treatment of zebrafish embryos with 50 µM cyclopamine disrupts a1-NSE’s activity (Quantitative 
Analysis). Graphical representation of the results from two replicate experiments showing the percentages of 
injected embryos with normal and reduced/patchy pattern of a1-NSE-directed EGFP expression from both 
control (blue-colored columns) and cyclopamine-treated groups (red-colored columns). “Normal expression 
pattern” of EGFP is defined in the text. Note that the percentage of embryos with complete absence of EGFP 
signal in the neural tube in both the control and cyclopamine-treated groups is not indicated on the graph. 
Importantly, the mean number of control fish with normal EGFP expression is significantly higher than the 
mean number of cyclopamine-treated fish with normal EGFP pattern (which equal zero), as shown statistically 
by unpaired two-tailed t-test in GraphPad Prism. The black bars above the columns represent the standard error 
of the mean (SEM) for each column.  
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8.3. Smoothened is required for the activity of a1-NSE 
Smoothened is an essential component of HH signal pathway transduction that is negatively 
modulated by patched in the absence of HH (Beachy et al. 2010; Yavari et al. 2010). 
Therefore, an alternative and genetic approach to test whether a1-NSE function depends on 
activated Hh signalling is to inject the a1-NSE::EGFP construct into smoothened-deficient 
zebrafish embryos, which are characterised by abrogated Hh signalling (Barresi et al. 2000; 
Chen et al. 2001). 
8.3.1. Introduction. 
Smoothened (SMO) is a seven-transmembrane domain containing protein that is conserved 
across eumetazoans and is required for the response of cells to hedgehog signals (Alcedo et 
al. 1996; van den Heuvel and Ingham 1996). Studies in Drosophila have shown that the 
stability and subcellular localisation of smoothened are regulated by patched in a non-
stoichiometric way (Denef et al. 2000; Ingham et al. 2000), perhaps by modulating the 
transport of small lipid molecule activators or inhibitors of Smo (Taipale et al. 2002). 
Binding of Hedgehog to Patched causes phosphorylated Smo to move from intracellular 
membranes to the cell surface where it activates the Hh signalling pathway, and forced 
localisation of Smo to the plasma membrane leads to constitutive activation of Hh target 
genes transcription (Nakano et al. 2004; Zhu et al. 2003). Studies in mice and zebrafish 
demonstrated that vertebrate smoothened is trafficked to the primary cilium upon 
engagement of patched by HH and this translocation to the cilium is required for activation 
of HH signalling by SMO (Corbit et al. 2005; Kim et al. 2010; Glazer et al. 2010). 
The zebrafish smoothened (smo) gene was first described in analyses of the smu
-/-
 
(slow-muscle-omitted) mutant fish embryos, which displayed complete loss of eng
+
 muscle 
pioneers, severe reduction in the number of slow muscle fibers, ventrally curved tails, U-
shaped somites, partial cyclopia, loss of cranial cartilages, reduced pectoral fin size, lack of 
secondary motor neurons, loss of the lateral floor plate and parts of the ventral forebrain 
(Barresi et al. 2000; Varga et al. 2001). All smu mutant defects were remarkably similar to 
those observed in Hh signalling deficient fish mutants, like the syu (sonic you) and yot (you-
too), encoding shha and gli2a, respectively (Karlstrom et al. 1999; Schauerte et al. 1998), 
and it was eventually demonstrated that smu encodes the zebrafish smoothened ortholog 
(Varga et al. 2001).  
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Another study using retroviral mutagenesis in zebrafish obtained two loss-of-function 
alleles of smo, smo
hi229
and smo
hi1640
, both of which have a 6 kb pro-viral insertion in the first 
exon of the smo gene at positions -110 and +220 relative to the start codon, respectively 
(Amsterdam et al., 1999; Chen et al., 2001). The two alleles are considered null as both RT-
PCR and in situ hybridisation in 26 hpf embryos of either mutant failed to detect the presence 
of smo mRNA (Chen et al. 2001). Importantly, both smo
hi229
and smo
hi1640
 mutants displayed 
morphological and gene expression abnormalities that are indicative of perturbed Hh 
signalling, like U-shaped somites, reduced floor plate and foxa2 expression, partial cyclopia, 
microcephaly, agenesis of cranial cartilages, almost complete absence of ptch1 expression, 
lack of myoD expression in the paraxial mesoderm, absence of muscle pioneers, reduced 
number of slow muscle fibers at 24 hpf, etc (Chen et al. 2001). Subsequently, the smo
hi1640
 
mutant has been widely used in multiple studies (Aanstad et al. 2009; Cunliffe 2004; 
Elworthy et al. 2008). For instance, Bergeron et al. (2008) employed a combination of DNA 
microarrays and in situ hybridisation using smo
hi1640 
and other mutants to uncover genes 
previously unknown to be Hh-responsive, such as neuroD, follistatin, wt1a, irx1b and 
claudin b, and genes negatively controlled by Hh signalling such as smarca2 (Bergeron et al. 
2008). 
Based on the results from previous studies, I decided to take advantage of the 
smo
hi1640 
mutant zebrafish line (Chen et al. 2001) as an in vivo system to address a1-NSE’s 
requirement for active Hh signalling. 
8.3.2. Results. 
In order to test whether the activity of a1-NSE requires the presence of intact smoothened 
(smo), I co-injected the a1-NSE::EGFP plasmid with Tol2 mRNA and 400 ng/µL H2B-
mCherry mRNA (which served as a marker to control for injection efficiency) into 1-cell 
stage zebrafish embryos that were obtained from incrosses of smo
hi1640/+ 
parents, and all 
subsequent analyses were performed at the 31 hpf stage. 
As expected for typical Mendelian inheritance, the injected embryos segregated into 
two phenotypic classes: approximately ¾ of the fish displayed a wild type phenotype and 
these were assumed to represent embryos with smo
+/+ 
or smo
hi1640Tg/+ 
genotype (hereafter 
named “siblings”) (Table 8.2 and Figure 8.4B and C), while the remaining ¼ of the embryos 
exhibited U-shaped somites, reduced head size and mild cyclopia - morphological defects 
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that are observed in the smo
hi1640Tg/hi1640Tg
 mutant embryos and are also a general 
characteristic of disrupted Hh signalling pathway (Brand et al. 1996; Chen et al. 2001) 
(Figure 8.4E and F). Therefore, the latter embryos are considered to represent animals with 
the smo
hi1640Tg/hi1640T g
genotype, which are loss-of-function smo mutants (hereafter named 
smo
-/-
; Table 8.2) (Chen et al. 2001). 
Interestingly, none of the smo
-/-
 embryos displayed a normal pattern of EGFP 
expression (as defined earlier in the text). Instead, 96.2% of these embryos lacked any EGFP 
expression, whereas the remaining 3.8% smo
-/-
 embryos showed only patchy and reduced 
signal in the brain (Figure 8.4D and Figure 8.5). In contrast, nearly 67% of the siblings 
featured a normal expression of EGFP in the brain, with only 2% of sibling embryos 
displaying patchy/reduced expression in that domain (Figure 8.4A and Figure 8.5). The 
remaining 31% were not EGFP-positive (data not shown). The consistent lack of EGFP 
expression in smo
-/-
embryos is not due to failure of injection as evidenced by the presence of 
H2B-mCherry staining in the cell nuclei in both wild type and mutant embryos (Figure 8.4B 
and E). H2B-mCherry was chosen as an injection control as it incorporates efficiently into 
nucleosome core particles, due to the human histone 2B moiety, while the mCherry 
fluorescent protein enables in vivo cell labelling without perturbations of the cell cycle and 
interference with normal development (Kanda et al. 1996; Shaner et al. 2004).  
 
 repeat 1 repeat 2 
 smo+/+, smo+/- smo-/- smo+/+, smo+/- smo-/- 
Total No. of embryos 112 34 156 41 
No. of embryos with normal 
expression 
77 0 102 0 
No. of embryos with 
patchy/reduced expression 
2 1 3 2 
% embryos with normal 
expression 
68.75 0 65.38 0 
% embryos with reduced 
expression 
1.79 2.94 1.92 4.88 
% embryos with no 
expression 
29.46 97.06 32.7 95.12 
 
Table 8.2. Numbers and percentages of smo
+/+
, smo
+/-
and smo-/- zebrafish embryos with normal or 
patchy/reduced a1-NSE-driven EGFP expression from two independent replicate experiments. 
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Figure 8.4.  smoothened (smo) is required for the activity of a1-NSE. a1-NSE-driven EGFP expression is absent 
in smo
-/- 
embryos (D) compared to smo
+/+
, smo
+/-
 embryos (A) at 31 hpf. (B, C) and (E, F) – antibody staining of 
the positive control H2B-mCherry indicates similar injection efficiency in both the smo
+/+
, smo
+/-
 and smo
-/-
 fish. 
Note the characteristic U-shaped somites in the smo
-/-
 embryo (white outline and arrow in F) compared to the 
chevron-, or V-shaped somites in the fish with wild type phenotype (white outline and arrow in C). Note also 
the abnormal morphology of the anterior diencephalon in (E), which is another feature of smo-defficient 
embryos. Abbreviations: de, diencephalon; hb, hindbrain; tg, tegmentum (ventral half of the midbrain). 
 
Figure 8.5. smoothened (smo) is required for the activity of a1-NSE (Quantitative Analysis). Graphical 
representation of the results from two replicate experiments showing the percentages of injected smo embryos 
with normal and reduced/patchy pattern of a1-NSE-directed EGFP expression from both smo
+/+
, smo
+/-
 (blue-
colored columns) and smo
-/-
 (red-colored columns) embryos. “Normal expression pattern” of EGFP is defined in 
the text. Note that the percentage of embryos with complete absence of EGFP signal in the neural tube in both 
“smo+/+, smo+/-“ and “smo-/-“ groups is not indicated on the graph. Importantly, the mean number of smo+/+, 
smo
+/-
 fish with normal EGFP expression is significantly higher than the mean number of smo
-/-
 fish with 
normal EGFP pattern (which equal zero), as shown statistically by unpaired two-tailed t-test in GraphPad Prism. 
The black bars above the columns represent the standard error of the mean (SEM) for each column. 
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The results from the injections of a1-NSE::EGFP in smo mutant zebrafish indicate 
that intact smoothened is necessary for the activity of a1-NSE. Combined with the effect of 
treating zebrafish embryos with cyclopamine, this strongly supports the conclusion that 
active Hh signalling is required for the function of a1-NSE. 
8.4. A dominant negative form of PKA causes ectopic activation of a1-NSE. 
Protein kinase A (PKA) is a negative modulator of the HH signalling pathway that lies 
downstream of smoothened, and forms part of the complex that targets GLI proteins for 
processing through its kinase activity (Tempe et al. 2006). Consequently, loss-of-function of 
PKA leads to increased and ectopic transcription of Hh target genes (Jiang and Struhl 1995; 
Concordet et al. 1996). Therefore, to address whether constitutively active Hh signalling is 
sufficient to activate a1-NSE at ectopic sites in the embryo, I co-injected zebrafish embryos 
with the a1-NSE::EGFP construct and mRNA encoding a dominant negative form of PKA. 
8.4.1. Introduction. 
PKA is a cAMP-dependent serine-threonine kinase that is expressed in many tissues and is 
involved in the regulation of multiple cellular processes during growth and embryonic 
development, response to stress, memory and apoptosis (Song et al. 2003; Taylor et al. 
2004). At low levels of cAMP, PKA is a tetrameric holoenzyme (R2C2) consisting of two 
catalytic (C) subunits bound to a dimer of inhibitory regulatory (R) subunits, which renders 
the complex inactive. When the intracellular concentration of cAMP increases, the regulatory 
subunits bind cAMP. This destabilises their interaction with the catalytic subunits, and the 
holoenzyme dissociates into one R2(cAMP)4 dimer and two monomeric catalytic subunits (Su 
et al. 1995). The activity of the catalytic monomers is further increased by 
autophosphorylation, which makes them capabale to phosphorylate their target proteins in the 
cytosol and nucleus (Voet 2004). 
Some of the many targets of PKA are the GLI proteins. It has been shown that 
Drososphila Cubitus interruptus (Ci) and vertebrate GLI proteins contain a cluster of sites 
downstream of the Zn-finger domain that are sequentially phosphorylated by PKA, glycogen 
synthase kinase 3 (GSK3) and casein kinase 1 (CK1) (Jiang and Struhl 1998; Tempe et al. 
2006). This recruits Slimb/beta-TrCP, a substrate-specific component of the SCF-type E3 
ubiquitin ligase, that eventually results in the partial proteasome-mediated removal of the 
activation-domain-containing C-terminus of Ci/GLI, leaving the N-terminal half, which 
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contains the repressor and DNA-binding domains of Ci/GLI (Pan et al. 2009; Price and 
Kalderon 2002; Smelkinson et al. 2007). Thus, in the absence of HH ligand, PKA 
phosphorylates Ci/GLI, resulting in the generation of Ci
R
/GLI
R 
(repressor forms of Ci/GLI) 
and repression of HH target gene transcription (Aza-Blanc et al. 1997).  
That basal levels of PKA negatively modulate the HH signalling pathway in the 
absence of HH ligand was first demonstrated in the patterning of Drosophila wing and leg 
imaginal discs, where the hh-responsive genes dpp and wg are ectopically induced in PKA-
deficient clones in the anterior wing/leg disc compartment (Jiang and Struhl 1995; Li et al. 
1995; Pan and Rubin 1995). Subsequently, knocking down PKA activity in zebrafish 
embryos by injection of mRNA encoding a dominant negative form of the regulatory subunit 
of PKA (dnPKA) resulted in up-regulation and ectopic expression of Hh target genes, like 
ptch1, myoD and nkx2.2 in the lateral mesoderm and dorsal neural tube (Concordet et al. 
1996). This demonstrated the conserved role of PKA in both Drosophila and vertebrate HH 
signalling. In a similar study, it was shown that dnPKA leads to ventralisation of the 
zebrafish neural tube indicated by the dorsal expansion of the floor plate-restricted foxa2 
mRNA transcription and the elevated and ectopic expression of the motor-neuron specific 
islet1 in the hindbrain and anterior spinal cord (Hammerschmidt et al. 1996), which was 
reminiscent to the ventralising effects of shh overexpression (Hammerschmidt et al. 1996; 
Krauss et al. 1993; Ungar et al. 1996). 
The dominant negative form of PKA used in zebrafish by Concordet et al. (1996) 
contains a point mutation in the cAMP-binding site of the regulatory subunit (R), which 
locks the inhibitory R2 dimer to the catalytic subunits irrespective of elevated cAMP, 
resulting in severe reduction or loss of catalytic PKA subunit activity (Clegg et al. 1987). 
Based on these observations, I decided to use dnPKA mRNA injections to up-regulate 
the Hh signalling pathway in zebrafish embryos and examine whether constitutive activation 
of the pathway is sufficient to induce a1-NSE::EGFP at ectopic locations in the embryo. 
8.4.2. Results 
In order to examine whether ectopic activation of the Hh signalling pathway was sufficient to 
direct a1-NSE-driven expression of EGFP, I co-injected the a1-NSE::EGFP plasmid with 
Tol2 mRNA and with 400 ng/µL dnPKA mRNA in 1-cell stage wild type zebrafish embryos, 
and analysed the injected embryos at the 31 hpf stage. Another group of wild type embryos 
  
 
  
188 
served as a negative control where the dnPKA mRNA was substituted for an equivalent 
volume of water.  
However, prior to the planned experiment, I tested the efficiency of the dnPKA 
mRNA preparation to up-regulate the Hh signalling pathway by injecting dnPKA mRNA into 
embryos of the Tg(olig2:EGFP) transgenic zebrafish line (Shin et al. 2003). This line 
recapitulates the endogenous pattern of olig2 expression in the progenitors of motor neurons 
and oligodendrocytes in the embryonic spinal cord (Shin et al. 2003). Olig2 is a class II 
(positive target) gene of SHH in the embryonic neural tube, and it has been demonstrated in 
zebrafish and mice that HH signalling is both required for and sufficient to up-regulate Olig2 
expression (Lu et al. 2000; Nery et al. 2002; Park et al. 2002). In control Tg(olig2:EGFP) 
fish embryos, the EGFP signal at 31 hpf appears as a narrow longitudinal stripe in the ventral 
spinal cord (Figure 8.6D), located in close proximity to the sources of Shh (Krauss et al. 
1993). Notably, in the embryos that received dnPKA mRNA, this domain is expanded 
dorsally in the neural tube (Figure 8.6H), which is consistent with Olig2 expression observed 
in the neural tube of Wnt1::Shh transgenic or Ptch1
-/-
; Hhip1
-/-
  knockout mouse embryos 
with ectopic or up-regulated SHH signalling, respectively (Rowitch et al. 1999; Lu et al. 
2000; Jeong and McMahon, 2005). This observation demonstrates the efficiency of the 
dnPKA mRNA preparation to up-regulate the Hh signalling pathway. 
Having confirmed the potency of my dnPKA mRNA preparation, I proceeded with 
co-injecting wild type zebrafish embryos with the a1-NSE::EGFP plasmid and Tol2 mRNA 
in the presence or absence (negative control) of dnPKA mRNA, the results of which are 
presented in Table 8.3 and Figures 8.6 and 8.7. As expected, a large fraction (56%) of the 
embryos which received dnPKA mRNA displayed ectopic expansion of EGFP expression in 
the dorsal half of the neural tube (Figure 8.6E and G), while only a minor fraction (2.2%) of 
the dnPKA mRNA-injected embryos exhibited normal EGFP pattern restricted to the ventral 
half of the neural tube (Table 8.3; Figure 8.7). In contrast, none of the control embryos 
showed ectopic expression of the EGFP reporter in the dorsal half of the neural tube; instead, 
65.8% of these embryos displayed normal pattern of EGFP signal, which was specifically 
restricted to the ventral half of the neural tube (Figure 8.6A and C; Figure 8.7). 
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 repeat 1 repeat 2 
 control dnPKA mRNA control dnPKA mRNA 
Total No. of embryos 208 111 189 151 
No. of embryos with 
normal expression 
125 2 135 4 
No. of embryos with 
ectopic expression 
0 55 0 94 
% embryos with 
normal expression 
60.1 1.80 71.43 2.65 
% embryos with 
ectopic expression 
0 49.55 0 62.25 
 
Table 8.3. Numbers and percentages of control and dnPKA mRNA-injected zebrafish embryos with normal or 
ectopic a1-NSE-driven EGFP expression from two independent replicate experiments. 
 
Figure 8.6. Blocking PKA function causes ectopic activation of a1-NSE. a1-NSE-driven EGFP expression pattern in 
control (A-C) and 400 ng/µL dnPKA mRNA-injected (E-G) wild type embryos at 31 hpf. (A) and (E) show anti-EGFP 
antibody staining of a 
control and a dnPKA 
mRNA-injected embryo, 
respectively. (B) and (F) 
show bright field images of 
a control and dnPKA 
mRNA-injected embryos, 
respectively, while (C) and 
(G) are merged images of 
A+B and E+F, respectively. 
Note the ectopic expansion 
of EGFP expression in the 
dorsal half of the neural 
tube of the dnPKA mRNA-
injected embryo (E; 
indicated by a white bar in 
G) as contrasted to the 
ventrally-restricted normal 
expression of EGFP in the 
control embryo (A; 
indicated by a white bar in 
C). (H) shows the potency 
of dnPKA to up-regulate Hh 
signalling evidenced by the 
expansion of the EGFP+ 
domain (white arrows in H) 
in olig2:EGFP zebrafish 
embryos that received 
dnPKA mRNA as contrasted 
to the narrow stripe of EGFP expression in control embryos (white arrows in D). Abbreviations: de, diencephalon; hb, 
hindbrain; te, telencephalon. 
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Figure 8.7. Blocking PKA function causes ectopic activation of a1-NSE (Quantitative Analysis). Graphical 
representation of the results from two replicate experiments showing the percentages of embryos with normal 
and ectopic pattern of a1-NSE-directed EGFP expression from both control (blue-colored columns) and dnPKA 
mRNA-injected (red-colored columns) wild type embryos at 31 hpf. “Normal expression pattern” of EGFP is 
defined in the text. Importantly, the mean number of dnPKA mRNA-injected fish with ectopic EGFP expression 
is significantly higher than the mean number of controlfish with ectopic EGFP pattern (which equal zero). The 
opposite is true for fish with normal EGFP expression - the mean number of dnPKA mRNA-injected fish with 
normal EGFP expression is significantly lower than the mean number of control fish with normal EGFP pattern. 
The unpaired two-tailed t-test in GraphPad Prism was performed to statistically analyse the data. The black bars 
above the columns represent the standard error of the mean (SEM) for each column. 
 
These findings indicate that dnPKA is sufficient to cause activation of the a1-
NSE::EGFP construct at ectopic sites in the neural tube of zebrafish embryos, and strongly 
suggest that the observed effect is due to constitutive up-regulation of the Hh signalling 
pathway in the dorsal neural tube. 
8.5. Overexpression of shh mRNA causes ectopic activation of a1-NSE 
Although inactivation of PKA function effectively up-regulates the HH signalling pathway 
leading to ectopic activation of HH-responsive genes, the possibility that disruption in other 
signalling pathways contributes to the ectopic pattern cannot be excluded. In fact, multiple 
studies have shown that PKA is involved in some aspects of FGF (Baron et al. 2000), WNT 
(Chen et al. 2005; Gallegos et al. 2012) and BMP signalling (Ghayor et al. 2009; Liu et al. 
2005; Sakai et al. 2006). Therefore, in order to confirm that the ectopic activation of a1-NSE 
observed in the dorsal neural tube of dnPKA mRNA-injected embryos is specifically caused 
by the constitutive up-regulation of Hh signalling, I co-injected the a1-NSE::EGFP plasmid 
together with zebrafish shha mRNA. 
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8.5.1. Introduction 
The zebrafish ortholog of the mouse SHH gene, shha, exhibits a dynamic expression pattern 
with the first transcripts detected in the converging axial mesoderm at 60%-epiboly, and later 
during somitogenesis (from ~10.5 hpf to 22-24 hpf) in the neural tube from the tip of the 
diencephalon rostrally to the floor plate caudally (Krauss et al. 1993). By 36 hpf, shha 
mRNAs are reduced in the ventral spinal cord remaining high in the floor plate at the tail bud 
level, and in the fore- and hindbrain (Krauss et al. 1993). The zebrafish genome encodes 
another shh gene – shhb (previously known as tiggy winkle hedgehog) that displays similar 
expression in the neural tube but becomes down-regulated in the axial mesoderm earlier than 
shha (Ekker et al. 1995). The other two members of the zebrafish Hh family – dhh, ihha and 
ihhb (synonym of echidna hedgehog) are predominantly expressed by mesoderm-derived 
skeletal tissues (Currie et al. 1996; Avaron et al. 2006). 
Zebrafish embryos with shha deficiency (the syu (sonic you) group of mutants) 
feature various defects in somite and neural tube patterning (Schauerte et al. 1998; van Eeden 
et al. 1996): they lack eng
+
 muscle pioneers, which leads to the absence of horizontal 
myoseptum; myoD expression in the adaxial cells is strongly reduced; the fkd4
+
 lateral floor 
plate cells are absent, but medial floor plate development is unaffected (as indicated by 
unperturbed  expression of F-spondin2 and col2a1); primary and secondary motor neurons 
are present in sya mutants but the extension, branching and patterning of their axons is 
abnormal (Schauerte et al. 1998). It is interesting that the abnormalities in neural tube 
patterning in shha mutant zebrafish are milder than those of Shh-null mouse embryos, which 
have complete absence of Foxa2
+
 floor plate cells and motor neurons (Chiang et al. 1996). 
This might be due to partial compensation by shhb and ihhb in the zebrafish (Schauerte et al. 
1998).  
Conversely, constitutive expression of shha mRNA in wild type zebrafish embryos 
leads to alterations in neural tube patterning, such as: ectopic dorsal expansion of foxa2 
expression in the diencephalon, midbrain, hindbrain and anterior spinal cord; dorsal 
expansion of other Class II genes whose expression in the neural tube is positively-regulated 
by Hh signaling, like olig2, nkx2.6 and nkx2.9; severe dorsal depletion in the expression of 
Class I target genes, like pax3, pax7, pax6a, dbx1a and dbx2a, which are normally repressed 
by Hh only ventrally; failure of brain ventricles formation; absence of the lens and reduced 
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ocular pigmentation (Guner et al. 2007; Krauss et al. 1993; Ekker et al. 1995). Somitic 
development is also affected in shha- and ihha-overexpressing fish embryos: myoD mRNA, 
which is normally restricted to the adaxial cells, expands laterally through the whole width of 
the paraxial mesoderm, the number of eng
+
 pioneer cells is strongly increased, while the 
horizontal myosepta exhibit irregular morphology (Hammerschmidt et al. 1996). 
These studies demonstrate that the administration of excessive amounts of shha 
mRNA in early zebrafish embryos results in the constitutive up-regulation of Hh signaling in 
responsive tissues. Therefore, I decided to use shha mRNA to up-regulate Hh signaling and 
to assess whether this approach affects a1-NSE activity in a similar manner as dnPKA does. 
8.4.2. Results 
The a1-NSE::EGFP plasmid was co-injected with Tol2 mRNA and 400 ng/µL shha mRNA 
into 1-cell stage wild type zebrafish embryos, and injected embryos were analysed at the 31 
hpf stage. Interestingly, and consistent with the result from the dnPKA mRNA-injections, 
nearly 57% of the fish embryos that received shha mRNA exhibited an expansion of EGFP 
signal in the dorsal half of the neural tube, while 3% displayed a normal pattern of EGFP 
(Table 8.4; Figure 8.8E, F; Figure 8.9). In contrast, none of the control embryos showed 
ectopic expression of EGFP in the dorsal neural tube; instead, 61% of those embryos had 
normal pattern of EGFP signal restricted to the ventral half of the neural tube (Table 8.4; 
Figure 8.8A, B: Figure 8.9). These results support my previous conclusion and indicate that 
constitutively active Hh signalling is sufficient to activate the a1-NSE::EGFP construct at 
ectopic locations in the neural tube. 
 repeat 1 repeat 2 
 control shh mRNA control shh mRNA 
Total No. of embryos 200 172 157 192 
No. of embryos with 
normal expression 
124 7 94 4 
No. of embryos with 
ectopic expression 
0 98 0 109 
% embryos with 
normal expression 
62 4.07 59.87 2.08 
% embryos with 
ectopic expression 
0 56.98 0 56.77 
 
Table 8.4. Numbers and percentages of control and shha mRNA-injected zebrafish embryos with normal or 
ectopic  a1-NSE-driven EGFP expression from two independent replicate experiments. 
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Figure 8.8. Over-expression of shha causes ectopic activation of a1-NSE. a1-NSE-driven EGFP expression 
pattern in wid type control embryos (A-D), and in wild type embryos injected with 400 ng/µL shha mRNA (E-
H), at 31 hpf. (A) and (E) show anti-EGFP antibody staining of a control and a shha mRNA-injected embryo, 
respectively. (B) and (F) show merged DAPI and anti-EGFP staining of a control and a shha mRNA-injected 
embryo, respectively. (C) and (G) indicate anti-Pax3/Pax7staining in control and shha mRNA injected embryos, 
respectively, while (D) and (H) are the corresponding merged images of DAPI and anti-Pax3/Pax7 staining. 
Note the ectopic expansion of EGFP expression in the dorsal half of the neural tube of the shha mRNA-injected 
embryo (indicated by a white bar in E) as contrasted to the ventrally-restricted normal expression of EGFP in 
the control embryo (indicated by a white bar in A). (G) and (H) show the potency of excess shha to up-regulate 
Hh signalling evidenced by the down-regulation of Pax3/Pax7 expression in the optic tectum and eye (green 
asterisks) as contrasted to normal expression of Pax3/Pax7 in control embryos (C and D). White arrowheads in 
(C) and (G) indicate Pax3/Pax7 expressing neural crest- and/or placode-derived glial and neuronal precursors of 
the cranial ganglia (Minchin and Hughes 2008; Schlosser and Ahrens 2004). Abbreviations: de, diencephalon; 
hb, hindbrain; tc, optic tectum; te, telencephalon. 
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Figure 8.9. Over-expression of shha causes ectopic activation of a1-NSE (Quantitative Analysis). Graphical 
representation of the results from two replicate experiments showing the percentage of embryos with normal 
and ectopic pattern of a1-NSE-directed EGFP expression from both control (blue-colored columns) and shha 
mRNA-injected (red-colored columns) wild type embryos at 31 hpf. “Normal expression pattern” of EGFP is 
defined in the text. Importantly, the mean number of shha mRNA-injected fish with ectopic EGFP expression is 
significantly higher than the mean number of control fish with ectopic EGFP pattern (which equal zero). The 
opposite is true for fish with normal EGFP expression - the mean number of shha mRNA-injected fish with 
normal EGFP expression is significantly lower than the mean number of control fish with normal EGFP pattern. 
The unpaired two-tailed t-test in GraphPad Prism was performed to statistically analyse the data. The black bars 
above the columns represent the standard error of the mean (SEM) for each column. 
Changes in the expression of Pax3/Pax7 in shha mRNA-injected fish were used to 
monitor the effect of shha mRNA. Indeed, pax3 and pax7 are Class I Hh responsive genes, 
which are restricted to the dorsal half of the neural tube by repressive Shh signals, and 
participate in the specification of dorsal interneuron progenitors (Bergeron et al. 2008; Guner 
et al. 2007; Liem et al. 1995; Luo et al. 2006; Ericson et al. 1997). Notably, zebrafish 
embryos that received shha mRNA displayed strong reduction in Pax3Ppax7 expression in 
the optic tectum, eyes and hindbrain (Figure 8.8G and H), such that expression was limited to 
the dorsal-most compartments of the neural tube. This result is consistent with previous 
studies and clearly demonstrates the efficiency of my shha RNA preparation to up-regulate 
the Hh signalling pathway.  
8.6. The activity of a1-NSE requires intact GLI binding motifs 
As described in Chapter 1, GLI transcription factors mediate the response to Hh signals in all 
vertebrates (Hui and Angers 2011). GLI proteins bind DNA at the consensus motif sequence 
5’-TGGGTGGTC-3’ and operate as bi-functional transcription factors – either as GLIR 
(repressor) or GLIA (activator), depending on the absence or presence of HH signals, 
respectively (Kinzler and Vogelstein 1990; Sasaki et al. 1999).  
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The zebrafish genome encodes four gli genes: gli1, gli2a, gli2b and gli3. A major site 
of Gli function is the developing CNS, where all four gli paralogs show complex expression 
patterns. At early stages, gli2a and gli3 mRNA transcription initiates throughout the 
neuroectoderm but by 15 hpf they are restricted to the dorsal neural tube, whereas gli1 
displays a complementary expression pattern with high mRNA levels in the ventral neural 
tube and absence of expression in the floor plate and dorsal neural tube (Karlstrom et al. 
1999; Karlstrom et al. 2003; Tyurina et al. 2005; Vanderlaan et al. 2005). Mutations and 
morpholino-mediated knockdowns of zebrafish gli result in multiple abnormalities of CNS 
development, as detailed in Chapter 1. 
Taking together the facts that all four zebrafish gli genes are transcribed in the neural 
tube and that deficiency in their expression leads to aberrations in the transcription of Hh-
responsive genes and neuronal development, I decided to test whether the CNS-specific 
activity of a1-NSE depends on the five GLI binding motifs within its sequence. If the GLI 
binding motifs are essential for a1-NSE function, then their inactivation should impair a1-
NSE-mediated EGFP expression. 
8.6.1. Results 
I used the SequenceShaper in silico tool from the Genomatix Software Suite (Cartharius et al. 
2005) to design base pair substitutions in each of the five GLI binding motifs within a1-NSE. 
The parametres of SequenceShaper were adjusted to avoid the elimination or creation of 
binding motifs for other transcription factors. The GLI motifs received from 2 to 3 point 
mutations each such that the core and matrix similarity scores of every GLI motif were 
severely reduced, which is a predictor of decreased affinity of the sequence to its binding 
protein (as indicated in Table 8.5). The mutated a1-NSE, with all five GLI binding motifs 
harbouring substitutions is referred to as mut a1-NSE in this study, while the un-modified a1-
NSE is called wt a1-NSE. The so designed mut a1-NSE was obtained by customised gene 
synthesis from Genscript, and cloned into the EGFP-reporter vector. 
In order to test whether the activity of a1-NSE depends on the GLI binding motifs, I 
co-injected the mut a1-NSE::EGFP plasmid with Tol2 mRNA and 400 ng/µL H2B-mCherry 
mRNA into 1-cell stage wild type zebrafish embryos, and analysed the embryos at the 31 hpf 
stage. Concomitantly, a second group of wild type embryos received the unmodified wt-a1-
NSE::EGFP construct and these served as control. 
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Table 8.5. Sequence features of the five GLI binding motifs within a1-NSE, indicating the changes caused by the 
introduced mutations in mut a1-NSE. Here are displayed the sequences of the five GLI binding motifs 
according to MatInspector, together with the consensus GLI motif (Kinzler and Vogelstein 1990). For 
comparative purposes, the regions of the predicted motifs that overlap the consensus motif are shaded in light 
blue; yellow shading indicates the positions in the predicted motifs that differ from the consensus sequence. 
Motif names with asterisks label the mutated motifs. Positions in red indicate the base substitutions in the 
mutated motifs, as designed by SequenceShaper. A green bar underlines the core of each predicted motif 
(according to MatInspector). Since a particular transcription factor usually binds to a range of related sequences, 
a weight matrix is generated for each set of related sequences and represents “the complete nucleotide 
distribution for each single position” in the set (Cartharius et al., 2005). The “core” of a motif, in the context of 
SequenceShaper and MatInspector (Cartharius et al., 2005), is a sequence of 4 consecutive base-pairs that is 
conserved in at least 90% of all sequences used to define a weight matrix. The highest core and matrix 
similarity score that a predicted motif can obtain is a 1, and for the five wild type GLI motifs in a1-NSE these 
scores range from 1 to 0.884, which is sufficiently high. In contrast, each of the mutated GLI motifs features 
core and matrix similarity scores in the range of 0.012 to 0.258, which indicates that the mutated sequences are 
highly dissimilar from the core and weight matrix of GLI factors and this predicts decreased affinity (or lack of 
thereof) of the mutated Gli motifs for their cognate GLI proteins. Note that when bound to DNA, GLI factors 
protect a region of 23-24 base pairs, as shown by DNase footprinting (Kinzler and Vogelstein 1990). However, 
most of the GLI protein-DNA contatcts are established within the 9-mer regions (shaded in light blue), with 
some additional contacts as far as 5 base pairs upstream of the 9-mer sequence (Pavletich and Pabo 1993), 
which is perhaps the reason why MatInspector and SequenceShaper operate with extended GLI motif sequences 
(15 bp), instead of the 9-bp region only. 
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Remarkably, none of the embryos that received the mut-a1-NSE presented a normal 
EGFP expression pattern. Instead, 1% embryos showed only mosaic (patchy) and reduced 
EGFP expression (Table 8.6 and Figures 8.10C and 8.11). In contrast, most control embryos 
exhibited normal pattern of EGFP expression in the ventral half of the neural tube, with only 
3% showing reduced/patchy EGFP expression (Table 8.6 and Figures 8.10A and 8.11). The 
presence of H2B-mCherry in all/most cell nuclei of both mut-a1-NSE- and control-injected 
embryos indicates that the absence of EGFP expression in mut-a1-NSE-injected fish is not 
due to injection inefficiency (Figure 8.10B and D). 
These results demonstrate that the activity of a1-NSE requires intact GLI binding 
motifs. 
 repeat 1 repeat 2 
 wt-a1-NSE (control) mut-a1-NSE wt-a1-NSE (control) mut-a1-NSE 
Total No. of embryos 273 160 199 264 
No. of embryos with 
normal expression 
126 0 119 0 
No. of embryos with 
reduced expression 
4 1 9 4 
% embryos with 
normal expression 
46.15 0 59.80 0 
% embryos with 
reduced expression 
1.47 0.63 4.52 1.52 
% embryos with no 
expression 
52.38 99.37 35.68 98.48 
 
Table 8.6. Numbers and percentages of control and mut a1-NSE::EGFP-injected zebrafish embryos with 
normal, reduced and absent a1-NSE-driven EGFP expression from two independent replicate experiments. 
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Figure 8.10. Intact GLI-binding motifs are essential for a1-NSE’s activity. Immunofluorescent images of wild 
type embryos injected with 30 ng/µL wt a1-NSE::EGFP plasmid (A, B), and wild type embryos injected with 
30 ng/µL mut a1-NSE::EGFP plasmid (C, D), at 31 hpf. In both cases, the reporter plasmids were co-injected 
with 400 ng/µl H2B-mCherry mRNA. Note the inability of mut a1-NSE to activate EGFP expression in the 
neural tube (white arrows in C), in contrast to the situation in control embryos (A). Importantly, this difference 
is not caused by injection inefficiency as both groups express H2B-mCherry (B and C). Abbreviations: de, 
diencephalon; e, eye; hb, hindbrain; te, telencephalon. 
 
Figure 8.11. Intact GLI-binding motifs are essential for a1-NSE’s activity (Quantitative Analysis). Graphical 
representation of the results from two replicate experiments showing the percentage of embryos injected with 
wt a1-NSE::EGFP plasmid (control) and of those embryos injected with mut a1-NSE. “Normal expression 
pattern” of EGFP is defined in the text. Note that the percentage of embryos with complete absence of EGFP 
signal in the neural tube in both the “wt a1-NSE” and “mut a1-NSE” groups is not indicated on the graph. 
Importantly, the mean number of control zebrafish with normal EGFP expression is significantly higher than the 
mean number of “mut a1-NSE” zebrafish with normal EGFP pattern (which equal zero), as shown statistically 
by unpaired two-tailed t-test in GraphPad Prism. The black bars above the columns represent the standard error 
of the mean (SEM) for each column. 
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8.7. Intact GLI binding motifs are required for ectopic activation of a1-NSE by dnPKA 
There is evidence that in some systems HH signalling is not mediated by the GLI 
transcription factors. This phenomenon is commonly known as “non-canonical” Hh 
signalling of which two types have been recognised: type I is mediated by patched but does 
not involve smoothened, whereas type II non-canonical HH signaling operates through 
smoothened but independently of GLI (Brennan et al. 2012). For instance, Ptch1 exhibits 
smoothened-independent pro-apoptotic effects in 293T cells and anti-mitotic effects in 
urinary and epidermal epithelia in the absence of HH ligands (Adolphe et al. 2006; 
Chinchilla et al. 2010; Jenkins et al. 2007). An example of type II non-canonical HH 
signalling is the promotion of vascular tubulogenesis by HH ligands in human umbilical vein 
and microvascular endothelial cells, which appears to be independent from GLI-induced 
transcription, but relies on smoothened and RAC1-mediated regulation on RHOA activity 
(Chinchilla et al. 2010). Conversely, some GLI-dependent cellular responses may be 
independent of HH signalling. Dennler et al. (2007) showed that transcription of GLI1 (a 
positive target gene of HH signalling) in cyclopamine-treated human dermal fibroblasts is 
uncoupled from SHH-smoothened but is triggered by SMAD3-dependent activation of GLI2, 
instead. Similarly, it was demonstrated that the cytokine osteopontin (OPN) regulates the 
activation and subcellular distribution of GLI1 via Akt-GSK3β signalling in human 
neoplastic cells and this process is insensitive to cyclopamine inhibition of SMO (Das et al. 
2013). 
Therefore, I tested whether the ectopic effects of dnPKA on a1-NSE activity require 
intact GLI motifs. I predicted that if there was such requirement, then dnPKA mRNA would 
fail to trigger EGFP expression from the mut-a1-NSE. 
8.7.1. Results 
In order to test the dependence of dnPKA-induced ectopic activation of a1-NSE on intact 
GLI binding motifs, I performed three different parallel injections at the 1-cell stage of wild 
type zebrafish embryos. One group of embryos received the wt-a1-NSE::EGFP construct 
alone; a second group received the wt-a1-NSE::EGFP construct together with 400 ng/µL 
dnPKA mRNA; and a third group of embryos were injected with the mut-a1-NSE::EGFP 
construct together with 400 ng/µL dnPKA mRNA. All embryos received 20 ng/µL Tol2 
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mRNA, as well. Then, the embryos were analysed at the 31 hpf stage (Table 8.7; Figures 
8.12 and 8.13). 
Interestingly, dnPKA was unable to ectopically activate EGFP driven by the mut a1-
NSE, either in the dorsal or ventral halves of the neural tube, in contrast to the embryos that 
received wt a1-NSE plus dnPKA mRNA, which displayed ectopic EGFP expression in the 
dorsal neural tube (compare Figure 8.12C and E). It is unlikely that the failure of EGFP 
expression was caused by issues during microinjection for expression of Pax7 appeared 
reduced in the optic tectum and dorsal hindbrain in the embryos that received mut a1-
NSE::EGFP with dnPKA mRNA (Figure 8.12B, D and F), suggesting that the dominant 
negative form of PKA was able to up-regulate the Hh signalling pathway. These observations 
suggest that the effects of Hh signalling on a1-NSE function are directly mediated by the GLI 
binding motifs, as mutations in these sites render a1-NSE refractory to even constitutively-
active Hh signalling. 
 
 wt-a1-NSE wt-a1-NSE + dnPKA mRNA mut-a1-NSE + dnPKA mRNA 
Total No. of embryos 194 137 175 
No. of embryos with 
normal expression 
141 2 0 
No. of embryos with 
patchy expression 
3 0 2 
No. of embryos with 
ectopic expression 
0 68 0 
% embryos with normal 
expression 
72.68 1.46 0 
% embryos with reduced 
expression 
1.55 0 1.14 
% embryos with ectopic 
expression 
0 49.64 0 
 
Table 8.7. Numbers and percentages of zebrafish embryos injected with wt a1-NSE::EGFP alone or with 
dnPKA mRNA, and of mut a1-NSE::EGFP + dnPKA mRNA, showing the effects on EGFP reporter expression 
as derived from a single experiment. 
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Figure 8.12. Intact GLI binding motifs are required for activation of EGFP expression by dnPKA. 
Immunofluorescent images of: (A, B) a “control 1” embryo injected with 30n g/µL wt a1-NSE; (C, D) a 
“control 2” embryo co-injected with 30 ng/µL wt a1-NSE::EGFP plasmid and 400 ng/µL dnPKA mRNA; (E, F) 
an embryo co-injected with 30 ng/µL mut a1-NSE::EGFP plasmid and 400 ng/µL dnPKA mRNA; all embryos 
are at stage 31 hpf. (E) Up-regulated Hh signalling by dnPKA is insufficient to activate EGFP expression in the 
absence of intact GLI-binding sites, in contrast to “control 2” embryos (C), suggesting that the effects of Hh 
signalling on a1-NSE’s activity are mediated by the GLI-binding sites. (B, D, F) anti-Pax7 antibody staining 
showing the efficiency of injection for dnPKA mRNA-injected embryos (D and F) exhibit reduced Pax7 
expression in the dorsal brain, in contrast to “control 1” embryos (B) which show normal expression. 
Abbreviations: de, diencephalon; hb, hindbrain; tc, tectum. 
 
Figure 8.13. Intact  GLI binding motifs are required for activation of EGFP expression by dnPKA (Quantitative 
Data). Graphical representation of the results from a single experiment showing the percentage of embryos 
injected with wt a1-NSE::EGFP plasmid, with wt a1-NSE::EGFP plasmid + dnPKA mRNA, and with mut a1-
NSE::EGFP plasmid + dnPKA mRNA. “Normal”, “reduced” and “ectopic” patterns of EGFP expression are 
defined in the text. Note that the percentage of embryos with complete absence of EGFP signal in the neural 
tube in all three groups is not indicated on the graph. Importantly, embryos injected with dnPKA mRNA are 
unable to generate either ectopic or normal pattern of EGFP expression driven from mut a1-NSE. 
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8.8. Discussion 
Here, I demonstrated that the function of a1-NSE requires active Hh-signalling pathway. In 
smo zebrafish mutants and cyclopamine-treated wild type fish a1-NSE fails to drive EGFP 
expression. Moreover, constitutive activation of the pathway either by interfering with PKA 
function or via shha over-expression is sufficient to ectopically direct a1-NSE::EGFP 
expression in the dorsal neural tube. Finally, a1-NSE’ response to Shh signalling maps to the 
GLI binding motifs that are essential for reporter gene expression. 
8.8.1. Active Hh signalling is required for a1-NSE’s activity 
Cyclopamine treatment led to complete abrogation of the normal pattern of a1-NSE-driven 
EGFP expression in the ventral neural tube (Figure 8.2), analogously to the down-regulation 
of the Hh target genes olig2 and nkx6.1 in cyclopamine-treated wild-type zebrafish (Guner et 
al. 2007; Park et al. 2002). However, few cyclopamine-treated a1-NSE::EGFP-injected 
embryos retained patches of reduced EGFP signal in the brain which could be due to 
incomplete tissue penetration of cyclopamine and/or fortuitous activation of the β-globin 
promoter in the a1-NSE::EGFP construct by Hh-independent enhancers at the site of 
chromosomal integration (Wilson et al. 1990). 
Likewise, a1-NSE was inactive in smo
-/-
 embryos (Figure 8.4D). This is reminiscent 
of the defects in the expression of class II Hh targets like gli1, ptch1, and nkx2.2, reported 
previously (Karlstrom et al. 2003; Varga et al. 2001). However, 3 out of 75 smo-null fish had 
small clusters of EGFP-expressing cells in the brain. It is possible that in these cases residual 
smoothened activity from maternally deposited smo mRNA was sufficient to activate a1-
NSE in few cells of the mutant embryos, and Chen et al. (2001) show that there is abundant 
supply of maternal smo mRNA. Maternally deposited smoothened is sufficient to transduce 
Hh signals at early stages (but not at the 18-somites stage), as demonstrated by the ability of 
smo mutants to increase the expression of nkx2.2 in the neuroectoderm upon injection of 
shha mRNA (Varga et al., 2001).  
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8.8.2. Intact GLI-binding motifs are required for a1-NSE’s activity 
The GLI-binding motifs appear to be essential for a1-NSE’s activity as none of the mut-a1-
NSE::EGFP-injected zebrafish embryos succeeded in generating a normal pattern of EGFP 
expression (Figure 8.10C; Figure 8.11), probably because Gli proteins failed to bind to the 
mutated GLI motifs. However, 1% of the mut-a1-NSE::EGFP-injected embryos (n=5) 
exhibited few patches of EGFP signal in the neural tube (“reduced expression” in Figure 
8.11), which is most likely the result of chromosome integration-site effects, as discussed 
above. Although the a1-NSE element has been shown to be occupied by GLI factors in vivo 
(Vokes et al. 2008), it remains to be demonstrated that GLI proteins directly bind to the GLI 
motifs, and that GLI factors are essential for a1-NSE’s activity. Direct binding could be 
tested by DNase I footprinting where radioactively labelled wild type or mutant a1-NSE is 
incubated with purified GLI proteins, or by EMSA where short radioactively labelled 
oligonucleotide sequences carrying either the wild type or mutant GLI motifs are incubated 
with purified GLI proteins. If GLI proteins directly bind to the GLI motifs in a1-NSE, it 
could be expected that these motifs will be protected from the action of the DNase, or will 
form detectable gel-shifted complexes in EMSA. A comparison between the latter EMSA 
experiment with purified GLI proteins and an EMSA with nuclear extracts from embryos or 
GLI-expressing cell lines, will inform about whether the GLI factors are the only proteins 
able to cccupy the GLI motifs in a1-NSE, or there are other proteins capable of binding these 
motifs. In addition, a requirement for the GLI proteins could be tested via the analysis of a1-
NSE-driven reporter expression in Gli-deficient embryos or cell lines (Gli mutants, or RNAi-
mediated knockdowns).  
 Alternatively, it could be that binding of factors other than GLI is affected in mut a1-
NSE. The GLI binding motifs identified by MatInspector overlap with motifs of other 
transcription factors, some of which are expressed in the developing CNS, such as PAX3 and 
HMX2 (Table 8.8). Thus, the absence of reporter activity from the mut a1-NSE-driven 
construct might be caused by the abrogation of DNA binding of some of the factors listed in 
Table 8.8. This possibility can be addressed by 1) testing whether any of these factors is 
required for a1-NSE’s activity via an analysis of a1-NSE-driven reporter expression in 
embryos deficient for the factor (either mutants, morpholino- or siRNA-treated embryos), 
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and 2) by testing whether any of the factors binds to a1-NSE in transgenic embryos via 
performing a ChIP analysis. 
GLI motif Overlapping motifs 
1 
NR5A2 (nuclear receptor subfamily 5, group A, member 2) 
AR (androgen receptor) 
NR3C1 (nuclear receptor subfamily 3, group C, member 1; glucocorticoid receptor) 
PAX3 (paired box 3) 
2 
KLF1 (Kruppel-like factor 1 (erythroid)) 
SALL2 (sal-like 2 (Drosophila)) 
ZBTB7A (zinc finger and BTB domain containing 7a) 
E2F (E2F transcription factor) 
3 
HMGA1 (high mobility group AT-hook 1) 
ZFP263 (zinc finger protein 263) 
4 
MECOM (MDS1 and EVI1 complex locus) 
HIC1 (hypermethylated in cancer 1) 
SALL2 (sal-like 2 (Drosophila)) 
GATA1 (GATA binding protein 1) 
5 
ZBTB7A (zinc finger and BTB domain containing 7a) 
HMX2 (H6 homeobox 2) 
MESP1 (mesoderm posterior 1) 
PAX3 (paired box3) 
Table 8.8. Transcription factor binding motifs that overlap with the GLI motifs in a1-NSE. Each GLI motif 
within a1-NSE partially overlaps with predicted motifs of other transcription factors. 
 
In conclusion, based on the current data one cannot rule out the possibility that the 
introduced substitutions into one or more of the five GLI motifs did actually create new 
binding sites for some transcriptional repressors, such that it was recruitment of these 
repressors that led to the failure of mut-a1-NSE activity, and not the abrogation of GLI factor 
binding per se, although SequenceShaper deliberately avoided the creation of other motifs. 
This scenario can be examined by generating a variant mut-a1-NSE with complete deletions 
of the GLI motifs to test whether absence of the sites also perturbs a1-NSE’s function. 
8.8.3. a1-NSE activity depends on the canonical Shh signalling pathway 
The findings in this chapter suggest that it is the canonical SHH-signalling (the signalling 
cascade involving smoothened and GLI functions) that is responsible for a1-NSE’s activity, 
instead of the non-canonical pathways described in Section 8.6 (Brennan et al. 2012; Jenkins 
2009). Such non-canonical Hh signalling is hypothesised in the GLI-independent modulation 
of cell motility in C3H10T1/2 fibroblasts treated with SHH, where the latter acts as a 
chemoattractant and induces reorganisation of the actin cytoskeleton followed by 
lamellipodia formation within 10 minutes of SHH administration, a response more than 36-
fold faster than GLI-mediated responses (Bijlsma et al. 2007). In another study, Bourikas et 
al. (2005) showed that SHH expressed in the chicken embryo floor plate acts as a 
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chemorepellent for commissural axons (CAs) in a smoothened-independent manner as 
cyclopamine has no effect on CA migration and these axons do not express either Patched or 
Smoothened (Bourikas et al. 2005). However, such non-canonical mechanisms are less likely 
to account for a1-NSE’s function as I showed the requirement for smoothened (Figure 8.4), 
and for the presence of intact GLI-binding motifs (Figure 8.10) for a1-NSE’s activity. 
However, the current data do not exclude the possibility of parallel involvement of 
inputs from other signalling systems, such as the BMP, Wnt and retinoic acid pathways. For 
instance, the precise dorso-ventral boundaries of Nkx2.2 expression in the murine spinal cord 
depend on the combinatorial binding of GLI activator and TCF4 repressor inputs to an 
enhancer located 2 kb upstream of the promoter (Lei et al. 2006; Ulloa and Marti 2010). 
Interestingly, a1-NSE harbours LEF1/TCF motifs suggesting that WNT signalling may be 
involved in a1-NSE’s function by inhibiting its activity in the dorsal neural tube. Moreover, 
the effect of WNT signals may be indirect via regulation of Gli gene expression, as 
previously shown for Gli3 in the neural tube (Alvarez-Medina et al. 2008; Yu et al. 2008), 
and for Gli2 and Gli3 in the somites (Borycki et al. 2000). The role of WNT and/or BMP 
signalling pathways in a1-NSE’ function can be tested in a1-NSE::EGFP transgenic 
zebrafish embryos treated with morpholinos against components of these pathways, or in 
zebrafish mutants. 
8.8.4. Shh signalling may directly regulate a1-NSE’s activity, via the GLI factors  
Up-regulation of Hh signalling by both dnPKA and shha overexpression resulted in ectopic 
expansion of a1-NSE-driven EGFP expression in the dorsal half of the neural tube (Figure 
8.6E, G and 8.8E). This is highly reminiscent to the effects on ptch1, gli1 and foxa mRNA 
expression, which in untreated embryos is confined to the ventral half of the neural tube, but 
their expression expands dorsally upon injection of shha or dnPKA mRNA (Karlstrom et al. 
2003; Krauss et al. 1993). It is suggested that Ptch1, Gli1 and Foxa2 are direct targets of HH 
signalling for all three of them harbour essential GLI binding motifs within their promoters 
(Vokes et al. 2007), as does a1-NSE as well (Figure 7.1). This, combined with the inability of 
mut a1-NSE to drive ectopic reporter expression in conditions of up-regulated Hh signalling 
(Figure 8.12), suggests that the activity of a1-NSE may be directly dependent on Shh 
signalling mediated by the GLI transcription factors.  
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Chapter 9 
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9.1. A summary of results 
In this study, I reported the tissue-specific expression pattern of the murine Lama1 gene in 
the neural tube, somites, presomitic mesoderm, head mesenchyme and nephric structures, 
and also confirmed the essential role of SHH in the control of Lama1 transcription in the 
somites and neural tube. Furthermore, I revealed that SHH is differentially required for the 
maintenance of Lama1 expression in the neural tube and the activation of Lama1 in the 
somites. Finally, expression of Lamb1 and Lamc1 does not depend on SHH. Interestingly, I 
showed that the expression pattern of chicken Lama1 (cLama1) is highly similar to the 
pattern of its mouse ortholog, except for the striking absence of cLama1 mRNA in the 
presomitic mesoderm. Thus, Lama1 displays conserved expression pattern in evolution 
hinting for the conservation of signalling and transcriptional regulatory mechanisms 
controlling its activity. 
Using bioinformatics, I identified 25 conserved non-coding elements (CNE1-24, and 
CNEb) distributed within a 361 kb region located upstream of the murine Lama1 locus 
(except for CNEb located in the 3
rd
 intron of the murine Lama1 gene), six of which contained 
putative GLI/ZIC binding sites, raising the possibility that some of them may mediate the 
effects of SHH on Lama1 expression. Luciferase reporter assays in cultured fibroblasts 
suggested that one of the GLI-motif-containing elements – CNE7, may possess silencing 
activity, whereas the remaining of the tested CNEs failed to significantly change reporter’s 
activity. Similarly, when tested in vivo in transient transgenic zebrafish embryos the CNEs 
failed to display enhancer activity, except for CNE3, which directed reporter gene expression 
in skeletal muscles. 
Data mining for genome-wide occupancy of GLI transcription factors led to the 
identification of a GLI3-bound non-conserved 1 kb region, a1-NSE, located in the first intron 
of the murine Lama1 gene (Vokes et al. 2008). Remarkably, when tested in transgenic mouse 
and zebrafish embryos, a1-NSE directs tissue-specific reporter expression in the neural tube 
in a pattern highly reminiscent to the expression of the endogenous Lama1 mRNA. 
Functional analyses of a1-NSE in transient transgenic zebrafish embryos revealed that Shh 
signalling is both required and sufficient for a1-NSE’s transcriptional activity. Moreover, 
mutations in the GLI binding motifs within a1-NSE demonstrated that they are essential for 
a1-NSE’s activity and its response to Hh signalling. Taken together, these results suggest that 
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a1-NSE might be a SHH-dependent enhancer responsible for Lama1 gene expression in the 
neural tube of mouse embryos. 
9.2. Sequence conservation versus functional conservation of Lama1 enhancers 
Although the 25 CNEs identified initially by bioinformatics, and a1-NSE identified by data 
mining, are conserved within mammals, none share sequence similarities with the zebrafish 
genome, except for CNEa and CNEb, whose putative activities have not been examined yet. 
Nevertheless, both CNE3 and a1-NSE behave as tissue-specific enhancers in vivo, generating 
consistent reporter expression patterns, at least for a1-NSE, in both mouse and zebrafish 
transgenics. Therefore, I hypothesise that these two elements are examples of the so called 
type of “billboard” enhancer (Arnosti and Kulkarni 2005). 
 Depending on the mode of input computation within enhancers, two models of 
enhancer structure have been proposed – the “enhanceosome” and “billboard” models 
(Arnosti and Kulkarni 2005), which are the two contrasting extremes of a continuum, where 
most enhancers in nature fall in between those two models (Meireles-Filho and Stark 2009). 
Enhanceosome-like enhancers (EEs) consist of spacing-, orientation-, and arrangement-
sensitive transcription factor binding sites (TFBSs) (Merika and Thanos 2001; Valentine et 
al. 1998). Most TFBSs within EEs are essential for their cognate transcription factors bind 
cooperatively and produce a supra-molecular structure with specific geometry, which is 
required for transcriptional activation (Thanos and Maniatis 1995). Because of this 
cooperative combinatorial requirement, EEs regulate their target genes in an ON/OFF mode 
(or bimodal)(Sutherland et al. 1997). Also, because of the constraints on TFBSs organization, 
enhanceosome-like enhancers are expected to be highly sequence-conserved across species 
(Carroll et al. 2004). The best known example of such elements is the virus-induced enhancer 
of the human interferon-beta gene (IFN-β) which receives cooperative inputs from NF-
kappaB, IRF-3/IRF-7 and ATF-2/c-JUN (Panne et al. 2007) 
 In contrast, “billboard” enhancers (BBE) consist of independently- (or quasi-
independently) acting TFBSs or short clusters of TFBSs, each of which is able to bind its 
transcription factor and interact with the basal transcription machinery independently from 
the others (Arnosti and Kulkarni 2005). The key is that the contribution of individual TFBSs 
within a “billboard” enhancer is summed up to give a total output (Gao and Finkelstein et al. 
1998). Thus, the transcription rate of a target gene driven by such enhancers exhibits 
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continuous (or rheostatic) profile depending on the transcription factor occupancy in the 
enhancer - there are not just two simple on/off responses (Biggar and Crabtree 2001; Rossi et 
al. 2000). Importantly, “billboard” enhancers can tolerate considerable turnover in sequence 
(like changes in spacing, orientation, order and even composition of TFBSs), without 
affecting their function. What matters at the end is that the sum of all transcription factor 
inputs should be unchanged (in terms of final output) (Arnosti and Kulkarni 2005). Thus, 
new TFBSs for functionally equivalent transcription factors may evolve without modifying 
the output (Ludwig et al. 1998). Therefore, because of their inherent plasticity, “billboard” 
enhancers are expected to evolve faster and display considerable sequence variation between 
species (Arnosti et al. 1996; Ludwig et al. 1998), sometimes even hindering their 
identification by sequence comparison, and several examples of such enhancers were 
described in Section 1.10.2.1 (Chapter 1). 
 Based on this, a1-NSE appears to exhibit characteristics of a “billboard” enhancer – 
its sequence is highly divergent, even within mammals, and yet it generates similar 
expression outputs in mouse and in a heterologous species – the zebrafish (Figure 7.14). The 
characteristic operational organization of “billboard” enhancers, and possibly of a1-NSE as 
well, allows them to quantitatively modulate the transcription rate of their target genes, and 
hence the amount of synthesized protein. This may be important in the case of laminin α1 
expression, where the amount of laminin α1 production in the neural tube may have 
implications for the rate of basement membrane assembly (Anderson et al. 2009), 
sequestration of signaling molecules and cell migration (Condic and Letourneau 1997; 
Huttenlocher et al. 1995). 
 Remarkably, although I could not identify a “zebrafish a1-NSE” element, earlier 
research from our laboratory demonstrated that the 9.8 kb intron 1 of the zebrafish lama1 
locus contains almost all of the cis-regulatory information required for proper tissue-specific 
expression of lama1, including the enhancer(s) for expression in the neural tube (Joseph 
Pickering’s Thesis 2012). However, this neural tube element lies in the second half of the 
intron – from position +4416 to +9779, unlike a1-NSE, which is located within the first 1.5 
kilobases of the 19.3 kb intron 1 of the murine Lama1 locus. Nevertheless, zebrafish intron 1 
of lama1 contains three putative binding sites for Gli factors and two conserved regions 
(conserved with the Fugu genome but not with mammals) (Joseph Pickering’s Thesis 2012). 
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Thus, it appears that despite the great extent of sequence divergence between mammalian and 
teleost genomes, the enhancer(s) for neural expression of laminin α1 are still present in intron 
1 of the locus in both clades, albeit in a shuffled configuration (Sanges et al. 2006). 
Moreover, the observations from zebrafish suggest that some of the other regulatory 
sequences of the mouse Lama1 gene may also be located in intron 1. This requires further 
studies using bacterial artificial chromosome-based approaches coupled with serial deletions 
in intron 1 of Lama1. 
Taken together, the case of a1-NSE highlights the evolutionary plasticity of enhancer 
sequences and demonstrates that methods alternative to sequence comparisons are 
instrumental in identifying the full complement of transcription-regulatory regions of a gene.  
9.3. A potential for interaction between a1-NSE and some CNEs 
An attractive possibility is that the neural-specific activity of a1-NSE in its native context in 
the mouse genome might be modulated through interactions with other Lama1 regulatory 
elements, including some CNEs. Such relationships between transcription regulatory 
elements are well established in the literature and a prominent example include several 
enhancer elements located within the 600 kb “gene desert” on one side of the mammalian 
HoxD cluster which interact between each other and with the HoxD loci by chromatin 
looping to ensure proper patterning of the autopod (Montavon et al. 2011). Similarly, the 
MAF- and BACH1-bound MARE elements in the locus control region of the human β-globin 
genes physically interact and this appears to be crucial for β-globin gene expression (Yoshida 
et al. 1999). Such physical interactions between regulatory elements can boost or attenuate 
the expression of target genes, or alter their spatial and temporal pattern of expression 
(Frankel 2012).  
In this regard, I would like to consider the possibility of a putative communication 
between a1-NSE and CNE7. As described and discussed in Chapter 5, CNE7 exhibits weak 
but statistically significant transcriptional-silencer activity and contains a conserved CTCF 
motif. As discussed, there is evidence for the involvement of CTCF in developmental gene 
repression, among other transcription-related processes (Gao et al. 2011). Thus, it is possible 
that CTCF-bound CNE7 interacts with a1-NSE to shut down its enhancer activity in cells 
undergoing neural differentiation, but not in neural stem cells in the ventricular zone and 
neural progenitors in the sub-ventricular zone, where some inhibitory mechanisms (perhaps 
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DNA methylation of the CTCF site) would prevent CNE7 from communicating with a1-
NSE. This could explain the lack of Lama1 mRNA expression in the mantle layers of the 
central nervous system, which contains differentiated neurons and glia, and the wide-spread 
β-Gal staining in the spinal cord of the two E13.5 a1-NSE::lacZ  transgenic mouse embryos. 
In the latter case, the absence of CNE7 from the a1-NSE::lacZ construct might have allowed 
persistent activity of a1-NSE in differentiated neural cells. 
9.4. SHH might directly regulate the expression of an ECM gene 
To my knowledge, this study is the first to suggest a direct GLI-mediated role of SHH 
signalling in the transcriptional regulation of an extracellular matrix component during 
mouse embryogenesis. However, Dr. Xin Gang Wang from Prof. Philip Ingham’s laboratory 
(IMCB, Singapore) showed that Gli2a binds to regions close to the lamc1 gene promoter in 
zebrafish, and that abrogation of Hh signalling results in down-regulation of lamc1 mRNA 
expression in both the neural tube and somites (Wang et al. 2013). This is in contrast to the 
mouse, where Lamc1 expression does not require SHH activity (see Chapter 3 of this study), 
suggesting differences in the mechanisms regulating laminin expression in mammals and 
teleosts. 
There are studies, although not in neural cells, showing direct activation of Lamc1 
transcription by interleukin-1-beta via NF-kappaB (O’Neill et al. 1997), or by TGF-β signals 
mediated by cooperative interaction between TEF3 and SMAD transcription factors (Kawata 
et al. 2002), whereas Lamb1 transcription in F9 teratocarcinoma cells depends on retinoic 
acid-induced binding of RAR-alpha/beta receptors to the promoter of Lamb1 (Vasios et al. 
1991). Perhaps, the activation of different laminin genes by distinct signalling pathways 
ensures that a particular laminin trimer is synthesised only when the producing cells have 
received several combinatorial inputs, thus decreasing the chance of stochastic/aberrant 
energy-demanding synthesis of these crucial ECM components, caused by noise in the 
developmental system. 
Through its induction of Lama1expression in the neural tube via a1-NSE, SHH may 
execute two tasks. First, it enables the synthesis of an important adhesive and signalling 
component of the pial basement membrane, as described in Chapter 1, and second, Shh may 
indirectly enhance/inhibit the availability of diffusible signalling molecules, including its 
own, to neuroepithelial cells (Borycki 2013). The latter phenomenon could operate through 
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the association of laminins with heparan sulphate proteoglycans (Hantaz-Ambroise et al. 
1987), which are known to modulate the diffusion and morphogen gradient properties of 
SHH, WNT and BMP ligands (Belenkaya et al. 2004; Bornemann et al. 2004; Han et al. 
2004), and such indirect role of laminin γ1-mediated restriction of BMP signalling has 
already been demonstrated in the zebrafish somites (Dolez et al. 2011), as described in 
Chapter 1. 
9.5. Is a1-NSE essential for expression of Lama1 in the murine central nervous system? 
My analyses of a1-NSE activity in both mouse and zebrafish embryos indicate that this 
enhancer is active in the whole neuraxis – from the rostral-most part of the diencephalon to 
the caudal most regions of the spinal cord, whereas data argue against activity in the 
telencephalon. The latter finding suggests the existence of another, distinct enhancer 
directing Lama1 expression in the telencephalon, as endogenous Lama1 mRNA is detected in 
this domain (Chapter 3 of this study; Miner et al. 2004). The genomic location of this 
enhancer is currently unknown but as discussed above, extrapolating from studies in 
zebrafish (Section 9.2), it could be located in intron 1 of the murine Lama1 locus, and BAC-
reporter deletion studies might help to uncover it. Thus, when summed together a1-NSE, the 
putative telencephalic enhancer and also the hypothetical SHH-independent enhancer for 
initiation of Lama1 transcription in the neural tube, should be able to recapitulate the full 
pattern of endogenous Lama1 expression in the murine CNS. 
However, a critical question remains unanswered – is a1-NSE required for Lama1 
expression in its native genomic context in vivo? Most enhancer elements are absolutely 
required for tissue-specific activation of their target genes, as clearly evidenced by 
pathological conditions in human patients carrying inactivating mutations in critical 
enhancers of genes like ATOH7 (Ghiasvand et al. 2011), EGR2 (Funalot et al. 2012), SHH 
(Lettice et al. 2003), SOX9 (Benko et al. 2009), and IRF6 (Rahimov et al. 2008,) to name a 
few. Thus, would deletion of a1-NSE (and its human counterpart) result in developmental 
abnormalities of the central nervous system as those described by Heng et al. (2011) and  
Ichikawa-Tomikawa et al. (2012) in Lama1
-/-
 mutant mice (see Chapter 1)? I hypothesise that 
a1-NSE is essential for normal neural development, as explained below. 
Many genes are regulated by seemingly redundant elements termed “shadow 
enhancers” which when tested individually in transgenic animals generate highly similar or 
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identical patterns of reporter expression (Hong et al. 2008; Jeong et al. 2006; Frankel et al. 
2010). A revealing example comes from a study in Drosophila by Frankel et al. (2010), 
where expression of the cuticle patterning gene shavenbaby (svb) is regulated by multiple 
enhancers. The combined pattern of the distant enhancers D2 and Z overlaps with the pattern 
driven by the proximal enhancers A and E, and all are synchronously active in the cuticle, 
suggesting that they may be redundant (Frankel et al. 2010). Interestingly, mutant flies with 
deletion of D2 and Z have wild type phenotype under normal temperature, which strikingly 
contrasts with the severe reduction of trichome formation when the same mutants are grown 
at extreme temperatures. Analogous perturbations of cuticle morphogenesis in D2-Z deletion 
mutant flies was observed on a wg/+ genetic background but not on a +/+ background 
(Frankel et al. 2010) and similar dependencies were documented in the regulation of the snail 
gene in Drosophila (Perry et al. 2010). What has emerged from these studies is that “shadow 
enhancers” are essential for ensuring robust expression of their target genes when the 
developmental system is faced with extreme environmental conditions (like high 
temperature) or is under genetic background stress due to the presence of suboptimal 
variation elsewhere in the genome (Hong et al. 2008; Frankel 2012). 
This is important for interpreting future experiments on a1-NSE function, where one 
might delete the element from its genomic context to study its requirement for development. 
Two outcomes are possible: 1) the knockout animal displays abnormalities of CNS 
development associated with lack of Lama1 mRNA in neural tissues, or 2) there are no 
discernible effects on CNS development and Lama1 expression. The first scenario would 
directly demonstrate the importance of a1-NSE for Lama1 expression in the neural tube, 
while the second scenario could be accounted for by the presence of a “shadow enhancer” 
somewhere else in the Lama1 locus, which is functionally equivalent to a1-NSE. However, 
as discussed above, in such case a1-NSE and its “shadow” counterpart would seem 
dispensable in laboratory and normal conditions, but would be indispensable to buffer, or 
canalise, development in case of external or internal perturbations, which is frequently the 
case in the wild. 
9.6. Concluding remarks 
This study provides interesting novel insights regarding the transcriptional regulation of a 
laminin gene – Lama1, which is essential for embryonic and postnatal development in the 
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vertebrate embryo. My data suggest that some of the conserved non-coding elements around 
the murine Lama1 locus are probably mammal-specific, that they may represent potential cis-
regulatory elements devoted to the control of Lama1 expression and/or to the regulation of 
other genome processes that are unrelated to transcription. Among these could be the 
enhancer mediating the SHH-dependent control on Lama1 expression in the somites. 
Therefore, further understanding of the putative in vivo functions of the CNEs could be 
gained by reporter assays in transgenic mouse embryos.  
Importantly, the existence of a GLI-occupied neural-specific SHH-responsive 
enhancer, a1-NSE, in the first intron of the murine Lama1 gene suggests, but does not 
unequivocally proves, for a direct role of SHH in the expression of Lama1 in the developing 
central nervous system, and thus provides some insight in the molecular mechanism behind 
the lack of Lama1 mRNA expression in the neural tube of Shh-deficient mouse embryos 
(Anderson et al. 2009). However, my investigation hints for additional complexity in the 
control of Lama1 expression in the CNS, manifested in the hypothetical existence of 
“initiator” and “telencephalic” enhancers. Future BAC-reporter analyses and genome-wide 
assays of transcription factor occupancy will help to uncover these elements. Additionally, 
the regulatory elements identified in this study could find potential applications in the 
exploration of developmental processes in normal and pathological conditions including cell 
lineage tracing, design of conditionally expressed transgenes and knockout animals, and even 
for therapeutic purposes to target diseased tissues in the future. 
 Finally, the weakly conserved a1-NSE element could be used as a model enhancer to 
gain further insight into the complex relationship between sequence and function, and into 
the constraints, as well as opportunities, such relationship imposes on organismal evolution. 
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